<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus - Salpeter, SR - 2010 | Cochrane Library</title> <meta property="og:title" content="Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus - Salpeter, SR - 2010 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002967.pub4/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD002967.pub4" /> <meta name="citation_title" content="Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus" /> <meta name="citation_author" content="Shelley R Salpeter" /> <meta name="citation_author_institution" content="Stanford University, and Santa Clara Valley Medical Center" /> <meta name="citation_author_email" content="salpeter@stanford.edu" /> <meta name="citation_author" content="Elizabeth Greyber" /> <meta name="citation_author_institution" content="Santa Clara Valley Medical Center" /> <meta name="citation_author" content="Gary A Pasternak" /> <meta name="citation_author_institution" content="Santa Clara Valley Medical Center" /> <meta name="citation_author" content="Edwin E Salpeter" /> <meta name="citation_author_institution" content="Cornell University" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="4" /> <meta name="citation_doi" content="10.1002/14651858.CD002967.pub4" /> <meta name="citation_date" content="2010" /> <meta name="citation_online_date" content="2010/04/14" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002967.pub4/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002967.pub4/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002967.pub4/pdf/CDSR/CD002967/CD002967.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Acidosis, Lactic [*chemically induced, mortality]; Cohort Studies; Contraindications; Diabetes Mellitus, Type 2 [*drug therapy]; Hypoglycemic Agents [*adverse effects]; Incidence; Lactic Acid [blood]; Metformin [*adverse effects]; Prospective Studies; Risk" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1513680834000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718256000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EfT7x5RD";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002967\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002967\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","hr","fr","ta"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD002967.pub4",title:"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus",firstPublishedDate:"Apr 14, 2010 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581422282000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002967.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002967.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD002967.pub4/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD002967.pub4/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002967.pub4%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD002967.PUB4" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#" data-copyright="Copyright © 2010 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002967.pub4/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002967.pub4/full"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/full#CD002967-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/appendices#CD002967-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/table_n/CD002967StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/table_n/CD002967StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD002967.PUB4"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD002967-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD002967-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD002967-bbs1-0003">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Aarsand 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0001"> <div class="citation-journal">Aarsand AK, Carlsen SM. <span class="citation-title">Folate administration reduces circulating homocysteine levels in NIDDM patients on long‐term metformin treatment</span>. <span class="citation"> Journal of Internal Medicine </span><span class="pubYear">1998</span>;<span class="volume">244</span>:169‐74. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10095804" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Folate+administration+reduces+circulating+homocysteine+levels+in+NIDDM+patients+on+long%E2%80%90term+metformin+treatment+&author=AK+Aarsand&author=SM+Carlsen&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Abbasi 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0002"> <div class="citation-journal">Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM. <span class="citation-title">Results of a placebo‐controlled study of the metabolic effects of the addition of metformin to sulfonylurea‐treated patients. Evidence for a central role of adipose tissue</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(12):1863‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9405908" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Results+of+a+placebo%E2%80%90controlled+study+of+the+metabolic+effects+of+the+addition+of+metformin+to+sulfonylurea%E2%80%90treated+patients.+Evidence+for+a+central+role+of+adipose+tissue+&author=F+Abbasi&author=V+Kamath&author=AA+Rizvi&author=M+Carantoni&author=YD+Chen&author=GM+Reaven&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">Abbasi 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0003"> <div class="citation-journal">Abbasi F, Carantoni M, Chen YD, Reaven GM. <span class="citation-title">Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin [see comments]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(8):1301‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9702437" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Further+evidence+for+a+central+role+of+adipose+tissue+in+the+antihyperglycemic+effect+of+metformin+[see+comments]+&author=F+Abbasi&author=M+Carantoni&author=YD+Chen&author=GM+Reaven&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Abbasi 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0004"> <div class="citation-journal">Abbasi AA, Kasmikha R, Stoingeanu DG. <span class="citation-title">Metformin‐induced lacicadidemia in patients with type 2 diabetes mellitus</span>. <span class="citation"> Endocrine Practice </span><span class="pubYear">2000</span>;<span class="volume">6</span>:442‐446. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11155215" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90induced+lacicadidemia+in+patients+with+type+2+diabetes+mellitus&author=AA+Abbasi&author=R+Kasmikha&author=DG+Stoingeanu&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Abbink 2001 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0005"> <div class="citation-other">Abbink A. unpublished data. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Abbink 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0006"> <div class="citation-journal">Abbink EJ, Tack CJ, Pickkers P Jansen van Rosendaal A, Smits P. <span class="citation-title">Vascular effects of glibenclamide, glimepiride, metformin and acarbose in Type 2 DM patients</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A39. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vascular+effects+of+glibenclamide,+glimepiride,+metformin+and+acarbose+in+Type+2+DM+patients+&author=EJ+Abbink&author=CJ+Tack&author=A+PickkersPJansenvanRosendaal&author=P+Smits&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Adamia 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0007"> <div class="citation-journal">Adamia N, Virsaladze D, Charkviani N, Skhirtladze M, Khutsishvili M. <span class="citation-title">Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes</span>. <span class="citation"> Georgian Medical News </span><span class="pubYear">2007</span>;<span class="volume">News.</span>(145):52‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+therapy+on+plasma+adiponectin+and+leptin+levels+in+obese+and+insulin+resistant+postmenopausal+females+with+type+2+diabetes+&author=N+Adamia&author=D+Virsaladze&author=N+Charkviani&author=M+Skhirtladze&author=M+Khutsishvili&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Aguilar 1992a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0008"> <div class="citation-journal">Aguilar CA, Wong B, Gomez‐Perez FJ, Rull JA. <span class="citation-title">Combination daytime chlorpropamide‐metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes</span>. <span class="citation"> Revista de Investigacion Clinica </span><span class="pubYear">1992</span>;<span class="volume">44</span>(1):71‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1523352" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+daytime+chlorpropamide%E2%80%90metformin/bedtime+insulin+in+the+treatment+of+secondary+failures+in+non+insulin+dependent+diabetes+&author=CA+Aguilar&author=B+Wong&author=FJ+Gomez%E2%80%90Perez&author=JA+Rull&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Ahren 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0009"> <div class="citation-journal">Ahren B, Pacini G, Floey JE, Schweizer A. <span class="citation-title">Improved meal‐related beta‐cell function and insulin sensitivity by the dipeptidyl peptidase‐IV inhibitor Vildagliptin in metformin‐treated patients with type 2 diabetes over 1 year</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:1936‐1940. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16043735" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+meal%E2%80%90related+beta%E2%80%90cell+function+and+insulin+sensitivity+by+the+dipeptidyl+peptidase%E2%80%90IV+inhibitor+Vildagliptin+in+metformin%E2%80%90treated+patients+with+type+2+diabetes+over+1+year+&author=B+Ahren&author=G+Pacini&author=JE+Floey&author=A+Schweizer&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Allen 1961 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0010"> <div class="citation-journal">Allen GE, Montgomery DAD, Weaver JA. <span class="citation-title">[Dimethylbiguanide in the treatment of diabetes mellitus]</span>. <span class="citation"> La Revue Francaise d'Endocrinologie Clinique </span><span class="pubYear">1961</span>;<span class="volume">2</span>:347‐52. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Dimethylbiguanide+in+the+treatment+of+diabetes+mellitus]&author=GE+Allen&author=DAD+Montgomery&author=JA+Weaver&publication_year=1961&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Amador‐Licona 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0011"> <div class="citation-journal">Amador‐Licona N, Guizar‐Mendoza J, Vargas E, Sanchez‐Camargo G, Zamora‐Mata L. <span class="citation-title">The short‐term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus</span>. <span class="citation"> Archives of Medical Research </span><span class="pubYear">2000</span>;<span class="volume">31</span>:571‐575. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11257323" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+short%E2%80%90term+effect+of+a+switch+from+glibenclamide+to+metformin+on+blood+pressure+and+microalbuminuria+in+patients+with+type+2+diabetes+mellitus+&author=N+Amador%E2%80%90Licona&author=J+Guizar%E2%80%90Mendoza&author=E+Vargas&author=G+Sanchez%E2%80%90Camargo&author=L+Zamora%E2%80%90Mata&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Andras 1962 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0012"> <div class="citation-journal">Andras K, Tamas H, Gyorgy K. <span class="citation-title">[Experience with biguanide treatment for diabetes mellitus]</span>. <span class="citation"> Orvosi hetilap </span><span class="pubYear">1962</span>;<span class="volume">103</span>:1029‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14458361" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Experience+with+biguanide+treatment+for+diabetes+mellitus]&author=K+Andras&author=H+Tamas&author=K+Gyorgy&publication_year=1962&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Ascic‐Buturovic 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0013"> <div class="citation-journal">Ascic‐Buturovic BKacila M. <span class="citation-title">Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction</span>. <span class="citation"> Bosnian Journal of Basic Medical Sciences </span><span class="pubYear">2008</span>;<span class="volume">8</span>(4):309‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19125700" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+basal+insulin+analog+and+metformin+on+glycaemia+control+and+weight+as+risk+factors+for+endothelial+dysfunction+&author=M+Ascic%E2%80%90ButurovicBKacila&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Aviles‐Santa 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0014"> <div class="citation-journal">Aviles‐Santa L, Sinding J, Raskin P. <span class="citation-title">Effects of metformin in patients with poorly controlled, insulin‐treated type 2 diabetes mellitus. A randomized, double‐blind, placebo‐controlled trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1999</span>;<span class="volume">131</span>(3):182‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10428734" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+in+patients+with+poorly+controlled,+insulin%E2%80%90treated+type+2+diabetes+mellitus.+A+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=L+Aviles%E2%80%90Santa&author=J+Sinding&author=P+Raskin&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Azerad 1960 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0015"> <div class="citation-journal">Azerad E, Lasry M. <span class="citation-title">[Treatment of diabetes with NN‐Dimethyl Biguanide]</span>. <span class="citation"> Gazette Medicale de France </span><span class="pubYear">1960</span>;<span class="volume">1</span>(7):1555‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+diabetes+with+NN%E2%80%90Dimethyl+Biguanide]&author=E+Azerad&author=M+Lasry&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Bacci 1961 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0016"> <div class="citation-journal">Bacci L, Cassarini F. <span class="citation-title">[N.N. dimethyl‐biguanide (DMGG) in the treatment of Diabetes meliitus]</span>. <span class="citation"> Minerva Medica </span><span class="pubYear">1961</span>;<span class="volume">52</span>:2770‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13685617" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[N.N.+dimethyl%E2%80%90biguanide+(DMGG)+in+the+treatment+of+Diabetes+meliitus]&author=L+Bacci&author=F+Cassarini&publication_year=1961&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Bailey 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0017"> <div class="citation-journal">Bailey CJ, Bagdonas A, Rubes J, McMorn SO, Donaldson J, Biswas N, Stewart MW. <span class="citation-title">Rosiglitazone/Metformin fixed‐dose combination compared iwth uptitrated metformin alone in type 2 diabetes mellitus: a 24‐week multicenter randomized double‐blind parallel‐group study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>:1545‐1561. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone/Metformin+fixed%E2%80%90dose+combination+compared+iwth+uptitrated+metformin+alone+in+type+2+diabetes+mellitus:+a+24%E2%80%90week+multicenter+randomized+double%E2%80%90blind+parallel%E2%80%90group+study+&author=CJ+Bailey&author=A+Bagdonas&author=J+Rubes&author=SO+McMorn&author=J+Donaldson&author=N+Biswas&author=MW+Stewart&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Balasubramanian 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0018"> <div class="citation-journal">Balasubramanian R, Varadharajan S, Kathale A, Nagraj LM, Periyandavar I, Nayak UP, et al. <span class="citation-title">Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10mg+ metformin SR 500mg in diabetic dyslipidaemia in adult Indian patients</span>. <span class="citation"> Journal of the Indian Medical Association </span><span class="pubYear">2008</span>;<span class="volume">106</span>(7):464‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18975505" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessment+of+the+efficacy+and+tolerability+of+a+fixed+dose+combination+of+atorvastatin+10mg++metformin+SR+500mg+in+diabetic+dyslipidaemia+in+adult+Indian+patients+&author=R+Balasubramanian&author=S+Varadharajan&author=A+Kathale&author=LM+Nagraj&author=I+Periyandavar&author=UP+Nayak&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Bao 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0019"> <div class="citation-journal">Bao Y, Zhao T, Wang X, Qiu Y, Su M, Jia W, et al. <span class="citation-title">Metabonomic variations in the drug‐treated type 2 diabetes mellitus patients and healthy volunteers</span>. <span class="citation"> Journal of Proteome Research </span><span class="pubYear">2009</span>;<span class="volume">8</span>(4):1623‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19714868" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabonomic+variations+in+the+drug%E2%80%90treated+type+2+diabetes+mellitus+patients+and+healthy+volunteers+&author=Y+Bao&author=T+Zhao&author=X+Wang&author=Y+Qiu&author=M+Su&author=W+Jia&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Bastyr 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0020"> <div class="citation-journal">Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE. <span class="citation-title">Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>:1236‐1241. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10977012" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapy+focused+on+lowering+postprandial+glucose,+not+fasting+glucose,+may+be+superior+for+lowering+HbA1c+&author=EJ+Bastyr&author=CA+Stuart&author=RG+Brodows&author=S+Schwartz&author=CJ+Graf&author=A+Zagar&author=KE+Robertson&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Basu 2008a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0021"> <div class="citation-journal">Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, et al. <span class="citation-title">Effects of pioglitazone and metformin on NEFA‐induced insulin resistance in type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2008</span>;<span class="volume">51</span>(11):2031‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18769904" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+pioglitazone+and+metformin+on+NEFA%E2%80%90induced+insulin+resistance+in+type+2+diabetes+&author=R+Basu&author=A+Basu&author=V+Chandramouli&author=B+Norby&author=B+Dicke&author=P+Shah&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0022"> <div class="citation-journal">Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, et al. <span class="citation-title">Comparison of the effects of pioglitazone and metformin on hepatic and extra‐hepatic insulin action in people with type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2008</span>;<span class="volume">57</span>(1):24‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17914032" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+the+effects+of+pioglitazone+and+metformin+on+hepatic+and+extra%E2%80%90hepatic+insulin+action+in+people+with+type+2+diabetes+&author=R+Basu&author=P+Shah&author=A+Basu&author=B+Norby&author=B+Dicke&author=V+Chandramouli&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Bauman 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0023"> <div class="citation-journal">Bauman WA, Shaw S, Jaytilleke E, Spungen AM, Herbert V. <span class="citation-title">Increaesed intake of calcium reverses vitamin B12 malabsroption induced by metformin</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>:1227‐1231. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10977010" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Increaesed+intake+of+calcium+reverses+vitamin+B12+malabsroption+induced+by+metformin&author=WA+Bauman&author=S+Shaw&author=E+Jaytilleke&author=AM+Spungen&author=V+Herbert&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Bayraktar 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0024"> <div class="citation-journal">Bayraktar M, Thiel DH, Adalar N. <span class="citation-title">A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea‐treated NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(3):252‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8742572" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+acarbose+versus+metformin+as+an+adjuvant+therapy+in+sulfonylurea%E2%80%90treated+NIDDM+patients+&author=M+Bayraktar&author=DH+Thiel&author=N+Adalar&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Beisswenger 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0025"> <div class="citation-journal">Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS. <span class="citation-title">Metformin reduces systemic methylglyoxal levels in type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">1999</span>;<span class="volume">48</span>(1):198‐202. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9892243" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+reduces+systemic+methylglyoxal+levels+in+type+2+diabetes&author=PJ+Beisswenger&author=SK+Howell&author=AD+Touchette&author=S+Lal&author=BS+Szwergold&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Belcher 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0026"> <div class="citation-journal">Blecher G, Schernthaner G. <span class="citation-title">Changes in liver tests during 1‐year treatment of patients with type 2 diabetes with pioglitazone, metformin or glicazinde</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:973‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16026360" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Changes+in+liver+tests+during+1%E2%80%90year+treatment+of+patients+with+type+2+diabetes+with+pioglitazone,+metformin+or+glicazinde+&author=G+Blecher&author=G+Schernthaner&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Bell 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0027"> <div class="citation-journal">Bell DSH, Mayo MS. <span class="citation-title">Outcome of metformin‐facilitated reinitiation of oral diabetic therapy in insulin‐treated patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Endocrinology Practice </span><span class="pubYear">1997</span>;<span class="volume">3</span>:73‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Outcome+of+metformin%E2%80%90facilitated+reinitiation+of+oral+diabetic+therapy+in+insulin%E2%80%90treated+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=DSH+Bell&author=MS+Mayo&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Bermudez 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0028"> <div class="citation-journal">Bermudez V, Cano R, Cano C, Bermudez F, Leal E, Acosta K, et al. <span class="citation-title">Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes</span>. <span class="citation"> American Journal of Therapeutics </span><span class="pubYear">2008</span>;<span class="volume">15</span>(4):409‐16. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18645347" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Homeostasis+model+assessment+(HOMA)+as+surrogate+insulinization+criteria+in+patients+with+type+2+diabetes+&author=V+Bermudez&author=R+Cano&author=C+Cano&author=F+Bermudez&author=E+Leal&author=K+Acosta&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Bermudez‐Pirela 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0029"> <div class="citation-journal">Bermudez‐Pieral VJ, Cano C, Medina MT, Souki A, Lemus MA, Leal EM, Seyfi HA, Cano R, Ciscek A, Bermudez‐Arias F, Contreras F, Israili ZH, Hernadez‐Hernandez R, Valasco M. <span class="citation-title">Metformin plus low‐dose glimerperide significantly improves homeostasis model assessment for insulin resistance (HOMA‐IR) and beta‐cell function (HOMA‐beta‐cell) without hyperinsulinemia in patients with type 2 diabetes mellitus</span>. <span class="citation"> American Journal of Therapeutics </span><span class="pubYear">2007</span>;<span class="volume">14</span>:194‐202. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17414590" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+plus+low%E2%80%90dose+glimerperide+significantly+improves+homeostasis+model+assessment+for+insulin+resistance+(HOMA%E2%80%90IR)+and+beta%E2%80%90cell+function+(HOMA%E2%80%90beta%E2%80%90cell)+without+hyperinsulinemia+in+patients+with+type+2+diabetes+mellitus+&author=VJ+Bermudez%E2%80%90Pieral&author=C+Cano&author=MT+Medina&author=A+Souki&author=MA+Lemus&author=EM+Leal&author=HA+Seyfi&author=R+Cano&author=A+Ciscek&author=F+Bermudez%E2%80%90Arias&author=F+Contreras&author=ZH+Israili&author=R+Hernadez%E2%80%90Hernandez&author=M+Valasco&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Berne 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0030"> <div class="citation-journal">Berne C, on behalf of the Orlistat Swedish Type 2 Diabetes Study Group. <span class="citation-title">A randomized study of orlistat in combination with a weight management programme in obese patients with type 2 diabetes treated with metformin</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2004</span>;<span class="volume">22</span>:612‐618. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+study+of+orlistat+in+combination+with+a+weight+management+programme+in+obese+patients+with+type+2+diabetes+treated+with+metformin+&author=C+Berne&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Betteridge 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0031"> <div class="citation-journal">Betteridge DJ, Verges B. <span class="citation-title">Long‐term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>:2477‐2481. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16283239" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+on+lipids+and+lipoproteins+of+pioglitazone+versus+gliclazide+addition+to+metformin+and+pioglitazone+versus+metformin+addition+to+sulphonylurea+in+the+treatment+of+type+2+diabetes+&author=DJ+Betteridge&author=B+Verges&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Beyer 1975 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0032"> <div class="citation-journal">Beyer G. <span class="citation-title">[Results in the treatment of diabetes with glucophage retard]</span>. <span class="citation"> Therapie der Gegenwert </span><span class="pubYear">1975</span>;<span class="volume">114</span>(9):1426‐37. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Results+in+the+treatment+of+diabetes+with+glucophage+retard]&author=G+Beyer&publication_year=1975&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Bhansali 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0033"> <div class="citation-journal">Bhansali A, Masoodi SR. <span class="citation-title">Efficacy of once‐ or twice‐daily extended release metformin compared with thrice‐daily immediate release metformin in type 2 diabetes mellitus</span>. <span class="citation"> Journal of the Association of Physicians of India </span><span class="pubYear">2005</span>;<span class="volume">53</span>:441‐445. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16124352" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+once%E2%80%90+or+twice%E2%80%90daily+extended+release+metformin+compared+with+thrice%E2%80%90daily+immediate+release+metformin+in+type+2+diabetes+mellitus+&author=A+Bhansali&author=SR+Masoodi&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Bingle 1964 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0034"> <div class="citation-journal">Bingle JP, James JI. <span class="citation-title">Metformin combined with chlorpropamide in the treatment of Diabetes mellitus</span>. <span class="citation"> Practitioner </span><span class="pubYear">1964</span>;<span class="volume">192</span>:567‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14143336" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+combined+with+chlorpropamide+in+the+treatment+of+Diabetes+mellitus&author=JP+Bingle&author=JI+James&publication_year=1964&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Bjorntorp 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0035"> <div class="citation-journal">Bjorntorp P, Carlstrom S, Fagerberg SE, Hermann LS, Holm AG, Schersten B, et al. <span class="citation-title">Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1978</span>;<span class="volume">15</span>(2):95‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/700278" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Influence+of+phenformin+and+metformin+on+exercise+induced+lactataemia+in+patients+with+diabetes+mellitus+&author=P+Bjorntorp&author=S+Carlstrom&author=SE+Fagerberg&author=LS+Hermann&author=AG+Holm&author=B+Schersten&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Blonde 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0036"> <div class="citation-journal">Blonde L, Rosenstock J, Mooradian AD, Piper B‐A, Henry D. <span class="citation-title">Glyburide/Metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy</span>. <span class="citation"> Diabetes Obesity &amp; Metabolism </span><span class="pubYear">2002</span>;<span class="volume">4</span>:368‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glyburide/Metformin+combination+product+is+safe+and+efficacious+in+patients+with+type+2+diabetes+failing+sulphonylurea+therapy+&author=L+Blonde&author=J+Rosenstock&author=AD+Mooradian&author=B%E2%80%90A+Piper&author=D+Henry&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Boronat 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0037"> <div class="citation-journal">Boronat CM, Marrero AD, Roche BF, Ojeda PA, Carillo DA, Novoa MFJ. <span class="citation-title">[Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment]</span>. <span class="citation"> Revista Clinica Espanola </span><span class="pubYear">2000</span>;<span class="volume">200</span>(2):74‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10776038" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Effectiveness+of+treatment+with+metformin+in+patients+with+type+2+diabetes+mellitus+poorly+controlled+with+insulin+treatment]+&author=CM+Boronat&author=AD+Marrero&author=BF+Roche&author=PA+Ojeda&author=DA+Carillo&author=MFJ+Novoa&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Bosi 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0038"> <div class="citation-journal">Bosi E, Dotta F, Jia Y, Goodman M. <span class="citation-title">Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(5):506‐15. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vildagliptin+plus+metformin+combination+therapy+provides+superior+glycaemic+control+to+individual+monotherapy+in+treatment%E2%80%90naive+patients+with+type+2+diabetes+mellitus+&author=E+Bosi&author=F+Dotta&author=Y+Jia&author=M+Goodman&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Botha 1977 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0039"> <div class="citation-journal">Botha JL, Vinik AI, Jackson WP. <span class="citation-title">Association of lactic acidosis with biguanide therapy [letter]</span>. <span class="citation"> South African Medical Journal </span><span class="pubYear">1977</span>;<span class="volume">52</span>(8):301‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/897932" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Association+of+lactic+acidosis+with+biguanide+therapy+[letter]&author=JL+Botha&author=AI+Vinik&author=WP+Jackson&publication_year=1977&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Boyd 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0040"> <div class="citation-journal">Boyd K, Rogers C, Boreham C, Andrews WJ, Hadden DR. <span class="citation-title">Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy</span>. <span class="citation"> Diabetes Research </span><span class="pubYear">1992</span>;<span class="volume">19</span>(2):69‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1286541" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin,+glibenclamide+or+metformin+treatment+for+non+insulin+dependent+diabetes:+heterogenous+responses+of+standard+measures+of+insulin+action+and+insulin+secretion+before+and+after+differing+hypoglycaemic+therapy+&author=K+Boyd&author=C+Rogers&author=C+Boreham&author=WJ+Andrews&author=DR+Hadden&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Brazg 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0041"> <div class="citation-journal">Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP. <span class="citation-title">Effect of adding sitagliptin, a dipeptidyl peptidase‐4 inhibitor, to metformin on 24‐h glycaemic control and beta‐cell function in patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(2):186‐93. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17300594" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+adding+sitagliptin,+a+dipeptidyl+peptidase%E2%80%904+inhibitor,+to+metformin+on+24%E2%80%90h+glycaemic+control+and+beta%E2%80%90cell+function+in+patients+with+type+2+diabetes+&author=R+Brazg&author=L+Xu&author=C+DallaMan&author=C+Cobelli&author=K+Thomas&author=PP+Stein&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Brown 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0042"> <div class="citation-journal">Brown JB, Pedula KL. <span class="citation-title">Metformin as secondary therapy in a defined population with Type 2 Diabetes</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1999</span>;<span class="volume">21</span>(10):1678‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10566564" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+as+secondary+therapy+in+a+defined+population+with+Type+2+Diabetes&author=JB+Brown&author=KL+Pedula&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Bruce 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0043"> <div class="citation-journal">Bruce S, Park JS, Fiedorek FT, Howlett HCS. <span class="citation-title">Beta‐cell response to metformin‐gli benclamide combination tablets (Glucovance) in patients with type 2 diabetes</span>. <span class="citation"> Internation Journal of Clinical Practice </span><span class="pubYear">2006</span>;<span class="volume">60</span>:783‐790. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beta%E2%80%90cell+response+to+metformin%E2%80%90gli+benclamide+combination+tablets+(Glucovance)+in+patients+with+type+2+diabetes+&author=S+Bruce&author=JS+Park&author=FT+Fiedorek&author=HCS+Howlett&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Cairns 1977 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0044"> <div class="citation-journal">Cairns SA, Shalet S, Marshall AJ, Hartog M. <span class="citation-title">A comparison of phenformin and metformin in the treatment of maturity onset diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1977</span>;<span class="volume">3</span>(3):183‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/913750" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+phenformin+and+metformin+in+the+treatment+of+maturity+onset+diabetes&author=SA+Cairns&author=S+Shalet&author=AJ+Marshall&author=M+Hartog&publication_year=1977&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Calle‐Pascual 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0045"> <div class="citation-journal">Calle‐Pascual AL, Garcia‐Honduvilla J, Martin‐Alvarez PJ, Vara E, Calle JR, Munguira ME, et al. <span class="citation-title">Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1995</span>;<span class="volume">21</span>(4):256‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8529760" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+between+acarbose,+metformin,+and+insulin+treatment+in+type+2+diabetic+patients+with+secondary+failure+to+sulfonylurea+treatment+&author=AL+Calle%E2%80%90Pascual&author=J+Garcia%E2%80%90Honduvilla&author=PJ+Martin%E2%80%90Alvarez&author=E+Vara&author=JR+Calle&author=ME+Munguira&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Campbell 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0046"> <div class="citation-journal">Campbell IW, Menzies DG, McBain AM, Brown IRF. <span class="citation-title">Effects of metformin on blood pressure and microalbuminuria in diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1988</span>;<span class="volume">14</span>:613‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+blood+pressure+and+microalbuminuria+in+diabetes+mellitus&author=IW+Campbell&author=DG+Menzies&author=AM+McBain&author=IRF+Brown&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Campbell 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0047"> <div class="citation-journal">Campbell IW, Menzies DG, Chalmers J, McBain AM, Brown IR. <span class="citation-title">One year comparative trial of metformin and glipizide in type 2 diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1994</span>;<span class="volume">20</span>(4):394‐400. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7843470" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=One+year+comparative+trial+of+metformin+and+glipizide+in+type+2+diabetes+mellitus&author=IW+Campbell&author=DG+Menzies&author=J+Chalmers&author=AM+McBain&author=IR+Brown&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Canivet 1962 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0048"> <div class="citation-journal">Canivet J, Roux P. <span class="citation-title">[The treatment of Diabetes mellitus: Statistical results after a review of 1190 cases]</span>. <span class="citation"> La Presse Medicale </span><span class="pubYear">1962</span>;<span class="volume">70</span>:2038‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14018300" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[The+treatment+of+Diabetes+mellitus:+Statistical+results+after+a+review+of+1190+cases]&author=J+Canivet&author=P+Roux&publication_year=1962&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Carpentier 1975 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0049"> <div class="citation-journal">Carpentier J, Luyckx AS, Lefebvre PJ. <span class="citation-title">Influence of metformin on arginine‐induced glucagon secretion in human diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1975</span>;<span class="volume">1</span>:23‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1234063" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Influence+of+metformin+on+arginine%E2%80%90induced+glucagon+secretion+in+human+diabetes&author=J+Carpentier&author=AS+Luyckx&author=PJ+Lefebvre&publication_year=1975&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Carter 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0050"> <div class="citation-journal">Carter AM, Bennett CE, Bostock JA, Grant PJ. <span class="citation-title">Metformin reduces C‐reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:1282‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16108864" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+reduces+C%E2%80%90reactive+protein+but+not+complement+factor+C3+in+overweight+patients+with+type+2+diabetes+mellitus+&author=AM+Carter&author=CE+Bennett&author=JA+Bostock&author=PJ+Grant&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Cavallo‐Perin 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0051"> <div class="citation-journal">Cavallo‐Perin P, Aluffi E, Estivi P, Bruno A, Carta Q, Pagano G, et al. <span class="citation-title">The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6‐month treatment</span>. <span class="citation"> European Review for Medical Pharmacological Science </span><span class="pubYear">1989</span>;<span class="volume">11</span>(1):45‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+hyperlactatemic+effect+of+biguanides:+a+comparison+between+phenformin+and+metformin+during+a+6%E2%80%90month+treatment+&author=P+Cavallo%E2%80%90Perin&author=E+Aluffi&author=P+Estivi&author=A+Bruno&author=Q+Carta&author=G+Pagano&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Cefalu 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0052"> <div class="citation-journal">Cefalu WT, Schneider DJ, Carlson HE, Gan Lim L, Izon MP, Kappor A, Bell‐Farrow A, Terry JG, Sobel BE. <span class="citation-title">Effect of combination glipizide GITS/Metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:2123‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12453948" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+combination+glipizide+GITS/Metformin+on+fibrinolytic+and+metabolic+parameters+in+poorly+controlled+type+2+diabetic+subjects+&author=WT+Cefalu&author=DJ+Schneider&author=HE+Carlson&author=L+GanLim&author=MP+Izon&author=A+Kappor&author=A+Bell%E2%80%90Farrow&author=JG+Terry&author=BE+Sobel&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Ceriello 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0053"> <div class="citation-journal">Ceriello A, Johns D, Widel M, Eckland DJ, Gilmore KJ, Tan MH. <span class="citation-title">Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:266‐272. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15677777" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+effect+of+pioglitazone+with+metformin+or+sulfonylurea+(monotherapy+and+combination+therapy)+on+postload+glycemia+and+composite+insulin+sensitivity+index+during+an+oral+glucose+tolerance+test+in+patients+with+type+2+diabetes+&author=A+Ceriello&author=D+Johns&author=M+Widel&author=DJ+Eckland&author=KJ+Gilmore&author=MH+Tan&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Chakrabarti 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0054"> <div class="citation-journal">Chakrabarti R, Hocking ED, Fearnley GR. <span class="citation-title">Fibrinolyitic effect of metformin in coronary‐artety disease</span>. <span class="citation"> Lancet </span><span class="pubYear">1965</span>;<span class="volume">2</span>:256‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14330058" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Fibrinolyitic+effect+of+metformin+in+coronary%E2%80%90artety+disease&author=R+Chakrabarti&author=ED+Hocking&author=GR+Fearnley&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Chalmers 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0055"> <div class="citation-journal">Chalmers J, Hunter JE, Robertson SJ, Baird J, Martin M, Franks CI, et al. <span class="citation-title">Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes</span>. <span class="citation"> Current Medical Research &amp; Opinion </span><span class="pubYear">2007</span>;<span class="volume">23</span>(8):1775‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+early+use+of+pioglitazone+in+combination+with+metformin+in+patients+with+newly+diagnosed+type+2+diabetes+&author=J+Chalmers&author=JE+Hunter&author=SJ+Robertson&author=J+Baird&author=M+Martin&author=CI+Franks&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Chan 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0056"> <div class="citation-journal">Chan JC, Tomlinson B, Critchley JA, Cockram CS, Walden RJ. <span class="citation-title">Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1993</span>;<span class="volume">16</span>(7):1035‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8359098" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+and+hemodynamic+effects+of+metformin+and+glibenclamide+in+normotensive+NIDDM+patients+&author=JC+Chan&author=B+Tomlinson&author=JA+Critchley&author=CS+Cockram&author=RJ+Walden&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Charpentier 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0057"> <div class="citation-journal">Charpentier G, Fleury F, Kabir M, Vaur L, Halim S. <span class="citation-title">Improved glycemic control by addition of glumepiride to metformin monotherapy in type 2 diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2001</span>;<span class="volume">18</span>:828‐834. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11678974" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycemic+control+by+addition+of+glumepiride+to+metformin+monotherapy+in+type+2+diabetic+patients+&author=G+Charpentier&author=F+Fleury&author=M+Kabir&author=L+Vaur&author=S+Halim&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Chiasson 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0058"> <div class="citation-journal">Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, et al. <span class="citation-title">The efficacy of acarbose in the treatment of patients with non‐insulin‐dependent diabetes mellitus. A multicenter controlled clinical trial [see comments]</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1994</span>;<span class="volume">121</span>(12):928‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7734015" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+efficacy+of+acarbose+in+the+treatment+of+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus.+A+multicenter+controlled+clinical+trial+[see+comments]+&author=JL+Chiasson&author=RG+Josse&author=JA+Hunt&author=C+Palmason&author=NW+Rodger&author=SA+Ross&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0059"> <div class="citation-journal">Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, et al. <span class="citation-title">No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30‐60% of energy from carbohydrate [see comments]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:1612‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9773719" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=No+relationship+between+carbohydrate+intake+and+effect+of+acarbose+on+HbA1c+or+gastrointestinal+symptoms+in+type+2+diabetic+subjects+consuming+30%E2%80%9060%+of+energy+from+carbohydrate+[see+comments]+&author=TM+Wolever&author=JL+Chiasson&author=RG+Josse&author=JA+Hunt&author=C+Palmason&author=NW+Rodger&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0060"> <div class="citation-journal">Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, et al. <span class="citation-title">Small weight loss on long‐term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non‐insulin‐dependent diabetes</span>. <span class="citation"> International Journal of Obesity and Related Metabolic Disorders </span><span class="pubYear">1997</span>;<span class="volume">21</span>(9):756‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9376887" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Small+weight+loss+on+long%E2%80%90term+acarbose+therapy+with+no+change+in+dietary+pattern+or+nutrient+intake+of+individuals+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+&author=TM+Wolever&author=JL+Chiasson&author=RG+Josse&author=JA+Hunt&author=C+Palmason&author=NW+Rodger&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Chiasson 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0061"> <div class="citation-journal">Chiasson J‐L, Naditch L. <span class="citation-title">The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(6):989‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11375358" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+synergistic+effect+of+miglitol+plus+metformin+combination+therapy+in+the+treatment+of+type+2+diabetes+&author=J%E2%80%90L+Chiasson&author=L+Naditch&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Cho 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0062"> <div class="citation-journal">Cho YW, Yang DH, Oh DY, Baick SH, Kim SK, Kim SJ, et al. <span class="citation-title">Plasma t‐PA and PAl‐1 antigen concentrations in non‐insulin dependent diabetic patients: effects of treatment modality on fibrinolysis</span>. <span class="citation"> Korean Journal of Internal Medicine </span><span class="pubYear">1992</span>;<span class="volume">7</span>(2):81‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1306076" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Plasma+t%E2%80%90PA+and+PAl%E2%80%901+antigen+concentrations+in+non%E2%80%90insulin+dependent+diabetic+patients:+effects+of+treatment+modality+on+fibrinolysis+&author=YW+Cho&author=DH+Yang&author=DY+Oh&author=SH+Baick&author=SK+Kim&author=SJ+Kim&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Ciraldi 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0063"> <div class="citation-journal">Ciraldi TP, Kong APS, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S, Henry RR. <span class="citation-title">Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabtic subjects</span>. <span class="citation"> Diabetes </span><span class="pubYear">2002</span>;<span class="volume">51</span>:30‐36. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11756319" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Regulation+of+glucose+transport+and+insulin+signaling+by+troglitazone+or+metformin+in+adipose+tissue+of+type+2+diabtic+subjects+&author=TP+Ciraldi&author=APS+Kong&author=NV+Chu&author=DD+Kim&author=S+Baxi&author=M+Loviscach&author=R+Plodkowski&author=R+Reitz&author=M+Caulfield&author=S+Mudaliar&author=RR+Henry&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Civera 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0064"> <div class="citation-journal">Civera M, Merchante A, Salvador M, Sanz J, Martinez I. <span class="citation-title">Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">79</span>(1):42‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17714824" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Safety+and+efficacy+of+repaglinide+in+combination+with+metformin+and+bedtime+NPH+insulin+as+an+insulin+treatment+regimen+in+type+2+diabetes+&author=M+Civera&author=A+Merchante&author=M+Salvador&author=J+Sanz&author=I+Martinez&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Clarke 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0065"> <div class="citation-journal">Clarke BF, Duncan LJP. <span class="citation-title">Combined Metformin‐Chlorpropamide therapy in 108 diabetic sulphonylurea‐failures</span>. <span class="citation"> Lancet </span><span class="pubYear">1965</span>;<span class="volume">1</span>:1248‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+Metformin%E2%80%90Chlorpropamide+therapy+in+108+diabetic+sulphonylurea%E2%80%90failures&author=BF+Clarke&author=LJP+Duncan&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Clarke 1968 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0066"> <div class="citation-journal">Clarke BF, Duncan LJ. <span class="citation-title">Comparison of chlorpropamide and metformin treatment on weight and blood‐glucose response of uncontrolled obese diabetics</span>. <span class="citation"> Lancet </span><span class="pubYear">1968</span>;<span class="volume">1</span>(7534):123‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/4169605" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+chlorpropamide+and+metformin+treatment+on+weight+and+blood%E2%80%90glucose+response+of+uncontrolled+obese+diabetics+&author=BF+Clarke&author=LJ+Duncan&publication_year=1968&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Clarke 1977 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0067"> <div class="citation-journal">Clarke BF, Campbell IW. <span class="citation-title">Comparison of metformin and chlorpropamide in non‐obese, maturity‐onset diabetics uncontrolled by diet</span>. <span class="citation"> British Medical Journal </span><span class="pubYear">1977</span>;<span class="volume">2</span>(6102):1576‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/589351" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+metformin+and+chlorpropamide+in+non%E2%80%90obese,+maturity%E2%80%90onset+diabetics+uncontrolled+by+diet+&author=BF+Clarke&author=IW+Campbell&publication_year=1977&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Collier 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0068"> <div class="citation-journal">Collier A, Watson HH, Patrick AW, Ludlam CA, Clarke BF. <span class="citation-title">Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non‐insulin‐dependent) diabetic patients</span>. <span class="citation"> Diabete &amp; Metabolism </span><span class="pubYear">1989</span>;<span class="volume">15</span>(6):420‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+glycaemic+control,+metformin+and+gliclazide+on+platelet+density+and+aggregability+in+recently+diagnosed+type+2+(non%E2%80%90insulin%E2%80%90dependent)+diabetic+patients+&author=A+Collier&author=HH+Watson&author=AW+Patrick&author=CA+Ludlam&author=BF+Clarke&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Cosic 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0069"> <div class="citation-journal">Cosic V, Antic S, Pesic M, Jovanovic O, Jundalie S, Djordjevic VB. <span class="citation-title">Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients?</span>. <span class="citation"> Clinical Chemistry and Laboratory Medicine </span><span class="pubYear">2001</span>;<span class="volume">39</span>:818‐821. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11601679" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Monotherapy+with+metformin:+does+it+improve+hypoxia+in+type+2+diabetic+patients?&author=V+Cosic&author=S+Antic&author=M+Pesic&author=O+Jovanovic&author=S+Jundalie&author=VB+Djordjevic&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Cryer 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0070"> <div class="citation-journal">Cryer DR, Nicholas SP, Henry DH, Mills DJ, Stadel BV. <span class="citation-title">Comparative outcomes study of metformin intervention versus conventional approach</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:539‐43. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15735184" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+outcomes+study+of+metformin+intervention+versus+conventional+approach&author=DR+Cryer&author=SP+Nicholas&author=DH+Henry&author=DJ+Mills&author=BV+Stadel&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Cusi 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0071"> <div class="citation-journal">Cusi K, Consoli A, DeFronzo RA. <span class="citation-title">Metabolic effects of metformin on glucose and lactate metabolism in noninsulin‐dependent diabetes mellitus</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1996</span>;<span class="volume">81</span>:4059‐67. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8923861" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+metformin+on+glucose+and+lactate+metabolism+in+noninsulin%E2%80%90dependent+diabetes+mellitus+&author=K+Cusi&author=A+Consoli&author=RA+DeFronzo&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">D'Argenzio 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0072"> <div class="citation-journal">D'Argenzio R, Cavallo P, Merante D, Morelli A. <span class="citation-title">[Comparison of two treatment models in type‐II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono‐therapy with sulfonylurea at maximal doses? An evaluation at six months]</span>. <span class="citation"> Minerva Endocrinologica </span><span class="pubYear">1996</span>;<span class="volume">21</span>(3):101‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9072666" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Comparison+of+two+treatment+models+in+type%E2%80%90II+diabetic+patients+with+poor+metabolic+control:+Preformed+combination+of+glibenclamide+2,5+mg+++metformin+400+mg+or+mono%E2%80%90therapy+with+sulfonylurea+at+maximal+doses?+An+evaluation+at+six+months]+&author=R+D'Argenzio&author=P+Cavallo&author=D+Merante&author=A+Morelli&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Damsbo 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0073"> <div class="citation-journal">Damsbo P, Hermann LS, Vaag A, Hother‐Nielsen O, Beck‐Nielsen H. <span class="citation-title">Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(9):1489‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9727896" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Irreversibility+of+the+defect+in+glycogen+synthase+activity+in+skeletal+muscle+from+obese+patients+with+NIDDM+treated+with+diet+and+metformin+&author=P+Damsbo&author=LS+Hermann&author=A+Vaag&author=O+Hother%E2%80%90Nielsen&author=H+Beck%E2%80%90Nielsen&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Davidson 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0074"> <div class="citation-journal">Davidson J, Mooradian A, Piper B. <span class="citation-title">Effect of metformin/glyburide tablets on HBA1c in first‐line treatment of Type 2 Diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A184. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin/glyburide+tablets+on+HBA1c+in+first%E2%80%90line+treatment+of+Type+2+Diabetes&author=J+Davidson&author=A+Mooradian&author=B+Piper&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Davies 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0075"> <div class="citation-journal">Davies MJ, Thaware PK, Tringham JR, Howe J, Jarvis J, Johnston V, et al. <span class="citation-title">A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>(7):714‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17403126" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+controlled+trial+examining+combinations+of+repaglinide,+metformin+and+NPH+insulin+&author=MJ+Davies&author=PK+Thaware&author=JR+Tringham&author=J+Howe&author=J+Jarvis&author=V+Johnston&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">De Silva 1979 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0076"> <div class="citation-journal">Silva SR, Betteridge DJ, Shawe JEH, Cudworth AG, Alberti KGMM. <span class="citation-title">Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1979</span>;<span class="volume">5</span>:223‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/574098" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+clofibrate+in+maturity+onset+diabetes+mellitus:+advantages+of+combined+treatment+&author=SR+Silva&author=DJ+Betteridge&author=JEH+Shawe&author=AG+Cudworth&author=KGMM+Alberti&publication_year=1979&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">DeFronzo 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0077"> <div class="citation-journal">DeFronzo RA, Barzilai N, Simonson D. <span class="citation-title">Mechanism of metformin action in obese and lean noninsulin‐dependent diabetic subjects</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1991</span>;<span class="volume">73</span>:1294‐1301. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1955512" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mechanism+of+metformin+action+in+obese+and+lean+noninsulin%E2%80%90dependent+diabetic+subjects&author=RA+DeFronzo&author=N+Barzilai&author=D+Simonson&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">DeFronzo 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0078"> <div class="citation-journal">DeFronzo RA, Goodman A and the Metformin Investigator Group. <span class="citation-title">Combined metformin/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonyluria: Results of a multicenter trial.</span>. <span class="citation"> Diabetes </span><span class="pubYear">1993</span>;<span class="volume">42</span>(Suppl 1):146A (abs 455). <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+metformin/glyburide+treatment+in+NIDDM+patients+not+optimally+responding+to+maximum+dose+sulfonyluria:+Results+of+a+multicenter+trial.+&author=RA+DeFronzo&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0079"> <div class="citation-journal">DeFronzo RA, Goodman AM. <span class="citation-title">Efficacy of metformin in patients with non‐insulin‐dependent diabetes mellitus. The Multicenter Metformin Study Group [see comments]</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1995</span>;<span class="volume">333</span>(9):541‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7623902" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+metformin+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus.+The+Multicenter+Metformin+Study+Group+[see+comments]+&author=RA+DeFronzo&author=AM+Goodman&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0080"> <div class="citation-journal">Goodman AM and the Metformin Investigator Group. <span class="citation-title">Efficacy and safety of metformin in NIDDM: Results of a muticenter trial</span>. <span class="citation"> Diabetes </span><span class="pubYear">1993</span>;<span class="volume">42</span>(Suppl 1):Abs 178. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Derosa 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0081"> <div class="citation-journal">Derosa G, Mugellini Am, Ciccarelli L, Crescenzi G, Fogari R. <span class="citation-title">Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformine</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2003</span>;<span class="volume">60</span>:161‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12757988" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+glycaemic+control+and+cardiovascular+risk+profile+in+patients+with+type+2+diabetes+during+treatment+with+either+repaglinide+or+metformine+&author=G+Derosa&author=Am+Mugellini&author=L+Ciccarelli&author=G+Crescenzi&author=R+Fogari&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Derosa 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0082"> <div class="citation-journal">Derosa G, Gaddi AV, Ciccarelli I, Fogari E, Ghelfi M, Ferrari I, Cicero AFG. <span class="citation-title">Long‐term effect of glimepiride and rosiglitazone on non‐conventional cardiovascular risk factors in metformin‐treated patients affected by metabolic syndrome: a randomized, double‐blind clinical trial</span>. <span class="citation"> The Journal of International Medical Research </span><span class="pubYear">2005</span>;<span class="volume">33</span>:284‐294. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15938589" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effect+of+glimepiride+and+rosiglitazone+on+non%E2%80%90conventional+cardiovascular+risk+factors+in+metformin%E2%80%90treated+patients+affected+by+metabolic+syndrome:+a+randomized,+double%E2%80%90blind+clinical+trial+&author=G+Derosa&author=AV+Gaddi&author=I+Ciccarelli&author=E+Fogari&author=M+Ghelfi&author=I+Ferrari&author=AFG+Cicero&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Derosa 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0083"> <div class="citation-journal">Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SAT, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AFG. <span class="citation-title">Metformin‐pioglitazone and metformin‐rosiglitazone effects on non‐conventional cardiovascular risk factors plasma levels in type 2 diabetic patients with metabolic syndrome</span>. <span class="citation"> Journal of Clinical Pharmacy and Therapeutics </span><span class="pubYear">2006</span>;<span class="volume">31</span>:375‐383. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16882108" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90pioglitazone+and+metformin%E2%80%90rosiglitazone+effects+on+non%E2%80%90conventional+cardiovascular+risk+factors+plasma+levels+in+type+2+diabetic+patients+with+metabolic+syndrome+&author=G+Derosa&author=A+D'Angelo&author=PD+Ragonesi&author=L+Ciccarelli&author=MN+Piccinni&author=F+Pricolo&author=SAT+Salvadeo&author=L+Montagna&author=A+Gravina&author=I+Ferrari&author=S+Paniga&author=AFG+Cicero&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">Derosa 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0084"> <div class="citation-journal">Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, et al. <span class="citation-title">Effects of nateglinide and glibenclamide on prothrombotic factors in naive type 2 diabetic patients treated with metformin: a 1‐year, double‐blind, randomized clinical trial</span>. <span class="citation"> Internal Medicine </span><span class="pubYear">2007</span>;<span class="volume">46</span>(22):1837‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18025765" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+nateglinide+and+glibenclamide+on+prothrombotic+factors+in+naive+type+2+diabetic+patients+treated+with+metformin:+a+1%E2%80%90year,+double%E2%80%90blind,+randomized+clinical+trial+&author=G+Derosa&author=A+D'Angelo&author=E+Fogari&author=S+Salvadeo&author=A+Gravina&author=I+Ferrari&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Derosa 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0085"> <div class="citation-journal">Derosa G, Salvadeo SAT, D'Angelo A, Fogari E, Ragonesi PD, Ciccarelli L, et al. <span class="citation-title">Rosiglitazone Therapy Improves Insulin Resistance Parameters in Overweight and Obese Diabetic Patients Intolerant To Metformin</span>. <span class="citation"> Archives of Medical Research </span><span class="pubYear">2008</span>;<span class="volume">39</span>(4):412‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18375253" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+Therapy+Improves+Insulin+Resistance+Parameters+in+Overweight+and+Obese+Diabetic+Patients+Intolerant+To+Metformin+&author=G+Derosa&author=SAT+Salvadeo&author=A+D'Angelo&author=E+Fogari&author=PD+Ragonesi&author=L+Ciccarelli&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Derosa 2009a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0086"> <div class="citation-journal">Derosa G, Maffioli P, Salvadeo SAT, Ferrari I, Gravina A, Mereu R, et al. <span class="citation-title">Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study</span>. <span class="citation"> Metabolism: Clinical and Experimental </span><span class="pubYear">2009</span>;<span class="volume">58</span>(8):1059‐66. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19394976" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Direct+comparison+among+oral+hypoglycemic+agents+and+their+association+with+insulin+resistance+evaluated+by+euglycemic+hyperinsulinemic+clamp:+the+60's+study+&author=G+Derosa&author=P+Maffioli&author=SAT+Salvadeo&author=I+Ferrari&author=A+Gravina&author=R+Mereu&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Dies 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0087"> <div class="citation-journal">Dies H, Lozano Castaneda O, Garcia Viveros M, Schulte J, Figueroa J, Rull JA. <span class="citation-title">[Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide‐metformin (author's transl)]</span>. <span class="citation"> La Revista de Inverstigation Clinica </span><span class="pubYear">1978</span>;<span class="volume">30</span>(2):131‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Long+range+results+(5+years)+in+the+treatment+of+stable+diabetes+with+low+doses+of+clorpropamide%E2%80%90metformin+(author's+transl)]+&author=H+Dies&author=O+LozanoCastaneda&author=M+GarciaViveros&author=J+Schulte&author=J+Figueroa&author=JA+Rull&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Donnelly 1960 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0088"> <div class="citation-journal">Donnelly P. <span class="citation-title">Dimethyldiguanide in diabetes mellitus: Report of a small trial</span>. <span class="citation"> Journal of the Irish Medical Association </span><span class="pubYear">1960</span>;<span class="volume">47</span>:142‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13723763" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dimethyldiguanide+in+diabetes+mellitus:+Report+of+a+small+trial&author=P+Donnelly&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Dornan 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0089"> <div class="citation-journal">Dornan TL, Heller SR, Peck G, Gregory R, Tattersall RB. <span class="citation-title">Metformin monotherapy for obese non‐insulin‐dependent diabetes. A double‐blind evaluation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1988</span>;<span class="volume">5</span>(Suppl 2):5 (Abs A17). <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+monotherapy+for+obese+non%E2%80%90insulin%E2%80%90dependent+diabetes.+A+double%E2%80%90blind+evaluation&author=TL+Dornan&author=SR+Heller&author=G+Peck&author=R+Gregory&author=RB+Tattersall&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0090"> <div class="citation-journal">Dornan TL, Heller SR, Peck GM, Tattersall RB. <span class="citation-title">Double‐blind evaluation of efficacy and tolerability of metformin in NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1991</span>;<span class="volume">14</span>(4):342‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2060439" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Double%E2%80%90blind+evaluation+of+efficacy+and+tolerability+of+metformin+in+NIDDM&author=TL+Dornan&author=SR+Heller&author=GM+Peck&author=RB+Tattersall&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Douek 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0091"> <div class="citation-journal">Douek IF, Allen SE, Ewings P, Gale EAM, Bingley PJ. <span class="citation-title">Continuing metformin when starting insulin in patients with type 2 diabetes: a double‐blind randomized placebo‐controlled trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:634‐640. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15842521" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Continuing+metformin+when+starting+insulin+in+patients+with+type+2+diabetes:+a+double%E2%80%90blind+randomized+placebo%E2%80%90controlled+trial+&author=IF+Douek&author=SE+Allen&author=P+Ewings&author=EAM+Gale&author=PJ+Bingley&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Eguchi 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0092"> <div class="citation-journal">Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kario K. <span class="citation-title">Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes</span>. <span class="citation"> Hypertension Research </span><span class="pubYear">2007</span>;<span class="volume">30</span>:23‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17460368" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+the+effects+of+pioglitazone+and+metformin+on+insulin+resistance+and+hormonal+markers+in+patients+with+impaired+glucose+tolerance+and+early+diabetes+&author=K+Eguchi&author=H+Tomizawa&author=J+Ishikawa&author=S+Hoshide&author=T+Numao&author=T+Fukuda&author=K+Shimada&author=K+Kario&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Einhorn 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0093"> <div class="citation-journal">Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathsen AJ, Schneider RL. <span class="citation-title">Piioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo‐controlled study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2000</span>;<span class="volume">22</span>:1395‐1409. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11192132" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Piioglitazone+hydrochloride+in+combination+with+metformin+in+the+treatment+of+type+2+diabetes+mellitus:+a+randomized,+placebo%E2%80%90controlled+study+&author=D+Einhorn&author=M+Rendell&author=J+Rosenzweig&author=JW+Egan&author=AJ+Mathsen&author=RL+Schneider&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Elkeles 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0094"> <div class="citation-journal">Elkeles RS. <span class="citation-title">The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non‐insulin‐dependent diabetes (NIDDM)</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):197‐200. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936476" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+oral+hypoglycaemic+drugs+on+serum+lipids+and+lipoproteins+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+(NIDDM)+&author=RS+Elkeles&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">Erdem 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0095"> <div class="citation-journal">Erdem G, Dogru T, Tasci I, Bozoglu E, Muhsiroglu O, Tapan S, et al. <span class="citation-title">The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">82</span>(2):214‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18778865" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+pioglitazone+and+metformin+on+plasma+visfatin+levels+in+patients+with+treatment+naive+type+2+diabetes+mellitus+&author=G+Erdem&author=T+Dogru&author=I+Tasci&author=E+Bozoglu&author=O+Muhsiroglu&author=S+Tapan&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Eriksson 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0096"> <div class="citation-journal">Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA. <span class="citation-title">Short‐term effects of metformin in type 2 diabetes</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:483‐489. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Short%E2%80%90term+effects+of+metformin+in+type+2+diabetes&author=A+Eriksson&author=S+Attvall&author=M+Bonnier&author=JW+Eriksson&author=B+Rosander&author=FA+Karlsson&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Eriksson 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0097"> <div class="citation-journal">Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA. <span class="citation-title">Short‐term effects of metformin in type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(4):483‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17587390" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Short%E2%80%90term+effects+of+metformin+in+type+2+diabetes&author=A+Eriksson&author=S+Attvall&author=M+Bonnier&author=JW+Eriksson&author=B+Rosander&author=FA+Karlsson&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">Erle 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0098"> <div class="citation-journal">Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, et al. <span class="citation-title">A comparison of preconstituted, fixed combinations of low‐dose glyburide plus metformin versus high‐dose glyburide alone in the treatment of type 2 diabetic patients</span>. <span class="citation"> Acta Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">36</span>(1‐2):61‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+preconstituted,+fixed+combinations+of+low%E2%80%90dose+glyburide+plus+metformin+versus+high%E2%80%90dose+glyburide+alone+in+the+treatment+of+type+2+diabetic+patients+&author=G+Erle&author=S+Lovise&author=C+Stocchiero&author=L+Lora&author=A+Coppini&author=P+Marchetti&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">Ersoy 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0099"> <div class="citation-journal">Ersoy C, Kiyici S, Budak F, Oral B, Guclu M, Duran C, et al. <span class="citation-title">The effect of metformin treatment on VEGF and PAI‐1 levels in obese type 2 diabetic patients</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">81</span>(1):56‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18358555" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+treatment+on+VEGF+and+PAI%E2%80%901+levels+in+obese+type+2+diabetic+patients+&author=C+Ersoy&author=S+Kiyici&author=F+Budak&author=B+Oral&author=M+Guclu&author=C+Duran&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">Esposito 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0100"> <div class="citation-journal">Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, et al. <span class="citation-title">Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: A randomized trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2008</span>;<span class="volume">149</span>(8):531‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18936501" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+neutral+protamine+lispro+insulin+or+insulin+glargine+to+oral+type+2+diabetes+regimens+for+patients+with+suboptimal+glycemic+control:+A+randomized+trial+&author=K+Esposito&author=M+Ciotola&author=MI+Maiorino&author=R+Gualdiero&author=B+Schisano&author=A+Ceriello&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Fanghanel 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0101"> <div class="citation-journal">Fanghanel G, Sanchez‐Reyes L, Trujillo C, Sotres D, Espinosa‐Campos J. <span class="citation-title">Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(11):1185‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8908377" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin's+effects+on+glucose+and+lipid+metabolism+in+patients+with+secondary+failure+to+sulfonylureas+&author=G+Fanghanel&author=L+Sanchez‐Reyes&author=C+Trujillo&author=D+Sotres&author=J+Espinosa‐Campos&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Fanghanel 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0102"> <div class="citation-journal">Fanghanel G, Silva U, Sanchez‐Reyes L, Sisson D, Sotres D, Torres EM. <span class="citation-title">Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes</span>. <span class="citation"> La Revista de Investigacion Clinica </span><span class="pubYear">1998</span>;<span class="volume">50</span>(5):389‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+fibrinogen+levels+in+obese+patients+with+type+2+diabetes&author=G+Fanghanel&author=U+Silva&author=L+Sanchez%E2%80%90Reyes&author=D+Sisson&author=D+Sotres&author=EM+Torres&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Feinglos 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0103"> <div class="citation-journal">Feinglos M, Dailey G, Cefalu W, Osei K, Tayek J, Canovatchel W, Chaiken R, Kourides I. <span class="citation-title">Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">68</span>:167‐175. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15860246" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+on+glycemic+control+of+the+addition+of+2.5+mg+glipizide+GITS+to+metformin+in+patients+with+T2DM+&author=M+Feinglos&author=G+Dailey&author=W+Cefalu&author=K+Osei&author=J+Tayek&author=W+Canovatchel&author=R+Chaiken&author=I+Kourides&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Ferner 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0104"> <div class="citation-journal">Ferner RE, Rawlins MD, Alberti KG. <span class="citation-title">Impaired beta‐cell responses improve when fasting blood glucose concentration is reduced in non‐insulin‐dependent diabetes</span>. <span class="citation"> Quarterly Journal of Medicine </span><span class="pubYear">1988</span>;<span class="volume">66</span>(250):137‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3051084" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impaired+beta%E2%80%90cell+responses+improve+when+fasting+blood+glucose+concentration+is+reduced+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+&author=RE+Ferner&author=MD+Rawlins&author=KG+Alberti&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Fisman 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0105"> <div class="citation-journal">Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M. <span class="citation-title">Antihyperglycemic treatment in diabetics with coronary disease: Increased metformin‐associated mortality over a 5‐year follow‐up</span>. <span class="citation"> Cardiology </span><span class="pubYear">1999</span>;<span class="volume">91</span>:195‐202. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10516414" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antihyperglycemic+treatment+in+diabetics+with+coronary+disease:+Increased+metformin%E2%80%90associated+mortality+over+a+5%E2%80%90year+follow%E2%80%90up+&author=EZ+Fisman&author=A+Tenenbaum&author=M+Benderly&author=U+Goldbourt&author=S+Behar&author=M+Motro&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0106"> <div class="citation-journal">Fisman EZ, Tennenbaum A, Boyko V, Benderly M, Adler Y, Friedensohn M, et al. <span class="citation-title">Oral antidiabetic treatment in patients with coronary disease: Time‐related increased mortality on combined glyburide/metformin therapy over a 7.7‐year follow‐up</span>. <span class="citation"> Clinical Cardiology </span><span class="pubYear">2001</span>;<span class="volume">24</span>:151‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11460818" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Oral+antidiabetic+treatment+in+patients+with+coronary+disease:+Time%E2%80%90related+increased+mortality+on+combined+glyburide/metformin+therapy+over+a+7.7%E2%80%90year+follow%E2%80%90up+&author=EZ+Fisman&author=A+Tennenbaum&author=V+Boyko&author=M+Benderly&author=Y+Adler&author=M+Friedensohn&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0100"> <div class="reference-title-banner"> <h4 class="title">Fonseca 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0107"> <div class="citation-journal">Fonseca V, Rosenstock J, Patwardhan R, Salzman A. <span class="citation-title">Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">2000</span>;<span class="volume">283</span>(13):1695‐702. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10755495" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+and+rosiglitazone+combination+therapy+in+patients+with+type+2+diabetes+mellitus:+a+randomized+controlled+trial+&author=V+Fonseca&author=J+Rosenstock&author=R+Patwardhan&author=A+Salzman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0101"> <div class="reference-title-banner"> <h4 class="title">Formoso 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0108"> <div class="citation-journal">Formoso G, Filippis EA, Michetti N, Fulvio P, Pandolfi A, Bucciarelli T, et al. <span class="citation-title">Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2008</span>;<span class="volume">24</span>(3):231‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Decreased+in+vivo+oxidative+stress+and+decreased+platelet+activation+following+metformin+treatment+in+newly+diagnosed+type+2+diabetic+subjects+&author=G+Formoso&author=EA+Filippis&author=N+Michetti&author=P+Fulvio&author=A+Pandolfi&author=T+Bucciarelli&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0102"> <div class="reference-title-banner"> <h4 class="title">Fritsche 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0109"> <div class="citation-journal">Fritsche A, Schmulling R‐M, Haring H‐U, Stumvoll M. <span class="citation-title">Intensive insulin therapy combined with metformin in obese type 2 diabetic patients</span>. <span class="citation"> Acta Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">37</span>(1):13‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+insulin+therapy+combined+with+metformin+in+obese+type+2+diabetic+patients&author=A+Fritsche&author=R%E2%80%90M+Schmulling&author=H%E2%80%90U+Haring&author=M+Stumvoll&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0103"> <div class="reference-title-banner"> <h4 class="title">Fujioka 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0110"> <div class="citation-journal">Fujioka K, Brazg RL, Raz, I, Bruce S, Joyal S, Sanink R, Pans M. <span class="citation-title">Efficacy, dose‐response relationship and safety of once‐daily extended‐release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double‐blind, placebo‐controlled studies</span>. <span class="citation"> Diabetes Obesity &amp; Metabolism </span><span class="pubYear">2005</span>;<span class="volume">7</span>:28‐39. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy,+dose%E2%80%90response+relationship+and+safety+of+once%E2%80%90daily+extended%E2%80%90release+metformin+(Glucophage+XR)+in+type+2+diabetic+patients+with+inadequate+glycaemic+control+despite+prior+treatment+with+diet+and+exercise:+results+from+two+double%E2%80%90blind,+placebo%E2%80%90controlled+studies+&author=K+Fujioka&author=RL+Brazg&author=+Raz&author=+I&author=S+Bruce&author=S+Joyal&author=R+Sanink&author=M+Pans&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0104"> <div class="reference-title-banner"> <h4 class="title">Galeone 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0111"> <div class="citation-journal">Galeone F, Fiore G, Arcangeli A, Mannucci E. <span class="citation-title">[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data]</span>. <span class="citation"> Minerva Endocrinologica </span><span class="pubYear">1998</span>;<span class="volume">23</span>(3):71‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10063324" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Gliclazide+and+metformin+combination+in+patients+with+type+2+diabetes.+Preliminary+data]+&author=F+Galeone&author=G+Fiore&author=A+Arcangeli&author=E+Mannucci&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0105"> <div class="reference-title-banner"> <h4 class="title">Gao 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0112"> <div class="citation-journal">Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, et al. <span class="citation-title">The metabolic effects of once daily extended‐release metformin in patients with type 2 diabetes: A multicentre study</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">62</span>(5):695‐700. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18412932" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+metabolic+effects+of+once+daily+extended%E2%80%90release+metformin+in+patients+with+type+2+diabetes:+A+multicentre+study+&author=H+Gao&author=W+Xiao&author=C+Wang&author=J+Zhang&author=Y+Yang&author=J+Yang&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0106"> <div class="reference-title-banner"> <h4 class="title">Gao 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0113"> <div class="citation-journal">Gao Y, Yoon KH, Chuang L‐M, Mohan V, Ning G, Shah S, et al. <span class="citation-title">Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2009</span>;<span class="volume">83</span>(1):69‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19019476" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+exenatide+in+patients+of+Asian+descent+with+type+2+diabetes+inadequately+controlled+with+metformin+or+metformin+and+a+sulphonylurea+&author=Y+Gao&author=KH+Yoon&author=L%E2%80%90M+Chuang&author=V+Mohan&author=G+Ning&author=S+Shah&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0107"> <div class="reference-title-banner"> <h4 class="title">Garber 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0114"> <div class="citation-journal">Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. <span class="citation-title">Efficacy of metformin in type II diabetes: results of a double‐blind, placebo‐controlled, dose‐response trial</span>. <span class="citation"> American Journal of Medicine </span><span class="pubYear">1997</span>;<span class="volume">103</span>(6):491‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9428832" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+metformin+in+type+II+diabetes:+results+of+a+double%E2%80%90blind,+placebo%E2%80%90controlled,+dose%E2%80%90response+trial+&author=AJ+Garber&author=TG+Duncan&author=AM+Goodman&author=DJ+Mills&author=JL+Rohlf&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0108"> <div class="reference-title-banner"> <h4 class="title">Garber 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0115"> <div class="citation-journal">Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D and the Glyburide/Metformin Initial Therapy Study Group. <span class="citation-title">Simultaenous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes</span>. <span class="citation"> Diabetes Obesity &amp; Metabolism </span><span class="pubYear">2002</span>;<span class="volume">4</span>:201‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Simultaenous+glyburide/metformin+therapy+is+superior+to+component+monotherapy+as+an+initial+pharmacological+treatment+for+type+2+diabetes+&author=AJ+Garber&author=J+Larsen&author=SH+Schneider&author=BA+Piper&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0109"> <div class="reference-title-banner"> <h4 class="title">Garber 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0116"> <div class="citation-journal">Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. <span class="citation-title">Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:156‐163. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90glibenclamide+versus+metformin+plus+rosiglitazone+in+patients+with+type+2+diabetes+inadequately+controlled+on+metformin+monotherapy+&author=A+Garber&author=E+Klein&author=S+Bruce&author=S+Sankoh&author=P+Mohideen&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0110"> <div class="reference-title-banner"> <h4 class="title">Garcia 1971 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0117"> <div class="citation-journal">Garcia Viveros M, Prado Vega R, Rull JA, Lozano‐Castaneda O. <span class="citation-title">[Chlorpropamide‐metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2‐year results]</span>. <span class="citation"> La Prensa Medica Mexicana </span><span class="pubYear">1971</span>;<span class="volume">36</span>(7):347‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5096256" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Chlorpropamide%E2%80%90metformin+in+obese+diabetics+or+diabetics+with+side+effects+from+sulfonylureas.+2%E2%80%90year+results]+&author=M+GarciaViveros&author=R+PradoVega&author=JA+Rull&author=O+Lozano%E2%80%90Castaneda&publication_year=1971&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0111"> <div class="reference-title-banner"> <h4 class="title">Garcia‐Soria 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0118"> <div class="citation-journal">Garcia‐Soria G, Gonzalez‐Galvez G, Argoud GM, Gerstman M, Littlejohn III TW, Schwartz SL, et al. <span class="citation-title">The dipeptidyl peptidase‐4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10</span>(4):293‐300. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+dipeptidyl+peptidase%E2%80%904+inhibitor+PHX1149+improves+blood+glucose+control+in+patients+with+type+2+diabetes+mellitus+&author=G+Garcia%E2%80%90Soria&author=G+Gonzalez%E2%80%90Galvez&author=GM+Argoud&author=M+Gerstman&author=TW+LittlejohnIII&author=SL+Schwartz&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0112"> <div class="reference-title-banner"> <h4 class="title">Gerich 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0119"> <div class="citation-journal">Berich J, Raskin P, Jean‐Louis L, Purkayastha D, Baron MA. <span class="citation-title">Preserve‐beta: Two‐year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:2093‐2099. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16123472" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preserve%E2%80%90beta:+Two%E2%80%90year+efficacy+and+safety+of+initial+combination+therapy+with+nateglinide+or+glyburide+plus+metformin+&author=J+Berich&author=P+Raskin&author=L+Jean%E2%80%90Louis&author=D+Purkayastha&author=MA+Baron&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0120"> <div class="citation-journal">Schwarz SL, Gerich JE, Marcellari A, Jean‐louis L, Purkayastha D, Baron MA. <span class="citation-title">Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment‐naive elderly patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10</span>(8):652‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nateglinide,+alone+or+in+combination+with+metformin,+is+effective+and+well+tolerated+in+treatment%E2%80%90naive+elderly+patients+with+type+2+diabetes+&author=SL+Schwarz&author=JE+Gerich&author=A+Marcellari&author=L+Jean%E2%80%90louis&author=D+Purkayastha&author=MA+Baron&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0113"> <div class="reference-title-banner"> <h4 class="title">Giugliano 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0121"> <div class="citation-journal">Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, Rosa N, et al. <span class="citation-title">Metformin for obese, insulin‐treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1993</span>;<span class="volume">44</span>(2):107‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8453955" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+for+obese,+insulin%E2%80%90treated+diabetic+patients:+improvement+in+glycaemic+control+and+reduction+of+metabolic+risk+factors+&author=D+Giugliano&author=A+Quatraro&author=G+Consoli&author=A+Minei&author=A+Ceriello&author=N+Rosa&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0114"> <div class="reference-title-banner"> <h4 class="title">Gokcel 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0122"> <div class="citation-journal">Glokcel Am Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N. <span class="citation-title">Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control</span>. <span class="citation"> Diabetes Mellitus </span><span class="pubYear">2001</span>;<span class="volume">24</span>:1957‐1960. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+sibutramine+in+obese+female+subjects+with+type+2+diabetes+and+poor+blood+glucose+control+&author=H+GlokcelAmKarakose&author=EM+Ertorer&author=N+Tanaci&author=NB+Tutuncu&author=N+Guvener&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0115"> <div class="reference-title-banner"> <h4 class="title">Goke 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0123"> <div class="citation-journal">Goke B, Hershon K, Kerr D, Calle Pascual A, Schweizer A, Foley J, et al. <span class="citation-title">Efficacy and safety of vildagliptin monotherapy during 2‐year treatment of drug‐naive patients with type 2 diabetes: Comparison with metformin</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">2008</span>;<span class="volume">40</span>(12):892‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18726829" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+vildagliptin+monotherapy+during+2%E2%80%90year+treatment+of+drug%E2%80%90naive+patients+with+type+2+diabetes:+Comparison+with+metformin+&author=B+Goke&author=K+Hershon&author=D+Kerr&author=A+CallePascual&author=A+Schweizer&author=J+Foley&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0116"> <div class="reference-title-banner"> <h4 class="title">Goldstein 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0124"> <div class="citation-journal">Goldstein BJ, Pans M, Rubin CJ. <span class="citation-title">Multicenter, randomized, double‐mased, parallel‐group assessment of simultaneous glipizide/metformin as second‐line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2003</span>;<span class="volume">25</span>(3):890‐903. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12852706" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Multicenter,+randomized,+double%E2%80%90mased,+parallel%E2%80%90group+assessment+of+simultaneous+glipizide/metformin+as+second%E2%80%90line+pharmacologic+treatment+for+patients+with+type+2+diabetes+mellitus+that+is+inadequately+controlled+by+a+sulfonylurea+&author=BJ+Goldstein&author=M+Pans&author=CJ+Rubin&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0117"> <div class="reference-title-banner"> <h4 class="title">Goldstein 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0125"> <div class="citation-journal">Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams‐Herman DE, Study Group. <span class="citation-title">Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.[erratum appears in Diabetes Care. 2008 Aug;31(8):1713]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2007</span>;<span class="volume">30</span>(8):1979‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17485570" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+initial+combination+therapy+with+sitagliptin,+a+dipeptidyl+peptidase%E2%80%904+inhibitor,+and+metformin+on+glycemic+control+in+patients+with+type+2+diabetes.[erratum+appears+in+Diabetes+Care.+2008+Aug;31(8):1713]+&author=BJ+Goldstein&author=MN+Feinglos&author=JK+Lunceford&author=J+Johnson&author=DE+Williams%E2%80%90Herman&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0126"> <div class="citation-journal">Williams‐Herman D, Johnson J, Teng R, Luo E, Davies MJ, Kaufman KD, et al. <span class="citation-title">Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: A 54‐week study</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2009</span>;<span class="volume">25</span>(3):569‐83. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19232032" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+initial+combination+therapy+with+sitagliptin+and+metformin+in+patients+with+type+2+diabetes:+A+54%E2%80%90week+study+&author=D+Williams%E2%80%90Herman&author=J+Johnson&author=R+Teng&author=E+Luo&author=MJ+Davies&author=KD+Kaufman&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0118"> <div class="reference-title-banner"> <h4 class="title">Gonzalez‐Ortiz 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0127"> <div class="citation-journal">Gonzalez‐Ortiz M, Martinez‐Abundis E y el Grupo para el Tratamiento de la Diabetes Mellitus con Combinaciones. <span class="citation-title">Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy</span> [Eficacia y seguridad de la terapia hypoglycemiente oral combinada de glimepirida mas metformina en una sola forma farmaceutica en pacientes con diabetes mellitus type 2 y falla secundaria a monoterapia con glibenclamida]. <span class="citation"> Revista de Investigacion Clinica </span><span class="pubYear">2004</span>;<span class="volume">56</span>(3):327‐333. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15612515" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+glimepiride+plus+metformin+in+a+single+presentation,+as+combined+therapy,+in+patients+with+type+2+diabetes+mellitus+and+secondary+failure+to+glibenclamide,+as+monotherapy+&author=M+Gonzalez%E2%80%90Ortiz&author=Combinaciones+Martinez%E2%80%90AbundisEyelGrupoparaelTratamientodelaDiabetesMellituscon&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0119"> <div class="reference-title-banner"> <h4 class="title">Goodman 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0128"> <div class="citation-journal">Goodman M, Thurston H, Penman J. <span class="citation-title">Efficacy and tolerability of vildagliptin in patients with type 2 diabetes inadequately controlled with metformin monotherapy</span>. <span class="citation"> Hormone &amp; Metabolic Research </span><span class="pubYear">2009</span>;<span class="volume">41</span>(5):368‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+tolerability+of+vildagliptin+in+patients+with+type+2+diabetes+inadequately+controlled+with+metformin+monotherapy+&author=M+Goodman&author=H+Thurston&author=J+Penman&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0120"> <div class="reference-title-banner"> <h4 class="title">Gottlieb 1962 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0129"> <div class="citation-journal">Gottlieb B. <span class="citation-title">Metformin in treatment of Diabetes mellitus</span>. <span class="citation"> British Medical Journal </span><span class="pubYear">1962</span>;<span class="volume">5279</span>:680‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+in+treatment+of+Diabetes+mellitus&author=B+Gottlieb&publication_year=1962&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0121"> <div class="reference-title-banner"> <h4 class="title">Gottschalk 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0130"> <div class="citation-journal">Gottschalk M, Danne T, Vlajnic a, Cara JF. <span class="citation-title">Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2007</span>;<span class="volume">30</span>(4):790‐794. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17392540" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glimepiride+versus+metformin+as+monotherapy+in+pediatric+patients+with+type+2+diabetes&author=M+Gottschalk&author=T+Danne&author=a+Vlajnic&author=JF+Cara&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0122"> <div class="reference-title-banner"> <h4 class="title">Grant 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0131"> <div class="citation-journal">Grant PJ, Stickland MH, Booth NA, Prentice CR. <span class="citation-title">Metformin causes a reduction in basal and post‐venous occlusion plasminogen activator inhibitor‐1 in type 2 diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1991</span>;<span class="volume">8</span>(4):361‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1713132" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+causes+a+reduction+in+basal+and+post%E2%80%90venous+occlusion+plasminogen+activator+inhibitor%E2%80%901+in+type+2+diabetic+patients+&author=PJ+Grant&author=MH+Stickland&author=NA+Booth&author=CR+Prentice&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0123"> <div class="reference-title-banner"> <h4 class="title">Grant 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0132"> <div class="citation-journal">Grant PJ. <span class="citation-title">The effects of high‐ and medium‐dose metformin therapy on cardiovascular risk factors in patients with type II diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(1):64‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8720537" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+high%E2%80%90+and+medium%E2%80%90dose+metformin+therapy+on+cardiovascular+risk+factors+in+patients+with+type+II+diabetes+&author=PJ+Grant&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0124"> <div class="reference-title-banner"> <h4 class="title">Grant 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0133"> <div class="citation-journal">Grant PJ. <span class="citation-title">Metformin reduces circulating Factor VII concentrations in patients with Type II Diabetes mellitus</span>. <span class="citation"> Thrombosis and Haemostasis </span><span class="pubYear">1998</span>;<span class="volume">80</span>:209‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9684819" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+reduces+circulating+Factor+VII+concentrations+in+patients+with+Type+II+Diabetes+mellitus+&author=PJ+Grant&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0125"> <div class="reference-title-banner"> <h4 class="title">Gregorio 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0134"> <div class="citation-journal">Gregorio F, Ambrosi F, Angelici F, Cristallini S, Dini FL, Vespasiani G, et al. <span class="citation-title">[Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus]</span>. <span class="citation"> Medicina (Firenze) </span><span class="pubYear">1989</span>;<span class="volume">9</span>(2):200‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2682123" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Body+mass+index,+blood+lactate+and+therapeutic+effectiveness+of+metformin+in+type+II+diabetes+mellitus]+&author=F+Gregorio&author=F+Ambrosi&author=F+Angelici&author=S+Cristallini&author=FL+Dini&author=G+Vespasiani&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0126"> <div class="reference-title-banner"> <h4 class="title">Gregorio 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0135"> <div class="citation-journal">Gregorio F, Ambrosi F, Marchetti P, Cristallini S, Navalesi R, Brunetti P, et al. <span class="citation-title">Low dose metformin in the treatment of type II non‐insulin‐dependent diabetes: clinical and metabolic evaluations</span>. <span class="citation"> Acta Diabetologica Latina </span><span class="pubYear">1990</span>;<span class="volume">27</span>(2):139‐55. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2198745" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Low+dose+metformin+in+the+treatment+of+type+II+non%E2%80%90insulin%E2%80%90dependent+diabetes:+clinical+and+metabolic+evaluations+&author=F+Gregorio&author=F+Ambrosi&author=P+Marchetti&author=S+Cristallini&author=R+Navalesi&author=P+Brunetti&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0127"> <div class="reference-title-banner"> <h4 class="title">Gregorio 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0136"> <div class="citation-journal">Gregorio F, Ambrosi F, Manfrini S, Santucci A, Filipponi P. <span class="citation-title">Meformin, plasma glucose and free fatty acids in type II diabetic out‐patients: results of a clinical study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1997</span>;<span class="volume">37</span>(1):21‐33. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9279474" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meformin,+plasma+glucose+and+free+fatty+acids+in+type+II+diabetic+out%E2%80%90patients:+results+of+a+clinical+study+&author=F+Gregorio&author=F+Ambrosi&author=S+Manfrini&author=A+Santucci&author=P+Filipponi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0128"> <div class="reference-title-banner"> <h4 class="title">Groop 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0137"> <div class="citation-journal">Groop L, Widen E, Franssila‐Kallunki A, Ekstrand A, Saloranta C, Schalin C, et al. <span class="citation-title">Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non‐insulin‐dependent) diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1989</span>;<span class="volume">32</span>(8):599‐605. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2506091" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Different+effects+of+insulin+and+oral+antidiabetic+agents+on+glucose+and+energy+metabolism+in+type+2+(non%E2%80%90insulin%E2%80%90dependent)+diabetes+mellitus+&author=L+Groop&author=E+Widen&author=A+Franssila%E2%80%90Kallunki&author=A+Ekstrand&author=C+Saloranta&author=C+Schalin&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0129"> <div class="reference-title-banner"> <h4 class="title">Groop 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0138"> <div class="citation-journal">Groop L, Widen E. <span class="citation-title">Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):218‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936480" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+strategies+for+secondary+sulfonylurea+failure.+Should+we+start+insulin+or+add+metformin?+Is+there+a+place+for+intermittent+insulin+therapy?+&author=L+Groop&author=E+Widen&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0130"> <div class="reference-title-banner"> <h4 class="title">Guillausseau 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0139"> <div class="citation-journal">Guillausseau PJ. <span class="citation-title">Monitoring of metabolic control in patients with non‐insulin‐dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1997</span>;<span class="volume">14</span>(9):798‐802. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Monitoring+of+metabolic+control+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+on+oral+hypoglycaemic+agents:+value+of+evening+blood+glucose+determination+&author=PJ+Guillausseau&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0131"> <div class="reference-title-banner"> <h4 class="title">Gupta 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0140"> <div class="citation-journal">Gupta AK, Smith SR, Greenway FL, Bray GA. <span class="citation-title">Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(4):330‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+treatment+in+type+2+diabetes+mellitus+when+combined+with+portion+control+diet+modifies+the+metabolic+syndrome+&author=AK+Gupta&author=SR+Smith&author=FL+Greenway&author=GA+Bray&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0132"> <div class="reference-title-banner"> <h4 class="title">Gursoy 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0141"> <div class="citation-journal">Gursoy N, Ilcol Y, Tuncel E, Imamoglu S, Erturk E. <span class="citation-title">The effect of metformin on insulin resistance and serum lipid profiles</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A150. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+insulin+resistance+and+serum+lipid+profiles&author=N+Gursoy&author=Y+Ilcol&author=E+Tuncel&author=S+Imamoglu&author=E+Erturk&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0133"> <div class="reference-title-banner"> <h4 class="title">Hamann 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0142"> <div class="citation-journal">Hamann A, Garcia‐Puig J, Paul G, Donaldson J, Stewart M. <span class="citation-title">Comparison of fixed‐dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with type 2 diabetes inadequately controlled on metformin alone</span>. <span class="citation"> Experimental and Clinical Endocrinology and Diabetes </span><span class="pubYear">2008</span>;<span class="volume">116</span>(1):6‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18095238" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+fixed%E2%80%90dose+rosiglitazone/metformin+combination+therapy+with+sulphonylurea+plus+metformin+in+overweight+individuals+with+type+2+diabetes+inadequately+controlled+on+metformin+alone+&author=A+Hamann&author=J+Garcia%E2%80%90Puig&author=G+Paul&author=J+Donaldson&author=M+Stewart&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0134"> <div class="reference-title-banner"> <h4 class="title">Haupt 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0143"> <div class="citation-journal">Haupt E, Knick B, Koschinsky T, Liebermeister H, Schneider J, Hirche H. <span class="citation-title">Oral antidiabetic combination therapy with sulphonylureas and metformin</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):224‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936481" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Oral+antidiabetic+combination+therapy+with+sulphonylureas+and+metformin&author=E+Haupt&author=B+Knick&author=T+Koschinsky&author=H+Liebermeister&author=J+Schneider&author=H+Hirche&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0135"> <div class="reference-title-banner"> <h4 class="title">Heine 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0144"> <div class="citation-journal">Heine RJ, Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG. <span class="citation-title">Exanatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2005</span>;<span class="volume">143</span>:559‐569. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16230722" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Exanatide+versus+insulin+glargine+in+patients+with+suboptimally+controlled+type+2+diabetes:+a+randomized+trial+&author=RJ+Heine&author=LF+Gaal&author=D+Johns&author=MJ+Mihm&author=MH+Widel&author=RG+Brodows&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0136"> <div class="reference-title-banner"> <h4 class="title">Herman 1961 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0145"> <div class="citation-journal">Herman JB, Jackson WPU. <span class="citation-title">Dimethyldiguanide (Glucophage, LA 6023) in Diabetes mellitus</span>. <span class="citation"> South African Medical Journal </span><span class="pubYear">1961</span>;<span class="volume">35</span>:286‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13713605" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dimethyldiguanide+(Glucophage,+LA+6023)+in+Diabetes+mellitus&author=JB+Herman&author=WPU+Jackson&publication_year=1961&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0137"> <div class="reference-title-banner"> <h4 class="title">Hermann 1991a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0146"> <div class="citation-journal">Hermann LS, Bitzen PO, Kjellstrom T, Lindgarde F, Schersten B. <span class="citation-title">Comparative efficacy of metformin and glibenclamide in patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):201‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936477" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+efficacy+of+metformin+and+glibenclamide+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=LS+Hermann&author=PO+Bitzen&author=T+Kjellstrom&author=F+Lindgarde&author=B+Schersten&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0147"> <div class="citation-journal">Hermann LS, Kjellstrom T, Nilsson‐Ehle P. <span class="citation-title">Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):174‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936472" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+and+glibenclamide+alone+and+in+combination+on+serum+lipids+and+lipoproteins+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=LS+Hermann&author=T+Kjellstrom&author=P+Nilsson%E2%80%90Ehle&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0138"> <div class="reference-title-banner"> <h4 class="title">Hermann 1991b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0148"> <div class="citation-journal">Hermann LS, Karlsson JE, Sjostrand A. <span class="citation-title">Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1991</span>;<span class="volume">41</span>(3):263‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1748145" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective+comparative+study+in+NIDDM+patients+of+metformin+and+glibenclamide+with+special+reference+to+lipid+profiles+&author=LS+Hermann&author=JE+Karlsson&author=A+Sjostrand&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0139"> <div class="reference-title-banner"> <h4 class="title">Hermann 1994a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0149"> <div class="citation-journal">Hermann LS, Schersten B, Melander A. <span class="citation-title">Antihyperglycaemic efficacy, response prediction and dose‐response relations of treatment with metformin and sulphonylurea, alone and in primary combination</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1994</span>;<span class="volume">11</span>(10):953‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antihyperglycaemic+efficacy,+response+prediction+and+dose%E2%80%90response+relations+of+treatment+with+metformin+and+sulphonylurea,+alone+and+in+primary+combination+&author=LS+Hermann&author=B+Schersten&author=A+Melander&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0140"> <div class="reference-title-banner"> <h4 class="title">Hermann 1994b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0150"> <div class="citation-journal">Hermann LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A. <span class="citation-title">Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double‐blind controlled study [see comments]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1994</span>;<span class="volume">17</span>(10):1100‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7821128" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapeutic+comparison+of+metformin+and+sulfonylurea,+alone+and+in+various+combinations.+A+double%E2%80%90blind+controlled+study+[see+comments]+&author=LS+Hermann&author=B+Schersten&author=PO+Bitzen&author=T+Kjellstrom&author=F+Lindgarde&author=A+Melander&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0141"> <div class="reference-title-banner"> <h4 class="title">Higginbotham 1979 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0151"> <div class="citation-journal">Higginbotham L, Martin FIR. <span class="citation-title">Double‐blind trial of metformin in the therapy of non‐ketotic diabetics</span>. <span class="citation"> Medical Journal of Australia </span><span class="pubYear">1979</span>;<span class="volume">2</span>:154‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Double%E2%80%90blind+trial+of+metformin+in+the+therapy+of+non%E2%80%90ketotic+diabetics&author=L+Higginbotham&author=FIR+Martin&publication_year=1979&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0142"> <div class="reference-title-banner"> <h4 class="title">Hirsch 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0152"> <div class="citation-journal">Hirsch IB. <span class="citation-title">Metformin added to insulin therapy in poorly controlled Type‐II Diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(5):854. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10332695" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+added+to+insulin+therapy+in+poorly+controlled+Type%E2%80%90II+Diabetes&author=IB+Hirsch&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0143"> <div class="reference-title-banner"> <h4 class="title">Hoffmann 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0153"> <div class="citation-journal">Hoffmann J, Spengler M. <span class="citation-title">Efficacy of 24‐week monotherapy with acarbose, metformin, or placebo in dietary‐treated NIDDM patients: the Essen‐II Study</span>. <span class="citation"> American Journal of Medicien </span><span class="pubYear">1997</span>;<span class="volume">103</span>(6):483‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+24%E2%80%90week+monotherapy+with+acarbose,+metformin,+or+placebo+in+dietary%E2%80%90treated+NIDDM+patients:+the+Essen%E2%80%90II+Study+&author=J+Hoffmann&author=M+Spengler&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0144"> <div class="reference-title-banner"> <h4 class="title">Hollenbeck 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0154"> <div class="citation-journal">Hollenbeck CB, Johnston P, Varasteh BB, Chen YD, Reaven GM. <span class="citation-title">Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non‐insulin dependent diabetes by glucose tolerance test criteria</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(5):483‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1752350" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+glucose,+insulin+and+lipid+metabolism+in+patients+with+mild+hypertriglyceridaemia+and+non%E2%80%90insulin+dependent+diabetes+by+glucose+tolerance+test+criteria+&author=CB+Hollenbeck&author=P+Johnston&author=BB+Varasteh&author=YD+Chen&author=GM+Reaven&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0145"> <div class="reference-title-banner"> <h4 class="title">Holman 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0155"> <div class="citation-journal">Holman RR, Steemson J, Turner RC. <span class="citation-title">Sulphonylurea failure in Type 2 Diabetes: Treatment with a basal insulin supplement</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1987</span>;<span class="volume">4</span>:457‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sulphonylurea+failure+in+Type+2+Diabetes:+Treatment+with+a+basal+insulin+supplement&author=RR+Holman&author=J+Steemson&author=RC+Turner&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0146"> <div class="reference-title-banner"> <h4 class="title">Home 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0156"> <div class="citation-journal">Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW. <span class="citation-title">A double‐blind randomized study comparing the effects of continuing or not continuin rosiglitazone and metformin therapy when starting insulin therapy in people with type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>:618‐625. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17403121" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+double%E2%80%90blind+randomized+study+comparing+the+effects+of+continuing+or+not+continuin+rosiglitazone+and+metformin+therapy+when+starting+insulin+therapy+in+people+with+type+2+diabetes+&author=PD+Home&author=CJ+Bailey&author=J+Donaldson&author=H+Chen&author=MW+Stewart&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0147"> <div class="reference-title-banner"> <h4 class="title">Horton 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0157"> <div class="citation-journal">Horton ES, Clinkenbeard C, Gatlin M, Foley J, Mallows S, Shen S. <span class="citation-title">Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(11):1660‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11092289" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nateglinide+alone+and+in+combination+with+metformin+improves+glycemic+control+by+reducing+mealtime+glucose+levels+in+type+2+diabetes+&author=ES+Horton&author=C+Clinkenbeard&author=M+Gatlin&author=J+Foley&author=S+Mallows&author=S+Shen&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0148"> <div class="reference-title-banner"> <h4 class="title">Horton 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0158"> <div class="citation-journal">Horton ES, Doley JE, Shen SG, Baron MA. <span class="citation-title">Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment‐naive patients with thpe 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2004</span>;<span class="volume">20</span>(6):883‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15200747" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+tolerability+of+initial+combination+therapy+with+nateglinide+and+metformin+in+treatment%E2%80%90naive+patients+with+thpe+2+diabetes+&author=ES+Horton&author=JE+Doley&author=SG+Shen&author=MA+Baron&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0149"> <div class="reference-title-banner"> <h4 class="title">Hother‐Nielsen 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0159"> <div class="citation-journal">Hother‐Nielsen O, Schmitz O, Andersen PH, Beck‐Nielsen H, Pedersen O. <span class="citation-title">Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes</span>. <span class="citation"> Acta Endocrinologica (Copenhagen) </span><span class="pubYear">1989</span>;<span class="volume">120</span>(3):257‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+improves+peripheral+but+not+hepatic+insulin+action+in+obese+patients+with+type+II+diabetes+&author=O+Hother%E2%80%90Nielsen&author=O+Schmitz&author=PH+Andersen&author=H+Beck%E2%80%90Nielsen&author=O+Pedersen&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0150"> <div class="reference-title-banner"> <h4 class="title">Hsieh 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0160"> <div class="citation-journal">Hsei CH, He CT, Lee CH, Wu LY, Hung YJ. <span class="citation-title">Both slow‐release and regular‐form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus</span>. <span class="citation"> Metabolism Clinical and Experimental </span><span class="pubYear">2007</span>;<span class="volume">56</span>:1087‐1092. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17618954" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Both+slow%E2%80%90release+and+regular%E2%80%90form+metformin+improve+glycemic+control+without+altering+plasma+visfatin+level+in+patients+with+type+2+diabetes+mellitus+&author=CH+Hsei&author=CT+He&author=CH+Lee&author=LY+Wu&author=YJ+Hung&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0151"> <div class="reference-title-banner"> <h4 class="title">Hsu 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0161"> <div class="citation-journal">Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. <span class="citation-title">The mushroom Agaricus blazei Murill in combination with metformin and glicazide improves insulin resistance in type 2 diabetes: a randomized double‐blinded, and placebo‐controlled clinical trial</span>. <span class="citation"> The Journal of Alternative and Complementary Medicine </span><span class="pubYear">2007</span>;<span class="volume">13</span>:97‐102. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17309383" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+mushroom+Agaricus+blazei+Murill+in+combination+with+metformin+and+glicazide+improves+insulin+resistance+in+type+2+diabetes:+a+randomized+double%E2%80%90blinded,+and+placebo%E2%80%90controlled+clinical+trial+&author=CH+Hsu&author=YL+Liao&author=SC+Lin&author=KC+Hwang&author=P+Chou&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0152"> <div class="reference-title-banner"> <h4 class="title">Hu 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0162"> <div class="citation-journal">Hu M, Tian H, Zhou X, Wu W, Luo Y, Zhang H. <span class="citation-title">[Effect of insulin plus rosiglitazone or metformin on serum N‐terminal pro‐brain natriuretic peptide in type 2 diabetes mellitus: a randomized‐controlled study]. [Chinese]</span>. <span class="citation"> Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering </span><span class="pubYear">2008</span>;<span class="volume">25</span>(3):682‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18693456" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Effect+of+insulin+plus+rosiglitazone+or+metformin+on+serum+N%E2%80%90terminal+pro%E2%80%90brain+natriuretic+peptide+in+type+2+diabetes+mellitus:+a+randomized%E2%80%90controlled+study].+[Chinese]+&author=M+Hu&author=H+Tian&author=X+Zhou&author=W+Wu&author=Y+Luo&author=H+Zhang&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0153"> <div class="reference-title-banner"> <h4 class="title">Hundal 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0163"> <div class="citation-journal">Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli C, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI. <span class="citation-title">Mechanism by which metformin reduces glucose production in type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>:2063‐2069. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11118008" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mechanism+by+which+metformin+reduces+glucose+production+in+type+2+diabetes&author=RS+Hundal&author=M+Krssak&author=S+Dufour&author=D+Laurent&author=V+Lebon&author=C+Chandramouli&author=SE+Inzucchi&author=WC+Schumann&author=KF+Petersen&author=BR+Landau&author=GI+Shulman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0154"> <div class="reference-title-banner"> <h4 class="title">Hussain 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0164"> <div class="citation-journal">Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS. <span class="citation-title">Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin</span>. <span class="citation"> Saudi Medical Journal </span><span class="pubYear">2006</span>;<span class="volume">27</span>(10):1483‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17013468" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+melatonin+and+zinc+on+glycemic+control+in+type+2+diabetic+patients+poorly+controlled+with+metformin+&author=SA+Hussain&author=HM+Khadim&author=BH+Khalaf&author=SH+Ismail&author=KI+Hussein&author=AS+Sahib&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0155"> <div class="reference-title-banner"> <h4 class="title">Imano 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0165"> <div class="citation-journal">Imano E, Kanda T, Nakatani Y, Nishida T, Arai K, Motomura M, et al. <span class="citation-title">Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(12):2135‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9839106" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+troglitazone+on+microalbuminuria+in+patients+with+incipient+diabetic+nephropathy&author=E+Imano&author=T+Kanda&author=Y+Nakatani&author=T+Nishida&author=K+Arai&author=M+Motomura&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0156"> <div class="reference-title-banner"> <h4 class="title">Inzucchi 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0166"> <div class="citation-journal">Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al. <span class="citation-title">Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus [see comments]</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">338</span>(13):867‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9516221" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+metabolic+effects+of+metformin+and+troglitazone+in+type+II+diabetes+mellitus+[see+comments]+&author=SE+Inzucchi&author=DG+Maggs&author=GR+Spollett&author=SL+Page&author=FS+Rife&author=V+Walton&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0157"> <div class="reference-title-banner"> <h4 class="title">Jackson 1962 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0167"> <div class="citation-journal">Jackson WPU. <span class="citation-title">Combined oral therapy in Diabetes</span>. <span class="citation"> South African Medical Journal </span><span class="pubYear">1962</span>;<span class="volume">36</span>:727‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14450632" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+oral+therapy+in+Diabetes&author=WPU+Jackson&publication_year=1962&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0158"> <div class="reference-title-banner"> <h4 class="title">Jackson 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0168"> <div class="citation-journal">Jackson RA, Hawa MI, Jaspan JB, Sim BM, Disilvio L, Featherbe D, et al. <span class="citation-title">Mechanism of metformin action in non‐insulin‐dependent diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">1987</span>;<span class="volume">36</span>(5):632‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3552795" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mechanism+of+metformin+action+in+non%E2%80%90insulin%E2%80%90dependent+diabetes&author=RA+Jackson&author=MI+Hawa&author=JB+Jaspan&author=BM+Sim&author=L+Disilvio&author=D+Featherbe&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0159"> <div class="reference-title-banner"> <h4 class="title">Jadzinsky 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0169"> <div class="citation-journal">Jadzinsky M, Pfutzner A, Paz‐Pacheco E, Xu Z, Allen E, Chen R, et al. <span class="citation-title">Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: A randomized controlled trial</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(6):611‐22. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Saxagliptin+given+in+combination+with+metformin+as+initial+therapy+improves+glycaemic+control+in+patients+with+type+2+diabetes+compared+with+either+monotherapy:+A+randomized+controlled+trial+&author=M+Jadzinsky&author=A+Pfutzner&author=E+Paz%E2%80%90Pacheco&author=Z+Xu&author=E+Allen&author=R+Chen&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0160"> <div class="reference-title-banner"> <h4 class="title">Jager 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0170"> <div class="citation-journal">Jager JD, Kooy A, Lehert P, Bets D, Wulffele MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJM, Stehouwer CDA. <span class="citation-title">Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial</span>. <span class="citation"> Journal of Internal Medicine </span><span class="pubYear">2005</span>;<span class="volume">257</span>:100‐109. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15606381" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+short%E2%80%90term+treatment+with+metformin+on+markers+of+endothelial+function+and+inflammatory+activity+in+type+2+diabetes+mellitus:+a+randomized,+placebo%E2%80%90controlled+trial+&author=JD+Jager&author=A+Kooy&author=P+Lehert&author=D+Bets&author=MG+Wulffele&author=T+Teerlink&author=PG+Scheffer&author=CG+Schalkwijk&author=AJM+Donker&author=CDA+Stehouwer&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0161"> <div class="reference-title-banner"> <h4 class="title">Janka 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0171"> <div class="citation-journal">Janka HU, Plewe G, Busch K. <span class="citation-title">Comination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus</span>. <span class="citation"> Journal of the American Geriatric Society </span><span class="pubYear">2007</span>;<span class="volume">55</span>:182‐188. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comination+of+oral+antidiabetic+agents+with+basal+insulin+versus+premixed+insulin+alone+in+randomized+elderly+patients+with+type+2+diabetes+mellitus+&author=HU+Janka&author=G+Plewe&author=K+Busch&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0162"> <div class="reference-title-banner"> <h4 class="title">Jeppesen 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0172"> <div class="citation-journal">Jeppesen J, Zhou M‐Y, Chen Y‐D I, Reaven GM. <span class="citation-title">Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1994</span>;<span class="volume">17</span>(10):1093‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7821127" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+postprandial+lipemia+in+patients+with+fairly+to+poorly+controlled+NIDDM+&author=J+Jeppesen&author=M%E2%80%90Y+Zhou&author=I+ChenY%E2%80%90D&author=GM+Reaven&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0163"> <div class="reference-title-banner"> <h4 class="title">Johansen 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0173"> <div class="citation-journal">Johansen K. <span class="citation-title">Acarbose treatment of sulfonylurea‐treated non‐insulin dependent diabetics. A double‐blind cross‐over comparison of an alpha‐glucosidase inhibitor with metformin</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1984</span>;<span class="volume">10</span>(4):219‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6391973" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+treatment+of+sulfonylurea%E2%80%90treated+non%E2%80%90insulin+dependent+diabetics.+A+double%E2%80%90blind+cross%E2%80%90over+comparison+of+an+alpha%E2%80%90glucosidase+inhibitor+with+metformin+&author=K+Johansen&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0164"> <div class="reference-title-banner"> <h4 class="title">Johnson 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0174"> <div class="citation-journal">Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG, et al. <span class="citation-title">The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients</span>. <span class="citation"> Metabolism </span><span class="pubYear">1993</span>;<span class="volume">42</span>(9):1217‐22. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8412779" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+impact+of+metformin+therapy+on+hepatic+glucose+production+and+skeletal+muscle+glycogen+synthase+activity+in+overweight+type+II+diabetic+patients+&author=AB+Johnson&author=JM+Webster&author=CF+Sum&author=L+Heseltine&author=M+Argyraki&author=BG+Cooper&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0165"> <div class="reference-title-banner"> <h4 class="title">Johnson 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0175"> <div class="citation-journal">Johnson M, Krosnick A, Carson P, McDade AM, Laraway K. <span class="citation-title">A retrospective chart review of uncontrolled use of metformin as an add‐on therapy in type 2 diabetes</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">1998</span>;<span class="volume">20</span>(4):691‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9737829" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+retrospective+chart+review+of+uncontrolled+use+of+metformin+as+an+add%E2%80%90on+therapy+in+type+2+diabetes+&author=M+Johnson&author=A+Krosnick&author=P+Carson&author=AM+McDade&author=K+Laraway&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0166"> <div class="reference-title-banner"> <h4 class="title">Jones 2000 b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0176"> <div class="citation-journal">Jones NP, Mather R, Owen S, Porter LE, Patwardhan R. <span class="citation-title">Long‐term efficacy of rosiglitazone as monotherapy or in combination with metformin</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A192. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+efficacy+of+rosiglitazone+as+monotherapy+or+in+combination+with+metformin&author=NP+Jones&author=R+Mather&author=S+Owen&author=LE+Porter&author=R+Patwardhan&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0167"> <div class="reference-title-banner"> <h4 class="title">Jones 2000a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0177"> <div class="citation-journal">Jones T, Jones NP, Sautter M. <span class="citation-title">Addition of rosiglitazone to metformin is effective in obese, insulin‐resistant patients with Type 2 Diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A191. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+rosiglitazone+to+metformin+is+effective+in+obese,+insulin%E2%80%90resistant+patients+with+Type+2+Diabetes+&author=T+Jones&author=NP+Jones&author=M+Sautter&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0168"> <div class="reference-title-banner"> <h4 class="title">Jones 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0178"> <div class="citation-journal">Jones KL, Arslanian S, Peterokova VA, Park J‐S, Tomlinson MJ. <span class="citation-title">Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:89‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11772907" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+in+pediatric+patients+with+type+2+diabetes:+a+randomized+controlled+trial+&author=KL+Jones&author=S+Arslanian&author=VA+Peterokova&author=J%E2%80%90S+Park&author=MJ+Tomlinson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0169"> <div class="reference-title-banner"> <h4 class="title">Josephkutty 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0179"> <div class="citation-journal">Josephkutty S, Potter JM. <span class="citation-title">Comparison of tolbutamide and metformin in elderly diabetic patients</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1990</span>;<span class="volume">7</span>(6):510‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+tolbutamide+and+metformin+in+elderly+diabetic+patients&author=S+Josephkutty&author=JM+Potter&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0170"> <div class="reference-title-banner"> <h4 class="title">Josse 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0180"> <div class="citation-journal">Josse RG. <span class="citation-title">Acarbose for the treatment of type II diabetes: the results of a Canadian multi‐centre trial [published erratum appears in Diabetes Res Clin Pract 1995 Sep;29(3):215]</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1995</span>;<span class="volume">28</span>(Suppl):S167‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8529510" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+the+treatment+of+type+II+diabetes:+the+results+of+a+Canadian+multi%E2%80%90centre+trial+[published+erratum+appears+in+Diabetes+Res+Clin+Pract+1995+Sep;29(3):215]+&author=RG+Josse&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0171"> <div class="reference-title-banner"> <h4 class="title">Jung 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0181"> <div class="citation-journal">Jung HS, Youhn B‐S, Cho YM, Yu K‐Y, Park HJ, Shin CS, Kim SY, Lee HK, Park KS. <span class="citation-title">The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus</span>. <span class="citation"> Metabolism Clinical and Experimental </span><span class="pubYear">2005</span>;<span class="volume">54</span>:314‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15736108" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+rosiglitazone+and+metformin+on+the+plasma+concentrations+of+resistin+in+patients+with+type+2+diabetes+mellitus+&author=HS+Jung&author=B%E2%80%90S+Youhn&author=YM+Cho&author=K%E2%80%90Y+Yu&author=HJ+Park&author=CS+Shin&author=SY+Kim&author=HK+Lee&author=KS+Park&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0172"> <div class="reference-title-banner"> <h4 class="title">Juurinen 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0182"> <div class="citation-journal">Juurinen L, Tiikkainen M, Saltevo J, Nikkila K, Lanki H, Leppavuori E, et al. <span class="citation-title">Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2009</span>;<span class="volume">26</span>(4):409‐15. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19388972" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nateglinide+combination+therapy+with+basal+insulin+and+metformin+in+patients+with+Type+2+diabetes+&author=L+Juurinen&author=M+Tiikkainen&author=J+Saltevo&author=K+Nikkila&author=H+Lanki&author=E+Leppavuori&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0173"> <div class="reference-title-banner"> <h4 class="title">Kabadi 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0183"> <div class="citation-journal">Kabadi UM, Kabadi M. <span class="citation-title">Comparative eficacy of glimepiride and/or metformin with insulin in type 2 diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2006</span>;<span class="volume">72</span>:265‐270. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16406190" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+eficacy+of+glimepiride+and/or+metformin+with+insulin+in+type+2+diabetes&author=UM+Kabadi&author=M+Kabadi&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0174"> <div class="reference-title-banner"> <h4 class="title">Kadoglou 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0184"> <div class="citation-journal">Kadoglou NPE, Iliadis F, Angelopoulou N, Perrea D, Liapis CD, Alevizos M. <span class="citation-title">Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2008</span>;<span class="volume">25</span>(3):333‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18307460" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beneficial+effects+of+rosiglitazone+on+novel+cardiovascular+risk+factors+in+patients+with+Type+2+diabetes+mellitus+&author=NPE+Kadoglou&author=F+Iliadis&author=N+Angelopoulou&author=D+Perrea&author=CD+Liapis&author=M+Alevizos&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0175"> <div class="reference-title-banner"> <h4 class="title">Kahn 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0185"> <div class="citation-journal">Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill C, Zinman B, Viberti G. <span class="citation-title">Glycemic durability of rosiglitazone, metformin or glyburide monotherapy</span>. <span class="citation"> The New England Journal of Medicine </span><span class="pubYear">2006</span>;<span class="volume">355</span>:2427‐2443. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17145742" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+durability+of+rosiglitazone,+metformin+or+glyburide+monotherapy&author=SE+Kahn&author=SM+Haffner&author=MA+Heise&author=WH+Herman&author=RR+Holman&author=NP+Jones&author=BG+Kravitz&author=JM+Lachin&author=C+O'Neill&author=B+Zinman&author=G+Viberti&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0176"> <div class="reference-title-banner"> <h4 class="title">Kaku 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0186"> <div class="citation-journal">Kaku K. <span class="citation-title">Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: A double‐blind, placebo‐controlled, clinical trial</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2009</span>, (5):1111‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19309251" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+therapy+with+metformin+plus+pioglitazone+in+the+treatment+of+patients+with+type+2+diabetes:+A+double%E2%80%90blind,+placebo%E2%80%90controlled,+clinical+trial+&author=K+Kaku&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0177"> <div class="reference-title-banner"> <h4 class="title">Kann 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0187"> <div class="citation-journal">Kann PH, Wascher T, Zackova V, Moeller J, Medding J, Azocs A, Mokan M, Mrevlje F, Regulski M. <span class="citation-title">Starting insulin therapy in type 2 diabetes: twice‐daily biphasic insulin aspart 30 plus metformin versus once‐daily insulin glargine plus glimepiride</span>. <span class="citation"> Experimental and Clinical Endocrinology and Diabetes </span><span class="pubYear">2006</span>;<span class="volume">114</span>:527‐532. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17115351" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Starting+insulin+therapy+in+type+2+diabetes:+twice%E2%80%90daily+biphasic+insulin+aspart+30+plus+metformin+versus+once%E2%80%90daily+insulin+glargine+plus+glimepiride+&author=PH+Kann&author=T+Wascher&author=V+Zackova&author=J+Moeller&author=J+Medding&author=A+Azocs&author=M+Mokan&author=F+Mrevlje&author=M+Regulski&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0178"> <div class="reference-title-banner"> <h4 class="title">Karlsson 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0188"> <div class="citation-journal">Karlsson HKR, Hallsten K, Bjornholm M, Tsuchida H, Chibalin AV, Virtanen KA, Heinonen OJ, Lonnqvist F, Nuutila P, Zierath JR. <span class="citation-title">Effects of metformin anad rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2005</span>;<span class="volume">54</span>:1459‐67. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15855334" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+anad+rosiglitazone+treatment+on+insulin+signaling+and+glucose+uptake+in+patients+with+newly+diagnosed+type+2+diabetes+&author=HKR+Karlsson&author=K+Hallsten&author=M+Bjornholm&author=H+Tsuchida&author=AV+Chibalin&author=KA+Virtanen&author=OJ+Heinonen&author=F+Lonnqvist&author=P+Nuutila&author=JR+Zierath&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0179"> <div class="reference-title-banner"> <h4 class="title">Kawai 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0189"> <div class="citation-journal">Kawai T, Funae O, Shimada A, Tabata M, Hirata T, Atsumi Y, et al. <span class="citation-title">Effects of pretreatment with low‐dose metformin on metabolic parameters and weight gain by pioglitazone in Japanese patients with type 2 diabetes</span>. <span class="citation"> Internal Medicine </span><span class="pubYear">2008</span>;<span class="volume">47</span>(13):1181‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18591838" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+pretreatment+with+low%E2%80%90dose+metformin+on+metabolic+parameters+and+weight+gain+by+pioglitazone+in+Japanese+patients+with+type+2+diabetes+&author=T+Kawai&author=O+Funae&author=A+Shimada&author=M+Tabata&author=T+Hirata&author=Y+Atsumi&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0180"> <div class="reference-title-banner"> <h4 class="title">Khanolkar 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0190"> <div class="citation-journal">Khanolkar MP, Morris RHK, Thomas AW, Bolusani H, Roberts AW, Geen J, et al. <span class="citation-title">Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus‐An effect probably mediated by direct platelet PPARgamma activation</span>. <span class="citation"> Atherosclerosis </span><span class="pubYear">2008</span>;<span class="volume">197</span>(2):718‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17765245" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+produces+a+greater+reduction+in+circulating+platelet+activity+compared+with+gliclazide+in+patients+with+type+2+diabetes+mellitus%E2%80%90An+effect+probably+mediated+by+direct+platelet+PPARgamma+activation+&author=MP+Khanolkar&author=RHK+Morris&author=AW+Thomas&author=H+Bolusani&author=AW+Roberts&author=J+Geen&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0181"> <div class="reference-title-banner"> <h4 class="title">Kiayias 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0191"> <div class="citation-journal">Kiayias JA, Vlachou ED, Papadodima EL. <span class="citation-title">Metformin and Lipoprotein (a) levels</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(4):859. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10332699" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+Lipoprotein+(a)+levels&author=JA+Kiayias&author=ED+Vlachou&author=EL+Papadodima&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0182"> <div class="reference-title-banner"> <h4 class="title">Kim 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0192"> <div class="citation-journal">Kim Y‐B, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar Su, Henry RR, Kahn BB. <span class="citation-title">Troglitazone but not metformin restores insulin‐stimulated phosphoinositide 3‐kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects</span>. <span class="citation"> Diabetes </span><span class="pubYear">2002</span>;<span class="volume">51</span>:443‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11812753" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Troglitazone+but+not+metformin+restores+insulin%E2%80%90stimulated+phosphoinositide+3%E2%80%90kinase+activity+and+increases+p110beta+protein+levels+in+skeletal+muscle+of+type+2+diabetic+subjects+&author=Y%E2%80%90B+Kim&author=TP+Ciaraldi&author=A+Kong&author=D+Kim&author=N+Chu&author=P+Mohideen&author=Su+Mudaliar&author=RR+Henry&author=BB+Kahn&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0183"> <div class="reference-title-banner"> <h4 class="title">Kim 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0193"> <div class="citation-journal">Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Cung CH, Lee KW, Nam CM, Lee HC. <span class="citation-title">Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin‐18 is an independent factor for the improvement of homeostasis model assessment‐beta in type 2 diabetes mellitus</span>. <span class="citation"> Clinical Endocrinology </span><span class="pubYear">2007</span>;<span class="volume">66</span>:282‐289. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17224000" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+and+metformin+on+inflammatory+markers+and+adipokines:+decrease+in+interleukin%E2%80%9018+is+an+independent+factor+for+the+improvement+of+homeostasis+model+assessment%E2%80%90beta+in+type+2+diabetes+mellitus+&author=HJ+Kim&author=ES+Kang&author=DJ+Kim&author=SH+Kim&author=CW+Ahn&author=BS+Cha&author=M+Nam&author=CH+Cung&author=KW+Lee&author=CM+Nam&author=HC+Lee&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0184"> <div class="reference-title-banner"> <h4 class="title">Kirk 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0194"> <div class="citation-journal">Kirk JK, Pearce KA, Michielutte R, Summerson JH. <span class="citation-title">Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?</span>. <span class="citation"> Journal of Family Practice </span><span class="pubYear">1999</span>;<span class="volume">48</span>(11):879‐82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10907625" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Troglitazone+or+metformin+in+combination+with+sulfonylureas+for+patients+with+type+2+diabetes?+&author=JK+Kirk&author=KA+Pearce&author=R+Michielutte&author=JH+Summerson&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0185"> <div class="reference-title-banner"> <h4 class="title">Klein 1975 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0195"> <div class="citation-journal">Klein W, Herrmann A. <span class="citation-title">[Therapy of diabetes mellitus using metformin. Clinical study on 60 patients]</span>. <span class="citation"> Medizinische Welt </span><span class="pubYear">1975</span>;<span class="volume">26</span>(11):516‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1091803" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Therapy+of+diabetes+mellitus+using+metformin.+Clinical+study+on+60+patients]&author=W+Klein&author=A+Herrmann&publication_year=1975&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0186"> <div class="reference-title-banner"> <h4 class="title">Klein 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0196"> <div class="citation-journal">Klein W. <span class="citation-title">Sulfonylurea‐metformin‐combination versus sulfonylurea‐insulin‐combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):235‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936483" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sulfonylurea%E2%80%90metformin%E2%80%90combination+versus+sulfonylurea%E2%80%90insulin%E2%80%90combination+in+secondary+failures+of+sulfonylurea+monotherapy.+Results+of+a+prospective+randomized+study+in+50+patients+&author=W+Klein&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0187"> <div class="reference-title-banner"> <h4 class="title">Kooy 2009a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0197"> <div class="citation-journal">Kooy A, Jager J, Lehert P, Bets D, Wulffele MG, Donker AJM, et al. <span class="citation-title">Long‐term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">169</span>(6):616‐25. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19307526" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+metformin+on+metabolism+and+microvascular+and+macrovascular+disease+in+patients+with+type+2+diabetes+mellitus+&author=A+Kooy&author=J+Jager&author=P+Lehert&author=D+Bets&author=MG+Wulffele&author=AJM+Donker&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0198"> <div class="citation-journal">Kooy A, Jager JD, Lehert P, Bets D, Wulffele MG, Donker AJM, et al. <span class="citation-title">Increase in value of adding metformin to insulin therapy in type 2 diabetes: More favorable weight with less macrovascular complications</span>. <span class="citation"> Nederlands Tijdschrift voor Geneeskunde </span><span class="pubYear">2009</span>;<span class="volume">153</span>(21):1005‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Increase+in+value+of+adding+metformin+to+insulin+therapy+in+type+2+diabetes:+More+favorable+weight+with+less+macrovascular+complications+&author=A+Kooy&author=JD+Jager&author=P+Lehert&author=D+Bets&author=MG+Wulffele&author=AJM+Donker&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0188"> <div class="reference-title-banner"> <h4 class="title">Kudolo 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0199"> <div class="citation-journal">Kudolo GB, Wang W, Javors M, Blodgett J. <span class="citation-title">The effect of the ingestions of Ginkgo Biloba extract (EGb 761) on the pharmacokinetics of metformin in non‐diabetic and type 2 diabetic subjects ‐ A double‐blind placebo‐controlled crossover study</span>. <span class="citation"> Clinical Nutrition </span><span class="pubYear">2006</span>;<span class="volume">25</span>:606‐616. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16698134" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+the+ingestions+of+Ginkgo+Biloba+extract+(EGb+761)+on+the+pharmacokinetics+of+metformin+in+non%E2%80%90diabetic+and+type+2+diabetic+subjects+%E2%80%90+A+double%E2%80%90blind+placebo%E2%80%90controlled+crossover+study+&author=GB+Kudolo&author=W+Wang&author=M+Javors&author=J+Blodgett&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0189"> <div class="reference-title-banner"> <h4 class="title">Kusaka 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0200"> <div class="citation-journal">Kusaka I, Nagasaka S, Horie H, Ishibashi S. <span class="citation-title">Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: A possible role in weight stability?</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10</span>(11):1039‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin,+but+not+pioglitazone,+decreases+postchallenge+plasma+ghrelin+levels+in+type+2+diabetic+patients:+A+possible+role+in+weight+stability?+&author=I+Kusaka&author=S+Nagasaka&author=H+Horie&author=S+Ishibashi&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0190"> <div class="reference-title-banner"> <h4 class="title">Kvapil 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0201"> <div class="citation-journal">Kvapil M, Swatko A, Kilberg C, Shestakova M. <span class="citation-title">Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2006</span>;<span class="volume">8</span>:39‐48. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biphasic+insulin+aspart+30+plus+metformin:+an+effective+combination+in+type+2+diabetes&author=M+Kvapil&author=A+Swatko&author=C+Kilberg&author=M+Shestakova&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0191"> <div class="reference-title-banner"> <h4 class="title">Lalau 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0202"> <div class="citation-journal">Lalau JD, Vermersch A, Hary L, Andrejak M, Isnard F, Quichaud J. <span class="citation-title">Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly)</span>. <span class="citation"> International Journal Clinical Pharmacocology Therapeutics and Toxicology </span><span class="pubYear">1990</span>;<span class="volume">28</span>(8):329‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Type+2+diabetes+in+the+elderly:+an+assessment+of+metformin+(metformin+in+the+elderly)&author=JD+Lalau&author=A+Vermersch&author=L+Hary&author=M+Andrejak&author=F+Isnard&author=J+Quichaud&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0192"> <div class="reference-title-banner"> <h4 class="title">Lalor 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0203"> <div class="citation-journal">Lalor BC, Bhatnagar D, Winocour PH, Ishola M, Arrol S, Brading M, et al. <span class="citation-title">Placebo‐controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1990</span>;<span class="volume">7</span>(3):242‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Placebo%E2%80%90controlled+trial+of+the+effects+of+guar+gum+and+metformin+on+fasting+blood+glucose+and+serum+lipids+in+obese,+type+2+diabetic+patients+&author=BC+Lalor&author=D+Bhatnagar&author=PH+Winocour&author=M+Ishola&author=S+Arrol&author=M+Brading&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0193"> <div class="reference-title-banner"> <h4 class="title">Lam 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0204"> <div class="citation-journal">Lam KSL, Tiu SC, Tsang MW, Ip TP, Tam SCF. <span class="citation-title">Acarbose in NIDDM patients with poor control on conventional oral agents</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(7):1154‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9653611" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+in+NIDDM+patients+with+poor+control+on+conventional+oral+agents&author=KSL+Lam&author=SC+Tiu&author=MW+Tsang&author=TP+Ip&author=SCF+Tam&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0194"> <div class="reference-title-banner"> <h4 class="title">Laurenti 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0205"> <div class="citation-journal">Laurenti O, Bravi MC, Faldetta MC, Mattia G. <span class="citation-title">[Evaluation of the efficacy of metformin‐glibenclamide treatment in overweight non‐insulin dependent diabetics]</span>. <span class="citation"> La Clinica Terapeutica </span><span class="pubYear">1992</span>;<span class="volume">140</span>(3):259‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1568370" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Evaluation+of+the+efficacy+of+metformin%E2%80%90glibenclamide+treatment+in+overweight+non%E2%80%90insulin+dependent+diabetics]+&author=O+Laurenti&author=MC+Bravi&author=MC+Faldetta&author=G+Mattia&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0195"> <div class="reference-title-banner"> <h4 class="title">Lawrence 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0206"> <div class="citation-journal">Lawrence JM, Reid J, Taylor GJ, Stirling C, Reckless J. <span class="citation-title">Favorable effects of pioglitazone and metformin compared with glicazide on lipoprotein subgractions in overweight patients with early type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>:41‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14693964" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Favorable+effects+of+pioglitazone+and+metformin+compared+with+glicazide+on+lipoprotein+subgractions+in+overweight+patients+with+early+type+2+diabetes+&author=JM+Lawrence&author=J+Reid&author=GJ+Taylor&author=C+Stirling&author=J+Reckless&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0196"> <div class="reference-title-banner"> <h4 class="title">Lean 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0207"> <div class="citation-journal">Lean ME, Borthwick LJ. <span class="citation-title">Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1983</span>;<span class="volume">25</span>(1):41‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6352281" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Ciclazindol:+an+oral+agent+with+weight+reducing+properties+and+hypoglycaemic+activity&author=ME+Lean&author=LJ+Borthwick&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0197"> <div class="reference-title-banner"> <h4 class="title">Lee 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0208"> <div class="citation-journal">Lee A, Morley JE. <span class="citation-title">Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non‐insulin‐dependent diabetes</span>. <span class="citation"> Obesity Research </span><span class="pubYear">1998</span>;<span class="volume">6</span>(1):47‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9526970" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+decreases+food+consumption+and+induces+weight+loss+in+subjects+with+obesity+with+type+II+non%E2%80%90insulin%E2%80%90dependent+diabetes+&author=A+Lee&author=JE+Morley&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0198"> <div class="reference-title-banner"> <h4 class="title">Lewin 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0209"> <div class="citation-journal">Lewin A, Lipetz R, Wu J, Schwartz S. <span class="citation-title">Comparison of extended‐release metformin in combination with a sulfonylurea (Glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double‐blind, randomized, contgrolled, phase III study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2007</span>;<span class="volume">29</span>:844‐855. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17697903" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+extended%E2%80%90release+metformin+in+combination+with+a+sulfonylurea+(Glyburide)+to+sulfonylurea+monotherapy+in+adult+patients+with+type+2+diabetes:+a+multicenter,+double%E2%80%90blind,+randomized,+contgrolled,+phase+III+study+&author=A+Lewin&author=R+Lipetz&author=J+Wu&author=S+Schwartz&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0199"> <div class="reference-title-banner"> <h4 class="title">Li 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0210"> <div class="citation-journal">Li K, Li L, Yang M, Zong H, Liu H, Yang G. <span class="citation-title">Effects of rosiglitazone on fasting plasma fibroblast growth factor‐21 levels in patients with type 2 diabetes mellitus</span>. <span class="citation"> European Journal of Endocrinology </span><span class="pubYear">2009</span>;<span class="volume">161</span>(3):391‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19528204" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+on+fasting+plasma+fibroblast+growth+factor%E2%80%9021+levels+in+patients+with+type+2+diabetes+mellitus+&author=K+Li&author=L+Li&author=M+Yang&author=H+Zong&author=H+Liu&author=G+Yang&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0200"> <div class="reference-title-banner"> <h4 class="title">Lingvay 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0211"> <div class="citation-journal">Lingvay I, Raskin P, Szczepaniak LS. <span class="citation-title">Effect of insulin‐metformin combination on hepatic statosis in patients with type 2 diabetes</span>. <span class="citation"> Journal of Diabets and its Complications </span><span class="pubYear">2007</span>;<span class="volume">21</span>:137‐142. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+insulin%E2%80%90metformin+combination+on+hepatic+statosis+in+patients+with+type+2+diabetes+&author=I+Lingvay&author=P+Raskin&author=LS+Szczepaniak&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0201"> <div class="reference-title-banner"> <h4 class="title">List 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0212"> <div class="citation-journal">List JF, Woo V, Morales E, Tang W, Fiedorek FT. <span class="citation-title">Sodium‐glucose cotransport inhibition with dapagliflozin in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(4):650‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19114612" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sodium%E2%80%90glucose+cotransport+inhibition+with+dapagliflozin+in+type+2+diabetes&author=JF+List&author=V+Woo&author=E+Morales&author=W+Tang&author=FT+Fiedorek&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0202"> <div class="reference-title-banner"> <h4 class="title">Lord 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0213"> <div class="citation-journal">Lord JM, White SI, Bailey CJ, Atkins TW, Fletcher RF, Taylor KG. <span class="citation-title">Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes</span>. <span class="citation"> British Medical Journal (Clinical Research Edition) </span><span class="pubYear">1983</span>;<span class="volume">286</span>(6368):830‐1. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+insulin+receptor+binding+and+glycaemic+control+in+type+II+diabetes&author=JM+Lord&author=SI+White&author=CJ+Bailey&author=TW+Atkins&author=RF+Fletcher&author=KG+Taylor&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0203"> <div class="reference-title-banner"> <h4 class="title">Luna 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0214"> <div class="citation-journal">Luna V, Casauban L, Sahan MP, Gomez‐Paspet J, Powe JL, Miura A, Rivas J, Standaert ML, Farese RV. <span class="citation-title">Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol‐3,4,5‐(PO4)3 in muscle of diabetic subjects</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2006</span>;<span class="volume">49</span>:375‐382. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16395615" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+improves+atypical+protein+kinase+C+activation+by+insulin+and+phosphatidylinositol%E2%80%903,4,5%E2%80%90(PO4)3+in+muscle+of+diabetic+subjects+&author=V+Luna&author=L+Casauban&author=MP+Sahan&author=J+Gomez%E2%80%90Paspet&author=JL+Powe&author=A+Miura&author=J+Rivas&author=ML+Standaert&author=RV+Farese&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0204"> <div class="reference-title-banner"> <h4 class="title">Lund 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0215"> <div class="citation-journal">Lund SS, Tarnow K, Stehouwer CCDA, Schalkwijk CG, Frandsen M, Smidt UM, Persen O, Parving HH, Vaag A. <span class="citation-title">Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>:394‐407. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Targeting+hyperglycaemia+with+either+metformin+or+repaglinide+in+non%E2%80%90obese+patients+with+type+2+diabetes:+results+from+a+randomized+crossover+trial+&author=SS+Lund&author=K+Tarnow&author=CCDA+Stehouwer&author=CG+Schalkwijk&author=M+Frandsen&author=UM+Smidt&author=O+Persen&author=HH+Parving&author=A+Vaag&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0205"> <div class="reference-title-banner"> <h4 class="title">Lund 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0216"> <div class="citation-journal">Lund SS, Tarnow L, Stehouwer CDA, Schalkwijk CG, Teerlink T, Gram J, et al. <span class="citation-title">Impact of metformin versus repaglinide on non‐glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non‐obese patients with type 2 diabetes</span>. <span class="citation"> European Journal of Endocrinology </span><span class="pubYear">2008</span>, (5):631‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18426821" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+metformin+versus+repaglinide+on+non%E2%80%90glycaemic+cardiovascular+risk+markers+related+to+inflammation+and+endothelial+dysfunction+in+non%E2%80%90obese+patients+with+type+2+diabetes+&author=SS+Lund&author=L+Tarnow&author=CDA+Stehouwer&author=CG+Schalkwijk&author=T+Teerlink&author=J+Gram&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0206"> <div class="reference-title-banner"> <h4 class="title">Lunetta 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0217"> <div class="citation-journal">Lunetta M, DiMauro M. <span class="citation-title">Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non‐insulin dependent diabetic patients</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1996</span>;<span class="volume">33</span>(1):53‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8877276" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Different+effect+of+acute+and+chronic+oral+metformin+administration+on+glucose+and+insulin+response+to+bread+and+to+pasta+in+non%E2%80%90insulin+dependent+diabetic+patients+&author=M+Lunetta&author=M+DiMauro&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0207"> <div class="reference-title-banner"> <h4 class="title">Makimattila 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0218"> <div class="citation-journal">Makimattila S, Nikkila K, Yki‐Jarvinen H. <span class="citation-title">Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">42</span>(4):406‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10230643" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Causes+of+weight+gain+during+insulin+therapy+with+and+without+metformin+in+patients+with+Type+II+diabetes+mellitus+&author=S+Makimattila&author=K+Nikkila&author=H+Yki%E2%80%90Jarvinen&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0208"> <div class="reference-title-banner"> <h4 class="title">Manzella 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0219"> <div class="citation-journal">Manzella D, Grella R, Esposito K, Giugliano D, Barbagallo M, Paolisso G. <span class="citation-title">Blood pressure and cardiac auonomic nervous system in obese type 2 diabetic patients: effect of metformin administration</span>. <span class="citation"> American Journal of Hypertension </span><span class="pubYear">2004</span>;<span class="volume">17</span>:223‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15001195" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Blood+pressure+and+cardiac+auonomic+nervous+system+in+obese+type+2+diabetic+patients:+effect+of+metformin+administration+&author=D+Manzella&author=R+Grella&author=K+Esposito&author=D+Giugliano&author=M+Barbagallo&author=G+Paolisso&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0209"> <div class="reference-title-banner"> <h4 class="title">Marena 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0220"> <div class="citation-journal">Marena S, Tagliaferro V, Montegrosso G, Pagano A, Scaglione L, Pagano G. <span class="citation-title">Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes [see comments]</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1994</span>;<span class="volume">20</span>(1):15‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8056129" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+metformin+addition+to+chronic+glibenclamide+treatment+in+type+2+diabetes+[see+comments]+&author=S+Marena&author=V+Tagliaferro&author=G+Montegrosso&author=A+Pagano&author=L+Scaglione&author=G+Pagano&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0210"> <div class="reference-title-banner"> <h4 class="title">Marfella 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0221"> <div class="citation-journal">Marfella R, Acampora R, Verrazzo G, Ziccardi P, Rosa N, Giunta R, et al. <span class="citation-title">Metformin improves hemodynamic and rheological responses to L‐arginine in NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(9):934‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8875085" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+improves+hemodynamic+and+rheological+responses+to+L%E2%80%90arginine+in+NIDDM+patients&author=R+Marfella&author=R+Acampora&author=G+Verrazzo&author=P+Ziccardi&author=N+Rosa&author=R+Giunta&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0211"> <div class="reference-title-banner"> <h4 class="title">Mari 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0222"> <div class="citation-journal">Mari A, Nielsen LL, Nanayakkara N, DeFronzo RA, Ferrannini E, Halseth A. <span class="citation-title">Mathematical modeling shows exenatide improved beta‐cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea</span>. <span class="citation"> Hormone and Matabolism Research </span><span class="pubYear">2006</span>;<span class="volume">38</span>:838‐844. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Mathematical+modeling+shows+exenatide+improved+beta%E2%80%90cell+function+in+patients+with+type+2+diabetes+treated+with+metformin+or+metformin+and+a+sulfonylurea+&author=A+Mari&author=LL+Nielsen&author=N+Nanayakkara&author=RA+DeFronzo&author=E+Ferrannini&author=A+Halseth&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0212"> <div class="reference-title-banner"> <h4 class="title">Marre 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0223"> <div class="citation-journal">Marre M, Howlett H, Lehertt P, Allavoine T. <span class="citation-title">Improved glycemic control with metformin‐glibenclamide combined tabled therapy (Glucovance) in type 2 diabetic patients inadequately controlled on metformin</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2002</span>;<span class="volume">19</span>:673‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12147149" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycemic+control+with+metformin%E2%80%90glibenclamide+combined+tabled+therapy+(Glucovance)+in+type+2+diabetic+patients+inadequately+controlled+on+metformin+&author=M+Marre&author=H+Howlett&author=P+Lehertt&author=T+Allavoine&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0213"> <div class="reference-title-banner"> <h4 class="title">Mashavi 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0224"> <div class="citation-journal">Mashavi M, Hanah R, Boaz M, Gavish D, Matas Z, Fux A, et al. <span class="citation-title">Effect of homocysteine‐lowering therapy on arterial elasticity and metabolic parameters in metformin‐treated diabetic patients</span>. <span class="citation"> Atherosclerosis </span><span class="pubYear">2008</span>;<span class="volume">199</span>(2):362‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18206891" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+homocysteine%E2%80%90lowering+therapy+on+arterial+elasticity+and+metabolic+parameters+in+metformin%E2%80%90treated+diabetic+patients+&author=M+Mashavi&author=R+Hanah&author=M+Boaz&author=D+Gavish&author=Z+Matas&author=A+Fux&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0214"> <div class="reference-title-banner"> <h4 class="title">Mather 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0225"> <div class="citation-journal">Mather KJ, Verma S, Anderson TJ. <span class="citation-title">Improved endothelial function with metformin in type 2 diabetes mellitus</span>. <span class="citation"> Journal of the American College of Cardiology </span><span class="pubYear">2001</span>;<span class="volume">37</span>:1344‐1350. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11300445" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+endothelial+function+with+metformin+in+type+2+diabetes+mellitus&author=KJ+Mather&author=S+Verma&author=TJ+Anderson&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0215"> <div class="reference-title-banner"> <h4 class="title">Matthews 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0226"> <div class="citation-journal">Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G. <span class="citation-title">Long‐term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2005</span>;<span class="volume">21</span>:167‐174. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+therapy+with+addition+of+pioglitazone+to+metformin+compared+with+the+addition+of+gliclazide+to+metformin+in+patients+with+type+2+diabetes:+a+randomized,+comparative+study+&author=DR+Matthews&author=BH+Charbonnel&author=M+Hanefeld&author=P+Brunetti&author=G+Schernthaner&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0216"> <div class="reference-title-banner"> <h4 class="title">McAlpine 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0227"> <div class="citation-journal">McAlpine LG, McAlpine CH, Waclawski ER, Storer AM, Kay JW, Frier BM. <span class="citation-title">A comparison of treatment with metformin and gliclazide in patients with non‐insulin‐dependent diabetes</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1988</span>;<span class="volume">34</span>(2):129‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3289948" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+treatment+with+metformin+and+gliclazide+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+&author=LG+McAlpine&author=CH+McAlpine&author=ER+Waclawski&author=AM+Storer&author=JW+Kay&author=BM+Frier&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0217"> <div class="reference-title-banner"> <h4 class="title">McBain 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0228"> <div class="citation-journal">McBain AM, Brown IR, Menzies DG, Campbell IW. <span class="citation-title">Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes</span>. <span class="citation"> Journal of Clinical Pathology </span><span class="pubYear">1988</span>;<span class="volume">41</span>(9):933‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3192752" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+improved+glycaemic+control+on+calcium+and+magnesium+homeostasis+in+type+II+diabetes+&author=AM+McBain&author=IR+Brown&author=DG+Menzies&author=IW+Campbell&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0218"> <div class="reference-title-banner"> <h4 class="title">McIntyre 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0229"> <div class="citation-journal">McIntyre HD, Ma A, Bird DM, Paterson CA, Ravenscroft PJ, Cameron DP. <span class="citation-title">Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non‐insulin dependent) diabetes mellitus</span>. <span class="citation"> Australian and New Zealand Journal of Medicine </span><span class="pubYear">1991</span>;<span class="volume">21</span>(5):714‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1759920" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+increases+insulin+sensitivity+and+basal+glucose+clearance+in+type+2+(non%E2%80%90insulin+dependent)+diabetes+mellitus+&author=HD+McIntyre&author=A+Ma&author=DM+Bird&author=CA+Paterson&author=PJ+Ravenscroft&author=DP+Cameron&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0219"> <div class="reference-title-banner"> <h4 class="title">Mehta 1963 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0230"> <div class="citation-journal">Mehta BJ, Vakil BJ, Narula DV, Vakil PR. <span class="citation-title">Utility of Metformin as a non‐hormonal agent in the treatment of Diabetes mellitus</span>. <span class="citation"> Journal of the Indian Medical Association </span><span class="pubYear">1963</span>;<span class="volume">40</span>:151‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13934517" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Utility+of+Metformin+as+a+non%E2%80%90hormonal+agent+in+the+treatment+of+Diabetes+mellitus&author=BJ+Mehta&author=BJ+Vakil&author=DV+Narula&author=PR+Vakil&publication_year=1963&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0220"> <div class="reference-title-banner"> <h4 class="title">Menzies 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0231"> <div class="citation-journal">Menzies DG, Campbell IW, McBain A, Brown IR. <span class="citation-title">Metformin efficacy and tolerance in obese non‐insulin dependent diabetics: a comparison of two dosage schedules</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">1989</span>;<span class="volume">11</span>(5):273‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2702849" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+efficacy+and+tolerance+in+obese+non%E2%80%90insulin+dependent+diabetics:+a+comparison+of+two+dosage+schedules+&author=DG+Menzies&author=IW+Campbell&author=A+McBain&author=IR+Brown&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0221"> <div class="reference-title-banner"> <h4 class="title">Mesirabi 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0232"> <div class="citation-journal">Mesirabi DM, Langade DG, Kinagi SB, Naikwadi A, Morye C, Chopra D. <span class="citation-title">Evaluation of efficacy and safety of fixed dose combination of glimepiride 2 mg plus pioglitazone 15 mg plus metformin SR 500 mg in the management of patients with type‐2 diabetes mellitus</span>. <span class="citation"> Journal of the Indian Medical Association </span><span class="pubYear">2005</span>;<span class="volume">103</span>:447‐450. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16363204" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+efficacy+and+safety+of+fixed+dose+combination+of+glimepiride+2+mg+plus+pioglitazone+15+mg+plus+metformin+SR+500+mg+in+the+management+of+patients+with+type%E2%80%902+diabetes+mellitus+&author=DM+Mesirabi&author=DG+Langade&author=SB+Kinagi&author=A+Naikwadi&author=C+Morye&author=D+Chopra&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0222"> <div class="reference-title-banner"> <h4 class="title">Moses 1999a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0234"> <div class="citation-journal">Moses R. <span class="citation-title">Repaglinide in combination therapy with metformin in Type 2 diabetes</span>. <span class="citation"> Exp Clin Endocrinol Diabetes </span><span class="pubYear">1999</span>;<span class="volume">107</span>(Suppl 4):S136‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10522839" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Repaglinide+in+combination+therapy+with+metformin+in+Type+2+diabetes&author=R+Moses&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0233"> <div class="citation-journal">Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, et al. <span class="citation-title">Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(1):119‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10333912" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+repaglinide+addition+to+metformin+monotherapy+on+glycemic+control+in+patients+with+type+2+diabetes+&author=R+Moses&author=R+Slobodniuk&author=S+Boyages&author=S+Colagiuri&author=W+Kidson&author=J+Carter&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0223"> <div class="reference-title-banner"> <h4 class="title">Mourao‐Junior 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0235"> <div class="citation-journal">Mourao‐Junior CA, Sa JR, Guedes OMS, Dib SA. <span class="citation-title">Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin</span>. <span class="citation"> Brazilian Journal of Medical and Biological Research </span><span class="pubYear">2006</span>;<span class="volume">39</span>:489‐494. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16612472" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+the+glycemic+control,+lipid+profile,+and+arterial+blood+pressure+of+type+2+diabetic+patients+with+metabolic+syndrome+already+on+insulin+&author=CA+Mourao%E2%80%90Junior&author=JR+Sa&author=OMS+Guedes&author=SA+Dib&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0224"> <div class="reference-title-banner"> <h4 class="title">Mughal 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0236"> <div class="citation-journal">Mughal MA, Jan M, Maheri WM, Memon MY, Ali M. <span class="citation-title">The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea‐treated type 2 diabtic patients with sub‐optimal metabolic control</span>. <span class="citation"> Journal of the Pakistani Medical Association </span><span class="pubYear">2000</span>;<span class="volume">50</span>:381‐386. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+glycemic+control,+serum+lipids+and+lipoproteins+in+diet+alone+and+sulfonylurea%E2%80%90treated+type+2+diabtic+patients+with+sub%E2%80%90optimal+metabolic+control+&author=MA+Mughal&author=M+Jan&author=WM+Maheri&author=MY+Memon&author=M+Ali&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0225"> <div class="reference-title-banner"> <h4 class="title">Munk 1975 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0237"> <div class="citation-journal">Munk W. <span class="citation-title">[Treatment of obese diabetic patients using glucophage retard]</span>. <span class="citation"> Zeltschrift fur Allgemeinmedzin </span><span class="pubYear">1975</span>;<span class="volume">51</span>(14):681‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+obese+diabetic+patients+using+glucophage+retard]&author=W+Munk&publication_year=1975&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0226"> <div class="reference-title-banner"> <h4 class="title">Nagi 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0238"> <div class="citation-journal">Nagi DK, Ali VM, Yudkin JS. <span class="citation-title">Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non‐insulin‐dependent (type 2) diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1996</span>;<span class="volume">13</span>(8):753‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+intact+proinsulin+and+des+31,32+proinsulin+concentrations+in+subjects+with+non%E2%80%90insulin%E2%80%90dependent+(type+2)+diabetes+mellitus+&author=DK+Nagi&author=VM+Ali&author=JS+Yudkin&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0239"> <div class="citation-journal">Nagi DK, Yudkin JS. <span class="citation-title">Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups [see comments]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1993</span>;<span class="volume">16</span>(4):621‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8462390" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+insulin+resistance,+risk+factors+for+cardiovascular+disease,+and+plasminogen+activator+inhibitor+in+NIDDM+subjects.+A+study+of+two+ethnic+groups+[see+comments]+&author=DK+Nagi&author=JS+Yudkin&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0227"> <div class="reference-title-banner"> <h4 class="title">Nar 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0240"> <div class="citation-journal">Nar A, Gedik O. <span class="citation-title">The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2009</span>;<span class="volume">46</span>(2):113‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18839053" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+leptin+in+obese+patients+with+type+2+diabetes+mellitus+and+nonalcoholic+fatty+liver+disease+&author=A+Nar&author=O+Gedik&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0228"> <div class="reference-title-banner"> <h4 class="title">Natali 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0241"> <div class="citation-journal">Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli Am Yudkin JS, Ferrannini E. <span class="citation-title">Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>:1349‐57. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15161787" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Vascular+effects+of+improving+metabolic+control+with+metformin+or+rosiglitazone+in+type+2+diabetes+&author=A+Natali&author=S+Baldeweg&author=E+Toschi&author=B+Capaldo&author=D+Barbaro&author=JS+GastaldelliAmYudkin&author=E+Ferrannini&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0229"> <div class="reference-title-banner"> <h4 class="title">Nattrass 1977 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0242"> <div class="citation-journal">Nattrass M, Todd PG, Hinks L, Lloyd B, Alberti KG. <span class="citation-title">Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity‐onset diabetics</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1977</span>;<span class="volume">13</span>(2):145‐52. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/404205" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+effects+of+phenformin,+metformin+and+glibenclamide+on+metabolic+rhythms+in+maturity%E2%80%90onset+diabetics+&author=M+Nattrass&author=PG+Todd&author=L+Hinks&author=B+Lloyd&author=KG+Alberti&publication_year=1977&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0230"> <div class="reference-title-banner"> <h4 class="title">Nauck 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0243"> <div class="citation-journal">Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP, Sitagliptin Study. <span class="citation-title">Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(2):194‐205. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17300595" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+the+dipeptidyl+peptidase%E2%80%904+inhibitor,+sitagliptin,+compared+with+the+sulfonylurea,+glipizide,+in+patients+with+type+2+diabetes+inadequately+controlled+on+metformin+alone:+a+randomized,+double%E2%80%90blind,+non%E2%80%90inferiority+trial+&author=MA+Nauck&author=G+Meininger&author=D+Sheng&author=L+Terranella&author=PP+Stein&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0231"> <div class="reference-title-banner"> <h4 class="title">Nauck 2009a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0244"> <div class="citation-journal">Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al. <span class="citation-title">Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(1):84‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18931095" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+comparison+of+liraglutide,+glimepiride,+and+placebo,+all+in+combination+with+metformin,+in+type+2+diabetes+&author=M+Nauck&author=A+Frid&author=K+Hermansen&author=NS+Shah&author=T+Tankova&author=IH+Mitha&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0232"> <div class="reference-title-banner"> <h4 class="title">Nauck 2009b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0245"> <div class="citation-journal">Nauck MA, Ratner RE, Kapitza C, Berria R, Boldrin M, Balena R. <span class="citation-title">Treatment with the human once‐weekly glucagon‐like peptide‐1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: A double‐blind placebo‐controlled study</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(7):1237‐43. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19366970" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+with+the+human+once%E2%80%90weekly+glucagon%E2%80%90like+peptide%E2%80%901+analog+taspoglutide+in+combination+with+metformin+improves+glycemic+control+and+lowers+body+weight+in+patients+with+type+2+diabetes+inadequately+controlled+with+metformin+alone:+A+double%E2%80%90blind+placebo%E2%80%90controlled+study+&author=MA+Nauck&author=RE+Ratner&author=C+Kapitza&author=R+Berria&author=M+Boldrin&author=R+Balena&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0233"> <div class="reference-title-banner"> <h4 class="title">Nauck 2009c {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0246"> <div class="citation-journal">Nauck MA, Ellis GC, Fleck PR, Wilson CA, Mekki Q. <span class="citation-title">Efficacy and safety of adding the dipeptidyl peptidase‐4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double‐blind, placebo‐controlled study</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2009</span>;<span class="volume">63</span>(1):46‐55. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19125992" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+adding+the+dipeptidyl+peptidase%E2%80%904+inhibitor+alogliptin+to+metformin+therapy+in+patients+with+type+2+diabetes+inadequately+controlled+with+metformin+monotherapy:+A+multicentre,+randomised,+double%E2%80%90blind,+placebo%E2%80%90controlled+study+&author=MA+Nauck&author=GC+Ellis&author=PR+Fleck&author=CA+Wilson&author=Q+Mekki&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0234"> <div class="reference-title-banner"> <h4 class="title">Niazi 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0247"> <div class="citation-journal">Niazi R, Muzaffar Z. <span class="citation-title">Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients</span>. <span class="citation"> Journal of the Pakistani Medical Association </span><span class="pubYear">1998</span>;<span class="volume">48</span>(11):336‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+bedtime+NPH+insulin+or+metformin+combined+with+glibenclamide+in+secondary+sulphonylurea+failure+in+obese+type+II+(NIDDM)+patients+&author=R+Niazi&author=Z+Muzaffar&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0235"> <div class="reference-title-banner"> <h4 class="title">Nosadini 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0248"> <div class="citation-journal">Nosadini R, Avogaro A, Trevisan R, Tessari P, Duner E, Tiengo A, Velussi M, Prata S, Kreutzenberg S, Muggeo M, crepaldi G. <span class="citation-title">Effect of metformin on insulin‐stimulated glucose turnover and insulin binding to receptors in Type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1987</span>;<span class="volume">10</span>:62‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3552515" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+insulin%E2%80%90stimulated+glucose+turnover+and+insulin+binding+to+receptors+in+Type+2+diabetes+&author=R+Nosadini&author=A+Avogaro&author=R+Trevisan&author=P+Tessari&author=E+Duner&author=A+Tiengo&author=M+Velussi&author=S+Prata&author=S+Kreutzenberg&author=M+Muggeo&author=G+crepaldi&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0236"> <div class="reference-title-banner"> <h4 class="title">Noury 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0249"> <div class="citation-journal">Noury J, Nandeuil A. <span class="citation-title">Comparative three‐month study of the efficacies of metformin and gliclazide in the treatment of NIDD</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):209‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936478" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+three%E2%80%90month+study+of+the+efficacies+of+metformin+and+gliclazide+in+the+treatment+of+NIDD+&author=J+Noury&author=A+Nandeuil&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0237"> <div class="reference-title-banner"> <h4 class="title">Ohira 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0250"> <div class="citation-journal">Ohira M, Miyashita Y, Ebisuno M, Saiki A, Endo K, Koide N, et al. <span class="citation-title">Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2007</span>;<span class="volume">78</span>(1):34‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+serum+lipoprotein+lipase+mass+levels+and+LDL+particle+size+in+type+2+diabetes+mellitus+patients+&author=M+Ohira&author=Y+Miyashita&author=M+Ebisuno&author=A+Saiki&author=K+Endo&author=N+Koide&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0238"> <div class="reference-title-banner"> <h4 class="title">Ohnhaus 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0251"> <div class="citation-journal">Ohnhaus EE, Berger W, Duckert F, Oesch F. <span class="citation-title">The influence of Dimethylbiguanide on Phenprocoumon elimination and its mode of action</span>. <span class="citation"> Klinische Wochenschrift </span><span class="pubYear">1983</span>;<span class="volume">61</span>:851‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6632727" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+influence+of+Dimethylbiguanide+on+Phenprocoumon+elimination+and+its+mode+of+action&author=EE+Ohnhaus&author=W+Berger&author=F+Duckert&author=F+Oesch&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0239"> <div class="reference-title-banner"> <h4 class="title">Ozata 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0252"> <div class="citation-journal">Ozata M, Oktenli C, Bingol N, Ozdemir IC. <span class="citation-title">The effects of metformin and diet on plasma testosterone and leptin levels in obese men</span>. <span class="citation"> Obesity Research </span><span class="pubYear">2001</span>;<span class="volume">9</span>:662‐667. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11707532" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+metformin+and+diet+on+plasma+testosterone+and+leptin+levels+in+obese+men+&author=M+Ozata&author=C+Oktenli&author=N+Bingol&author=IC+Ozdemir&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0240"> <div class="reference-title-banner"> <h4 class="title">Pala 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0253"> <div class="citation-journal">Pala L, Mannucci E, Dicembrini I, Rotella CM. <span class="citation-title">A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2007</span>;<span class="volume">78</span>(1):132‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+mealtime+insulin+aspart+and+human+insulin+in+combination+with+metformin+in+type+2+diabetes+patients+&author=L+Pala&author=E+Mannucci&author=I+Dicembrini&author=CM+Rotella&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0241"> <div class="reference-title-banner"> <h4 class="title">Panikar 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0254"> <div class="citation-journal">Panikar V, Joshi SR, Bukkawar A, Nasikkar N, Santwana C. <span class="citation-title">Induction of long‐term glycemic control in type 2 diabetic patients using pioglitazone and metformin combination</span>. <span class="citation"> Journal of the Association of Physicians of India </span><span class="pubYear">2007</span>;<span class="volume">55</span>:333‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17844692" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Induction+of+long%E2%80%90term+glycemic+control+in+type+2+diabetic+patients+using+pioglitazone+and+metformin+combination+&author=V+Panikar&author=SR+Joshi&author=A+Bukkawar&author=N+Nasikkar&author=C+Santwana&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0242"> <div class="reference-title-banner"> <h4 class="title">Papathanassiou 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0255"> <div class="citation-journal">Papathanassiou K, Naka KK, Kazakos N, Kanioglou C, Makriyiannis D, Pappas K, et al. <span class="citation-title">Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes</span>. <span class="citation"> Atherosclerosis </span><span class="pubYear">2009</span>;<span class="volume">205</span>(1):221‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19135671" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+vs+glimepiride:+Differential+effects+on+vascular+endothelial+function+in+patients+with+type+2+diabetes+&author=K+Papathanassiou&author=KK+Naka&author=N+Kazakos&author=C+Kanioglou&author=D+Makriyiannis&author=K+Pappas&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0243"> <div class="reference-title-banner"> <h4 class="title">Pavo 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0256"> <div class="citation-journal">Pavo I, Jermendy G, Varkonyi TT, Kerenyl Z, Gyimesi A, Shoustov S, Shestakova M, Herz M, Johns D, Schluchter BJ, Festa A, Tan MH. <span class="citation-title">Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2003</span>;<span class="volume">88</span>:1637‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12679450" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+pioglitazone+compared+with+metformin+on+glycemic+control+and+indicators+of+insulin+sensitivity+in+recently+diagnosed+patients+with+type+2+diabetes+&author=I+Pavo&author=G+Jermendy&author=TT+Varkonyi&author=Z+Kerenyl&author=A+Gyimesi&author=S+Shoustov&author=M+Shestakova&author=M+Herz&author=D+Johns&author=BJ+Schluchter&author=A+Festa&author=MH+Tan&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0244"> <div class="reference-title-banner"> <h4 class="title">Peacock 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0257"> <div class="citation-journal">Peacock I, Tattersall RB. <span class="citation-title">The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?</span>. <span class="citation"> British Medicial Journal (Clinical Research Edition) </span><span class="pubYear">1984</span>;<span class="volume">288</span>(6435):1956‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+difficult+choice+of+treatment+for+poorly+controlled+maturity+onset+diabetes:+tablets+or+insulin?+&author=I+Peacock&author=RB+Tattersall&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0245"> <div class="reference-title-banner"> <h4 class="title">Peacock 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0258"> <div class="citation-journal">Peacock I, Hawkins M, Heptinstall S. <span class="citation-title">Platelet behaviour in non‐insulin‐dependent Diabetes ‐ Influence of vascular complications, treatment and metabolic control</span>. <span class="citation"> Thrombosis and heamostasis </span><span class="pubYear">1986</span>;<span class="volume">55</span>:361‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Platelet+behaviour+in+non%E2%80%90insulin%E2%80%90dependent+Diabetes+%E2%80%90+Influence+of+vascular+complications,+treatment+and+metabolic+control+&author=I+Peacock&author=M+Hawkins&author=S+Heptinstall&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0246"> <div class="reference-title-banner"> <h4 class="title">Pedersen 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0259"> <div class="citation-journal">Pedersen J. <span class="citation-title">The effect of Metformin on weight loss in obesity</span>. <span class="citation"> Acta Endocrinologica </span><span class="pubYear">1965</span>;<span class="volume">49</span>:479‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14332328" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+Metformin+on+weight+loss+in+obesity&author=J+Pedersen&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0247"> <div class="reference-title-banner"> <h4 class="title">Pedersen 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0260"> <div class="citation-journal">Pedersen O, Nielsen O, Bak J, Richelsen B, Beck‐Nielsen H, Sorensen N. <span class="citation-title">The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1989</span>;<span class="volume">6</span>(3):249‐56. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+metformin+on+adipocyte+insulin+action+and+metabolic+control+in+obese+subjects+with+type+2+diabetes+&author=O+Pedersen&author=O+Nielsen&author=J+Bak&author=B+Richelsen&author=H+Beck%E2%80%90Nielsen&author=N+Sorensen&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0248"> <div class="reference-title-banner"> <h4 class="title">Phillips 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0261"> <div class="citation-journal">Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, et al. <span class="citation-title">Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans</span>. <span class="citation"> American Journal of Physiology ‐ Endocrinology and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">297</span>(3):E767‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19622782" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Selective+regulation+of+cellular+and+secreted+multimeric+adiponectin+by+antidiabetic+therapies+in+humans+&author=SA+Phillips&author=J+Kung&author=TP+Ciaraldi&author=C+Choe&author=L+Christiansen&author=S+Mudaliar&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0249"> <div class="reference-title-banner"> <h4 class="title">Pirart 1961 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0262"> <div class="citation-journal">Pirart J, Rutman S. <span class="citation-title">[A new oral antidiabetic medicine: N.N. Dimethylbiguanide. Clinical trial alternating a placebo with a sulfamide]</span>. <span class="citation"> Acta Clinica Belgica </span><span class="pubYear">1961</span>;<span class="volume">16</span>:575‐89. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14486867" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[A+new+oral+antidiabetic+medicine:+N.N.+Dimethylbiguanide.+Clinical+trial+alternating+a+placebo+with+a+sulfamide]+&author=J+Pirart&author=S+Rutman&publication_year=1961&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0250"> <div class="reference-title-banner"> <h4 class="title">Pitocco 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0263"> <div class="citation-journal">Pitocco D, Giubilato S, Zaccardi F, Stasio E, Buffon A, Biasucci LM, et al. <span class="citation-title">Pioglitazone reduces monocyte activation in type 2 diabetes</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2009</span>;<span class="volume">46</span>(1):75‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18820825" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+reduces+monocyte+activation+in+type+2+diabetes&author=D+Pitocco&author=S+Giubilato&author=F+Zaccardi&author=E+Stasio&author=A+Buffon&author=LM+Biasucci&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0251"> <div class="reference-title-banner"> <h4 class="title">Ponssen 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0264"> <div class="citation-journal">Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D. <span class="citation-title">Combined metformin and insulin therapy for patients with type 2 diabetes mellitus [In Process Citation]</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2000</span>;<span class="volume">22</span>(6):709‐18. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10929918" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+metformin+and+insulin+therapy+for+patients+with+type+2+diabetes+mellitus+[In+Process+Citation]+&author=HH+Ponssen&author=JW+Elte&author=P+Lehert&author=JP+Schouten&author=D+Bets&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0252"> <div class="reference-title-banner"> <h4 class="title">Pradhan 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0265"> <div class="citation-journal">Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM. <span class="citation-title">Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: The LANCET randomized trial</span>. <span class="citation"> JAMA </span><span class="pubYear">2009</span>;<span class="volume">302</span>(11):1186‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19755697" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+initiating+insulin+and+metformin+on+glycemic+control+and+inflammatory+biomarkers+among+patients+with+type+2+diabetes:+The+LANCET+randomized+trial+&author=AD+Pradhan&author=BM+Everett&author=NR+Cook&author=N+Rifai&author=PM+Ridker&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0253"> <div class="reference-title-banner"> <h4 class="title">Prager 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0266"> <div class="citation-journal">Prager R, Schernthaner G, Graf H. <span class="citation-title">Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1986</span>;<span class="volume">12</span>(6):346‐50. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3817257" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+peripheral+insulin+sensitivity+in+non+insulin+dependent+diabetes+mellitus+&author=R+Prager&author=G+Schernthaner&author=H+Graf&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0254"> <div class="reference-title-banner"> <h4 class="title">Puchegger 1964 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0267"> <div class="citation-journal">Puchegger R. <span class="citation-title">[Experience with the biguanide Glucophage]</span>. <span class="citation"> Wiener Klinische Wechenschrift </span><span class="pubYear">1964</span>;<span class="volume">76</span>:335‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Experience+with+the+biguanide+Glucophage]&author=R+Puchegger&publication_year=1964&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0255"> <div class="reference-title-banner"> <h4 class="title">Rachmani 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0268"> <div class="citation-journal">Rachmani R, Slavachevski I, Levi Z, Zadok B‐S, Kedar Y, Ravid M. <span class="citation-title">Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications</span>. <span class="citation"> Eur J Int Med </span><span class="pubYear">2002</span>;<span class="volume">13</span>:428‐433. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+in+patients+with+type+2+diabetes+mellitus:+reconsideration+of+traditional+contraindications+&author=R+Rachmani&author=I+Slavachevski&author=Z+Levi&author=B%E2%80%90S+Zadok&author=Y+Kedar&author=M+Ravid&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0256"> <div class="reference-title-banner"> <h4 class="title">Rains 1988 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0269"> <div class="citation-journal">Rains SG, Wilson GA, Richmond W, Elkeles RS. <span class="citation-title">The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1988</span>;<span class="volume">5</span>(7):653‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+glibenclamide+and+metformin+on+serum+lipoproteins+in+type+2+diabetes&author=SG+Rains&author=GA+Wilson&author=W+Richmond&author=RS+Elkeles&publication_year=1988&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0257"> <div class="reference-title-banner"> <h4 class="title">Rains 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0270"> <div class="citation-journal">Rains SG, Wilson GA, Richmond W, Elkeles RS. <span class="citation-title">The reduction of low density lipoprotein cholesterol by metformin is maintained with long‐term therapy</span>. <span class="citation"> Journal of the Royal Society of Medicine </span><span class="pubYear">1989</span>;<span class="volume">82</span>(2):93‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2647992" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+reduction+of+low+density+lipoprotein+cholesterol+by+metformin+is+maintained+with+long%E2%80%90term+therapy+&author=SG+Rains&author=GA+Wilson&author=W+Richmond&author=RS+Elkeles&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0258"> <div class="reference-title-banner"> <h4 class="title">Raptis 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0271"> <div class="citation-journal">Raptis AE, Tountas NB, Yalouris AG, Halvatsiotis PG, Raptis SA. <span class="citation-title">Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">1996</span>;<span class="volume">28</span>(2):89‐94. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8867905" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapeutic+effect+of+glibenclamide+in+a+fixed+combination+with+metformin+or+phenformin+in+NIDDM+patients+&author=AE+Raptis&author=NB+Tountas&author=AG+Yalouris&author=PG+Halvatsiotis&author=SA+Raptis&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0259"> <div class="reference-title-banner"> <h4 class="title">Raskin 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0272"> <div class="citation-journal">Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu P‐L, Braceras R, et al. <span class="citation-title">Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(1):27‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+biphasic+insulin+aspart+30+to+optimized+metformin+and+pioglitazone+treatment+of+type+2+diabetes+mellitus:+The+ACTION+Study+(Achieving+Control+Through+Insulin+plus+Oral+ageNts)+&author=P+Raskin&author=G+Matfin&author=SL+Schwartz&author=L+Chaykin&author=P%E2%80%90L+Chu&author=R+Braceras&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0260"> <div class="reference-title-banner"> <h4 class="title">Raskin 2009a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0273"> <div class="citation-journal">Raskin P, Lewin A, Reinhardt R, Lyness W, Adler J, Ahmed A, Ahmed K, Anderson D, et al. <span class="citation-title">Twice‐daily dosing of a repaglinide/metformin fixed‐dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(9):865‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Twice%E2%80%90daily+dosing+of+a+repaglinide/metformin+fixed%E2%80%90dose+combination+tablet+provides+glycaemic+control+comparable+to+rosiglitazone/metformin+tablet+&author=P+Raskin&author=A+Lewin&author=R+Reinhardt&author=W+Lyness&author=J+Adler&author=A+Ahmed&author=K+Ahmed&author=D+Anderson&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0261"> <div class="reference-title-banner"> <h4 class="title">Ratner 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0274"> <div class="citation-journal">Ratner RE, Maggs D, Nielsen LL, Stonehouse AH, Poon T, Zhang B, Bicsak TA, Brodows RG, Kim DD. <span class="citation-title">Long‐term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over‐weight metformin‐treated patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes Obesity and Metabolsim </span><span class="pubYear">2006</span>;<span class="volume">8</span>:419‐428. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+exenatide+therapy+over+82+weeks+on+glycaemic+control+and+weight+in+over%E2%80%90weight+metformin%E2%80%90treated+patients+with+type+2+diabetes+mellitus+&author=RE+Ratner&author=D+Maggs&author=LL+Nielsen&author=AH+Stonehouse&author=T+Poon&author=B+Zhang&author=TA+Bicsak&author=RG+Brodows&author=DD+Kim&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0262"> <div class="reference-title-banner"> <h4 class="title">Raz 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0275"> <div class="citation-journal">Raz I, Chen Y, Wu M, Hussain S, Kaufman KD, Amatruda JM, et al. <span class="citation-title">Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2008</span>;<span class="volume">24</span>(2):537‐50. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18194595" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+sitagliptin+added+to+ongoing+metformin+therapy+in+patients+with+type+2+diabetes+&author=I+Raz&author=Y+Chen&author=M+Wu&author=S+Hussain&author=KD+Kaufman&author=JM+Amatruda&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0263"> <div class="reference-title-banner"> <h4 class="title">Reaven 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0276"> <div class="citation-journal">Reaven GM, Johnston P, Hollenbeck CB, Skowronski R, Zhang JC, Goldfine ID, et al. <span class="citation-title">Combined metformin‐sulfonylurea treatment of patients with noninsulin‐dependent diabetes in fair to poor glycemic control</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1992</span>;<span class="volume">74</span>(5):1020‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1569149" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+metformin%E2%80%90sulfonylurea+treatment+of+patients+with+noninsulin%E2%80%90dependent+diabetes+in+fair+to+poor+glycemic+control+&author=GM+Reaven&author=P+Johnston&author=CB+Hollenbeck&author=R+Skowronski&author=JC+Zhang&author=ID+Goldfine&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0264"> <div class="reference-title-banner"> <h4 class="title">Relimpio 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0277"> <div class="citation-journal">Relimpio F, Pumar A, Losada F, Mangas MA, Acosta D, Astorga R. <span class="citation-title">Adding metformin versus insulin dose increase in insulin‐treated but poorly controlled Type 2 diabetes mellitus: an open‐label randomized trial</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1998</span>;<span class="volume">15</span>(12):997‐1002. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Adding+metformin+versus+insulin+dose+increase+in+insulin%E2%80%90treated+but+poorly+controlled+Type+2+diabetes+mellitus:+an+open%E2%80%90label+randomized+trial+&author=F+Relimpio&author=A+Pumar&author=F+Losada&author=MA+Mangas&author=D+Acosta&author=R+Astorga&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0265"> <div class="reference-title-banner"> <h4 class="title">Reyes 1969 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0278"> <div class="citation-journal">Reyes Larrasilla JM. <span class="citation-title">[Chlorpropamide‐dimethylbiguanide combination in the control of diabetes mellitus with complications]</span>. <span class="citation"> La Prensa Medica Mexicana </span><span class="pubYear">1969</span>;<span class="volume">34</span>(9):378‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5378263" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Chlorpropamide%E2%80%90dimethylbiguanide+combination+in+the+control+of+diabetes+mellitus+with+complications]+&author=JM+ReyesLarrasilla&publication_year=1969&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0266"> <div class="reference-title-banner"> <h4 class="title">Riccio 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0279"> <div class="citation-journal">Riccio A, Prato S, Vigili de Kretzenberg S, Tiengo A. <span class="citation-title">Glucose and lipid metabolism in non‐insulin‐dependent diabetes, effect of metformin</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 pt 2):180‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936473" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucose+and+lipid+metabolism+in+non%E2%80%90insulin%E2%80%90dependent+diabetes,+effect+of+metformin&author=A+Riccio&author=S+Prato&author=S+VigilideKretzenberg&author=A+Tiengo&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0267"> <div class="reference-title-banner"> <h4 class="title">Ristic 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0280"> <div class="citation-journal">Ristic S, Collober‐Maugeais C, Cressier F, Tang P, Pecher E. <span class="citation-title">Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1‐year trial results</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(4):506‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17587393" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nateglinide+or+gliclazide+in+combination+with+metformin+for+treatment+of+patients+with+type+2+diabetes+mellitus+inadequately+controlled+on+maximum+doses+of+metformin+alone:+1%E2%80%90year+trial+results+&author=S+Ristic&author=C+Collober%E2%80%90Maugeais&author=F+Cressier&author=P+Tang&author=E+Pecher&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0268"> <div class="reference-title-banner"> <h4 class="title">Roberts 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0281"> <div class="citation-journal">Roberts VL, Stewart J, Issa M, Lake B, Melis R. <span class="citation-title">Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30‐week, randomized, double‐blind, placebo‐controlled, parallel‐group study</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2005</span>;<span class="volume">27</span>:1535‐1547. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16330290" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Triple+therapy+with+glimepiride+in+patients+with+type+2+diabetes+mellitus+inadequately+controlled+by+metformin+and+a+thiazolidinedione:+results+of+a+30%E2%80%90week,+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled,+parallel%E2%80%90group+study+&author=VL+Roberts&author=J+Stewart&author=M+Issa&author=B+Lake&author=R+Melis&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0269"> <div class="reference-title-banner"> <h4 class="title">Robinson 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0282"> <div class="citation-journal">Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS. <span class="citation-title">The effects of metformin on glycemic control and serum lipids in insulin‐treated NIDDM patients with suboptimal metabolic control [see comments]</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(5):701‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9589227" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+metformin+on+glycemic+control+and+serum+lipids+in+insulin%E2%80%90treated+NIDDM+patients+with+suboptimal+metabolic+control+[see+comments]+&author=AC+Robinson&author=J+Burke&author=S+Robinson&author=DG+Johnston&author=RS+Elkeles&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0270"> <div class="reference-title-banner"> <h4 class="title">Roden 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0283"> <div class="citation-journal">Roden M, Laaksot M, Johns D, Widel M, Urquhart R, Richardson C, Mariz S, Tan MH. <span class="citation-title">Long‐term effects of pioglitazone and metformin on insulin sensitivity in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:1101‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16026380" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+pioglitazone+and+metformin+on+insulin+sensitivity+in+patients+with+type+2+diabetes+mellitus+&author=M+Roden&author=M+Laaksot&author=D+Johns&author=M+Widel&author=R+Urquhart&author=C+Richardson&author=S+Mariz&author=MH+Tan&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0271"> <div class="reference-title-banner"> <h4 class="title">Roden 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0284"> <div class="citation-journal">Roden M, Mariz S, Brazzale AR, Pacini G. <span class="citation-title">Free fatty acid kinetics during long‐term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes</span>. <span class="citation"> Journal of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">265</span>(4):476‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19298459" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Free+fatty+acid+kinetics+during+long%E2%80%90term+treatment+with+pioglitazone+added+to+sulfonylurea+or+metformin+in+Type+2+diabetes+&author=M+Roden&author=S+Mariz&author=AR+Brazzale&author=G+Pacini&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0272"> <div class="reference-title-banner"> <h4 class="title">Rodger 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0285"> <div class="citation-journal">Rodger NW, Chiasson JL, Josse RG, Hunt JA, Palmason C, Ross SA, et al. <span class="citation-title">Clinical experience with acarbose: results of a Canadian multicentre study</span>. <span class="citation"> Clinical Investigation in Medicine </span><span class="pubYear">1995</span>;<span class="volume">18</span>(4):318‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+experience+with+acarbose:+results+of+a+Canadian+multicentre+study&author=NW+Rodger&author=JL+Chiasson&author=RG+Josse&author=JA+Hunt&author=C+Palmason&author=SA+Ross&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0273"> <div class="reference-title-banner"> <h4 class="title">Rodriguez 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0286"> <div class="citation-journal">Rodriguez A, Reviriego J, Polavieja P, Mesa J. <span class="citation-title">Six‐month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus</span>. <span class="citation"> Medicina Clinica </span><span class="pubYear">2008</span>;<span class="volume">131</span>(19):721‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19091199" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Six%E2%80%90month+effectiveness+and+tolerability+of+pioglitazone+in+combination+with+sulfonylureas+or+metformin+for+the+treatment+of+type+2+diabetes+mellitus+&author=A+Rodriguez&author=J+Reviriego&author=P+Polavieja&author=J+Mesa&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0274"> <div class="reference-title-banner"> <h4 class="title">Roger 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0287"> <div class="citation-journal">Roger P, Auclair J, Drain P. <span class="citation-title">Addition of benflouorex to biguanide improves glycemic control in obese non‐insulin‐dependent diabets: a double‐blind study versus placebo</span>. <span class="citation"> Journal of Diabetes and its complications </span><span class="pubYear">1999</span>;<span class="volume">13</span>(2):62‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10432168" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Addition+of+benflouorex+to+biguanide+improves+glycemic+control+in+obese+non%E2%80%90insulin%E2%80%90dependent+diabets:+a+double%E2%80%90blind+study+versus+placebo+&author=P+Roger&author=J+Auclair&author=P+Drain&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0275"> <div class="reference-title-banner"> <h4 class="title">Rosak 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0288"> <div class="citation-journal">Rosak C, Petzoldt R, Wolf R, Reblin T, Dehmel B, Seidel D. <span class="citation-title">Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">59</span>:1131‐1136. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16178978" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+plus+metformin+is+effective+and+well+tolerated+in+clinical+practice:+results+from+large+observational+studies+in+people+with+type+2+diabetes+&author=C+Rosak&author=R+Petzoldt&author=R+Wolf&author=T+Reblin&author=B+Dehmel&author=D+Seidel&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0276"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0289"> <div class="citation-journal">Rosenstock J, Brown A, Fischer J, Jain A, Littlejohn T, Nadeau D, Sussman A, Taylor T, Krol A, Magner J. <span class="citation-title">Efficacy and safety of Acarbose in Metformin‐treated patients with Type 2 Diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:2050‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9839093" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+Acarbose+in+Metformin%E2%80%90treated+patients+with+Type+2+Diabetes&author=J+Rosenstock&author=A+Brown&author=J+Fischer&author=A+Jain&author=T+Littlejohn&author=D+Nadeau&author=A+Sussman&author=T+Taylor&author=A+Krol&author=J+Magner&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0277"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0290"> <div class="citation-journal">Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes‐Rak E, Dailey G. <span class="citation-title">Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin‐naive patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:554‐559. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16505505" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Triple+therapy+in+type+2+diabetes:+Insulin+glargine+or+rosiglitazone+added+to+combination+therapy+of+sulfonylurea+plus+metformin+in+insulin%E2%80%90naive+patients+&author=J+Rosenstock&author=D+Sugimoto&author=P+Strange&author=JA+Stewart&author=E+Soltes%E2%80%90Rak&author=G+Dailey&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0278"> <div class="reference-title-banner"> <h4 class="title">Russell‐Jones 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0291"> <div class="citation-journal">Russell‐Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, et al. <span class="citation-title">Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD‐5 met+SU): A randomised controlled trial</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2009</span>;<span class="volume">52</span>(10):2046‐55. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19688338" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Liraglutide+vs+insulin+glargine+and+placebo+in+combination+with+metformin+and+sulfonylurea+therapy+in+type+2+diabetes+mellitus+(LEAD%E2%80%905+met+SU):+A+randomised+controlled+trial+&author=D+Russell%E2%80%90Jones&author=A+Vaag&author=O+Schmitz&author=BK+Sethi&author=N+Lalic&author=S+Antic&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0279"> <div class="reference-title-banner"> <h4 class="title">Sahin 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0292"> <div class="citation-journal">Sahin M, Tutuncu NB, Ertungrul D, Tanaci N, Guvener ND. <span class="citation-title">Effects of metformin or rosiglitazone on serum concentrations of homocysteine, flotae and vitamin B12 in patients with type 2 diabetes mellitus</span>. <span class="citation"> Journal of Diabetes and its Complications </span><span class="pubYear">2007</span>;<span class="volume">21</span>:118‐123. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17331860" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+or+rosiglitazone+on+serum+concentrations+of+homocysteine,+flotae+and+vitamin+B12+in+patients+with+type+2+diabetes+mellitus+&author=M+Sahin&author=NB+Tutuncu&author=D+Ertungrul&author=N+Tanaci&author=ND+Guvener&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0280"> <div class="reference-title-banner"> <h4 class="title">Sanchez‐Barba 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0293"> <div class="citation-journal">Sanchez‐Barba Izquierdo MI, Ibarra Rueda JM, Ruiz de Adana Perez T. <span class="citation-title">[The combination of insulin and metformin in obese patients with type‐2 diabetes mellitus]</span>. <span class="citation"> Atencion Primaria </span><span class="pubYear">1999</span>;<span class="volume">24</span>(8):462‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10630028" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[The+combination+of+insulin+and+metformin+in+obese+patients+with+type%E2%80%902+diabetes+mellitus]&author=MI+Sanchez%E2%80%90BarbaIzquierdo&author=JM+IbarraRueda&author=T+RuizdeAdanaPerez&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0281"> <div class="reference-title-banner"> <h4 class="title">Santos 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0294"> <div class="citation-journal">Santos RF, Nomizo R, Wajhenberg BL, Reaven GM, Azhar S. <span class="citation-title">Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1995</span>;<span class="volume">21</span>(4):274‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8529763" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Changes+in+insulin+receptor+tyrosine+kinase+activity+associated+with+metformin+treatment+of+type+2+diabetes+&author=RF+Santos&author=R+Nomizo&author=BL+Wajhenberg&author=GM+Reaven&author=S+Azhar&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0282"> <div class="reference-title-banner"> <h4 class="title">Schernthaner 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0295"> <div class="citation-journal">Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P and the Quarter Study Group. <span class="citation-title">Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double‐blind, randomized trial</span>. <span class="citation"> The Journal of Clinical Endocrinology &amp; Metabolism </span><span class="pubYear">2004</span>;<span class="volume">89</span>:6‐68‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+pioglitazone+versus+metformin+in+patients+with+type+2+diabetes+mellitus:+a+double%E2%80%90blind,+randomized+trial+&author=G+Schernthaner&author=DR+Matthews&author=B+Charbonnel&author=M+Hanefeld&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0283"> <div class="reference-title-banner"> <h4 class="title">Schiel 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0296"> <div class="citation-journal">Schiel R, Muller UA. <span class="citation-title">Efficacy and treatment satisfaction of once‐daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long‐term conventional insulin therapy: The SWITCH pilot study</span>. <span class="citation"> Experimental and Clinical Endocrinology and Diabetes </span><span class="pubYear">2008</span>;<span class="volume">116</span>(1):58‐64. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17973208" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+treatment+satisfaction+of+once%E2%80%90daily+insulin+glargine+plus+one+or+two+oral+antidiabetic+agents+versus+continuing+premixed+human+insulin+in+patients+with+type+2+diabetes+previously+on+long%E2%80%90term+conventional+insulin+therapy:+The+SWITCH+pilot+study+&author=R+Schiel&author=UA+Muller&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0284"> <div class="reference-title-banner"> <h4 class="title">Schneider 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0297"> <div class="citation-journal">Schneider J, Erren T, Zofel P, Kaffarnik H. <span class="citation-title">Metformin‐induced changes in serum lipids, lipoproteins, and apoproteins in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Atherosclerosis </span><span class="pubYear">1990</span>;<span class="volume">82</span>(1‐2):97‐103. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2193640" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90induced+changes+in+serum+lipids,+lipoproteins,+and+apoproteins+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=J+Schneider&author=T+Erren&author=P+Zofel&author=H+Kaffarnik&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0285"> <div class="reference-title-banner"> <h4 class="title">Schulte 1973 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0298"> <div class="citation-journal">Schulte J, Garcia Viveros M, Rull J, Lozano‐Castaneda O. <span class="citation-title">[Long‐term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide‐metformin]</span>. <span class="citation"> La Prensa Medica Mexicana </span><span class="pubYear">1973</span>;<span class="volume">38</span>(7):281‐2. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/4789184" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Long%E2%80%90term+(3+year)+results+of+the+treatment+of+stable+diabetes+with+low+doses+of+chlopropamide%E2%80%90metformin]+&author=J+Schulte&author=M+GarciaViveros&author=J+Rull&author=O+Lozano%E2%80%90Castaneda&publication_year=1973&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0286"> <div class="reference-title-banner"> <h4 class="title">Schwartz 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0299"> <div class="citation-journal">Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. <span class="citation-title">Efficacy, tolerability and safety of a novel once‐daily extended‐release metformin in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:759‐764. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16567811" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy,+tolerability+and+safety+of+a+novel+once%E2%80%90daily+extended%E2%80%90release+metformin+in+patients+with+type+2+diabetes+&author=S+Schwartz&author=V+Fonseca&author=B+Berner&author=M+Cramer&author=YK+Chiang&author=A+Lewin&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0287"> <div class="reference-title-banner"> <h4 class="title">Schweizer 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0300"> <div class="citation-journal">Schweizer A, Couturier A, Foley JE, Dejager S. <span class="citation-title">Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug‐naive patients with Type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>(9):955‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17509069" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+between+vildagliptin+and+metformin+to+sustain+reductions+in+HbA(1c)+over+1+year+in+drug%E2%80%90naive+patients+with+Type+2+diabetes+&author=A+Schweizer&author=A+Couturier&author=JE+Foley&author=S+Dejager&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0288"> <div class="reference-title-banner"> <h4 class="title">Schweizer 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0301"> <div class="citation-journal">Schweizer A, Dejager S, Bosi E. <span class="citation-title">Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: A 24‐week, double‐blind, randomized trial</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2009</span>;<span class="volume">11</span>(8):804‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+vildagliptin+and+metformin+monotherapy+in+elderly+patients+with+type+2+diabetes:+A+24%E2%80%90week,+double%E2%80%90blind,+randomized+trial+&author=A+Schweizer&author=S+Dejager&author=E+Bosi&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0289"> <div class="reference-title-banner"> <h4 class="title">Scott 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0302"> <div class="citation-journal">Scott R, Loeys T, Davies MJ, Engel SS. <span class="citation-title">Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes</span>. <span class="citation"> Diabetes, Obesity and Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10</span>(10):959‐69. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+sitagliptin+when+added+to+ongoing+metformin+therapy+in+patients+with+type+2+diabetes+&author=R+Scott&author=T+Loeys&author=MJ+Davies&author=SS+Engel&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0290"> <div class="reference-title-banner"> <h4 class="title">Sharma 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0303"> <div class="citation-journal">Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P. <span class="citation-title">Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus</span>. <span class="citation"> Clinical Endocrinology </span><span class="pubYear">2006</span>;<span class="volume">65</span>:722‐728. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17121522" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+pioglitazone+and+metformin+on+plasma+adiponectin+in+newly+detected+type+2+diabetes+mellitus+&author=PK+Sharma&author=A+Bhansali&author=R+Sialy&author=S+Malhotra&author=P+Pandhi&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0291"> <div class="reference-title-banner"> <h4 class="title">Shimpi 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0304"> <div class="citation-journal">Shimpi RD, Patil PH, Kuchake VG, Ingle PV, Surana SJ, Dighore PN. <span class="citation-title">Comparison of effect of metformin in combination with glimepiride and glibenclamide on glycaemic control in patient with type 2 Diabetes Mellitus</span>. <span class="citation"> International Journal of PharmTech Research </span><span class="pubYear">2009</span>, (1):50‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+effect+of+metformin+in+combination+with+glimepiride+and+glibenclamide+on+glycaemic+control+in+patient+with+type+2+Diabetes+Mellitus+&author=RD+Shimpi&author=PH+Patil&author=VG+Kuchake&author=PV+Ingle&author=SJ+Surana&author=PN+Dighore&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0292"> <div class="reference-title-banner"> <h4 class="title">Sieradzki 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0305"> <div class="citation-journal">Siedradzki J, Soszynski P. <span class="citation-title">[Assessment of efficacy and safety of acarbose in the treatment of diabetes mellitus. Observation study in the conditions of general health care]</span>. <span class="citation"> Przeglad Lekarski </span><span class="pubYear">1999</span>;<span class="volume">56</span>(5):335‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10554569" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Assessment+of+efficacy+and+safety+of+acarbose+in+the+treatment+of+diabetes+mellitus.+Observation+study+in+the+conditions+of+general+health+care]+&author=J+Siedradzki&author=P+Soszynski&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0293"> <div class="reference-title-banner"> <h4 class="title">Stades 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0306"> <div class="citation-journal">Stades AM, Heikens JT, Holleman F, Hoekstra JB. <span class="citation-title">Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study</span>. <span class="citation"> Netherlands Journal of Medicine </span><span class="pubYear">2000</span>;<span class="volume">56</span>(3):86‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10759019" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+glycaemic+control+in+type+2+diabetes+in+daily+practice:+a+retrospective+study+&author=AM+Stades&author=JT+Heikens&author=F+Holleman&author=JB+Hoekstra&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0294"> <div class="reference-title-banner"> <h4 class="title">Stalhammar 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0307"> <div class="citation-journal">Stalhammer J, Bergman U, Boman K, Dahlen M. <span class="citation-title">Metabolic control in diabetic subjects in three Swedish areas with high, medium and low sales of antidiabetic drugs</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1991</span>;<span class="volume">14</span>:12‐19. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1899368" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+control+in+diabetic+subjects+in+three+Swedish+areas+with+high,+medium+and+low+sales+of+antidiabetic+drugs+&author=J+Stalhammer&author=U+Bergman&author=K+Boman&author=M+Dahlen&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0295"> <div class="reference-title-banner"> <h4 class="title">Standl 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0308"> <div class="citation-journal">Standl E, Schernthaner G, Rybka J, Hanefeld M, Raptis SA, Naditch I. <span class="citation-title">Improved glycaemic control with miglitol in inadequately‐controlled type 2 diabetics</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2001</span>;<span class="volume">51</span>:205‐213. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11269893" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycaemic+control+with+miglitol+in+inadequately%E2%80%90controlled+type+2+diabetics&author=E+Standl&author=G+Schernthaner&author=J+Rybka&author=M+Hanefeld&author=SA+Raptis&author=I+Naditch&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0296"> <div class="reference-title-banner"> <h4 class="title">Sterne 1963 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0309"> <div class="citation-journal">Sterne J. <span class="citation-title">[Report on five years experience with Metformin]</span>. <span class="citation"> Wiener Medizinische Wochenschrift </span><span class="pubYear">1963</span>;<span class="volume">113</span>:599‐602. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13983969" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Report+on+five+years+experience+with+Metformin]&author=J+Sterne&publication_year=1963&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0297"> <div class="reference-title-banner"> <h4 class="title">Stewart 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0310"> <div class="citation-journal">Stewart MW, Cirkel DT, Furuseth K, Donaldson J, Biswas N, Starkie MG, Phenkos C, Hamann A. <span class="citation-title">Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well‐controlled type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>:1069‐1078. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16978370" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+plus+roziglitazone+compared+with+metformin+alone+on+glycaemic+control+in+well%E2%80%90controlled+type+2+diabetes+&author=MW+Stewart&author=DT+Cirkel&author=K+Furuseth&author=J+Donaldson&author=N+Biswas&author=MG+Starkie&author=C+Phenkos&author=A+Hamann&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0298"> <div class="reference-title-banner"> <h4 class="title">Stocker 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0311"> <div class="citation-journal">Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA. <span class="citation-title">A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinial atherosclerosis in patients with type 2 diabetes</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2007</span>;<span class="volume">153</span>(3):445e1‐445e6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+trial+of+the+effects+of+rosiglitazone+and+metformin+on+inflammation+and+subclinial+atherosclerosis+in+patients+with+type+2+diabetes+&author=DJ+Stocker&author=AJ+Taylor&author=RW+Langley&author=MR+Jezior&author=RA+Vigersky&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0299"> <div class="reference-title-banner"> <h4 class="title">Stratmann 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0312"> <div class="citation-journal">Stratmann FW. <span class="citation-title">[Experience with Dimethylbiguanide in late failrues of oral diabetes therapy]</span>. <span class="citation"> Medizinische Welt </span><span class="pubYear">1965</span>;<span class="volume">49</span>:2743‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5884734" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Experience+with+Dimethylbiguanide+in+late+failrues+of+oral+diabetes+therapy]&author=FW+Stratmann&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0300"> <div class="reference-title-banner"> <h4 class="title">Strowig 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0313"> <div class="citation-journal">Strowig SM, Aviles‐Santa ML, Raskin P. <span class="citation-title">Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:1691‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12351463" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+monotherapy+and+combination+therapy+with+insulin+and+metformin+or+insulin+and+troglitazone+in+type+2+diabetes+&author=SM+Strowig&author=ML+Aviles%E2%80%90Santa&author=P+Raskin&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0301"> <div class="reference-title-banner"> <h4 class="title">Stumvoll 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0314"> <div class="citation-journal">Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich J. <span class="citation-title">Metabolic effects of metformin in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1995</span>;<span class="volume">333</span>:550‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7623903" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+metformin+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus&author=M+Stumvoll&author=N+Nurjhan&author=G+Perriello&author=G+Dailey&author=J+Gerich&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0302"> <div class="reference-title-banner"> <h4 class="title">Sundaresan 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0315"> <div class="citation-journal">Sundaresan P, Lykos D, Daher A, Diamond T, Morris R, Howes LG. <span class="citation-title">Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(5):692‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9135928" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+effects+of+glibenclamide+and+metformin+on+ambulatory+blood+pressure+and+cardiovascular+reactivity+in+NIDDM+&author=P+Sundaresan&author=D+Lykos&author=A+Daher&author=T+Diamond&author=R+Morris&author=LG+Howes&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0303"> <div class="reference-title-banner"> <h4 class="title">Swislocki 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0316"> <div class="citation-journal">Swislocki ALM, Knuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH. <span class="citation-title">Safety and efficacy of metformin in a restricted formulary</span>. <span class="citation"> American Journal of Managed Care </span><span class="pubYear">1999</span>;<span class="volume">5</span>:62‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10345968" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Safety+and+efficacy+of+metformin+in+a+restricted+formulary&author=ALM+Swislocki&author=Q+Knuu&author=E+Liao&author=E+Wu&author=F+Beza&author=J+Lopez&author=G+Kwan&author=RH+Noth&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0304"> <div class="reference-title-banner"> <h4 class="title">Szanto 1964 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0317"> <div class="citation-journal">Szanto S. <span class="citation-title">Combined trial of Acetohexamide and two Diguanide preparations</span>. <span class="citation"> Irish Journal of Medical Science </span><span class="pubYear">1964</span>:3‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14113902" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+trial+of+Acetohexamide+and+two+Diguanide+preparations&author=S+Szanto&publication_year=1964&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0305"> <div class="reference-title-banner"> <h4 class="title">Taylor 1982 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0318"> <div class="citation-journal">Taylor KG, John WG, Matthews KA, Wright AD. <span class="citation-title">A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A‐I and B in Type 2 (non‐insulin‐dependent) diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1982</span>;<span class="volume">23</span>(6):507‐10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6818080" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+prospective+study+of+the+effect+of+12+months+treatment+on+serum+lipids+and+apolipoproteins+A%E2%80%90I+and+B+in+Type+2+(non%E2%80%90insulin%E2%80%90dependent)+diabetes+&author=KG+Taylor&author=WG+John&author=KA+Matthews&author=AD+Wright&publication_year=1982&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0306"> <div class="reference-title-banner"> <h4 class="title">Teranishi 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0319"> <div class="citation-journal">Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, et al. <span class="citation-title">Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus</span>. <span class="citation"> Metabolism: Clinical &amp; Experimental </span><span class="pubYear">2007</span>;<span class="volume">56</span>(10):1418‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+pioglitazone+and+metformin+on+intracellular+lipid+content+in+liver+and+skeletal+muscle+of+individuals+with+type+2+diabetes+mellitus+&author=T+Teranishi&author=T+Ohara&author=K+Maeda&author=M+Zenibayashi&author=K+Kouyama&author=Y+Hirota&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0307"> <div class="reference-title-banner"> <h4 class="title">Tessari 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0320"> <div class="citation-journal">Tessari P, Biolo G, Bruttomesso D, Inchiostro S, Panebianco G, Vedovato M, et al. <span class="citation-title">Effects of metformin treatment on whole‐body and splanchnic amino acid turnover in mild type 2 diabetes</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1994</span>;<span class="volume">79</span>(6):1553‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7989455" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+treatment+on+whole%E2%80%90body+and+splanchnic+amino+acid+turnover+in+mild+type+2+diabetes+&author=P+Tessari&author=G+Biolo&author=D+Bruttomesso&author=S+Inchiostro&author=G+Panebianco&author=M+Vedovato&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0308"> <div class="reference-title-banner"> <h4 class="title">Tessier 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0321"> <div class="citation-journal">Tessier D, Maheux P, Khalil A, Fulop T. <span class="citation-title">Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes</span>. <span class="citation"> Metabolism </span><span class="pubYear">1999</span>;<span class="volume">48</span>(7):897‐903. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10421233" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+gliclazide+versus+metformin+on+the+clinical+profile+and+lipid+peroxidation+markers+in+type+2+diabetes+&author=D+Tessier&author=P+Maheux&author=A+Khalil&author=T+Fulop&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0309"> <div class="reference-title-banner"> <h4 class="title">Testa 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0322"> <div class="citation-journal">Testa R, Bonfigli AR, Piantanelli L, Manfrini S, Testa I, Gregorio F. <span class="citation-title">Relationship between plasminogen activator inhibitor type‐1 plasma levels and the lipoprotein(a) concentrations in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1996</span>;<span class="volume">33</span>(2):111‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8879966" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Relationship+between+plasminogen+activator+inhibitor+type%E2%80%901+plasma+levels+and+the+lipoprotein(a)+concentrations+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=R+Testa&author=AR+Bonfigli&author=L+Piantanelli&author=S+Manfrini&author=I+Testa&author=F+Gregorio&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0310"> <div class="reference-title-banner"> <h4 class="title">Teupe 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0323"> <div class="citation-journal">Teupe B, Bergis K. <span class="citation-title">Prospective randomized two‐years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):213‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936479" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prospective+randomized+two%E2%80%90years+clinical+study+comparing+additional+metformin+treatment+with+reducing+diet+in+type+2+diabetes+&author=B+Teupe&author=K+Bergis&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0311"> <div class="reference-title-banner"> <h4 class="title">Tikkainen 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0324"> <div class="citation-journal">Tikkainen M, Hakkinen A, Korsheninnikova E, Nyman T, Makimattila S, Yki‐Jarvinen H. <span class="citation-title">Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and fene expression in adipose tissue in patients with type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2004</span>;<span class="volume">53</span>:2169‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15277403" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+and+metformin+on+liver+fat+content,+hepatic+insulin+resistance,+insulin+clearance,+and+fene+expression+in+adipose+tissue+in+patients+with+type+2+diabetes+&author=M+Tikkainen&author=A+Hakkinen&author=E+Korsheninnikova&author=T+Nyman&author=S+Makimattila&author=H+Yki%E2%80%90Jarvinen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0312"> <div class="reference-title-banner"> <h4 class="title">Topiak 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0325"> <div class="citation-journal">Topiak H, Hamann A, Moore R, Masson E, Gorska M, Vercruysse F, Sun X, Fitchet M. <span class="citation-title">Efficacy and safety of topiramite in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double‐blind, placebo‐controlled study</span>. <span class="citation"> International Journal of Obesity </span><span class="pubYear">2007</span>;<span class="volume">31</span>:138‐146. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16703004" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+topiramite+in+combination+with+metformin+in+the+treatment+of+obese+subjects+with+type+2+diabetes:+a+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled+study+&author=H+Topiak&author=A+Hamann&author=R+Moore&author=E+Masson&author=M+Gorska&author=F+Vercruysse&author=X+Sun&author=M+Fitchet&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0313"> <div class="reference-title-banner"> <h4 class="title">Tosi 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0326"> <div class="citation-journal">Tosi F, Muggeo M, Brun E, Spiazzi G, Perbelli L, Zanolin E, Gori M, Coppini A, Moghetti P. <span class="citation-title">Combination treatment with metformin and glibenclamide versus single‐drug therapies in type 2 diabetes mellitus: a randomized, double‐blind, comparative study</span>. <span class="citation"> Metabolism </span><span class="pubYear">2003</span>;<span class="volume">52</span>:862‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12870162" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+treatment+with+metformin+and+glibenclamide+versus+single%E2%80%90drug+therapies+in+type+2+diabetes+mellitus:+a+randomized,+double%E2%80%90blind,+comparative+study+&author=F+Tosi&author=M+Muggeo&author=E+Brun&author=G+Spiazzi&author=L+Perbelli&author=E+Zanolin&author=M+Gori&author=A+Coppini&author=P+Moghetti&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0314"> <div class="reference-title-banner"> <h4 class="title">Triplitt 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0327"> <div class="citation-journal">Triplitt C, Glass L, Miyazaki Y, Wajcberg W, Gastaldelli Am, Filippis E, Cersosimo E, DeFronzo RA. <span class="citation-title">Comparison of glargine insulin versus rosiglitazone addition in poorly controlled trype 2 diabetic patients on metformin plus sulfonylurea</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:2371‐2377. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17065670" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+glargine+insulin+versus+rosiglitazone+addition+in+poorly+controlled+trype+2+diabetic+patients+on+metformin+plus+sulfonylurea+&author=C+Triplitt&author=L+Glass&author=Y+Miyazaki&author=W+Wajcberg&author=Am+Gastaldelli&author=E+Filippis&author=E+Cersosimo&author=RA+DeFronzo&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0315"> <div class="reference-title-banner"> <h4 class="title">Trischitta 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0328"> <div class="citation-journal">Trischitta V, Italia S, Mazzarino S, Buscema M, Rabuazzo AM, Sangiorgio L, et al. <span class="citation-title">Comparison of combined therapies in treatment of secondary failure to glyburide</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1992</span>;<span class="volume">15</span>(4):539‐42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1499473" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+combined+therapies+in+treatment+of+secondary+failure+to+glyburide&author=V+Trischitta&author=S+Italia&author=S+Mazzarino&author=M+Buscema&author=AM+Rabuazzo&author=L+Sangiorgio&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0316"> <div class="reference-title-banner"> <h4 class="title">Trischitta 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0329"> <div class="citation-journal">Trischitta V, Italia S, Raimondo M, Guardabasso V, Licciardello C, Runello F, et al. <span class="citation-title">Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?</span>. <span class="citation"> Journal of Endocrinological Investigation </span><span class="pubYear">1998</span>;<span class="volume">21</span>(11):744‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9972673" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+combined+treatments+in+NIDDM+patients+with+secondary+failure+to+sulphonylureas.+Is+it+predictable?+&author=V+Trischitta&author=S+Italia&author=M+Raimondo&author=V+Guardabasso&author=C+Licciardello&author=F+Runello&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0317"> <div class="reference-title-banner"> <h4 class="title">Turkmen 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0330"> <div class="citation-journal">Turkmen Kemal Y, Guvener Demirag N, Yildirir A, Atar A, Dogruk Unal A, Biyiklioglu Z. <span class="citation-title">Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2007</span>;<span class="volume">44</span>(3):149‐56. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17721754" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+on+plasma+brain+natriuretic+peptide+levels+and+myocardial+performance+index+in+patients+with+type+2+diabetes+mellitus+&author=Y+TurkmenKemal&author=N+GuvenerDemirag&author=A+Yildirir&author=A+Atar&author=A+DogrukUnal&author=Z+Biyiklioglu&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0318"> <div class="reference-title-banner"> <h4 class="title">Uehara 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0331"> <div class="citation-journal">Uehara MH, Kohlmann NEB, Zanella MT, Ferreira SRS. <span class="citation-title">Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2001</span>;<span class="volume">3</span>:319‐325. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+and+haemodynamic+effects+of+metformin+in+patients+with+type+2+diabetes+mellitus+and+hypertension+&author=MH+Uehara&author=NEB+Kohlmann&author=MT+Zanella&author=SRS+Ferreira&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0319"> <div class="reference-title-banner"> <h4 class="title">UKPDS‐34 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0332"> <div class="citation-journal">Holman RR, Cull CA, Turner RC and UKPDS Study Group. <span class="citation-title">A randomized double‐blind trial of Acarbose in Type II Diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>:960‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10372249" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+double%E2%80%90blind+trial+of+Acarbose+in+Type+II+Diabetes+shows+improved+glycemic+control+over+3+years+(UK+Prospective+Diabetes+Study+44)+&author=RR+Holman&author=CA+Cull&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0333"> <div class="citation-journal">Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. <span class="citation-title">10‐year follow‐up of intensive glucose control in type 2 diabetes</span>. <span class="citation"> New Eng J Med </span><span class="pubYear">2008</span>;<span class="volume">359</span>:1577‐1589. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18784090" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=10%E2%80%90year+follow%E2%80%90up+of+intensive+glucose+control+in+type+2+diabetes&author=RR+Holman&author=SK+Paul&author=MA+Bethel&author=DR+Matthews&author=HAW+Neil&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0334"> <div class="citation-journal">Turner R, Cull C, Holman R, and the UK Prospective Diabetes Study Group. <span class="citation-title">United Kingdom Prospective Diabetes Study 17: a 9‐year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1996</span>;<span class="volume">124</span>(1 Pt 2):136‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8554206" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=United+Kingdom+Prospective+Diabetes+Study+17:+a+9%E2%80%90year+update+of+a+randomized,+controlled+trial+on+the+effect+of+improved+metabolic+control+on+complications+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=R+Turner&author=C+Cull&author=R+Holman&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0335"> <div class="citation-journal">Turner RC, Cull CA, Frighi V, Holman RR, and the UK Prospective Diabetes Study Group. <span class="citation-title">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">1999</span>;<span class="volume">281</span>(21):2005‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10359389" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+control+with+diet,+sulfonylurea,+metformin,+or+insulin+in+patients+with+type+2+diabetes+mellitus:+progressive+requirement+for+multiple+therapies+(UKPDS+49).+UK+Prospective+Diabetes+Study+(UKPDS)+Group+&author=RC+Turner&author=CA+Cull&author=V+Frighi&author=RR+Holman&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0336"> <div class="citation-journal">U. K Prospective Diabetes Study (UKPDS) Group. <span class="citation-title">U. K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group [published erratum appears in Diabetes 1996 Nov;45(11):1655]</span>. <span class="citation"> Diabetes </span><span class="pubYear">1995</span>;<span class="volume">44</span>(11):1249‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7589820" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0337"> <div class="citation-journal">U.K. Prospective Diabetes Study Group. <span class="citation-title">U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity‐onset diabetes. A multicenter study</span>. <span class="citation"> Diabetes </span><span class="pubYear">1985</span>;<span class="volume">34</span>(8):793‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2862087" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0338"> <div class="citation-journal">U.K. Prospective Diabetes Study Group. <span class="citation-title">UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea‐treated type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(1):87‐92. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9538975" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0339"> <div class="citation-journal">U.K. Prospective Diabetes Study Group. <span class="citation-title">United Kingdom Prospective Diabetes Study (UKPDS) 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non‐insulin dependent diabetes followed for three years [see comments]</span>. <span class="citation"> British Medical Journal </span><span class="pubYear">1995</span>;<span class="volume">310</span>(6972):83‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7833731" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0340"> <div class="citation-journal">U.K. Prospective Diabetes Study Group. <span class="citation-title">United Kingdom Prospective Diabetes Study 24: a 6‐year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy [see comments]</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1998</span>;<span class="volume">128</span>(3):165‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9454524" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0341"> <div class="citation-journal">UK Prospective Diabetes Study (UKPDS) Group. <span class="citation-title">Effect of intensive blood‐glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>:854‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742977" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0320"> <div class="reference-title-banner"> <h4 class="title">Umpierrez 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0342"> <div class="citation-journal">Umpierrez G, Issa M, Vlajnic A. <span class="citation-title">Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial</span>. <span class="citation"> Current Medical Research and Opinions </span><span class="pubYear">2006</span>;<span class="volume">22</span>:751‐759. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glimepiride+versus+pioglitazone+combination+therapy+in+subjects+with+type+2+diabetes+inadequately+controlled+on+metformin+monotherapy:+results+of+a+randomized+clinical+trial+&author=G+Umpierrez&author=M+Issa&author=A+Vlajnic&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0321"> <div class="reference-title-banner"> <h4 class="title">Vahatalo 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0343"> <div class="citation-journal">Vahatalo M, Ronnemaa T, Viikari J. <span class="citation-title">Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice</span>. <span class="citation"> Scandinavian Journal of Primary Health Care </span><span class="pubYear">2007</span>;<span class="volume">25</span>(3):147‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17846932" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Recognition+of+fasting+or+overall+hyperglycaemia+when+starting+insulin+treatment+in+patients+with+type+2+diabetes+in+general+practice+&author=M+Vahatalo&author=T+Ronnemaa&author=J+Viikari&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0322"> <div class="reference-title-banner"> <h4 class="title">van der Meer 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0344"> <div class="citation-journal">Meer RW, Rijzewijk LJ, Jong HW, Lamb HJ, Lubberink M, Romijn JA, et al. <span class="citation-title">Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high‐energy phosphate metabolism in patients with well‐controlled type 2 diabetes mellitus.[see comment]</span>. <span class="citation"> Circulation </span><span class="pubYear">2009</span>;<span class="volume">119</span>(15):2069‐77. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19349323" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+improves+cardiac+function+and+alters+myocardial+substrate+metabolism+without+affecting+cardiac+triglyceride+accumulation+and+high%E2%80%90energy+phosphate+metabolism+in+patients+with+well%E2%80%90controlled+type+2+diabetes+mellitus.[see+comment]+&author=RW+Meer&author=LJ+Rijzewijk&author=HW+Jong&author=HJ+Lamb&author=M+Lubberink&author=JA+Romijn&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0323"> <div class="reference-title-banner"> <h4 class="title">Van Gaal 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0345"> <div class="citation-journal">Gaal L, Maislos M, Schernthaner G, Rybka J, Segal P. <span class="citation-title">Meglitol combined with metformin improves glycaemic control in type 2 diabetes</span>. <span class="citation"> Diabetes Obesity and Metabolism </span><span class="pubYear">2001</span>;<span class="volume">5</span>:326‐331. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meglitol+combined+with+metformin+improves+glycaemic+control+in+type+2+diabetes&author=L+Gaal&author=M+Maislos&author=G+Schernthaner&author=J+Rybka&author=P+Segal&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0324"> <div class="reference-title-banner"> <h4 class="title">Vannasaeng 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0346"> <div class="citation-journal">Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A. <span class="citation-title">Effects of alpha‐glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Journal of the Medical Association of Thailand </span><span class="pubYear">1995</span>;<span class="volume">78</span>(11):578‐85. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8576667" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+alpha%E2%80%90glucosidase+inhibitor+(acarbose)+combined+with+sulfonylurea+or+sulfonylurea+and+metformin+in+treatment+of+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=S+Vannasaeng&author=S+Ploybutr&author=W+Nitiyanant&author=T+Peerapatdit&author=A+Vichayanrat&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0325"> <div class="reference-title-banner"> <h4 class="title">Velojic‐Golubovic 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0347"> <div class="citation-journal">Velojic‐Golubovic M, Mikic D, Pesic M, Dimic D, Radenkovic S, Antic S. <span class="citation-title">Biphastic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes</span>. <span class="citation"> Journal of Endocrinological Investigation </span><span class="pubYear">2009</span>;<span class="volume">32</span>(1):23‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19337010" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biphastic+insulin+aspart+30:+Better+glycemic+control+than+with+premixed+human+insulin+30+in+obese+patients+with+Type+2+diabetes+&author=M+Velojic%E2%80%90Golubovic&author=D+Mikic&author=M+Pesic&author=D+Dimic&author=S+Radenkovic&author=S+Antic&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0326"> <div class="reference-title-banner"> <h4 class="title">Velussi 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0348"> <div class="citation-journal">Velussi M, Cernigoi AM, Viezzoli L, Caffau C. <span class="citation-title">[Median‐term (4 months) treatment with glibenclamide + metformin substituting for glibenclamide + fenformin lowers the lacticemia levels in type‐2 diabetics (NIDDM)]</span>. <span class="citation"> La Clinical Terapeutica </span><span class="pubYear">1992</span>;<span class="volume">141</span>(12):483‐92. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Median%E2%80%90term+(4+months)+treatment+with+glibenclamide+++metformin+substituting+for+glibenclamide+++fenformin+lowers+the+lacticemia+levels+in+type%E2%80%902+diabetics+(NIDDM)]+&author=M+Velussi&author=AM+Cernigoi&author=L+Viezzoli&author=C+Caffau&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0327"> <div class="reference-title-banner"> <h4 class="title">Vigneri 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0349"> <div class="citation-journal">Vigneri R, Trischitta V, Italia S, Mazzarino S, Rabuazzo MA, Squatrito S. <span class="citation-title">Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed‐time NPH insulin to glyburide</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1991</span>;<span class="volume">17</span>(1 Pt 2):232‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1936482" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+NIDDM+patients+with+secondary+failure+to+glyburide:+comparison+of+the+addition+of+either+metformin+or+bed%E2%80%90time+NPH+insulin+to+glyburide+&author=R+Vigneri&author=V+Trischitta&author=S+Italia&author=S+Mazzarino&author=MA+Rabuazzo&author=S+Squatrito&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0328"> <div class="reference-title-banner"> <h4 class="title">Viljanen 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0350"> <div class="citation-journal">Viljanen APM, Virtanen KA, Jarvisalo MJ, Hallsten K, Parkkola R, Ronnemaa T, Lonnqvist F, Iozzo P, Ferrannini E, Nuutila P. <span class="citation-title">Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double‐blind, randomized study with metformin</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">2005</span>;<span class="volume">90</span>:6523‐6528. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16189256" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+treatment+increases+subcutaneous+adipose+tissue+glucose+uptake+in+parallel+with+perfusion+in+patients+with+type+2+diabetes:+a+double%E2%80%90blind,+randomized+study+with+metformin+&author=APM+Viljanen&author=KA+Virtanen&author=MJ+Jarvisalo&author=K+Hallsten&author=R+Parkkola&author=T+Ronnemaa&author=F+Lonnqvist&author=P+Iozzo&author=E+Ferrannini&author=P+Nuutila&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0329"> <div class="reference-title-banner"> <h4 class="title">Vukovic 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0351"> <div class="citation-journal">Vukovic M, Lapcevic M, Kalezic N, Gvozdenovic BS. <span class="citation-title">[The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2]. [Serbian]</span>. <span class="citation"> Srpski Arhiv Za Celokupno Lekarstvo </span><span class="pubYear">2007</span>;<span class="volume">135</span>(7‐8):447‐52. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17929538" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[The+effect+of+metformin+on+fasting+and+postprandial+insulin+secretion+in+obese+patients+with+diabetes+mellitus+type+2].+[Serbian]+&author=M+Vukovic&author=M+Lapcevic&author=N+Kalezic&author=BS+Gvozdenovic&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0330"> <div class="reference-title-banner"> <h4 class="title">Weissman 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0352"> <div class="citation-journal">Weissman P, Goldstein BJ, Rosenstock J, Waterhouse B, Cobitz AR, Wooddell MJ, Strow LJ. <span class="citation-title">Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE study</span>. <span class="citation"> Current Medical Research and Opinions </span><span class="pubYear">2005</span>;<span class="volume">21</span>:2029‐2035. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+rosiglitazone+added+to+submaximal+doses+of+metformin+compared+with+dose+escalation+of+metformin+in+type+2+diabetes:+the+EMPIRE+study+&author=P+Weissman&author=BJ+Goldstein&author=J+Rosenstock&author=B+Waterhouse&author=AR+Cobitz&author=MJ+Wooddell&author=LJ+Strow&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0331"> <div class="reference-title-banner"> <h4 class="title">Willey 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0353"> <div class="citation-journal">Willey KA, Moyneaux JE, Overland JE, Yue DK. <span class="citation-title">The effects of dexfenluramine on blood glucose control in patients with Type 2 Diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1992</span>;<span class="volume">9</span>:341‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1600704" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+dexfenluramine+on+blood+glucose+control+in+patients+with+Type+2+Diabetes&author=KA+Willey&author=JE+Moyneaux&author=JE+Overland&author=DK+Yue&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0332"> <div class="reference-title-banner"> <h4 class="title">Willey 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0354"> <div class="citation-journal">Willey KA, Molyneaux LM, Yue DK. <span class="citation-title">Obese patients with type 2 Diabetes poorly controlled by insulin and metformin: Effects of adjunctive Dexfenfluramine therapy on glycaemic control</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1994</span>;<span class="volume">11</span>:701‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7955998" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Obese+patients+with+type+2+Diabetes+poorly+controlled+by+insulin+and+metformin:+Effects+of+adjunctive+Dexfenfluramine+therapy+on+glycaemic+control+&author=KA+Willey&author=LM+Molyneaux&author=DK+Yue&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0333"> <div class="reference-title-banner"> <h4 class="title">Willms 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0355"> <div class="citation-journal">Willms B, Ruge D. <span class="citation-title">Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo‐controlled study</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>(9):755‐61. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10510952" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+acarbose+and+metformin+in+patients+with+Type+2+diabetes+mellitus+insufficiently+controlled+with+diet+and+sulphonylureas:+a+randomized,+placebo%E2%80%90controlled+study+&author=B+Willms&author=D+Ruge&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0334"> <div class="reference-title-banner"> <h4 class="title">Wilson 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0356"> <div class="citation-journal">Wilson JA, Scott MM, Gray RS. <span class="citation-title">A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">1989</span>;<span class="volume">21</span>(6):317‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2777189" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+metformin+versus+guar+in+combination+with+sulphonylureas+in+the+treatment+of+non+insulin+dependent+diabetes+&author=JA+Wilson&author=MM+Scott&author=RS+Gray&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0335"> <div class="reference-title-banner"> <h4 class="title">Wolever 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0357"> <div class="citation-journal">Wolever TMS, Radmard R, Chiasson J‐L, Hunt JA, Josse RG, Palmason C, Rodgers NW, Ross SA, Ryan EA, Tan MH. <span class="citation-title">One‐year Acarbose treatment raises fasting serum acetate in Diabetic patients</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1995</span>;<span class="volume">12</span>:164‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7743764" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=One%E2%80%90year+Acarbose+treatment+raises+fasting+serum+acetate+in+Diabetic+patients&author=TMS+Wolever&author=R+Radmard&author=J%E2%80%90L+Chiasson&author=JA+Hunt&author=RG+Josse&author=C+Palmason&author=NW+Rodgers&author=SA+Ross&author=EA+Ryan&author=MH+Tan&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0336"> <div class="reference-title-banner"> <h4 class="title">Wolever 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0358"> <div class="citation-journal">Wolever TMS, Assiff L, Basu T, Chiasson J‐L, Boctor M, Gerstein HC, Hunt JA, Josse RG, et al. <span class="citation-title">Miglitol, an alpha‐glucosidase inhibitor, prevents the metformin‐induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes</span>. <span class="citation"> Nutrition Research </span><span class="pubYear">2000</span>;<span class="volume">20</span>(10):1447‐56. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Miglitol,+an+alpha%E2%80%90glucosidase+inhibitor,+prevents+the+metformin%E2%80%90induced+fall+in+serum+folate+and+vitamin+B12+in+subjects+with+type+2+diabetes+&author=TMS+Wolever&author=L+Assiff&author=T+Basu&author=J%E2%80%90L+Chiasson&author=M+Boctor&author=HC+Gerstein&author=JA+Hunt&author=RG+Josse&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0337"> <div class="reference-title-banner"> <h4 class="title">Wu 1990 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0359"> <div class="citation-journal">Wu MS, Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, et al. <span class="citation-title">Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1990</span>;<span class="volume">13</span>(1):1‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2404714" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+carbohydrate+and+lipoprotein+metabolism+in+NIDDM+patients&author=MS+Wu&author=P+Johnston&author=WH+Sheu&author=CB+Hollenbeck&author=CY+Jeng&author=ID+Goldfine&publication_year=1990&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0338"> <div class="reference-title-banner"> <h4 class="title">Wulffele 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0360"> <div class="citation-journal">Wulffele MG, Kooy A, Ogterop C, Borger vd Burg B, Stehouwer CDA, Donker AJM. <span class="citation-title">Metformin and insulin therapy decreases glycosylated hemoglobin and insulin requirement in Type 2 Diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A184. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+insulin+therapy+decreases+glycosylated+hemoglobin+and+insulin+requirement+in+Type+2+Diabetes+&author=MG+Wulffele&author=A+Kooy&author=C+Ogterop&author=B+BorgervdBurg&author=CDA+Stehouwer&author=AJM+Donker&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0339"> <div class="reference-title-banner"> <h4 class="title">Wulffele 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0361"> <div class="citation-journal">Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Burg BB, Fonker AJM, Stehouwer CDA. <span class="citation-title">Combination of insulin and metformin in the treatment of type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>:2133‐40. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12453950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combination+of+insulin+and+metformin+in+the+treatment+of+type+2+diabetes&author=MG+Wulffele&author=A+Kooy&author=P+Lehert&author=D+Bets&author=JC+Ogterop&author=BB+Burg&author=AJM+Fonker&author=CDA+Stehouwer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0340"> <div class="reference-title-banner"> <h4 class="title">Wulffele 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0362"> <div class="citation-journal">Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Can der Burg BB, Donker AHM, Stehouwer CDA. <span class="citation-title">Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial</span>. <span class="citation"> Journal of Internal Medicine </span><span class="pubYear">2003</span>;<span class="volume">254</span>:455‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14535967" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+short%E2%80%90term+treatment+with+metformin+on+serum+concentrations+of+homocysteine,+folate+and+vitamin+B12+in+type+2+diabetes+mellitus:+a+randomized,+placebo%E2%80%90controlled+trial+&author=MG+Wulffele&author=A+Kooy&author=P+Lehert&author=D+Bets&author=JC+Ogterop&author=BB+CanderBurg&author=AHM+Donker&author=CDA+Stehouwer&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0341"> <div class="reference-title-banner"> <h4 class="title">Wulffele 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0363"> <div class="citation-journal">Wulffele MG, Kooy A, Lehert P, Bets D, Donker AHM, Stehouwer CDA. <span class="citation-title">Does metformin decrease blood pressure in patients with type 2 diabetes intensively treated with insulin?</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:907‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15975107" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Does+metformin+decrease+blood+pressure+in+patients+with+type+2+diabetes+intensively+treated+with+insulin?+&author=MG+Wulffele&author=A+Kooy&author=P+Lehert&author=D+Bets&author=AHM+Donker&author=CDA+Stehouwer&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0342"> <div class="reference-title-banner"> <h4 class="title">Yale 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0364"> <div class="citation-journal">Yale JF, Valiquett TR, Ghazzi MN, Owens‐Grillo JK, Whitcomb RW, Foyt HL. <span class="citation-title">The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenter, randomized, double‐blind, placebo‐controlled trrial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2001</span>;<span class="volume">134</span>:737‐745. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11329231" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+a+thiazolidinedione+drug,+troglitazone,+on+glycemia+in+patients+with+type+2+diabetes+mellitus+poorly+controlled+with+sulfonylurea+and+metformin:+a+multicenter,+randomized,+double%E2%80%90blind,+placebo%E2%80%90controlled+trrial+&author=JF+Yale&author=TR+Valiquett&author=MN+Ghazzi&author=JK+Owens%E2%80%90Grillo&author=RW+Whitcomb&author=HL+Foyt&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0343"> <div class="reference-title-banner"> <h4 class="title">Yamanouchi 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0365"> <div class="citation-journal">Yamanouchi T, Sakai T, Igarashi K, Ichiyanagi K, Watanabe H, Kawasaki T. <span class="citation-title">Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed type 2 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>:980‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16026361" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+metabolic+effects+of+pioglitazone,+metformin,+and+glimepiride+over+1+year+in+Japanese+patients+with+newly+diagnosed+type+2+diabetes+&author=T+Yamanouchi&author=T+Sakai&author=K+Igarashi&author=K+Ichiyanagi&author=H+Watanabe&author=T+Kawasaki&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0344"> <div class="reference-title-banner"> <h4 class="title">Yener 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0366"> <div class="citation-journal">Yener S, Comlekci A, Akinci B, Akan P, Demir T, Bayraktar F, et al. <span class="citation-title">Serum transforming growth factor‐beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone</span>. <span class="citation"> Hormones </span><span class="pubYear">2008</span>;<span class="volume">7</span>(1):70‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18359746" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Serum+transforming+growth+factor%E2%80%90beta+1+levels+in+normoalbuminuric+and+normotensive+patients+with+type+2+diabetes.+Effect+of+metformin+and+rosiglitazone+&author=S+Yener&author=A+Comlekci&author=B+Akinci&author=P+Akan&author=T+Demir&author=F+Bayraktar&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD002967-bib-0367"> <div class="citation-journal">Yener S, Comlekci A, Akinci B, Demir T, Yuksel F, Ozcan MA, et al. <span class="citation-title">Soluble CD40 ligand, plasminogen activator inhibitor‐1 and thrombin‐activatable fibrinolysis inhibitor‐1‐antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone</span>. <span class="citation"> Medical Principles &amp; Practice </span><span class="pubYear">2009</span>;<span class="volume">18</span>(4):266‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Soluble+CD40+ligand,+plasminogen+activator+inhibitor%E2%80%901+and+thrombin%E2%80%90activatable+fibrinolysis+inhibitor%E2%80%901%E2%80%90antigen+in+normotensive+type+2+diabetic+subjects+without+diabetic+complications.+Effects+of+metformin+and+rosiglitazone+&author=S+Yener&author=A+Comlekci&author=B+Akinci&author=T+Demir&author=F+Yuksel&author=MA+Ozcan&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0345"> <div class="reference-title-banner"> <h4 class="title">Yki‐Jarvinen 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0368"> <div class="citation-journal">Yki‐Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. <span class="citation-title">Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial [see comments]</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1999</span>;<span class="volume">130</span>(5):389‐96. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10068412" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+bedtime+insulin+regimens+in+patients+with+type+2+diabetes+mellitus.+A+randomized,+controlled+trial+[see+comments]+&author=H+Yki%E2%80%90Jarvinen&author=L+Ryysy&author=K+Nikkila&author=T+Tulokas&author=R+Vanamo&author=M+Heikkila&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0346"> <div class="reference-title-banner"> <h4 class="title">Yu 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0369"> <div class="citation-journal">Yu JG, Kruszynska YT, Mulford MI, Olefsky JM. <span class="citation-title">A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin‐treated type 2 diabetic patients</span>. <span class="citation"> Diabetes </span><span class="pubYear">1999</span>;<span class="volume">48</span>(12):2414‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10580431" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+troglitazone+and+metformin+on+insulin+requirements+in+euglycemic+intensively+insulin%E2%80%90treated+type+2+diabetic+patients+&author=JG+Yu&author=YT+Kruszynska&author=MI+Mulford&author=JM+Olefsky&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD002967-bbs2-0347"> <div class="reference-title-banner"> <h4 class="title">Zinman 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0370"> <div class="citation-journal">Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, et al. <span class="citation-title">Efficacy and safety of the human glucagon‐like peptide‐1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD‐4 Met+TZD)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(7):1224‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19289857" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+the+human+glucagon%E2%80%90like+peptide%E2%80%901+analog+liraglutide+in+combination+with+metformin+and+thiazolidinedione+in+patients+with+type+2+diabetes+(LEAD%E2%80%904+Met+TZD)+&author=B+Zinman&author=J+Gerich&author=JB+Buse&author=A+Lewin&author=S+Schwartz&author=P+Raskin&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD002967-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD002967-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD002967-bbs1-0003">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0348"> <div class="reference-title-banner"> <h4 class="title">Aguilar 1992b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0371"> <div class="citation-journal">Aguilar C, Reza A, Garcia JE, Rull JA. <span class="citation-title">Biguanide related lactic acidosis: incidence and risk factors</span>. <span class="citation"> Archives of Medical Research </span><span class="pubYear">1992</span>;<span class="volume">23</span>(1):19‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1308787" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biguanide+related+lactic+acidosis:+incidence+and+risk+factors&author=C+Aguilar&author=A+Reza&author=JE+Garcia&author=JA+Rull&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0349"> <div class="reference-title-banner"> <h4 class="title">Belsey 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0372"> <div class="citation-journal">Belsey J, Krishnarajah G. <span class="citation-title">Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta‐analysis</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10 Suppl 1</span>:1‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18435668" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycaemic+control+and+adverse+events+in+patients+with+type+2+diabetes+treated+with+metformin+++sulphonylurea:+a+meta%E2%80%90analysis+&author=J+Belsey&author=G+Krishnarajah&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0350"> <div class="reference-title-banner"> <h4 class="title">Berhanu 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0373"> <div class="citation-journal">Berhanu P, Perez A, Yu S. <span class="citation-title">Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(4):512‐20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17587394" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+pioglitazone+in+combination+with+insulin+therapy+on+glycaemic+control,+insulin+dose+requirement+and+lipid+profile+in+patients+with+type+2+diabetes+previously+poorly+controlled+with+combination+therapy+&author=P+Berhanu&author=A+Perez&author=S+Yu&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0351"> <div class="reference-title-banner"> <h4 class="title">Bernard 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0374"> <div class="citation-journal">Bernard C, Bernard R. <span class="citation-title">[Tolbutamide‐dimethyl‐biguanide association in the treatment of diabetes mellitus]</span>. <span class="citation"> Gazette Medicale de France </span><span class="pubYear">1965</span>;<span class="volume">72</span>(14):2763‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5850517" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Tolbutamide%E2%80%90dimethyl%E2%80%90biguanide+association+in+the+treatment+of+diabetes+mellitus]&author=C+Bernard&author=R+Bernard&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0352"> <div class="reference-title-banner"> <h4 class="title">Bodmer 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0375"> <div class="citation-journal">Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. <span class="citation-title">Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia a nested case‐control analysis</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2008</span>;<span class="volume">31</span>(11):2086‐91. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18782901" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin,+sulfonylureas,+or+other+antidiabetes+drugs+and+the+risk+of+lactic+acidosis+or+hypoglycemia+a+nested+case%E2%80%90control+analysis+&author=M+Bodmer&author=C+Meier&author=S+Krahenbuhl&author=SS+Jick&author=CR+Meier&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0353"> <div class="reference-title-banner"> <h4 class="title">Bonfigli 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0376"> <div class="citation-journal">Bonfigli AR, Manfrini S, Gregorio F, Testa R, Sio G, Coppa G. <span class="citation-title">Determination of plasma Metformin by a new cation‐exchange HPLC technique</span>. <span class="citation"> Therapeutic Drug Monitoring </span><span class="pubYear">1999</span>;<span class="volume">21</span>:330‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10365648" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Determination+of+plasma+Metformin+by+a+new+cation%E2%80%90exchange+HPLC+technique&author=AR+Bonfigli&author=S+Manfrini&author=F+Gregorio&author=R+Testa&author=G+Sio&author=G+Coppa&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0354"> <div class="reference-title-banner"> <h4 class="title">Bruneder 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0377"> <div class="citation-journal">Bruneder H, Klein HJ. <span class="citation-title">[Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics]</span>. <span class="citation"> Acta Medica Austriaca </span><span class="pubYear">1978</span>;<span class="volume">5</span>(3):88‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/752220" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Blood+lactate+and+biguanide+therapy:+comparison+between+phenformin,+metformin+and+buformin+in+408+senile+diabetics]+&author=H+Bruneder&author=HJ+Klein&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0355"> <div class="reference-title-banner"> <h4 class="title">Cacciapuoti 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0378"> <div class="citation-journal">Cacciapuoti F, Spiezia R, Bianchi U, Lama D, D'Avino M, Varricchio M. <span class="citation-title">Effectiveness of Glibenclamide on myocardial ischemic ventricular arrhythmias in non‐insulin‐dependent Diabetes mellitus</span>. <span class="citation"> American Journal of Cardiology </span><span class="pubYear">1991</span>;<span class="volume">67</span>:843‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1707221" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effectiveness+of+Glibenclamide+on+myocardial+ischemic+ventricular+arrhythmias+in+non%E2%80%90insulin%E2%80%90dependent+Diabetes+mellitus+&author=F+Cacciapuoti&author=R+Spiezia&author=U+Bianchi&author=D+Lama&author=M+D'Avino&author=M+Varricchio&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0356"> <div class="reference-title-banner"> <h4 class="title">Chan 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0379"> <div class="citation-journal">Chan JYC, Leyk M, Frier BM, Tan MH. <span class="citation-title">Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin</span>. <span class="citation"> Diabetes/Metabolism Research and Reviews </span><span class="pubYear">2009</span>;<span class="volume">25</span>(3):224‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Relationship+between+HbA1c+and+hypoglycaemia+in+patients+with+type+2+diabetes+treated+with+different+insulin+regimens+in+combination+with+metformin+&author=JYC+Chan&author=M+Leyk&author=BM+Frier&author=MH+Tan&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0357"> <div class="reference-title-banner"> <h4 class="title">Charlton 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0380"> <div class="citation-journal">Charlton J, Latinovic R, Gulliford MC. <span class="citation-title">Explaining the decline in early mortality in men and women with type 2 diabetes: a population‐based cohort study</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2008</span>;<span class="volume">31</span>(9):1761‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18509209" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Explaining+the+decline+in+early+mortality+in+men+and+women+with+type+2+diabetes:+a+population%E2%80%90based+cohort+study+&author=J+Charlton&author=R+Latinovic&author=MC+Gulliford&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0358"> <div class="reference-title-banner"> <h4 class="title">Chow 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0381"> <div class="citation-journal">Chow C‐C, Tsand LWW, Sorensen JP, Cockram CS. <span class="citation-title">Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1995</span>;<span class="volume">18</span>(3):307‐14. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7555472" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+insulin+with+or+without+continuation+of+oral+hypoglycemic+agents+in+the+treatment+of+secondary+failure+in+NIDDM+patients+&author=C%E2%80%90C+Chow&author=LWW+Tsand&author=JP+Sorensen&author=CS+Cockram&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0359"> <div class="reference-title-banner"> <h4 class="title">Clauson 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0382"> <div class="citation-journal">Clauson P, Karlander S, Steen L, Efendic S. <span class="citation-title">Saytime Glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary Sulphonylurea failure: a 1‐year follow‐up</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1995</span>;<span class="volume">13</span>:471‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Saytime+Glibenclamide+and+bedtime+NPH+insulin+compared+to+intensive+insulin+treatment+in+secondary+Sulphonylurea+failure:+a+1%E2%80%90year+follow%E2%80%90up+&author=P+Clauson&author=S+Karlander&author=L+Steen&author=S+Efendic&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0360"> <div class="reference-title-banner"> <h4 class="title">Comaschi 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0383"> <div class="citation-journal">Comaschi M, Demicheli A, Pietro C, Bellatreccia A, Mariz S, Study Investigators. <span class="citation-title">Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed‐dose combination of metformin and glibenclamide in patients with type 2 diabetes</span>. <span class="citation"> Diabetes Technology &amp; Therapeutics </span><span class="pubYear">2007</span>;<span class="volume">9</span>(4):387‐98. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17705695" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+pioglitazone+in+combination+with+metformin+or+a+sulfonylurea+compared+to+a+fixed%E2%80%90dose+combination+of+metformin+and+glibenclamide+in+patients+with+type+2+diabetes+&author=M+Comaschi&author=A+Demicheli&author=C+Pietro&author=A+Bellatreccia&author=S+Mariz&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0361"> <div class="reference-title-banner"> <h4 class="title">Comaschi 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0384"> <div class="citation-journal">Comaschi M, Corsi A, Pietro C, Bellatreccia A, Mariz S, Study Investigators. <span class="citation-title">The effect of pioglitazone as add‐on therapy to metformin or sulphonylurea compared to a fixed‐dose combination of metformin and glibenclamide on diabetic dyslipidaemia</span>. <span class="citation"> Nutrition Metabolism &amp; Cardiovascular Diseases </span><span class="pubYear">2008</span>;<span class="volume">18</span>(5):373‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+pioglitazone+as+add%E2%80%90on+therapy+to+metformin+or+sulphonylurea+compared+to+a+fixed%E2%80%90dose+combination+of+metformin+and+glibenclamide+on+diabetic+dyslipidaemia+&author=M+Comaschi&author=A+Corsi&author=C+Pietro&author=A+Bellatreccia&author=S+Mariz&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0362"> <div class="reference-title-banner"> <h4 class="title">Connolly 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0385"> <div class="citation-journal">Connolly V, Kesson CM. <span class="citation-title">Metformin treatment in NIDDM patients with mild renal impairment</span>. <span class="citation"> Postgraduate Medical Journal </span><span class="pubYear">1996</span>;<span class="volume">72</span>(848):352‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8758014" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+treatment+in+NIDDM+patients+with+mild+renal+impairment&author=V+Connolly&author=CM+Kesson&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0363"> <div class="reference-title-banner"> <h4 class="title">Cook 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0386"> <div class="citation-journal">Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR. <span class="citation-title">Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:995‐1000. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15855556" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycemic+control+continues+to+deteriorate+after+sulfonylureas+are+added+to+metformin+among+patients+with+type+2+diabetes+&author=MN+Cook&author=CJ+Girman&author=PP+Stein&author=CM+Alexander&author=RR+Holman&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0364"> <div class="reference-title-banner"> <h4 class="title">Cunha 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0387"> <div class="citation-journal">Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, et al. <span class="citation-title">Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2008</span>;<span class="volume">10</span>(3):238‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18269639" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cardiovascular,+metabolic+and+hormonal+responses+to+the+progressive+exercise+performed+to+exhaustion+in+patients+with+type+2+diabetes+treated+with+metformin+or+glyburide+&author=MR+Cunha&author=ME+Silva&author=HA+Machado&author=RT+Fukui&author=MR+Correia&author=RF+Santos&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0365"> <div class="reference-title-banner"> <h4 class="title">Daniel 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0388"> <div class="citation-journal">Daniel JR, Hagmeyer KO. <span class="citation-title">Metformin and insulin: is there a role for combination therapy?</span>. <span class="citation"> Annals of Pharmacotherapy </span><span class="pubYear">1997</span>;<span class="volume">31</span>(4):474‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9101010" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+insulin:+is+there+a+role+for+combination+therapy?&author=JR+Daniel&author=KO+Hagmeyer&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0366"> <div class="reference-title-banner"> <h4 class="title">Debry 1964 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0389"> <div class="citation-journal">Debry G, Anziani, Cherrier, Laurent J. <span class="citation-title">[Study of lactic acid levels on an empty stomach in diabetic patients treated with N‐N‐dimethylbiguanide]</span>. <span class="citation"> Diabete </span><span class="pubYear">1964</span>;<span class="volume">12</span>:239‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14228352" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Study+of+lactic+acid+levels+on+an+empty+stomach+in+diabetic+patients+treated+with+N%E2%80%90N%E2%80%90dimethylbiguanide]+&author=G+Debry&author=+Anziani&author=+Cherrier&author=J+Laurent&publication_year=1964&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0367"> <div class="reference-title-banner"> <h4 class="title">Debry 1966a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0390"> <div class="citation-journal">Debry G, Laurent J. <span class="citation-title">[Results of the treatment of Diabetes mellitus in the adult with the association of Metformin and sulfamides (concerning 197 cases)]</span>. <span class="citation"> Journal de Medicine de Lyon </span><span class="pubYear">1966</span>;<span class="volume">47</span>:407‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Results+of+the+treatment+of+Diabetes+mellitus+in+the+adult+with+the+association+of+Metformin+and+sulfamides+(concerning+197+cases)]+&author=G+Debry&author=J+Laurent&publication_year=1966&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0368"> <div class="reference-title-banner"> <h4 class="title">Debry 1966b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0391"> <div class="citation-journal">Debry G, Laurent J. <span class="citation-title">[Results of the treatment of Diabetes mellitus in the adult with metformin (concerning 202 cases0]</span>. <span class="citation"> Journal de Medicine de Lyon </span><span class="pubYear">1966</span>;<span class="volume">47</span>:395‐404. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Results+of+the+treatment+of+Diabetes+mellitus+in+the+adult+with+metformin+(concerning+202+cases0]+&author=G+Debry&author=J+Laurent&publication_year=1966&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0369"> <div class="reference-title-banner"> <h4 class="title">Derosa 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0392"> <div class="citation-journal">Derosa G, Mereu R, Salvadeo SAT, D'Angelo A, Ciccarelli L, Piccini MN, et al. <span class="citation-title">Pioglitazone metabolic effect in metformin‐intolerant obese patients treated with sibutramine</span>. <span class="citation"> Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">48</span>(5):265‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19252346" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pioglitazone+metabolic+effect+in+metformin%E2%80%90intolerant+obese+patients+treated+with+sibutramine+&author=G+Derosa&author=R+Mereu&author=SAT+Salvadeo&author=A+D'Angelo&author=L+Ciccarelli&author=MN+Piccini&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0370"> <div class="reference-title-banner"> <h4 class="title">English 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0393"> <div class="citation-journal">English PJ, Ashcroft A, Patterson M, Dovey TM, Halford JC, Harrison J. <span class="citation-title">Metformin prolongs the posptrandial fall in plasma ghrelin concentrations in type 2 diabetes</span>. <span class="citation"> Diabetes Metabolism Research and Reviews </span><span class="pubYear">2007</span>;<span class="volume">23</span>:299‐303. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16952199" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+prolongs+the+posptrandial+fall+in+plasma+ghrelin+concentrations+in+type+2+diabetes+&author=PJ+English&author=A+Ashcroft&author=M+Patterson&author=TM+Dovey&author=JC+Halford&author=J+Harrison&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0371"> <div class="reference-title-banner"> <h4 class="title">Eurich 2005a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0394"> <div class="citation-journal">Eurich DT, Majumdar ST, McAlister FA, Johnson JA. <span class="citation-title">Improved clinical outcomes associated with metformin in patients with diabetes and heart failure</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:2345‐2351. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16186261" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+clinical+outcomes+associated+with+metformin+in+patients+with+diabetes+and+heart+failure+&author=DT+Eurich&author=ST+Majumdar&author=FA+McAlister&author=JA+Johnson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0372"> <div class="reference-title-banner"> <h4 class="title">Eurich 2005b {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0395"> <div class="citation-journal">Eurich DT, Simpson SH, Majumdar SR, Johnson JA. <span class="citation-title">Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus</span>. <span class="citation"> Pharmacotherapy </span><span class="pubYear">2005</span>;<span class="volume">25</span>:810‐816. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15927899" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Secondary+failure+rates+associated+with+metformin+and+sulfonylurea+therapy+for+type+2+diabetes+mellitus+&author=DT+Eurich&author=SH+Simpson&author=SR+Majumdar&author=JA+Johnson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0373"> <div class="reference-title-banner"> <h4 class="title">Evans 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0396"> <div class="citation-journal">Evans JMM, Ogston SA, Emslie‐Smith A, Morris AD. <span class="citation-title">Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2006</span>;<span class="volume">49</span>:930‐936. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16525843" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Risk+of+mortality+and+adverse+cardiovascular+outcomes+in+type+2+diabetes:+a+comparison+of+patients+treated+with+sulfonylureas+and+metformin+&author=JMM+Evans&author=SA+Ogston&author=A+Emslie%E2%80%90Smith&author=AD+Morris&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0374"> <div class="reference-title-banner"> <h4 class="title">Farah 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0397"> <div class="citation-journal">Farah R, Shurtz‐Swirski R, Lapin O. <span class="citation-title">Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment</span>. <span class="citation"> Cardiovascular Diabetology </span><span class="pubYear">2008</span>;<span class="volume">7</span>:20. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18570678" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensification+of+oxidative+stress+and+inflammation+in+type+2+diabetes+despite+antihyperglycemic+treatment+&author=R+Farah&author=R+Shurtz%E2%80%90Swirski&author=O+Lapin&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0375"> <div class="reference-title-banner"> <h4 class="title">Faure 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0398"> <div class="citation-journal">Faure P, Wiernsperger N, Polge C, Favier A, Halimi S. <span class="citation-title">Impairment of the antioxidant properties of serum albumin in patients with diabetes: Protective effects of metformin</span>. <span class="citation"> Clinical Science </span><span class="pubYear">2008</span>;<span class="volume">114</span>(3):251‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17922677" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impairment+of+the+antioxidant+properties+of+serum+albumin+in+patients+with+diabetes:+Protective+effects+of+metformin+&author=P+Faure&author=N+Wiernsperger&author=C+Polge&author=A+Favier&author=S+Halimi&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0376"> <div class="reference-title-banner"> <h4 class="title">Fery 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0399"> <div class="citation-journal">Fery F, Plat L, Balasse EO. <span class="citation-title">Effects of metformin on the pathways of glucose utilization after oral glucose in non‐insulin‐dependent diabetes mellitus patients</span>. <span class="citation"> Metabolism </span><span class="pubYear">1997</span>;<span class="volume">46</span>(2):227‐33. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9030834" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+the+pathways+of+glucose+utilization+after+oral+glucose+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+patients+&author=F+Fery&author=L+Plat&author=EO+Balasse&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0377"> <div class="reference-title-banner"> <h4 class="title">Forti 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0400"> <div class="citation-journal">Forti A, Garcia EG, Yu MB, Jimenez MC, Brodows RG, Oliveira JH. <span class="citation-title">Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2008</span>;<span class="volume">24</span>(9):2437‐47. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18662495" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+exenatide+administered+before+the+two+largest+daily+meals+of+Latin+American+patients+with+type+2+diabetes+&author=A+Forti&author=EG+Garcia&author=MB+Yu&author=MC+Jimenez&author=RG+Brodows&author=JH+Oliveira&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0378"> <div class="reference-title-banner"> <h4 class="title">Galuska 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0401"> <div class="citation-journal">Galuska D, Nolte LA, Zierath JR, Wallberg‐Henriksson H. <span class="citation-title">Effect of metformin on insulin‐stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1994</span>;<span class="volume">37</span>:826‐32. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7988785" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+insulin%E2%80%90stimulated+glucose+transport+in+isolated+skeletal+muscle+obtained+from+patients+with+NIDDM+&author=D+Galuska&author=LA+Nolte&author=JR+Zierath&author=H+Wallberg%E2%80%90Henriksson&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0379"> <div class="reference-title-banner"> <h4 class="title">Gibson 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0402"> <div class="citation-journal">Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JMP, Fraser W, Anderson C, White A, Young RJ. <span class="citation-title">Choice of treatment affects plasma levels of insulin‐like growth factor‐binding protein‐1 in noninsulin‐dependent Diabetes mellitus</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1995</span>;<span class="volume">80</span>:1369‐75. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7536208" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Choice+of+treatment+affects+plasma+levels+of+insulin%E2%80%90like+growth+factor%E2%80%90binding+protein%E2%80%901+in+noninsulin%E2%80%90dependent+Diabetes+mellitus+&author=JM+Gibson&author=M+Westwood&author=SR+Crosby&author=C+Gordon&author=JMP+Holly&author=W+Fraser&author=C+Anderson&author=A+White&author=RJ+Young&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0380"> <div class="reference-title-banner"> <h4 class="title">Gin 1982 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0403"> <div class="citation-journal">Gin H, Slama G, Weissbrodt P, Poynard T, Vexiau P, Klein JC, Tchobroutsky G. <span class="citation-title">Metformin reduces post‐prandial insulin needs in Type 1 (Insulin‐dependent) diabetic patients: Assessment by the artificial pancreas</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1982</span>;<span class="volume">23</span>:34‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6749582" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+reduces+post%E2%80%90prandial+insulin+needs+in+Type+1+(Insulin%E2%80%90dependent)+diabetic+patients:+Assessment+by+the+artificial+pancreas+&author=H+Gin&author=G+Slama&author=P+Weissbrodt&author=T+Poynard&author=P+Vexiau&author=JC+Klein&author=G+Tchobroutsky&publication_year=1982&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0381"> <div class="reference-title-banner"> <h4 class="title">Gin 1985 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0404"> <div class="citation-journal">Gin H, Messerchmitt C, Brottier E, Aubertin J. <span class="citation-title">Metformin improved insulin resistance in type I, insulin‐dependent, diabetic patients</span>. <span class="citation"> Metabolism </span><span class="pubYear">1985</span>;<span class="volume">34</span>(10):923‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/4046836" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+improved+insulin+resistance+in+type+I,+insulin%E2%80%90dependent,+diabetic+patients&author=H+Gin&author=C+Messerchmitt&author=E+Brottier&author=J+Aubertin&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0382"> <div class="reference-title-banner"> <h4 class="title">Gin 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0405"> <div class="citation-journal">Gin H, Freyburger G, Boisseau M, Aubertin J. <span class="citation-title">Study of the effect of metformin on platelet aggregation in insulin‐dependent diabetics</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1989</span>;<span class="volume">6</span>(1):61‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2702918" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Study+of+the+effect+of+metformin+on+platelet+aggregation+in+insulin%E2%80%90dependent+diabetics&author=H+Gin&author=G+Freyburger&author=M+Boisseau&author=J+Aubertin&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0383"> <div class="reference-title-banner"> <h4 class="title">Giugliano 1979 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0406"> <div class="citation-journal">Giugliano D, Torella R, Improta L, Scognamiglio G. <span class="citation-title">Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes</span>. <span class="citation"> Farmaco edizione Pratica </span><span class="pubYear">1979</span>;<span class="volume">34</span>(1):32‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/378687" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+on+plasma+glucose,+insulin,+FFA,+glucagon,+growth+hormone+and+cortisol+responses+to+oral+glucose+in+subjects+with+chemical+diabetes+&author=D+Giugliano&author=R+Torella&author=L+Improta&author=G+Scognamiglio&publication_year=1979&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0384"> <div class="reference-title-banner"> <h4 class="title">Gontier 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0407"> <div class="citation-journal">Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Stanc E, et al. <span class="citation-title">High and typical 18F‐FDG bowel uptake in patients treated with metformin</span>. <span class="citation"> European Journal of Nuclear Medicine &amp; Molecular Imaging </span><span class="pubYear">2008</span>;<span class="volume">35</span>(1):95‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=High+and+typical+18F%E2%80%90FDG+bowel+uptake+in+patients+treated+with+metformin&author=E+Gontier&author=E+Fourme&author=M+Wartski&author=C+Blondet&author=G+Bonardel&author=E+Stanc&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0385"> <div class="reference-title-banner"> <h4 class="title">Guthrie 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0408"> <div class="citation-journal">Guthrie R. <span class="citation-title">Treatment of non‐insulin‐dependent diabetes mellitus with metformin</span>. <span class="citation"> Journal of the American Board of Family Practice </span><span class="pubYear">1997</span>;<span class="volume">10</span>(3):213‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9159660" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+of+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+with+metformin&author=R+Guthrie&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0386"> <div class="reference-title-banner"> <h4 class="title">Harris 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0409"> <div class="citation-journal">Harris S, Yale J‐F, Dempsey E, Gerstein H. <span class="citation-title">Can family physicians help patients initiate basal insulin therapy successfully?: Randomized trial of patient‐titrated insulin glargine compared with standard oral therapy: Lessons for family practice from the Canadian INSIGHT trial</span>. <span class="citation"> Canadian Family Physician </span><span class="pubYear">2008</span>;<span class="volume">54</span>(4):550‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18411384" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Can+family+physicians+help+patients+initiate+basal+insulin+therapy+successfully?:+Randomized+trial+of+patient%E2%80%90titrated+insulin+glargine+compared+with+standard+oral+therapy:+Lessons+for+family+practice+from+the+Canadian+INSIGHT+trial+&author=S+Harris&author=J%E2%80%90F+Yale&author=E+Dempsey&author=H+Gerstein&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0387"> <div class="reference-title-banner"> <h4 class="title">He 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0410"> <div class="citation-journal">He Y‐L, Sabo R, Picard F, Wang Y, Herron J, Ligueros‐Saylan M, et al. <span class="citation-title">Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes</span>. <span class="citation"> Current Medical Research and Opinion </span><span class="pubYear">2009</span>;<span class="volume">25</span>(5):1265‐72. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19364302" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Study+of+the+pharmacokinetic+interaction+of+vildagliptin+and+metformin+in+patients+with+type+2+diabetes+&author=Y%E2%80%90L+He&author=R+Sabo&author=F+Picard&author=Y+Wang&author=J+Herron&author=M+Ligueros%E2%80%90Saylan&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0388"> <div class="reference-title-banner"> <h4 class="title">Herman 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0411"> <div class="citation-journal">Herman GA, Bergman A, Yi B, Kipnes M. <span class="citation-title">Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase‐4 inhibitor sitagliptin when co‐administered in patients with type 2 diabetes</span>. <span class="citation"> Clinical Medical Research and Opinion </span><span class="pubYear">2006</span>;<span class="volume">22</span>:1939‐1947. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Tolerability+and+pharmacokinetics+of+metformin+and+the+dipeptidyl+peptidase%E2%80%904+inhibitor+sitagliptin+when+co%E2%80%90administered+in+patients+with+type+2+diabetes+&author=GA+Herman&author=A+Bergman&author=B+Yi&author=M+Kipnes&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0389"> <div class="reference-title-banner"> <h4 class="title">Hermansen 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0412"> <div class="citation-journal">Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, et al. <span class="citation-title">Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2007</span>;<span class="volume">9</span>(5):733‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17593236" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+the+dipeptidyl+peptidase%E2%80%904+inhibitor,+sitagliptin,+in+patients+with+type+2+diabetes+mellitus+inadequately+controlled+on+glimepiride+alone+or+on+glimepiride+and+metformin+&author=K+Hermansen&author=M+Kipnes&author=E+Luo&author=D+Fanurik&author=H+Khatami&author=P+Stein&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0390"> <div class="reference-title-banner"> <h4 class="title">Hirsch 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0413"> <div class="citation-journal">Hirsch IB, Yuan H, Campaigne BN, Tan MH. <span class="citation-title">Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients</span>. <span class="citation"> Endocrine Practice </span><span class="pubYear">2009</span>;<span class="volume">15</span>(4):343‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19454394" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+prandial+plus+basal+vs+basal+insulin+on+glycemic+variability+in+type+2+diabetic+patients+&author=IB+Hirsch&author=H+Yuan&author=BN+Campaigne&author=MH+Tan&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0391"> <div class="reference-title-banner"> <h4 class="title">Home 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0414"> <div class="citation-journal">Home PD, Pocock SJ, Beck‐Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. <span class="citation-title">Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open‐label trial</span>. <span class="citation"> The Lancet </span><span class="pubYear">2009</span>;<span class="volume">373</span>(9681):2125‐35. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+evaluated+for+cardiovascular+outcomes+in+oral+agent+combination+therapy+for+type+2+diabetes+(RECORD):+a+multicentre,+randomised,+open%E2%80%90label+trial+&author=PD+Home&author=SJ+Pocock&author=H+Beck%E2%80%90Nielsen&author=PS+Curtis&author=R+Gomis&author=M+Hanefeld&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0392"> <div class="reference-title-banner"> <h4 class="title">Hong 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0415"> <div class="citation-journal">Hong Y, Rohatagi S, Habtemariam B, Walker JR, Schwartz SL, Mager DE. <span class="citation-title">Population exposure‐response modeling of metformin in patients with type 2 diabetes mellitus</span>. <span class="citation"> Journal of Clinical Pharmacology </span><span class="pubYear">2008</span>;<span class="volume">48</span>(6):696‐707. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18372428" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Population+exposure%E2%80%90response+modeling+of+metformin+in+patients+with+type+2+diabetes+mellitus+&author=Y+Hong&author=S+Rohatagi&author=B+Habtemariam&author=JR+Walker&author=SL+Schwartz&author=DE+Mager&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0393"> <div class="reference-title-banner"> <h4 class="title">Irsigler 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0416"> <div class="citation-journal">Irsigler K, Kritz H, Regal H, Foltin E. <span class="citation-title">[The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)]</span>. <span class="citation"> Wiener Klinische Wochenschrift </span><span class="pubYear">1978</span>;<span class="volume">90</span>(10):332‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/654296" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[The+risk+of+lacticate+acidosis:+a+comparison+of+the+3+biguanides+in+treatment+of+diabetics+(authors'+transl)]+&author=K+Irsigler&author=H+Kritz&author=H+Regal&author=E+Foltin&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0394"> <div class="reference-title-banner"> <h4 class="title">Ismail 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0417"> <div class="citation-journal">Ismail AA, Badrawi H, Nasr S, Khater R, Hafez AA, El‐Kirdassy ZH, et al. <span class="citation-title">The effect of metformin on individual amino acid absorption</span>. <span class="citation"> Journal of the Egyptian Medical Association </span><span class="pubYear">1978</span>;<span class="volume">61</span>(9‐10):673‐92. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/262252" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+individual+amino+acid+absorption&author=AA+Ismail&author=H+Badrawi&author=S+Nasr&author=R+Khater&author=AA+Hafez&author=ZH+El%E2%80%90Kirdassy&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0395"> <div class="reference-title-banner"> <h4 class="title">Isnard 1991 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0418"> <div class="citation-journal">Isnard F, Andre P. <span class="citation-title">[Glycemic equilibrium and weight evolution in diabetics taking metformin]</span>. <span class="citation"> Journees Annuelles Diabetology Hotel‐Dieu </span><span class="pubYear">1991</span>:297‐314. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Glycemic+equilibrium+and+weight+evolution+in+diabetics+taking+metformin]&author=F+Isnard&author=P+Andre&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0396"> <div class="reference-title-banner"> <h4 class="title">Isnard 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0419"> <div class="citation-journal">Isnard F. <span class="citation-title">[Long term treatment with biguanides in the natural evolution of non‐insulin‐dependent diabetes]</span>. <span class="citation"> Journ Annu Diabetol Hotel Dieu </span><span class="pubYear">1996</span>:273‐88. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8965430" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Long+term+treatment+with+biguanides+in+the+natural+evolution+of+non%E2%80%90insulin%E2%80%90dependent+diabetes]+&author=F+Isnard&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0397"> <div class="reference-title-banner"> <h4 class="title">Jansson 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0420"> <div class="citation-journal">Jansson PA, Gudbjornsdottir HS, Andersson OK, Lonnroth PN. <span class="citation-title">The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(2):160‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8718438" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+adipose+tissue+metabolism+and+peripheral+blood+flow+in+subjects+with+NIDDM+&author=PA+Jansson&author=HS+Gudbjornsdottir&author=OK+Andersson&author=PN+Lonnroth&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0398"> <div class="reference-title-banner"> <h4 class="title">Javaid 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0421"> <div class="citation-journal">Javaid A, Hasan R, Zaib A, Masroor S. <span class="citation-title">A comparative study of the effects of hypogycemic agents on serum electrolutes in the diabetic patients</span>. <span class="citation"> Pakistani Journal of Pharmacological Science </span><span class="pubYear">2007</span>;<span class="volume">20</span>:67‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+the+effects+of+hypogycemic+agents+on+serum+electrolutes+in+the+diabetic+patients+&author=A+Javaid&author=R+Hasan&author=A+Zaib&author=S+Masroor&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0399"> <div class="reference-title-banner"> <h4 class="title">Johansen 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0422"> <div class="citation-journal">Johansen K. <span class="citation-title">Efficacy of metformin in the treatment of NIDDM: Meta‐analysis</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>:33‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10333900" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+metformin+in+the+treatment+of+NIDDM:+Meta%E2%80%90analysis&author=K+Johansen&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0400"> <div class="reference-title-banner"> <h4 class="title">Kamber 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0423"> <div class="citation-journal">Kamber N, Davis WA, Bruce DG, Davis TM. <span class="citation-title">Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study</span>. <span class="citation"> Medical Journal of Australia </span><span class="pubYear">2008</span>;<span class="volume">188</span>(8):446‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18429709" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+lactic+acidosis+in+an+Australian+community+setting:+the+Fremantle+Diabetes+Study+&author=N+Kamber&author=WA+Davis&author=DG+Bruce&author=TM+Davis&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0401"> <div class="reference-title-banner"> <h4 class="title">Kim 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0424"> <div class="citation-journal">Kim HJ, Kim SK, Shim WS, Lee JH, Hur KY, Kang ES, et al. <span class="citation-title">Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">81</span>(1):42‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rosiglitazone+improves+insulin+sensitivity+with+increased+serum+leptin+levels+in+patients+with+type+2+diabetes+mellitus+&author=HJ+Kim&author=SK+Kim&author=WS+Shim&author=JH+Lee&author=KY+Hur&author=ES+Kang&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0402"> <div class="reference-title-banner"> <h4 class="title">Komajda 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0425"> <div class="citation-journal">Komajda M, Curtis P, Hanefeld M, Beck‐Nielsen H, Pocock SJ, Zambanini A, et al. <span class="citation-title">Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)</span>. <span class="citation"> Cardiovascular Diabetology </span><span class="pubYear">2008</span>;<span class="volume">7</span>:10. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18435852" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+the+addition+of+rosiglitazone+to+metformin+or+sulfonylureas+versus+metformin/sulfonylurea+combination+therapy+on+ambulatory+blood+pressure+in+people+with+type+2+diabetes:+A+randomized+controlled+trial+(the+RECORD+study)+&author=M+Komajda&author=P+Curtis&author=M+Hanefeld&author=H+Beck%E2%80%90Nielsen&author=SJ+Pocock&author=A+Zambanini&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0403"> <div class="reference-title-banner"> <h4 class="title">Lalau 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0426"> <div class="citation-journal">Lalau JD, Lacroix C, Cagny B, Fournier A. <span class="citation-title">Metformin‐associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis</span>. <span class="citation"> Nephrology Dialysis and Transplantation </span><span class="pubYear">1994</span>;<span class="volume">9</span>(Suppl 4):126‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90associated+lactic+acidosis+in+diabetic+patients+with+acute+renal+failure.+A+critical+analysis+of+its+pathogenesis+and+prognosis+&author=JD+Lalau&author=C+Lacroix&author=B+Cagny&author=A+Fournier&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0404"> <div class="reference-title-banner"> <h4 class="title">Lalau 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0427"> <div class="citation-journal">Lalau JD, Lacroix C, Compagnon P, Cagny B, Rigaud JP, Bleichner G, et al. <span class="citation-title">Role of metformin accumulation in metformin‐associated lactic acidosis</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1995</span>;<span class="volume">18</span>(6):779‐84. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7555503" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Role+of+metformin+accumulation+in+metformin%E2%80%90associated+lactic+acidosis&author=JD+Lalau&author=C+Lacroix&author=P+Compagnon&author=B+Cagny&author=JP+Rigaud&author=G+Bleichner&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0405"> <div class="reference-title-banner"> <h4 class="title">Lapina 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0428"> <div class="citation-journal">Lapina IuV, Narusov OI, Mareev VI, Bolotina MG, Shestakova MV, Masenko VP, et al. <span class="citation-title">[Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study &quot;rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure&quot;]. [Russian]</span>. <span class="citation"> Kardiologiia </span><span class="pubYear">2008</span>;<span class="volume">48</span>(3):58‐68. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18429758" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Efficacy+and+safety+of+the+use+of+metformin+in+patients+with+chronic+heart+failure+and+type+2+diabetes+mellitus.+results+of+the+study+" rational+effective+mulicomponent+therapy+in+the+battle+against+diabetes+mellitus+in+patients+with+chronic+heart+failure"].+[Russian]+&author=IuV+Lapina&author=OI+Narusov&author=VI+Mareev&author=MG+Bolotina&author=MV+Shestakova&author=VP+Masenko&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0406"> <div class="reference-title-banner"> <h4 class="title">Leslie 1987 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0429"> <div class="citation-journal">Leslie P, Jung RT, Isles TE, Baty J. <span class="citation-title">Energy expenditure in non‐insulin dependent diabetic subjects on metformin or sulphonylurea therapy</span>. <span class="citation"> Clinical Science </span><span class="pubYear">1987</span>;<span class="volume">73</span>(1):41‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3301165" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Energy+expenditure+in+non%E2%80%90insulin+dependent+diabetic+subjects+on+metformin+or+sulphonylurea+therapy+&author=P+Leslie&author=RT+Jung&author=TE+Isles&author=J+Baty&publication_year=1987&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0407"> <div class="reference-title-banner"> <h4 class="title">Lim 1970 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0430"> <div class="citation-journal">Lim P, Khoo OT. <span class="citation-title">Metformin compared with tolbutamide in the treatment of maturity‐onset diabetes mellitus</span>. <span class="citation"> Medical Journal of Australia </span><span class="pubYear">1970</span>;<span class="volume">1</span>(6):271‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5440868" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+compared+with+tolbutamide+in+the+treatment+of+maturity%E2%80%90onset+diabetes+mellitus&author=P+Lim&author=OT+Khoo&publication_year=1970&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0408"> <div class="reference-title-banner"> <h4 class="title">Lin 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0431"> <div class="citation-journal">Lin KD, Chang YH, Wang CL, Yang YH, Hsiao PJ, Li TH, et al. <span class="citation-title">Thiazolidinedione addition reduces the serum retinol‐binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea</span>. <span class="citation"> Translational Research: The Journal Of Laboratory &amp; Clinical Medicine </span><span class="pubYear">2008</span>;<span class="volume">151</span>(6):309‐14. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinedione+addition+reduces+the+serum+retinol%E2%80%90binding+protein+4+in+type+2+diabetic+patients+treated+with+metformin+and+sulfonylurea+&author=KD+Lin&author=YH+Chang&author=CL+Wang&author=YH+Yang&author=PJ+Hsiao&author=TH+Li&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0409"> <div class="reference-title-banner"> <h4 class="title">Magalhaes 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0432"> <div class="citation-journal">Magalhaes FO, Gouvela LMB, Torquato MTCG, Paccola GMGF, Piccinato CE, Foss, MC. <span class="citation-title">Metformin increases blood flow and forearm glucose uptake in a group of non‐obese type 2 diabetes patients</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">2006</span>;<span class="volume">38</span>:513‐517. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16941277" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+increases+blood+flow+and+forearm+glucose+uptake+in+a+group+of+non%E2%80%90obese+type+2+diabetes+patients+&author=FO+Magalhaes&author=LMB+Gouvela&author=MTCG+Torquato&author=GMGF+Paccola&author=CE+Piccinato&author=+Foss&author=+MC&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0410"> <div class="reference-title-banner"> <h4 class="title">Masoudi 2005 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0433"> <div class="citation-journal">Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. <span class="citation-title">Thiazolidinediones, metformin and outcomes in older patients with diabetes and heart failure</span>. <span class="citation"> Circulation </span><span class="pubYear">2005</span>;<span class="volume">111</span>:583‐590. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15699279" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Thiazolidinediones,+metformin+and+outcomes+in+older+patients+with+diabetes+and+heart+failure+&author=FA+Masoudi&author=SE+Inzucchi&author=Y+Wang&author=EP+Havranek&author=JM+Foody&author=HM+Krumholz&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0411"> <div class="reference-title-banner"> <h4 class="title">Mellbin 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0434"> <div class="citation-journal">Mellbin LG, Malmberg K, Norhammar A, Wedel H, Ryden L. <span class="citation-title">The impact of glucose lowering treatment on long‐term prognosis in patients with type 2 diabetes and myocardial infarction: A report from the DIGAMI 2 trial</span>. <span class="citation"> European Heart Journal </span><span class="pubYear">2008</span>;<span class="volume">29</span>(2):166‐76. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18156614" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+impact+of+glucose+lowering+treatment+on+long%E2%80%90term+prognosis+in+patients+with+type+2+diabetes+and+myocardial+infarction:+A+report+from+the+DIGAMI+2+trial+&author=LG+Mellbin&author=K+Malmberg&author=A+Norhammar&author=H+Wedel&author=L+Ryden&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0412"> <div class="reference-title-banner"> <h4 class="title">Messens 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0435"> <div class="citation-journal">Messens Y, Margoulies M. <span class="citation-title">[Treatment of 81 cases of diabetes mellitus with N.N. dimethyl‐biguanide]</span>. <span class="citation"> Revue Medicale de Liege </span><span class="pubYear">1965</span>;<span class="volume">20</span>(22):607‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5854952" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+81+cases+of+diabetes+mellitus+with+N.N.+dimethyl%E2%80%90biguanide]&author=Y+Messens&author=M+Margoulies&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0413"> <div class="reference-title-banner"> <h4 class="title">Messens 1966 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0436"> <div class="citation-journal">Messens Y, Margoulies M. <span class="citation-title">[Treatment of diabetes mellitus with N.N. dimethy‐biguanide]</span>. <span class="citation"> Diabete </span><span class="pubYear">1966</span>;<span class="volume">14</span>(2):74‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+diabetes+mellitus+with+N.N.+dimethy%E2%80%90biguanide]&author=Y+Messens&author=M+Margoulies&publication_year=1966&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0414"> <div class="reference-title-banner"> <h4 class="title">Monami 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0437"> <div class="citation-journal">Monami M, Luzzi C, Lamanna C, Chiasserini V, Addante F, Desideri CM, Masotti G, Marchionni N, Mannucci E. <span class="citation-title">Three‐year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin</span>. <span class="citation"> Diabetes and Metabolism Research and Reviews </span><span class="pubYear">2006</span>;<span class="volume">22</span>:477‐482. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Three%E2%80%90year+mortality+in+diabetic+patients+treated+with+different+combinations+of+insulin+secretagogues+and+metformin+&author=M+Monami&author=C+Luzzi&author=C+Lamanna&author=V+Chiasserini&author=F+Addante&author=CM+Desideri&author=G+Masotti&author=N+Marchionni&author=E+Mannucci&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0415"> <div class="reference-title-banner"> <h4 class="title">Monami 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0438"> <div class="citation-journal">Monami M, Lamanna C, Marchionni N, Mannucci E. <span class="citation-title">Comparison of different drugs as add‐on treatments to metformin in type 2 diabetes: A meta‐analysis</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">79</span>(2):196‐203. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17931733" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+different+drugs+as+add%E2%80%90on+treatments+to+metformin+in+type+2+diabetes:+A+meta%E2%80%90analysis+&author=M+Monami&author=C+Lamanna&author=N+Marchionni&author=E+Mannucci&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0416"> <div class="reference-title-banner"> <h4 class="title">Monami 2008a {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0439"> <div class="citation-journal">Monami M, Marchionni N, Masotti G, Mannucci E. <span class="citation-title">Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease</span>. <span class="citation"> International Journal of Cardiology </span><span class="pubYear">2008</span>;<span class="volume">126</span>(2):247‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17512619" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+combined+secretagogue/biguanide+treatment+on+mortality+in+type+2+diabetic+patients+with+and+without+ischemic+heart+disease+&author=M+Monami&author=N+Marchionni&author=G+Masotti&author=E+Mannucci&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0417"> <div class="reference-title-banner"> <h4 class="title">Muntoni 1965 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0440"> <div class="citation-journal">Muntoni S, Boero A, Corona M, Flores M. <span class="citation-title">[Dimethyl‐biguanide in the treatment of diabetes mellitus]</span>. <span class="citation"> La Clinica terapeutica </span><span class="pubYear">1965</span>;<span class="volume">35</span>:227‐51. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/5865542" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Dimethyl%E2%80%90biguanide+in+the+treatment+of+diabetes+mellitus]&author=S+Muntoni&author=A+Boero&author=M+Corona&author=M+Flores&publication_year=1965&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0418"> <div class="reference-title-banner"> <h4 class="title">Nauck 1993 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0441"> <div class="citation-journal">Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. <span class="citation-title">Normalization of fasting hyperglycaemia by exogenous glucagon‐like peptide 1 (17‐36 amide) in Type 2 (non‐insulin‐dependent) diabetic patients</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1993</span>;<span class="volume">36</span>:741‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8405741" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Normalization+of+fasting+hyperglycaemia+by+exogenous+glucagon%E2%80%90like+peptide+1+(17%E2%80%9036+amide)+in+Type+2+(non%E2%80%90insulin%E2%80%90dependent)+diabetic+patients+&author=MA+Nauck&author=N+Kleine&author=C+Orskov&author=JJ+Holst&author=B+Willms&author=W+Creutzfeldt&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0419"> <div class="reference-title-banner"> <h4 class="title">Nauck 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0442"> <div class="citation-journal">Nauck MA, Holst JJ, Wilms B. <span class="citation-title">Glucagon‐like peptide 1 and its potential in the treatment of non‐insulin‐dependent Diabetes mellitus</span>. <span class="citation"> Hormone and Metabolic Research </span><span class="pubYear">1997</span>;<span class="volume">29</span>:411‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9370106" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucagon%E2%80%90like+peptide+1+and+its+potential+in+the+treatment+of+non%E2%80%90insulin%E2%80%90dependent+Diabetes+mellitus+&author=MA+Nauck&author=JJ+Holst&author=B+Wilms&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0420"> <div class="reference-title-banner"> <h4 class="title">Nauck 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0443"> <div class="citation-journal">Nauck M, Marre M. <span class="citation-title">Adding liraglutide to oral antidiabetic drug monotherapy: Efficacy and weight benefits</span>. <span class="citation"> Postgraduate Medicine </span><span class="pubYear">2009</span>;<span class="volume">121</span>(3):5‐15. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19491535" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Adding+liraglutide+to+oral+antidiabetic+drug+monotherapy:+Efficacy+and+weight+benefits&author=M+Nauck&author=M+Marre&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0421"> <div class="reference-title-banner"> <h4 class="title">O'Connor 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0444"> <div class="citation-journal">O'Connor PJ, Spann SJ, Woolf SH. <span class="citation-title">Care of adults with type 2 diabetes mellitus. A review of the evidence [see comments]</span>. <span class="citation"> Journal of Family Practice </span><span class="pubYear">1998</span>;<span class="volume">47</span>(5 Suppl):S13‐22. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9834750" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Care+of+adults+with+type+2+diabetes+mellitus.+A+review+of+the+evidence+[see+comments]&author=PJ+O'Connor&author=SJ+Spann&author=SH+Woolf&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0422"> <div class="reference-title-banner"> <h4 class="title">Ong 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0445"> <div class="citation-journal">Ong CR, Molyneaux LM, Constantino MI, Twigg SM, Yue DK. <span class="citation-title">Long‐term efficacy of metformin therapy in nonobese individuals with type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:2361‐2364. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17065668" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+efficacy+of+metformin+therapy+in+nonobese+individuals+with+type+2+diabetes&author=CR+Ong&author=LM+Molyneaux&author=MI+Constantino&author=SM+Twigg&author=DK+Yue&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0423"> <div class="reference-title-banner"> <h4 class="title">Orlikowska 1966 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0446"> <div class="citation-journal">Orlikowska W. <span class="citation-title">[Influence of N.N. dimethyl biguandie on certain elements of lipid metabolism in diabetic patients]</span>. <span class="citation"> Le Diabete </span><span class="pubYear">1966</span>;<span class="volume">14</span>:183‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Influence+of+N.N.+dimethyl+biguandie+on+certain+elements+of+lipid+metabolism+in+diabetic+patients]+&author=W+Orlikowska&publication_year=1966&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0424"> <div class="reference-title-banner"> <h4 class="title">Panahloo 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0447"> <div class="citation-journal">Panahloo A, Mohamed‐Ali V, Lane A, Green F, Humphries SE, Yudkin JS. <span class="citation-title">Determinants of plasminogin activatory inhibitor 1 activiry in treated NIDDM and its relation to a polymorphosm in the Plasminogen Activator Inhibitor 1 gene</span>. <span class="citation"> Diabetes </span><span class="pubYear">1995</span>;<span class="volume">44</span>(1):37‐42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7813812" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Determinants+of+plasminogin+activatory+inhibitor+1+activiry+in+treated+NIDDM+and+its+relation+to+a+polymorphosm+in+the+Plasminogen+Activator+Inhibitor+1+gene+&author=A+Panahloo&author=V+Mohamed%E2%80%90Ali&author=A+Lane&author=F+Green&author=SE+Humphries&author=JS+Yudkin&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0425"> <div class="reference-title-banner"> <h4 class="title">Papa 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0448"> <div class="citation-journal">Papa G, Fedele V, Chiavetta A, Lorenti I, Leotta C, Luca S, et al. <span class="citation-title">Therapeutic options for elderly diabetic subjects: Open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">2008</span>;<span class="volume">45</span>(1):53‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18180864" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Therapeutic+options+for+elderly+diabetic+subjects:+Open+label,+randomized+clinical+trial+of+insulin+glargine+added+to+oral+antidiabetic+drugs+versus+increased+dosage+of+oral+antidiabetic+drugs+&author=G+Papa&author=V+Fedele&author=A+Chiavetta&author=I+Lorenti&author=C+Leotta&author=S+Luca&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0426"> <div class="reference-title-banner"> <h4 class="title">Perriello 1994 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0449"> <div class="citation-journal">Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferannini E, Ventura MM, Santeusanio F, Brunetti P, Bolli GB. <span class="citation-title">Acute antihyperglycemic mechanisms of Metformin in NIDDM: Evidence for suppression of lipid oxidation and hepatic glucose production</span>. <span class="citation"> Diabetes </span><span class="pubYear">1994</span>;<span class="volume">43</span>:920‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8013758" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acute+antihyperglycemic+mechanisms+of+Metformin+in+NIDDM:+Evidence+for+suppression+of+lipid+oxidation+and+hepatic+glucose+production+&author=G+Perriello&author=P+Misericordia&author=E+Volpi&author=A+Santucci&author=C+Santucci&author=E+Ferannini&author=MM+Ventura&author=F+Santeusanio&author=P+Brunetti&author=GB+Bolli&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0427"> <div class="reference-title-banner"> <h4 class="title">Pilger 1978 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0450"> <div class="citation-journal">Pilger E, Schmid P, Goebel R. <span class="citation-title">[Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing]</span>. <span class="citation"> Acta Medica Austriaca </span><span class="pubYear">1978</span>;<span class="volume">5</span>(3):91‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/752221" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Effect+of+biguanide+therapy+on+lactate+metabolism+during+graded+submaximal+ergometric+testing]+&author=E+Pilger&author=P+Schmid&author=R+Goebel&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0428"> <div class="reference-title-banner"> <h4 class="title">Prager 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0451"> <div class="citation-journal">Prager R, Schernthaner G. <span class="citation-title">Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double‐blind cross‐over study in type II diabetics</span>. <span class="citation"> Diabetes </span><span class="pubYear">1983</span>;<span class="volume">32</span>(12):1083‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6360756" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+receptor+binding+to+monocytes,+insulin+secretion,+and+glucose+tolerance+following+metformin+treatment.+Results+of+a+double%E2%80%90blind+cross%E2%80%90over+study+in+type+II+diabetics+&author=R+Prager&author=G+Schernthaner&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0429"> <div class="reference-title-banner"> <h4 class="title">Rambert 1961 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0452"> <div class="citation-journal">Rambert P, Canivet J, Quichaud J, Spitz B. <span class="citation-title">[Treatment of diabetes mellitus with NN‐dimethyl‐diguanide. Experience of 177 cases]</span>. <span class="citation"> Semaine des Hospitaux de Paris </span><span class="pubYear">1961</span>;<span class="volume">37</span>:247‐54. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+diabetes+mellitus+with+NN%E2%80%90dimethyl%E2%80%90diguanide.+Experience+of+177+cases]&author=P+Rambert&author=J+Canivet&author=J+Quichaud&author=B+Spitz&publication_year=1961&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0430"> <div class="reference-title-banner"> <h4 class="title">Rao 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0453"> <div class="citation-journal">Rao AD, Kuhadiya N, Reynolds K, Fonseca VA. <span class="citation-title">Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all‐ cause mortality?</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2008</span>;<span class="volume">31</span>(8):1672‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18458139" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Is+the+combination+of+sulfonylureas+and+metformin+associated+with+an+increased+risk+of+cardiovascular+disease+or+all%E2%80%90+cause+mortality?+&author=AD+Rao&author=N+Kuhadiya&author=K+Reynolds&author=VA+Fonseca&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0431"> <div class="reference-title-banner"> <h4 class="title">Rigas 1968 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0454"> <div class="citation-journal">Rigas AN, Bittles AH, Hadden DR, Montgomery DA. <span class="citation-title">Circadian variation of glucose, insulin, and free fatty acids during long‐term use of oral hypoglycaemic agents in diabetes mellitus</span>. <span class="citation"> British Medical Journal </span><span class="pubYear">1968</span>;<span class="volume">3</span>(622):25‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Circadian+variation+of+glucose,+insulin,+and+free+fatty+acids+during+long%E2%80%90term+use+of+oral+hypoglycaemic+agents+in+diabetes+mellitus+&author=AN+Rigas&author=AH+Bittles&author=DR+Hadden&author=DA+Montgomery&publication_year=1968&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0432"> <div class="reference-title-banner"> <h4 class="title">Rizkalla 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0455"> <div class="citation-journal">Rizkalla SW, Elgrably F, Tchobroutsky G, Slama G. <span class="citation-title">Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients</span>. <span class="citation"> Diabete &amp; Metabolisme </span><span class="pubYear">1986</span>;<span class="volume">12</span>(4):219‐24. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3533670" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+metformin+treatment+on+erythrocyte+insulin+binding+in+normal+weight+subjects,+in+obese+non+diabetic+subjects,+in+type+1+and+type+2+diabetic+patients+&author=SW+Rizkalla&author=F+Elgrably&author=G+Tchobroutsky&author=G+Slama&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0433"> <div class="reference-title-banner"> <h4 class="title">Runge 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0456"> <div class="citation-journal">Runge S, Alte D, Baumeister SE, Volzke H. <span class="citation-title">Prevalence of risk determinants for metformin‐associated lactic acidosis and metformin utilization in the study of health in pomerania.[erratum appears in Horm Metab Res. 2008 Oct;40(10):735]</span>. <span class="citation"> Hormone &amp; Metabolic Research </span><span class="pubYear">2008</span>;<span class="volume">40</span>(7):491‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevalence+of+risk+determinants+for+metformin%E2%80%90associated+lactic+acidosis+and+metformin+utilization+in+the+study+of+health+in+pomerania.[erratum+appears+in+Horm+Metab+Res.+2008+Oct;40(10):735]+&author=S+Runge&author=D+Alte&author=SE+Baumeister&author=H+Volzke&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0434"> <div class="reference-title-banner"> <h4 class="title">Sambol 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0457"> <div class="citation-journal">Sambol NC, Chiang J, O'Conner M, Liu CY, Lin ET, Goodman AM, et al. <span class="citation-title">Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin‐dependent diabetes mellitus</span>. <span class="citation"> Journal of Clinical Pharmacology </span><span class="pubYear">1996</span>;<span class="volume">36</span>(11):1012‐21. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8973990" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pharmacokinetics+and+pharmacodynamics+of+metformin+in+healthy+subjects+and+patients+with+noninsulin%E2%80%90dependent+diabetes+mellitus+&author=NC+Sambol&author=J+Chiang&author=M+O'Conner&author=CY+Liu&author=ET+Lin&author=AM+Goodman&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0435"> <div class="reference-title-banner"> <h4 class="title">Scarpello 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0458"> <div class="citation-journal">Scarpello JH, Hodgson E, Howlett HC. <span class="citation-title">Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>(8):651‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9702467" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+metformin+on+bile+salt+circulation+and+intestinal+motility+in+type+2+diabetes+mellitus+&author=JH+Scarpello&author=E+Hodgson&author=HC+Howlett&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0436"> <div class="reference-title-banner"> <h4 class="title">Schaffalitzky 1979 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0459"> <div class="citation-journal">Schaffalitzky de Muckadell OB, Mortensen H, Lyngsoe J. <span class="citation-title">Metabolic effects of glucocorticoid and ethanol administration in phenformin‐ and metformin‐treated obese diabetics</span>. <span class="citation"> Acta Medica Scandinavia </span><span class="pubYear">1979</span>;<span class="volume">206</span>(4):269‐73. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metabolic+effects+of+glucocorticoid+and+ethanol+administration+in+phenformin%E2%80%90+and+metformin%E2%80%90treated+obese+diabetics+&author=OB+SchaffalitzkydeMuckadell&author=H+Mortensen&author=J+Lyngsoe&publication_year=1979&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0437"> <div class="reference-title-banner"> <h4 class="title">Selby 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0460"> <div class="citation-journal">Selby JV, Ettinger B, Swain BE, Brown JB. <span class="citation-title">First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(1):38‐44. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10333901" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=First+20+months'+experience+with+use+of+metformin+for+type+2+diabetes+in+a+large+health+maintenance+organization+&author=JV+Selby&author=B+Ettinger&author=BE+Swain&author=JB+Brown&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0438"> <div class="reference-title-banner"> <h4 class="title">Seufert 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0461"> <div class="citation-journal">Seufert J, Urquhart R. <span class="citation-title">2‐Year effects of pioglitazone add‐on to sulfonylurea or metformin on oral glucose tolerance in patients with Type 2 diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2008</span>;<span class="volume">79</span>(3):453‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18160120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=2%E2%80%90Year+effects+of+pioglitazone+add%E2%80%90on+to+sulfonylurea+or+metformin+on+oral+glucose+tolerance+in+patients+with+Type+2+diabetes+&author=J+Seufert&author=R+Urquhart&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0439"> <div class="reference-title-banner"> <h4 class="title">Sharabashi 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0462"> <div class="citation-journal">Sharabashi HM, Remington TL, Mar P, Winston R, Walker PC. <span class="citation-title">Retrospecitve review of metformin in inpatients and outpatients at the University of Michigan</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>:170‐171. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Retrospecitve+review+of+metformin+in+inpatients+and+outpatients+at+the+University+of+Michigan+&author=HM+Sharabashi&author=TL+Remington&author=P+Mar&author=R+Winston&author=PC+Walker&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0440"> <div class="reference-title-banner"> <h4 class="title">Signore 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0463"> <div class="citation-journal">Signore A, Fiore V, Chianelli M, Procaccini E, Barone R, Ronga G, et al. <span class="citation-title">The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1996</span>;<span class="volume">33</span>(2):83‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8879962" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+metformin+on+liver+blood+flow+in+vivo+in+normal+subjects+and+patients+with+non+insulin+dependent+diabetes+&author=A+Signore&author=V+Fiore&author=M+Chianelli&author=E+Procaccini&author=R+Barone&author=G+Ronga&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0441"> <div class="reference-title-banner"> <h4 class="title">Simpson 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0464"> <div class="citation-journal">Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. <span class="citation-title">Dose‐response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population‐based cohort study</span>. <span class="citation"> Canadian Medical Association Journal </span><span class="pubYear">2006</span>;<span class="volume">174</span>:169‐174. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16415461" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dose%E2%80%90response+relation+between+sulfonylurea+drugs+and+mortality+in+type+2+diabetes+mellitus:+a+population%E2%80%90based+cohort+study+&author=SH+Simpson&author=SR+Majumdar&author=RT+Tsuyuki&author=DT+Eurich&author=JA+Johnson&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0442"> <div class="reference-title-banner"> <h4 class="title">Slama 1984 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0465"> <div class="citation-journal">Slama G, Jean‐Joseph P, Goicolea I, Elgrably F, Haardt MJ, Costagliola D, Bournet F, Tchobroutsky G. <span class="citation-title">Sucrose taken during mixed meal has no additional hypergycemic action over isocaloric amounts of starch in well‐controlled diabetics</span>. <span class="citation"> Lancet </span><span class="pubYear">1984</span>;<span class="volume">July 21</span>:122‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sucrose+taken+during+mixed+meal+has+no+additional+hypergycemic+action+over+isocaloric+amounts+of+starch+in+well%E2%80%90controlled+diabetics+&author=G+Slama&author=P+Jean%E2%80%90Joseph&author=I+Goicolea&author=F+Elgrably&author=MJ+Haardt&author=D+Costagliola&author=F+Bournet&author=G+Tchobroutsky&publication_year=1984&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0443"> <div class="reference-title-banner"> <h4 class="title">Stefanovic 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0466"> <div class="citation-journal">Stefanovic V, Antic S, Mitic‐Zlatkovic M, Vlahovic P. <span class="citation-title">Reversal of increased lymphocyte PC‐1 activity in patients with type 2 diabetes treated with metformin</span>. <span class="citation"> Diabetes/Metabolism Research Reviews </span><span class="pubYear">1999</span>;<span class="volume">15</span>(6):400‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reversal+of+increased+lymphocyte+PC%E2%80%901+activity+in+patients+with+type+2+diabetes+treated+with+metformin+&author=V+Stefanovic&author=S+Antic&author=M+Mitic%E2%80%90Zlatkovic&author=P+Vlahovic&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0444"> <div class="reference-title-banner"> <h4 class="title">Sugawara 1962 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0467"> <div class="citation-journal">Sugawara Y, Nitmi T, Sato T, Nakai Y, Mivata K, Kano H, Kumatsubara K. <span class="citation-title">[Clinical trial with DMBG (Melbin) in diabetes mellitus]</span>. <span class="citation"> Naika hokan, Japanese archives of Internal Medicine </span><span class="pubYear">1962</span>;<span class="volume">9</span>:405‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Clinical+trial+with+DMBG+(Melbin)+in+diabetes+mellitus]&author=Y+Sugawara&author=T+Nitmi&author=T+Sato&author=Y+Nakai&author=K+Mivata&author=H+Kano&author=K+Kumatsubara&publication_year=1962&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0445"> <div class="reference-title-banner"> <h4 class="title">Sum 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0468"> <div class="citation-journal">Sum C‐F, Webster JM, Johnson AB, Catalano C, Cooper BG, Taylor R. <span class="citation-title">The effect of intravenous Metformin on glucose metabolism during hyperglycemia in Type 2 Diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1992</span>;<span class="volume">9</span>:61‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1551312" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+intravenous+Metformin+on+glucose+metabolism+during+hyperglycemia+in+Type+2+Diabetes+&author=C%E2%80%90F+Sum&author=JM+Webster&author=AB+Johnson&author=C+Catalano&author=BG+Cooper&author=R+Taylor&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0446"> <div class="reference-title-banner"> <h4 class="title">Teitelbaum 1963 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0469"> <div class="citation-journal">Teitelbaum M, Marchant J‐M. <span class="citation-title">[Biguanides and sulfamides in small doses in the initial treatment of diabetes in obese patients]</span>. <span class="citation"> Diabete </span><span class="pubYear">1963</span>;<span class="volume">11</span>:342‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14097463" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Biguanides+and+sulfamides+in+small+doses+in+the+initial+treatment+of+diabetes+in+obese+patients]+&author=M+Teitelbaum&author=J%E2%80%90M+Marchant&publication_year=1963&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0447"> <div class="reference-title-banner"> <h4 class="title">Tomioka 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0470"> <div class="citation-journal">Tomioka S, Ogata H, Tamura Y, Shimizu T, Watada H, Fujitani Y, et al. <span class="citation-title">Clinical characteristics influencing the effectiveness of metformin on Japanese type 2 diabetes receiving sulfonylureas</span>. <span class="citation"> Endocrine Journal </span><span class="pubYear">2007</span>;<span class="volume">54</span>(2):247‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17303931" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+characteristics+influencing+the+effectiveness+of+metformin+on+Japanese+type+2+diabetes+receiving+sulfonylureas+&author=S+Tomioka&author=H+Ogata&author=Y+Tamura&author=T+Shimizu&author=H+Watada&author=Y+Fujitani&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0448"> <div class="reference-title-banner"> <h4 class="title">Trischitta 1983 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0471"> <div class="citation-journal">Trischitta V, Gullo D, Pezzino V, Vigneri R. <span class="citation-title">Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients</span>. <span class="citation"> Journal of Clinical Endocrinology and Metabolism </span><span class="pubYear">1983</span>;<span class="volume">57</span>(4):713‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6350337" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+normalizes+insulin+binding+to+monocytes+from+obese+nondiabetic+subjects+and+obese+type+II+diabetic+patients+&author=V+Trischitta&author=D+Gullo&author=V+Pezzino&author=R+Vigneri&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0449"> <div class="reference-title-banner"> <h4 class="title">Turner 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0472"> <div class="citation-journal">Turner RC, Holman RR. <span class="citation-title">Lessons from IK prospective diabetes study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">1995</span>;<span class="volume">28</span>(Suppl):S151‐S157. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8529508" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lessons+from+IK+prospective+diabetes+study&author=RC+Turner&author=RR+Holman&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0450"> <div class="reference-title-banner"> <h4 class="title">Yegnanarayan 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0473"> <div class="citation-journal">Yegnanarayan R, Suryavanshi M, Singh M, Desai S. <span class="citation-title">A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus</span>. <span class="citation"> Journal of Diabetes and its Complications </span><span class="pubYear">2008</span>;<span class="volume">22</span>(2):104‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18280440" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparative+study+of+the+glycemic+control+of+various+antidiabetic+agents+and+the+role+of+homocysteine+in+the+therapy+of+type+2+diabetes+mellitus+&author=R+Yegnanarayan&author=M+Suryavanshi&author=M+Singh&author=S+Desai&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0451"> <div class="reference-title-banner"> <h4 class="title">Zapecka‐Dubno 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0474"> <div class="citation-journal">Zapecka‐Dubno B, Czyzyk A, Dworak A, Bak MI. <span class="citation-title">Effect of oral antidiabetic agents on plasma amylin level in patients with non‐insulin‐dependent Diabetes mellitus (Type 2)</span>. <span class="citation"> Arzliche‐Forschung/ Drug Research </span><span class="pubYear">1999</span>;<span class="volume">49</span>(1):330‐4. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+oral+antidiabetic+agents+on+plasma+amylin+level+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+Diabetes+mellitus+(Type+2)+&author=B+Zapecka%E2%80%90Dubno&author=A+Czyzyk&author=A+Dworak&author=MI+Bak&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD002967-bbs2-0452"> <div class="reference-title-banner"> <h4 class="title">Zhang 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD002967-bib-0475"> <div class="citation-journal">Zhang J‐Y, Ma B, Yang K‐H, Cheng W‐D. <span class="citation-title">Metformin plus roziglitazone versus metformin for type 2 diabetes: A systematic review</span>. <span class="citation"> Chinese Journal of Evidence‐Based Medicine </span><span class="pubYear">2009</span>, (4):437‐45. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+plus+roziglitazone+versus+metformin+for+type+2+diabetes:+A+systematic+review&author=J%E2%80%90Y+Zhang&author=B+Ma&author=K%E2%80%90H+Yang&author=W%E2%80%90D+Cheng&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD002967-bbs1-0003"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD002967-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD002967-bbs1-0002">excluded studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0453"> <div class="reference-title-banner"> <h4 class="title">AHFS 1999</h4> </div> <div class="bibliography-section" id="CD002967-bib-0476"> <div class="citation-book"><span class="citation-title">Metformin hydrochloride</span>. <span class="citation">American Hospital Formulary Service Drug Information</span>. Bethesda: American Society of Health‐System Pharmacists, Inc, <span class="pubYear">1999</span>:2755‐63. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0454"> <div class="reference-title-banner"> <h4 class="title">Bailey 1996</h4> </div> <div class="bibliography-section" id="CD002967-bib-0477"> <div class="citation-journal">Bailey CJ, Turner RC. <span class="citation-title">Metformin</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1996</span>;<span class="volume">334</span>:574‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8569826" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin&author=CJ+Bailey&author=RC+Turner&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0455"> <div class="reference-title-banner"> <h4 class="title">Bergman 1978</h4> </div> <div class="bibliography-section" id="CD002967-bib-0478"> <div class="citation-journal">Bergman U, Boman G, Wiholm B‐E. <span class="citation-title">Epidemiology of adverse drug reactions to phenformin and metformin</span>. <span class="citation"> British Medicial Journal </span><span class="pubYear">1978</span>;<span class="volume">2</span>:464‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Epidemiology+of+adverse+drug+reactions+to+phenformin+and+metformin&author=U+Bergman&author=G+Boman&author=B%E2%80%90E+Wiholm&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0456"> <div class="reference-title-banner"> <h4 class="title">Bolen 2007</h4> </div> <div class="bibliography-section" id="CD002967-bib-0479"> <div class="citation-journal">Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL. <span class="citation-title">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</span>. <span class="citation"> Ann Intern Med </span><span class="pubYear">2007</span>;<span class="volume">147</span>:386‐399. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17638715" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Systematic+review:+comparative+effectiveness+and+safety+of+oral+medications+for+type+2+diabetes+mellitus+&author=S+Bolen&author=L+Feldman&author=J+Vassy&author=L+Wilson&author=HC+Yeh&author=S+Marinopoulos&author=C+Wiley&author=E+Selvin&author=R+Wilson&author=EB+Bass&author=FL+Brancati&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0457"> <div class="reference-title-banner"> <h4 class="title">Brown 1998</h4> </div> <div class="bibliography-section" id="CD002967-bib-0480"> <div class="citation-journal">Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. <span class="citation-title">Lactic acidosis rates in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>:1659‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9773726" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lactic+acidosis+rates+in+type+2+diabetes&author=JB+Brown&author=K+Pedula&author=J+Barzilay&author=MK+Herson&author=P+Latare&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0458"> <div class="reference-title-banner"> <h4 class="title">Calabrese 2002</h4> </div> <div class="bibliography-section" id="CD002967-bib-0481"> <div class="citation-journal">Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. <span class="citation-title">Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy</span>. <span class="citation"> Arch Intern Med </span><span class="pubYear">2002</span>;<span class="volume">162</span>:434‐437. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11863476" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+prescribing+practices:+risk+of+lactic+acidosis+with+metformin+therapy&author=AT+Calabrese&author=KC+Coley&author=SV+DaPos&author=D+Swanson&author=RH+Rao&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0459"> <div class="reference-title-banner"> <h4 class="title">Campbell 1985</h4> </div> <div class="bibliography-section" id="CD002967-bib-0482"> <div class="citation-journal">Campbell IW. <span class="citation-title">Metformin and the sulphonylureas: The comparative risk</span>. <span class="citation"> Hormone and Metababolism Research Supplement </span><span class="pubYear">1985</span>;<span class="volume">15</span>:105‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+and+the+sulphonylureas:+The+comparative+risk&author=IW+Campbell&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0460"> <div class="reference-title-banner"> <h4 class="title">Campbell 1995</h4> </div> <div class="bibliography-section" id="CD002967-bib-0483"> <div class="citation-journal">Campbell IW, Howlett HCS. <span class="citation-title">Worldwide experience of metformin as an effective glucose‐lowering agent: A meta‐analysis</span>. <span class="citation"> Diabetes Metabolism Reviews </span><span class="pubYear">1995</span>;<span class="volume">11 (Suppl 1)</span>:S57‐62. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8529486" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Worldwide+experience+of+metformin+as+an+effective+glucose%E2%80%90lowering+agent:+A+meta%E2%80%90analysis&author=IW+Campbell&author=HCS+Howlett&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0461"> <div class="reference-title-banner"> <h4 class="title">DeFronzo 1999</h4> </div> <div class="bibliography-section" id="CD002967-bib-0484"> <div class="citation-journal">DeFronzo RA. <span class="citation-title">Pharmacologic therapy for type 2 diabetes mellitus</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1999</span>;<span class="volume">131</span>:281‐303. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10454950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pharmacologic+therapy+for+type+2+diabetes+mellitus&author=RA+DeFronzo&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0462"> <div class="reference-title-banner"> <h4 class="title">Eurich 2007</h4> </div> <div class="bibliography-section" id="CD002967-bib-0485"> <div class="citation-journal">Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA. <span class="citation-title">Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: a systematic review</span>. <span class="citation"> BMJ </span><span class="pubYear">2007</span>;<span class="volume">335</span>:497‐501. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17761999" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Benefits+and+harms+of+antidiabetic+agents+in+patients+with+diabetes+and+heart+failure:+a+systematic+review+&author=DT+Eurich&author=FA+McAlister&author=DF+Blackburn&author=SR+Majumdar&author=RT+Tsuyuki&author=J+Varney&author=JA+Johnson&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0463"> <div class="reference-title-banner"> <h4 class="title">Fleiss 1981</h4> </div> <div class="bibliography-section" id="CD002967-bib-0486"> <div class="citation-book">Fleiss JL. <span class="citation">Statistical methods for rates and proportions</span>. 2nd Edition. New York: Wiley, <span class="pubYear">1981</span>:217‐34. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0464"> <div class="reference-title-banner"> <h4 class="title">Gan 1992</h4> </div> <div class="bibliography-section" id="CD002967-bib-0487"> <div class="citation-journal">Gan SC, Barr J, Arieff AI, Pearl RG. <span class="citation-title">Biguanide‐assoicated lactic acidosis: case report and review of the literature</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">1992</span>;<span class="volume">152</span>:2333‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1444694" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Biguanide%E2%80%90assoicated+lactic+acidosis:+case+report+and+review+of+the+literature&author=SC+Gan&author=J+Barr&author=AI+Arieff&author=RG+Pearl&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0465"> <div class="reference-title-banner"> <h4 class="title">Hamnvik 2009</h4> </div> <div class="bibliography-section" id="CD002967-bib-0488"> <div class="citation-journal">Hamnvik O‐P R, McMahon GT. <span class="citation-title">Balancing risk and benefit with oral hypoglycemic drugs</span>. <span class="citation"> Mount Sinai Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">76</span>:234‐243. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19421967" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Balancing+risk+and+benefit+with+oral+hypoglycemic+drugs&author=R+HamnvikO%E2%80%90P&author=GT+McMahon&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0466"> <div class="reference-title-banner"> <h4 class="title">Holstein 1999</h4> </div> <div class="bibliography-section" id="CD002967-bib-0489"> <div class="citation-journal">Holstein A, Nahrwold D, Hinze S, Egbert E‐H. <span class="citation-title">Contra‐indications to metformin therapy are largely disregarded</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1999</span>;<span class="volume">16</span>:692‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10477216" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Contra%E2%80%90indications+to+metformin+therapy+are+largely+disregarded&author=A+Holstein&author=D+Nahrwold&author=S+Hinze&author=E%E2%80%90H+Egbert&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0467"> <div class="reference-title-banner"> <h4 class="title">Jadad 1996</h4> </div> <div class="bibliography-section" id="CD002967-bib-0490"> <div class="citation-journal">Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. <span class="citation-title">Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">1996</span>;<span class="volume">17</span>:1‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8721797" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessing+the+quality+of+reports+of+randomized+clinical+trials:+Is+blinding+necessary?&author=AR+Jadad&author=A+Moore&author=D+Carroll&author=C+Jenkinson&author=DJM+Reynolds&author=DJ+Gavaghan&author=HJ+McQuay&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0468"> <div class="reference-title-banner"> <h4 class="title">Kreisberg 1980</h4> </div> <div class="bibliography-section" id="CD002967-bib-0491"> <div class="citation-journal">Kreisberg RA. <span class="citation-title">Lactate homerostasis and lactic acidosis</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1980</span>;<span class="volume">92</span>(Part 1):227‐37. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6766289" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lactate+homerostasis+and+lactic+acidosis&author=RA+Kreisberg&publication_year=1980&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0469"> <div class="reference-title-banner"> <h4 class="title">Laulau 2001</h4> </div> <div class="bibliography-section" id="CD002967-bib-0492"> <div class="citation-journal">Laulau JD, Race JM. <span class="citation-title">Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin‐associated lactic acidosis'.</span>. <span class="citation"> Diabetes Obes Metab </span><span class="pubYear">2001</span>;<span class="volume">3</span>(3):195‐201. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11412284" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lactic+acidosis+in+metformin+therapy:+searching+for+a+link+with+metformin+in+reports+of+'metformin‐associated+lactic+acidosis'.+&author=JD+Laulau&author=JM+Race&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0470"> <div class="reference-title-banner"> <h4 class="title">Luft 1978</h4> </div> <div class="bibliography-section" id="CD002967-bib-0493"> <div class="citation-journal">Luft D, Schmulling, Eggstein M. <span class="citation-title">Lactic acidosis in biguanide‐treated diabetics: a review of 330 cases</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1978</span>;<span class="volume">14</span>:75‐87. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/344119" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lactic+acidosis+in+biguanide%E2%80%90treated+diabetics:+a+review+of+330+cases&author=D+Luft&author=+Schmulling&author=M+Eggstein&publication_year=1978&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0471"> <div class="reference-title-banner"> <h4 class="title">Misbin 1998</h4> </div> <div class="bibliography-section" id="CD002967-bib-0494"> <div class="citation-journal">Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. <span class="citation-title">Lacic acidosis in patients with diabetes treated with metformin</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">338</span>:265‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9441244" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lacic+acidosis+in+patients+with+diabetes+treated+with+metformin&author=RI+Misbin&author=L+Green&author=BV+Stadel&author=JL+Gueriguian&author=A+Gubbi&author=GA+Fleming&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0472"> <div class="reference-title-banner"> <h4 class="title">Olivia 1970</h4> </div> <div class="bibliography-section" id="CD002967-bib-0495"> <div class="citation-journal">Olivia PB. <span class="citation-title">Lactic acidosis</span>. <span class="citation"> American Journal of Medicine </span><span class="pubYear">1970</span>;<span class="volume">48</span>:208‐25. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lactic+acidosis&author=PB+Olivia&publication_year=1970&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0473"> <div class="reference-title-banner"> <h4 class="title">Pagano 1983</h4> </div> <div class="bibliography-section" id="CD002967-bib-0496"> <div class="citation-journal">Pagano G, Tagliaferro V, Carta Q, Bozzo C, Vitelli F, Trovati M, Cocuzza E. <span class="citation-title">Metformin reduces insulin requirements in type 1 (insulin‐dependent) diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1983</span>;<span class="volume">24</span>:351‐354. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/6347782" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+reduces+insulin+requirements+in+type+1+(insulin%E2%80%90dependent)+diabetes&author=G+Pagano&author=V+Tagliaferro&author=Q+Carta&author=C+Bozzo&author=F+Vitelli&author=M+Trovati&author=E+Cocuzza&publication_year=1983&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0474"> <div class="reference-title-banner"> <h4 class="title">Palumbo 1998</h4> </div> <div class="bibliography-section" id="CD002967-bib-0497"> <div class="citation-journal">Palumbo PJ. <span class="citation-title">Metformin: Effects of cardiovascular risk factors in patients with non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Journal of Diabetes and its Complications </span><span class="pubYear">1998</span>;<span class="volume">12</span>:110‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9559489" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin:+Effects+of+cardiovascular+risk+factors+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=PJ+Palumbo&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0475"> <div class="reference-title-banner"> <h4 class="title">Saenz 2005</h4> </div> <div class="bibliography-section" id="CD002967-bib-0498"> <div class="citation-journal">Saenz A, Fernandez‐Esteban I, Mataix A, Ausenjo M, Roque M, Moher D. <span class="citation-title">Metformin monotherapy for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16034881" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin+monotherapy+for+type+2+diabetes+mellitus&author=A+Saenz&author=I+Fernandez%E2%80%90Esteban&author=A+Mataix&author=M+Ausenjo&author=M+Roque&author=D+Moher&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0476"> <div class="reference-title-banner"> <h4 class="title">Scheen 1996</h4> </div> <div class="bibliography-section" id="CD002967-bib-0499"> <div class="citation-journal">Scheen AJ. <span class="citation-title">Clinical pharmacokinetics of metformin</span>. <span class="citation"> Clinical Pharmacokinetics </span><span class="pubYear">1996</span>;<span class="volume">30</span>(5):359‐71. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8743335" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+pharmacokinetics+of+metformin&author=AJ+Scheen&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0477"> <div class="reference-title-banner"> <h4 class="title">Schulz 1995</h4> </div> <div class="bibliography-section" id="CD002967-bib-0500"> <div class="citation-journal">Schulz KF, Chalmers I, Hayes RJ, Altman DG. <span class="citation-title">Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">1995</span>;<span class="volume">273</span>:408‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7823387" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Empirical+evidence+of+bias:+Dimensions+of+methodological+quality+associated+with+estimates+of+treatment+effects+in+controlled+trials+&author=KF+Schulz&author=I+Chalmers&author=RJ+Hayes&author=DG+Altman&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0478"> <div class="reference-title-banner"> <h4 class="title">Sirtori 1994</h4> </div> <div class="bibliography-section" id="CD002967-bib-0501"> <div class="citation-journal">Sirtori CR, Pasik C. <span class="citation-title">Re‐evaluation of a biguanide, metformin: mechanism of action and tolerability</span>. <span class="citation"> Pharmacology Research </span><span class="pubYear">1994</span>;<span class="volume">30</span>(3):187‐228. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Re%E2%80%90evaluation+of+a+biguanide,+metformin:+mechanism+of+action+and+tolerability&author=CR+Sirtori&author=C+Pasik&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0479"> <div class="reference-title-banner"> <h4 class="title">Stacpoole 1998</h4> </div> <div class="bibliography-section" id="CD002967-bib-0502"> <div class="citation-journal">Stacpoole PW. <span class="citation-title">Matformin and lactic acidosis: guilt by association?</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(10):1587‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9773715" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Matformin+and+lactic+acidosis:+guilt+by+association?&author=PW+Stacpoole&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0480"> <div class="reference-title-banner"> <h4 class="title">Stang 1999</h4> </div> <div class="bibliography-section" id="CD002967-bib-0503"> <div class="citation-journal">Stang MR, Wysowski DK, Butler‐Jones D. <span class="citation-title">Incidence of lactic acidosis in metformin users</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>:925‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10372243" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Incidence+of+lactic+acidosis+in+metformin+users&author=MR+Stang&author=DK+Wysowski&author=D+Butler%E2%80%90Jones&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0481"> <div class="reference-title-banner"> <h4 class="title">Sterne 1959</h4> </div> <div class="bibliography-section" id="CD002967-bib-0504"> <div class="citation-journal">Sterne J. <span class="citation-title">[Treatment of Diabetes mellitus with N.N. Dimethyl Guanil Guanidine (LA 6023, glucophage)]</span>. <span class="citation"> Therapie </span><span class="pubYear">1959</span>;<span class="volume">14</span>:625‐30. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/13834497" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=[Treatment+of+Diabetes+mellitus+with+N.N.+Dimethyl+Guanil+Guanidine+(LA+6023,+glucophage)]&author=J+Sterne&publication_year=1959&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0482"> <div class="reference-title-banner"> <h4 class="title">Stroup 2000</h4> </div> <div class="bibliography-section" id="CD002967-bib-0505"> <div class="citation-journal">Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie, et al. <span class="citation-title">Meta‐analysis of observational studies in epidemiology. A proposal for reporting</span>. <span class="citation"> Journal of the American Medical Association </span><span class="pubYear">2000</span>;<span class="volume">283</span>(15):2008‐12. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10789670" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Meta%E2%80%90analysis+of+observational+studies+in+epidemiology.+A+proposal+for+reporting&author=DF+Stroup&author=JA+Berlin&author=SC+Morton&author=I+Olkin&author=GD+Williamson&author=+Rennie&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0483"> <div class="reference-title-banner"> <h4 class="title">Sulkin 1997</h4> </div> <div class="bibliography-section" id="CD002967-bib-0506"> <div class="citation-journal">Sulkin TV, Bosman D, Krentz AJ. <span class="citation-title">Contraindications to metformin therapy in patients with NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>:925‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9167101" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Contraindications+to+metformin+therapy+in+patients+with+NIDDM&author=TV+Sulkin&author=D+Bosman&author=AJ+Krentz&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD002967-bbs2-0484"> <div class="reference-title-banner"> <h4 class="title">Wilholm 1993</h4> </div> <div class="bibliography-section" id="CD002967-bib-0507"> <div class="citation-journal">Wilholm BE, Myrhed M. <span class="citation-title">Metformin‐associated lactic acidosis in Sweden 1977‐1991</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">1993</span>;<span class="volume">44</span>:589‐91. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8405019" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Metformin%E2%80%90associated+lactic+acidosis+in+Sweden+1977%E2%80%901991&author=BE+Wilholm&author=M+Myrhed&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD002967-sec2-0017"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD002967-sec2-0018" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Aarsand 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: at least one year, then 12 weeks. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Norway <br> SETTING: Endocrinology center Treatment N: 28, with 14 on folate and 14 on placebo. <br> Metformin + placebo AGE: 57+/‐2.8. Metformin + folate AGE: 62+/‐2.5. Metformin + placebo SEX: 79% men. Metformin + folate SEX: 71% men. INCLUSION: patients with type 2 DM, treated with metformin for a minimum of 1 year <br> EXCLUSIONS: vitamin use that would interfere with the study. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, at least 1g/day. One‐half of patients on folate 0.25 mg/day + iron 60mg/day, and one‐half on iron 60mg/day. <br> COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting homocysteine, cysteine, cysteinylglycine, vitamin B12, and folate.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Abbasi 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: research laboratory Treatment N: 15 <br> Control N: 8. <br> Treatment AGE: 53 +/‐3 <br> Control AGE: 51 +/‐4 <br> Treatment SEX: 64% men <br> Control SEX: 87% males <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: abnormal laboratory values, vascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin‐blind versus open‐label metformin, dosage adjused clinically. COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, insulin, and free fatty acids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Abbasi 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient and research center <br> Treatment N: 11 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: diet‐treated type 2 DM EXCLUSIONS: laboratory abnormalities, diabetic vascular complications, or abnormal electrocardiogram </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1‐2.5 g/day COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose, insulin, and free fatty acids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Abbasi 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 110 <br> Control N: 0 <br> AGE: 27‐85 <br> SEX: not stated <br> INCLUSION: type 2 DM with normal renal function <br> EXCLUSIONS: renal insufficiency </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Electrolytes, creatinine, plasma lactic acid</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Abbink 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial ‐ unpublished <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 12 <br> AGE: unclear <br> SEX: not listed. <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID COMPARISON: Glibenclamide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Abbink 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Abstract of a double‐blind randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 60 <br> AGE: unclear <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically COMPARISON: glibenclaminde or glimerperide or acarbose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Vasodilator responses to diazoxide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Adamia 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Georgia <br> SETTING: Outpatient <br> Treatment N: 26 <br> Control N: 0 <br> AGE: 59.7 <br> SEX: 0% men <br> INCLUSION: Type 2 DM, obese postmenopausal women <br> EXCLUSIONS: None listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1700 ‐ 2500 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Leptin, adiponectin, insulin resistance</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Aguilar 1992a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Mexico. Setting: diabetes institute. Treatment N: 9. Control N: 0. Age: unclear. Sex: 26% men. Inclusion: type 2 DM with secondary failure to oral agents. Exclusions: insulin dependence. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1200 mg/day, chlorpropamide 375 mg/day, and bedtime insulin 0.1 U/kg/day COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1c, insulin dose, and glucose tolerance.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ahren 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 107 <br> Control N; 0 <br> AGE: 57.7 <br> SEX: 45% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: clinically significant cardiovascular disease, carbohydrate disorders, elevated triglycerides </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus vildgliptin or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Beta‐cell function and insulin sensitivity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Allen 1961 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 57 <br> Control N: 0 <br> AGE: &gt;40 <br> SEX: not listed <br> INCLUSION: poorly controlled DM EXCLUSION: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Amador‐Licona 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomized controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 26 <br> Control N: 23 <br> AGE: &lt; 65 years <br> SEX: not listed <br> INCLUSION: type 2 diabetes and incipient nephropathy <br> EXCLUSION: hypertension, malignancy, hepatic or cardiovascular disorders </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: glibenclamide, dosage unclear </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Metabolic control, blood pressure, unsulin, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Andras 1962 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: approximately 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: unclear <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: maturity‐onset DM EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ascic‐Buturovic 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Bosnia <br> SETTING: Outpatient <br> Treatment N: 15 <br> Control N: 0 <br> AGE: 53.4 <br> SEX: 60% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin and insulin, varying dosage</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Aviles‐Santa 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: University clinic <br> Treatment N: 21 <br> Control N: 22 <br> Treatment AGE: 53 +/‐4 <br> Control AGE: 54 +/‐8 <br> Treatment SEX: 28% men <br> Control SEX: 45% men <br> INCLUSION: Poorly controlled Type 2 DM on insulin <br> EXCLUSIONS: pregnancy, creatinine &gt; 1.5, hepatic enzymes double normal, medical conditions that could promote lactic acidosis. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin + insulin <br> COMPARISON: placebo + insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, HbA1, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Azerad 1960 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: average 24 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 200 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, with goal of 3 g/day, maximum 5 g/day. <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, and glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bacci 1961 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 3‐6 months, average 4.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 42 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia and glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bailey 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdon <br> SETTING: outpatient <br> Treatment N: 568 <br> Control N: 0 <br> AGE: 57.9 <br> SEX: 57% men <br> INCLUSION: type 2 DM <br> EXLCUSIONS: angina, congestive heart failure, hypertension </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, up to 3 gm daily or metformin 2.5 gm daily plus rosiglitazone 4 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin resistance</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Balasubramanian 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: Outpatient <br> Treatment N: 213 <br> Control N: 0 <br> AGE: Not states <br> SEX: Not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: None listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Metformin 500 mg/day combined with lipitor 10 mg/day, in single pill</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight, lipids, tolerability</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bao 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomized controlled trial <br> DURATION: 48 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> SETTING: Outpatient <br> Treatment N: 22 <br> Control N: 60 <br> AGE: Not stated <br> SEX: Not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: None listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 750‐1500 mg/day COMPARISON: Repaglinide or Rosiglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic and metabolic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bastyr 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomized controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 40 <br> Control N: 91 <br> Treatment age: 58.1 <br> Control age: 55.7 <br> Treatment SEX: 55% men <br> Control SEX: 63% men <br> INCLUSION: type 2 DM not controlled on sulfonylureas <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 500 mg BID plus glyburide 10 mg BID <br> COMPARISON: glyburide 10 mg BID plus insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Basu 2008a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomized controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: <br> SETTING: Outpatient <br> Treatment N: 15 <br> Control N: 16 <br> AGE: 56 <br> SEX: 55% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1 gm BID COMPARISON: Pioglitzaone, 45 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin action</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bauman 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 14 <br> Control N: 7 <br> Treatment AGE: 49 <br> Control AGE: 54 <br> SEX: not stated <br> INCLUSION: type 2 DM on oral sulfonylurea <br> EXCLUSIONS: alcoholism, chronic renal failure, liver disease, cardiopulmonary disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: sulfonylurea, dosage unclear </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Vitamin B12 measurements</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bayraktar 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Crossover randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: University clinic Treatment N: 36 <br> Control N: 36 <br> AGE: 30‐63 <br> SEX: 100% men <br> INCLUSION : Type 2 DM with poor control <br> EXCLUSIONS: microvascular or macrovascular complIcations, liver function abnormalities. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500mg TID <br> COMPARISON: acarbose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin , c‐peptide, fibrinogen, lipids, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Beisswenger 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 30 <br> Control N: 0 <br> AGE: 62+/‐8 <br> SEX: 56% men <br> INCLUSION: Type 2 DM, some on metformin treatment and some not EXCLUSIONS: renal or hepatic impairment or cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500‐2500 mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, methylglyoxal levels, D‐lactate, and glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Belcher 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUTNRY: United Kingdom SETTING: outpatient <br> Treatment N: 917 <br> Control N: 2796 <br> Age: 57 +/‐ 9 <br> Sex: 55% men <br> Inclusion: type 2 DM <br> Exlcusions: ALT levels greater than 2.5 times upper limit of normal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2500 mg/day <br> COMPARISON: pioglitazone 45 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>liver enzyme levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bell 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 55 <br> Control N: 0 <br> AGE: 60.2+/‐13 <br> SEX: 45% men <br> INCLUSION: patients with non‐insulin‐dependent DM treated with insulin <br> EXCLUSIONS: creatinine &gt; 1.5 mg/dl, or c‐peptide &lt; 0.8 ng/ml </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1‐3 g/day, some with glyburide or insulin, dosage titrated clinically COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin requirement, HbA1, BMI, and % successfully changed to oral therapy.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bermudez 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Venezuela <br> SETTING: Outpatient <br> Treatment N: 189 <br> Control N: 0 <br> AGE: 58.3 <br> SEX: Not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: Gestational diabetes, endocrine disorders, pancreatitis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, glimepiride and rosiglitazone, varying doses</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Metabolic parameters</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bermudez‐Pirela 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 2.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Venezuela <br> SETTING: outpatient <br> Treatment N: 53 <br> Control N: 9 <br> Treatment AGE: 52 <br> Control AGE: 55.3 <br> SEX: not states <br> INCLUSION: type 2 DM <br> EXCLUSIONS: Age &gt; 60 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 500 mg TID <br> COMPARISON: metformin, 500 mg TID plus glimeperide 0.5 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin, insulin resistance</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Berne 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of orlistat <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 220 <br> Control N: 0 <br> AGE: 59.1 <br> SEX: 55% men <br> INCLUSION: type 2 DM and obesity <br> EXLCUSIONS: significant renal, peripheral vascular, gastrointestinal, respiratory or cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose unclear <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight loss, glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Betteridge 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: <br> Two prospective double‐blind randomised controlled trials <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 960 <br> Control N: 319 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXLCUSIONS: not listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: study 1: metformin, dosage unclear plus pioglitazone 15‐45 mg daily. Study 2: metformin 850‐2550 mg daily <br> COMPARISON: study 1: metformin, dosage unclear plus gliclazide 80‐320 mg daily. <br> study 2: pioglitazone 15‐45 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids and lipoproteints</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Beyer 1975 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 24 <br> Control N: 0 <br> AGE: not listed <br> SEX: 36% men <br> INCLUSION: adult‐onset DM EXCLUSION: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage titrated clinically <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bhansali 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study in a randomised trial of extended release metformin <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: outpatient <br> Treatment N: 40 <br> Control N: 0 <br> AGE: 57.3 <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSION: renal or hepatic dysfunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metfromin, up to 2 gm daily <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bingle 1964 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Blinded randomised controlled trial (unclear if double‐blind) <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 22 <br> Control N: 22 <br> AGE: unclear <br> SEX: not listed <br> INCLUSION: Type 2 DM not controlled on sulfonylureas EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐2 g/day + chlorpropamide <br> COMPARISON: placebo + chlorpropamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bjorntorp 1978 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective, cross‐over comparative trial; not randomised <br> DURATION: 8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 21 <br> Control N: 21 <br> AGE: 58 <br> SEX: 52% men <br> INCLUSION: Type 2 DM on long‐term biguanide treatment EXCLUSIONS: abnormal renal function or liver function </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1.5‐3.0 g/day <br> COMPARISON: phenformin, 50‐100 mg/day (not analysed) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose and fasting lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Blonde 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States SETTING: outpatient <br> Treatment N: 476 <br> Control N: 164 <br> Age: 55.6 +/‐ 9.4 <br> Sex: 57% men <br> Inclusion: type DM uncontrolled on sulfnylurea treatment <br> Exclusions: hepatic or renal dysfunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 g/day, with and without glyburide <br> COMPARISON: glybruide 20 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Boronat 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: average of 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain <br> SETTING: Endocrine center <br> Treatment N: 21 <br> Control N: 0 <br> AGE: unclear <br> SEX: 5% men <br> INCLUSION: obese insulin‐treated patients with type 2 DM, also on metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Insulin and metformin, dose adjusted clinically <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, weight, and insulin requirement.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bosi 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomized controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 879 <br> Control N: 300 <br> AGE: Not stated <br> SEX: Not stated <br> INCLUSION: Type 2 DM, treatment naive <br> EXCLUSIONS: Pregnancy, coronary artery disease, renal or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1 gm BID COMPARISON: Viladgliptin 50 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Botha 1977 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over trial; not randomised <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: South Africa <br> SETTING: general practice <br> Treatment N: 21 <br> Control N: 21 <br> AGE: unclear <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dose adjusted clinically <br> COMPARISON: phenformin, buformin (not analysed), and untreated controls. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Heart rate, blood lactate, and lactate/pyruvate ratios, at baseline and with exercise.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Boyd 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Randomised controlled trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 8 <br> Control N: 19 <br> Treatment AGE: 64+/‐6.2 <br> Control AGE: 63.5+/‐7.6 <br> Treatment SEX: 37% men <br> Control SEX: 68% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: glibenclamide or insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, HbA1, weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Brazg 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 28 <br> Control N: 0 <br> AGE: 55.9 <br> SEX:36% men <br> INCLUSION: Type 2 DM, poor control on metformin <br> EXCLUSIONS: Not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, varying dose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, beta‐cell function</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Brown 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: average 11.6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: patients in an HMO registry <br> Treatment N: 3402 <br> Control N: 0 <br> AGE: &gt; 30 <br> SEX: 53% men <br> INCLUSION: Type 2 DM on metformin treatment <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1000‐2550 mg/day COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, and fructosamine.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Bruce 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study in a randomised trial of metformin and glybenclamide <br> DURATION: 20 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 50 <br> Control N: 0 <br> IINCLUSION: type 2 DM, inadequately controlled <br> EXCLUSIONS: renal, cardiac or hepatic diseae, obesity </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus glubencalmide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin sensitivity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cairns 1977 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom SETTING: outpatient <br> Treatment N: 39 <br> Control N: 67 <br> AGE: 57 <br> SEX: 21% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal failure, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg BID <br> COMPARISON: phenformin (not analysed) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, body weight, and lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Calle‐Pascual 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label comparative trial; not randomised <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 24 <br> AGE: unclear <br> SEX: 50% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg TID <br> COMPARISON: insulin or acarbose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, blood pressure, HbA1, body weight, insulin sensitivity.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Campbell 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 38 <br> Control N: 24 <br> AGE: 54+/‐6.1 <br> SEX: 64% men <br> INCLUSION: Type 2 DM, diet failed <br> EXCLUSIONS: congestive heart failure, renal failure, liver function abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically. COMPARISON: glipizide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood pressure, heart rate, microalbuminuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Campbell 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 52 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 24 <br> Control N: 24 <br> Treatment AGE: 57+/‐10 <br> Control AGE: 57+/‐9 <br> Treatment SEX: 33% men <br> Control SEX: 33% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 500 mg BID to 3,000 mg/day maximum. <br> COMPARISON: glipizide, 5 mg/day to 39 mg/day maximum BID </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, lipids, lactate levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Canivet 1962 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: average 66 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 180 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: DM, 180 treated with metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose unclear <br> COMPARISON: some patients treated with other agents, not analysed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Carpentier 1975 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Belgium <br> SETTING: outpatient <br> Treatment N: 11 <br> Control N: 0 <br> AGE: 58.8 <br> SEX: 45% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1.5 g/day + arginine infusion 11.7 mg/kg/min <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, free fatty acids, and glycagon.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Carter 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial DURATION: 6 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom SETTING: outpatient <br> Treatment N: 26 <br> Control N: 16 <br> Age: not stated <br> Sex: not stated <br> Inclusion: poorly controlled overweight patients with type 2 DM <br> Exlcusions: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1.5 to 3 g/day COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>C‐reactive proteitn, complement factor C3</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cavallo‐Perin 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 10 <br> AGE: 51+/‐2.1 <br> SEX: 60% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: liver or kidney disease, heart failure, other drugs, or chronic infection </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg BID <br> CONTROL: phenformin 50 mg BID (not analysed) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, glucose, HbA1, and blood lactate levels at different times of day.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cefalu 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial DURATION: 4.5 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States SETTING: outpatient <br> Treatment N: 91 <br> Control N: 91 <br> Age: 35‐70 <br> Sex: not stated <br> Inclusion: type 2 DM <br> Exclusion: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg TID with and without glipizide <br> CONTROL: glipizide 20 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, body weight, abdominal fat distribution, PAI‐1 levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ceriello 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: 4 prospective double‐blind randomised controlled trials <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: multi‐center <br> Treatment N: 298 <br> Control N: 541 <br> Treatment AGE: 55.6 <br> Control AGE: 57 <br> Treatment SEX: 80% men <br> Control SEX: 71% men <br> INCLUSION: type 2 DM, 35‐75 years, poorly controlled <br> EXLCUSIONS: heart attack or stroke </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, alone or in combination with other medications <br> COMPARISON: pioglitazone, gliclazide, sulfonylureas </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin sensitvity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chakrabarti 1965 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Single‐blind crossover comparative trial; not randomised <br> DURATION: 2 months placebo, 4 months treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 27 <br> Control N: 27 <br> AGE: 56.3 <br> SEX: 95% men <br> INCLUSION: Type 2 DM with coronary artey disease, claudication <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg TID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Cholesterol, plasma fibrinogen.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chalmers 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Ongoing prospective observational cohort <br> DURATION: 3 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: Outpatient <br> Treatment N: 178 <br> Control N: 0 <br> AGE: 54.1 <br> SEX: Not stated <br> INCLUSION: Type 2 DM, 35‐80 years, poor control <br> EXCLUSIONS: None listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, with glicazide, repaglinide or pioglitazone, varying doses</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Deterioration of glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chan 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Crossover randomised controlled trial <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Hong Kong and United Kingdom <br> SETTING: outpatient <br> Treatment N: 24 <br> Control N: 24 <br> AGE: 48.5+/‐2.4 <br> SEX: 50% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal insufficiency, hypertension </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically COMPARISON: glybenclanide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, body mass index (BMI), lipids, blood pressure, systemic vascular resistance index. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Charpentier 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised controlled trial <br> DURATION: 20 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 222 <br> Control N: 150 <br> Treatment AGE: 56.7 <br> Control AGE: 55.4 <br> Treatment SEX: 60% men <br> Control SEX: 58% men <br> INCLUSION: type 2 DM age 35‐70, poorly controlled <br> EXCLUSIONS: severe chronic disease, morbid obesity, major cardiovascular event </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin with or without glimepiride <br> COMPARISON: Glimepiride </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chiasson 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Randomised controlled trial of acarbose versus placebo. Metformin in non‐randomised treatment strata. <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> SETTING: multicenter <br> Treatment N: 83 <br> Control N: 271 <br> Treatment AGE: 57.4+/‐1.1 <br> Control AGE: 57+/‐1.1 <br> Treatment SEX: 51% men <br> Control SEX: 58% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: gastrointestinal disease, various medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Main: acarbose versus placebo Treatment strata: metformin (dosage adjusted clinically), diet, sulfonylurea, insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandaial glucose, HbA1, lipds, c‐peptide levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chiasson 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 36 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> SETTING: multicenter <br> Treatment N: 156 <br> Control N: 162 <br> Treatment AGE: 57.9+/‐8.6 <br> Control AGE: 57.3+/‐9 <br> Treatment SEX: 77% men <br> Control SEX: 74% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: cardiovascular events, gastrointestinal disease, history of lactic acidosis, major debilitating disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, or metformin + miglitol. COMPARISON: miglitol or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, HbA1, insulin, weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cho 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label comparative trial; not randomised <br> DURATION: 36 days </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Korea <br> SETTING: University center <br> Treatment N: 22 <br> Control N: 27 <br> AGE: unclear <br> SEX: 47% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.5‐1.5 g/day <br> COMPARISON: insulin or sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma t‐PA and PAI‐1 antigen</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ciraldi 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 14 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 11 <br> Control N: 10 <br> Treatment AGE: 30‐70 years <br> Control AGE: 30‐70 years <br> SEX: not stated <br> INCLUSION: type 2 DM, poorly controlled <br> EXCLUSIONS: patients listed as "healthy" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2550 mg daily <br> COMPARISON: troglitazone 600 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose transport, insulin signaling</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Civera 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomized controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain <br> SETTING: Outpatient <br> Treatment N: 24 <br> Control N: 13 <br> AGE: 40‐70 <br> SEX: Not stated <br> INCLUSION: Type 2 DM, poor control <br> EXCLUSIONS: Pregnancy, morbid obesity, renal or hepatic failure, pulmonary or cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin and repaglinide, with or without insulin COMPARISON: NPH insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Clarke 1965 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: Average 21 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 108 <br> Control N: 0 <br> AGE: &gt; 30 to &lt; 60 <br> SEX: 38% men <br> INCLUSION: DM, treatment failures with sulfonyureas <br> EXCLUSIONS: ketonuria, bicarbonate &lt; 17 mEq/L, or serious organic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1 g/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemica, glycosuria, and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Clarke 1968 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Crossover randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 139 <br> Control N: 139 <br> Treatment AGE: 59 <br> Control AGE: 57 <br> SEX: not listed <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐3 g/day <br> COMPARISON: chlorpropamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, blood glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Clarke 1977 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom SETTING: outpatient <br> Treatment N:131 <br> Control N: 146 <br> Treatment AGE: 60 <br> Control AGE: 60 <br> Treatment SEX: 31% men <br> Control SEX: 31% men <br> INCLUSION: Newly diagnosed Type 2 DM <br> EXCLUSIONS: malignancy, congestive heart failure, obesity, other hypoglycemic medications. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1‐3 g/day <br> COMPARISON: chlorpropamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Collier 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Scotland <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 12 <br> Treatment AGE: 53.3 <br> Control AGE: 55.5 <br> SEX: 50% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: abnormal renal function, smokers, aspirin. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: gliclazide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Platelet density profiles and aggregability studies.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cosic 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial <br> DURATION: 8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Yugoslavia <br> SETTING: outpatient <br> Treatment N: 23 <br> Control N: 23 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLSUIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma xanthine oxidase, thiobarbituric acid‐reactive substance, lactate and frutosamine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cryer 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial DURATION: 12 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 7227 <br> Control N: 1505 <br> Age: 58.5 +/‐ 13 <br> Sex: 37% men <br> Inclusion: type 2 DM suboptimally controlled on diet or sulfonylurea <br> Exclusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.6 g/day <br> CONTROL: usual care </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Serious adverse effects such as lactic acidosis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Cusi 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 15 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 10. <br> Treatment AGE: 51+/‐3 <br> Control AGE: 54+/‐3 <br> Treatment SEX: 40% men <br> Control SEX: 60% men <br> INCLUSION: Type 2 DM, with body weight stable <br> EXCLUSION: sedentary or strenuous activities, renal disease, hepatic disease or other significant organ system disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg BID to 2500 mg/day maximum + glibenclamide, dose on clinical grounds <br> COMPARISON: glibenclamide + placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, lipids, blood lactate.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">D'Argenzio 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label, nonrandomised comparative trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 23 <br> Control N: 57 <br> AGE: 56 <br> SEX: 40% men <br> INCLUSION: Poorly controlled Type 2 DM <br> EXCLUSIONS: cardiac, liver or renal disease, contraindication to oral hypoglycemic medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically + glibenclamide <br> COMPARISON: glibenclamide or diet </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Basal glucose, HbA1, renal and liver functions, lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Damsbo 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 9 <br> Control N: 9 <br> Treatment AGE: 51 <br> Control AGE: 53 <br> Treatment SEX: 78% men <br> Control SEX: 66% men <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: abnormal renal, liver fucntion, or cardiac function </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐3 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, plasma glucose, insulin, c‐peptide, free fatty acids, lactate levels. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Davidson 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Abstract; randomised controlled trial, placebo‐controlled; unclear if single‐blind </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 484 <br> Control N: 161 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, versus metformin + glyburide <br> COMPARISON: glyburide or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Davies 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort of metformin, in an open‐label randomized controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: Outpatient <br> Treatment N: 82 <br> Control N: 0 <br> AGE: 57.4 <br> SEX: 44% men <br> INCLUSION: Type 2 DM, 20 ‐ 80 years <br> EXCLUSIONS: Recent heart attack or stroke, renal insufficiency, morbid obesity </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin and insulin, with and without regalinide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, hypoglycemia, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">De Silva 1979 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 21 <br> Control N: 20 <br> AGE: 55 <br> SEX: 32% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1.5 g/day + placebo <br> COMPARISON: clofibrate + placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, urinary glucose, lipids and fibrinogen.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">DeFronzo 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 14 <br> Control N: 14 <br> AGE: 60+/‐3 <br> SEX: 71% men <br> INCLUSION: Obese and lean type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐2.5 g/day <br> COMPARISON: no metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, glucose tolerance test, continuous indirect calorimetry, and lipids. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">DeFronzo 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 29 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 566 <br> Control N: 355 <br> Treatment AGE: 53+/‐1 <br> Control AGE: 55+/‐1 <br> Treatment SEX: 43% men <br> Control SEX: 49% men <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: creatinine &gt; 1.4, abnormal liver functions, cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg TID or metformin + glyburide <br> COMPARISON: glyburide or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting and postprandial glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 56 <br> Control N: 56 <br> Age: 54 +/‐ 9 <br> Sex: 50% men <br> Inclusion: type 2 DM <br> Exclusion: hypertension, heart disease, abnormal renal function, or drugs that interact with treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day <br> COMPARISON: repaglinide 4 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting plasma insulin, postprandial plasma insulin, lipid profile, homocysteine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of metformin plus rosiglitazone or glimepiride <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 99 <br> Control N: 0 <br> AGE: 53 <br> SEX: 50% men <br> INCLUSION: type 2 DM with metabolic syndrome <br> EXCLUSIONS: renal, hepatic cardiovascular and cerebrovacular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1.5 mg daily plus rosiglitazone or glimepitride <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Body mass index, glucose, lipids, homocysteine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of metformin plus pioglitazone or rosiglitazone <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 96 <br> Control N: 0 <br> INCLUSION: type 2 DM with metabolic syndrome and poor glycemic control <br> EXCLUSIONS: renal or cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT : metformin up to 3 gm daily plus pioglitazone or rosiglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Body mass index, glycemic control, insulin sensitivity, lipids, homocysteine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort in an open‐lable randomized controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 238 <br> Control N: 0 <br> AGE: 55 <br> SEX: 50% men <br> INCLUSION: Type 2 DM, poor control, overweight <br> EXCLUSIONS: history of ketoacidosis, liver or kidney abnormalities, congestive heart failure, coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, with nateglinide or glibencalime</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Prothrombotic factors</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort in a single‐blind randomized controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 117 <br> Control N: 0 <br> AGE: 56 <br> SEX: 47% men <br> INCLUSION: Type 2 DM, tolerant or intolerant of metformin <br> EXCLUSIONS: ketoacidosis, liver or kidney abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, with or without rosiglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin resistance, glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Derosa 2009a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomized controlled trial <br> DURATION: 15 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 202 <br> Control N: 69 <br> AGE: Not stated <br> SEX: 49% men <br> INCLUSION: Type 2 DM, overweight <br> EXCLUSIONS: ketoacidosis, liver or kidney abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 2 gm/day alone or with piioglitazone or glimeperide COMPARISON: Pioglitazone, 15 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Dies 1978 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: at least 5 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 25 <br> Control N: 0 <br> AGE: 56 <br> SEX: 35% men <br> INCLUSION: adult‐onset DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 560 mg/day + chlorpropamide 175 mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, glycosuria, and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Donnelly 1960 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATIONS: average 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Ireland <br> SETTING: outpatient <br> Treatment N: 25 <br> Control N: 0 <br> AGE: 21‐77 <br> Sex: 22% men <br> INCLUSION: type 2 DM <br> EXCLUSION: ketonuria or infection </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycosuria</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Dornan 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 8 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: university clinic <br> Treatment N: 30 <br> Control N: 30 <br> Treatment AGE: 55+/‐1 <br> Control AGE: 55+/‐1 <br> Treatment SEX: 53% men <br> Control SEX: 30% men <br> INCLUSION: Diet‐treated Type 2 DM <br> EXCLUSIONS: ketonuria, renal or liver dysfunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg QD‐TID COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, BMI, c‐peptide, blood pressure, lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Douek 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised placebo‐controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 92 <br> Control N: 91 <br> Treatment AGE: 58 <br> Control AGE: 58 <br> Treatment SEX: 67% men <br> Control SEX: 63% men <br> INCLUSION: type 2 DM on maximal oral agents <br> EXLCUSIONS: chronic renal insufficiency, hepatic diseaes, pulmonary disease, age &gt; 75 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2 gm daily <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Eguchi 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised cross‐over trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 13 <br> Treatment AGE: 61 <br> Control AGE: 61 <br> Treatment SEX: 83% men <br> Control SEX: 54% men <br> INCLUSION: early DM with impaired glucose tolerance <br> EXCLUSIONS: chronic renal insufficiency, hepatic disease, congestive heart failure, stroke </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500‐750 mg dailu <br> COMPARISON: pioglitazone 15 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin resistance, lipids, hemostatic factors, inflammatory markers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Einhorn 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trail of metformin plus pioglitazone <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 328 <br> Control N: 0 <br> AGE: 56 <br> SEX: 57% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal, hepatic or cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with or without pioglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Elkeles 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: 1) Open‐label cross‐over randomised controlled trial <br> 2) Single‐blind crossover trial <br> DURATION: 3 months, then 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 63 <br> Control N: 49 <br> AGE: &lt; 70 years <br> SEX: 64% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal or liver disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: 1) Metformin, dosage adjusted clinically 2) Metformin <br> COMPARISONS: 1) glibenclamide <br> 2) placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Serum lipids, lipoproteins, glucose, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Erdem 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomized controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: Outpatient <br> Treatment N: 44 <br> Control N: 15 <br> AGE: 55 <br> SEX: 39% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: obesity, liver or renal abnormalities, chronic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 2 gm/day COMPARISON: pioglitazone, 15 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma visfatin levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Eriksson 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 18 <br> Contyrol N: 5 <br> AGE: 64 <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: age &gt; 75 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doseage unclear <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose tolerance, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Eriksson 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Single‐blind randomized controlled trial <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: Outpatient <br> Treatment N: 16 <br> Control N: 5 <br> AGE: 64 <br> SEX: 78% men <br> INCLUSION: Type 2 DM, 46‐74 years <br> EXCLUSIONS: obesity </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 2 gm/day COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose tolerance tests, plasminogen‐activator inhibitor, leptin levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Erle 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: <br> SETTING: <br> Treatment N: <br> Control N: <br> AGE: <br> SEX: <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glyburide <br> COMPARISON: placebo + glyburide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ersoy 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: Outpatient <br> Treatment N: 24 <br> Control N: 0 <br> AGE: 20‐65 years <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: type 1 diabetes, kidney or liver disease, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>weight, glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Esposito 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort in an open‐label randomized controlled trial <br> DURATION: 9 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 116 <br> Control N: 0 <br> AGE: 30‐70 years <br> SEX: notstated <br> INCLUSION: Type 2 DM, on stable dose metformin and sulfonylurea <br> EXCLUSIONS: uncontrolled hypertension, liver or kidney abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, with NPH or glargine insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fanghanel 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 30 <br> Control N: 30 <br> Treatment AGE: 52.1+/‐ 8.8 <br> Control AGE: 51.2+/‐8.5 <br> Treatment SEX: 40% men <br> Control SEX: 30% men <br> INCLUSION: Type 2 DM, obese <br> EXCLUSIONS: abnormal liver functions, cardiomyopathy, lung disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg BID‐TID <br> COMPARISON: insulin BID </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, HbA1, blood pressure, BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fanghanel 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 30 <br> Control N: 30 <br> AGE: 49+/‐9.6 <br> SEX: 38% men <br> INCLUSION: Type 2 DM with sulfonylurea failure <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.85‐2.5 g/day <br> COMPARISON: insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose, fibrinogen, body mass index.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Feinglos 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of glipazide <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 122 <br> Control N: 0 <br> AGE: 58.1 <br> SEX: 43% men <br> INCLUSION: type 2 DM inadequately controlled on metformin <br> EXCLUSIONS: renal, hepatic, cardiovascular or gastrointestinal dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doase unclear with or without glipazide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1c, insulin, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ferner 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label nonrandomised comparative trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 6 <br> Control N: 12 <br> Treatment AGE: 56 <br> Control AGE: 56 <br> Treatment SEX: 67% men <br> Control SEX: 50% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: other medication, ketosis, ketonuria </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dose adjusted clilnically <br> COMPARISON: tolbutamide or diet </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity under euglycemic insulin clamp</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fisman 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label nonrandomised comparative trial <br> DURATION: 7.7 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Israel <br> SETTING: research institute <br> Treatment N: 332 <br> Control N: 1943 <br> Treatment AGE: 60.1+/‐6.5 <br> Control AGE: 59.9+/‐6.6 <br> Treatment SEX: 66% men <br> Control SEX: 76% men <br> INCLUSION: Type 2 DM with coronary artery disease <br> EXCLUSIONS: pacemaker, cerebrovascular disease, malignant disease, estrogen replacement, and insulin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin or metformin + sulfonylurea, dose adjusted clinically <br> COMPARISON: sulfonylurea or diet </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Crude mortality rate, time‐related mortality, and cause of death</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fonseca 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised controlled trial of rosiglitazone <br> DURATION: 6.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: mulitcenter outpatient <br> Treatment N: 348 <br> Control N: 0 <br> AGE: 58+/‐9 <br> SEX: 68% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal or hepatic disease, angina, congestive heart failure, abnormal laboratory result, or chronic use of insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day + placebo, metformin + rosiglitazone 4 mg/day, or metformin + rosiglitazone 8 mg/day. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose, insulin sensitivity, weight, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Formoso 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 13 <br> Control N: 13 <br> AGE: 58 <br> SEX: 50% men <br> INCLUSION: Type 2 DM, newly diagnosed <br> EXCLUSIONS: hypertension, abnormal function of an organ system </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose COMPARISON: glicazide, varying dose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>in vivo oxidative stress, platelet activation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fritsche 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind cross‐over randomised controlled trial <br> DURATION: 10 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 26 <br> Control N: 26 <br> AGE: 51+/‐9 <br> SEX: not listed <br> INCLUSION: Severely obese type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + insulin <br> COMPARISON: placebo + insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, insulin, c‐peptide, HbA1c, lipids, weight, venous lactic acid.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fujioka 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: <br> 2 double‐blind randomised controlled trials <br> DURATION: 3 months and 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 663 <br> Control N: 202 <br> Age: 56 +/‐ 10 <br> Sex: 50% men <br> Inclusion: type 2 DM inadequately controlled on diet and exercise <br> Exclusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin XR 500 ‐2000 mg/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose and insulin, lipid profiles</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Galeone 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: diabetes referral center <br> Treatment N: 57 <br> Control N: 0 <br> AGE: 61+/‐3.4 <br> SEX: 54% men <br> INCLUSION: type 2 DM for at least 5 years <br> EXCLUSIONS: hepatic or liver abnormalities, neurological, psychological or cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1500 mg/day and glicazide 120mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, 24‐hour glycosuria, and fasting and postprandial glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gao 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort of metformin in a randomised controlled trial DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> SETTING: Outpatient <br> Treatment N: 150 <br> Control N: 0 <br> AGE: 54.6 <br> SEX: 50% men <br> INCLUSION: Type 2 DM, 30‐70 years <br> EXCLUSIONS: kidney or liver abnormalties </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, extended‐release or immediate release</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gao 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Propsective observational cohort of metformin in a double‐blind randomised controlled trial DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China, India, Korea and Taiwan <br> SETTING: Outpatient <br> Treatment N: 466 <br> Control N: 0 <br> AGE: 54.5 <br> SEX: 45% men <br> INCLUSION: Type 2 DM, poor control <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, and sulfonylureas, with exanatide or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garber 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 11 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 222 <br> Control N: 229 <br> Treatment AGE: 57+/‐10 <br> Control AGE: 55+/‐11 <br> Treatment SEX: 62% men <br> Control SEX: 56% men <br> INCLUSION: Type 2 DM, not controlled <br> EXCLUSIONS: significant disease or contraindication likely to affect diabetes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garber 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 317 <br> Control N; 321 <br> Age: 56 +/‐ 10 <br> Sex: 53% men <br> Inclusion: type 2 DM that failed diet and exercise <br> Exclusions: polyurea, weight loss, acidosis, insulin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg BID with and without glyburide <br> CONTROL: gluburide 2.5 mg BID or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting and postprandial glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garber 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of rosiglitazone <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 318 <br> Control N: 0 <br> AGE: 56 <br> SEX: 61% men <br> INCLUSION: type 2 DM inadequately controlled on metformin <br> EXCLUSIONS: renal, cardiac or hepatic dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear with rosliglitazone or glibenclamide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbAic, hypoglycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garcia 1971 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 23 <br> Control N: 0 <br> AGE: 53.6 <br> SEX: 26% men <br> INCLUSION: DM, treated with sulfonylureas <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin + chlorpropamide in combination, dosage titrated clinically <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Garcia‐Soria 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States, Mexico and Australia <br> SETTING: Outpatient <br> Treatment N: 174 <br> Control N: 0 <br> AGE: 52 <br> SEX: 72% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: type 1 diabetes, insulin‐dependent type 2 diabetes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin with PHX1149 or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gerich 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of sibutramine <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: outpatient <br> Treatment N: 60 <br> Control N: 0 <br> AGE: 49.3 <br> SEX: 0% men <br> INCLUSION: obese women with type 2 DM and poor glycemic control <br> EXCLUSIONS: hypertension, glaucoma, antidepressant medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doase unclear, with or without sibutramine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, glucose, insulin, waist circumference, blood presure, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Giugliano 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 27 <br> Control N: <br> AGE: not listed <br> Sex: 23% men <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: intercurrent illness, age &gt; 70, creatinine &gt; 1.2 mg/dl, ischemic or wasting disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, lipids, c‐peptide, blood pressure, and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gokcel 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of nateglinide or glyburide <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 428 <br> Control N: 0 <br> AGE: 53.1 <br> SEX: 50% men <br> INCLUSION: type 2 DM, drug naive <br> EXCLUSIONS: renal or hepatic disiease or congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with nateglinide or glyburide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Goke 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial, extension of a previous study <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational, in Americas and Europe <br> SETTING: Multicenter outpatient <br> Treatment N: 158 <br> Control N: 304 <br> AGE: 54 <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 2 gm/day COMPARIOSON: vildagliptin 100 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Goldstein 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient Treatment N: 163 <br> Control N: 84 <br> Inclusions: type 2 DM inadequately controlled on sulfonylurea <br> Exclusions: renal and hepatic dysfunction, cardiovascular diseaese, acidosis or long‐term insulin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2 g/day with or without glipizide <br> CONTROL: glipizide 30 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>BMI, HbA1, fasting glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Goldstein 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mutinational <br> SETTING: Muticenter, outpatient <br> Treatment N: 1091 <br> Control N: 340 <br> AGE: 18‐78 years <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: unstable cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin varying dosease, with or without sitagliptin COMPARISON: Sitaglitpin 500 mg/day or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gonzalez‐Ortiz 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico <br> SETTING: outpatient <br> Treatment N: 67 <br> Control N: 37 <br> Age: 53 +/‐ 7 <br> Sex: 52% men <br> Inclusion: type 2 DM with secondary failure to monotherapy with glibenclamide <br> Exlcusions: cardiovascular, renal or hepatic dysfunction, insulin treatment, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1‐2 gm/day with or without glimepiride 2‐4 mg/day <br> COMPARISON: Glimipiride 2‐4 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, adverse events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Goodman 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mutinational in United States and Europe <br> SETTING: Muticenter, outpatient <br> Treatment N: 618 <br> Control N: 0 <br> AGE: 54.5 <br> SEX: 57% men <br> INCLUSION: Type 2 DM, 18‐78 years <br> EXCLUSIONS: liver disease, significant kidney dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses, with vildagliptin 100 md/day or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gottlieb 1962 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom SETTING: inpatient then outpatient <br> Treatment N: 39 <br> Control N: 0 <br> AGE: 21 ‐ &gt;80 <br> SEX: 58% men <br> INCLUSION: patients with DM, poorly controlled on previous regimen <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1‐3 g/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, and glycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gottschalk 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective single‐blind randomised cotnrolled trial <br> DURATION: 6 monghs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multi‐national <br> SETTING: multi‐center outpatient <br> Treatment N: 131 <br> Control N: 132 <br> Treatment AGE: 13.8 <br> Control AGE: 13.8 <br> Treatment SEX: 34% men <br> Control SEX: 33% men <br> INCLUSION: adolescents with DM, poorly controlled <br> EXCLUSION: history of ketoacidosis, medications that affect glucose metabolism, renal or hepatic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500‐1000 mg BID <br> COMPARISON: glimepiride 1‐8 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Grant 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: <br> Treatment N: 21 <br> Control N: 17 <br> Treatment AGE: 59.5+/‐9 <br> Control AGE: 63.2+/‐9.6 <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, low and high dose <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasminogen activator inhibitor, BMI, glucose, HbA1, insulin, lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Grant 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 52 <br> Control N: 23 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: insulin therapy, BMI &lt; 25, fasting glucose &lt; 6 mmol/L </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 3 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, HbA1, insulin, BMI, plasminogen activator inhibitor.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Grant 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 27 <br> Control N: 17 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1.5 g/day or metformin 3 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma insulin, glucose, lipids, and factor VII levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gregorio 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 5 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 53 <br> Control N: 53 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM, poor control <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + sulfonylurea <br> COMPARISON: placebo + sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, lipids, insulin, HbA1, and lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gregorio 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Single‐blind comparative trial. Patients were their own controls <br> DURATION: 5 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 10 <br> AGE: 50‐63 <br> Treatment SEX: 45% men <br> Control SEX: 40% men <br> INCLUSION: Type 2 DM with poor control <br> EXCLUSIONS: heptic, renal or vascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + sulfonylurea <br> COMPARISON: placebo + sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, insulin, c‐peptide, fructosamine, lipids, lactate, pyruvate, alanine, and glycerol. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gregorio 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 68 <br> Control N: 0 <br> AGE: 67+/‐1.2 <br> SEX: 43% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: liver or renal abnormality, respiratory insufficiency or congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2350 mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lactate, free fatty acids, lipids, insulin, c‐peptide, plasma metformin, and glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Groop 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 12 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: cardiac, renal, hepatic or endocrine disease, intercurrent illness </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID + glibenclamide <br> COMPARISON: insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, lipids, weight, BMI, basal hepatic glucose production</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Groop 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 24 <br> Treatment AGE: 60+/‐2 <br> Control AGE: 59+/‐2 <br> Treatment SEX: 50% men <br> Control SEX: 50% men <br> INCLUSION: Type 2 DM with sulfonylurea failure <br> EXCLUSIONS: intercurrent illness, hepatic, renal or cardiac disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1.5 g/day + glibenclamide. <br> COMPARISON: insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, HbA1, lipids, energy expenditure, glucose and fat oxidation.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Guillausseau 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label, nonrandomised comparative trial <br> DURATION: at least 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 26 <br> Control N: 36 <br> Treatment AGE: 60+/‐10 <br> Control AGE: 60+/‐12.9 <br> Treatment SEX: 73% men <br> Control SEX: 63% men <br> INCLUSION: Type 2 DM on sulfonylurea <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metfomin, dosage adjusted clinically + gliclazide <br> COMPARISON: gliclazide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gupta 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 17 <br> Control N: 34 <br> AGE: 35‐75 years <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, plus weight loss COMPARISON: pioglitazone plus weight loss </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, components of metabolic syndrome</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Gursoy 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Abstract of a prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 0 <br> AGE: 49+/‐8 <br> SEX: 80% men <br> INCLUSION: obese and nonobese patients with type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 2.5 g/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, lipid profiles, lactate, and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hamann 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 596 <br> Control N: 0 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: Type 2 DM, overweight, inadequately treated with metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 2 gm/day, with rosiglitazone or sulfonylurea</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Gycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Haupt 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: multicenter outpatient <br> Treatment N: 1823 <br> Control N: 0 <br> AGE: 64.8 <br> SEX: 39% men <br> INCLUSION: type 2 DM, poorly controlled <br> EXCLUSIONS: nephropathy, previous treatment with metformin, and insulin‐dependence </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850‐2550 mg/day + sulfonylurea, dosage titrated clinically <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HbA1, weight, blood pressure, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Heine 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised of exenatide or insulin <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multi‐national <br> SETTING: outpatient <br> Treatment N: 551 <br> Control N: 0 <br> AGE: 59 <br> SEX: 55% men <br> INCLUSION: type 2 DM inadequately controlled <br> EXCLUSIONS: renal or hepatic disease, malignancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with exenatide or insulin <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, safety, tolerability</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Herman 1961 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: approximately 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: South Africa <br> SETTING: outpatient <br> Treatment N: 47 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: maturity‐onset DM, juvenile‐onset patients were studied but not analysed <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1.5‐3 g/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose and glucose tolerance.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermann 1991a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 122 <br> Control N: 45 <br> AGE: 60 <br> SEX: 64% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: cardiac, renal or hepatic disease, alcohol abuse, severe chronic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1 g BID or metformin + glibenclamide <br> COMPARISON: glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermann 1991b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label crossover randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: outpatient <br> Treatment N: 22 <br> Control N: 22 <br> AGE: 59 <br> SEX: 72% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal or liver dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.5‐3 g/day <br> COMPARISON: glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, lipds, c‐peptide, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermann 1994a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 3 months. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: regional health centers <br> Treatment N: 110 <br> Control N: 34 <br> AGE: 34‐74 <br> SEX: 64% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: contraindications to the medications, or insulin requirements </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin or metformin, dosage adjusted clinically, + glibenclamide <br> COMPARISON: glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, body weight, and c‐peptide levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermann 1994b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden <br> SETTING: regional health centers <br> Treatment N: 108 <br> Control N: 36 <br> AGE: 60 <br> SEX: 63% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: insulin treatment, contraindications to the medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, c‐peptide levels, HbA1, blood pressure.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Higginbotham 1979 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind cross‐over randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Australia <br> SETTING: outpatient <br> Treatment N: 17 <br> Control N: 17 <br> AGE: 31‐79 <br> SEX: 29% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal or liver insufficiency, retinopathy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear <br> COMPARISON: glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, weight, insulin and lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hirsch 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: research center <br> Treatment N: 25 <br> Control N: 25 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM with poor control on insulin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 2.5 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, HbA1, insulin, c‐peptide, or insulin dose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hoffmann 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial. Single blind with respect to metformin treatment <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: <br> SETTING: multicenter <br> Treatment N: 31 <br> Control N: 63 <br> Treatment AGE: 55.9 <br> Control AGE: 59.2 <br> Treatment SEX: 45% men <br> Control SEX: 28.5% men <br> INCLUSION: Type 2 DM, previously on diet <br> EXCLUSIONS: renal, liver or cardiovascular disease, malignancy, pregnancy, infection </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg BID <br> COMPARISON: acarbose or placebo. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, insulin, lipids, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hollenbeck 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Veteran's Administration outpatient <br> Treatment N: 9 <br> Control N: 0 <br> AGE: 63+/‐3 <br> SEX: 89% men <br> INCLUSION: Type 2 DM, with elevated triglycerides <br> EXCLUSIONS: significant diseases or medication that could interfere with carbohydrate metabolism </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 2.5 g/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, plasma insulin, free fatty acids, triglyceride, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Holman 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: crossover randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 18 <br> Control N: 45 <br> AGE: 57+/‐11 <br> SEX: 33% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, or metformin + sulfonylurea <br> COMPARISON: sulfonylurea or sulfonylurea + insulin versus insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, c‐peptide, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Home 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: 5 European countries <br> SETTING: outpatient <br> Treatment N: 162 <br> Control N: 160 <br> Treatment AGE: 57.2 <br> Control AGE: 56.9 <br> Treatment SEX: 52% men <br> Control SEX: 85% men <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: history of acidosis, congestive heart failure, coronary artery disease, hypertension </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus insulin plus rosiglitazone <br> COMPARISON: placebo plus insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, treatment satisfaction</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Horton 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 350 <br> Control N: 351 <br> AGE: 56‐59 <br> Treatment SEX: 58% men <br> Control SEX: 61% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal impairment, significant diabetic complications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID or metformin + nateglininde <br> COMPARISON: nateglinide or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Horton 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial DURATION: 6 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States SETTING: outpatient <br> Treatment N: 193 <br> Control N: 297 <br> Age: 57 +/‐ 1.1 <br> Sex: 60% men <br> Inclusion: type 2 DM, treatment naive <br> Exclusions: renal dysfunction, diabetic complications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg TID with and without nateglinide COMPARISON: nateglinide 120 mg before meals </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting and postprandial glucose, post‐load insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hother‐Nielsen 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Denmark <br> SETTTING: outpatient <br> Treatment N: 9 <br> Control N: 9 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Obese patients with Type 2 DM <br> EXCLUSIONS: renal or liver dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin requirements, glucose, insulin, lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hsieh 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of slow‐release or regular‐release metformin <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Taiwan <br> SETTING: outpatient <br> Treatment N: 55 <br> Control N: 0 <br> AGE: 57.8 <br> SEX: 50% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal, hepatic, cardiovascular disease or chronic obstructive lung disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, slow‐release or regular‐release 2g daily <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, c‐reactive protein, insulin resistance, adipocytokines</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hsu 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin and gliclazide in a randomised trial of Agaricus blazei Murill extract <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Taiwan <br> SETTING: outpatient <br> Treatment N: 60 <br> Control N: 0 <br> AGE: 56.8 <br> SEX: 50% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: hepatic dysfunction, creatinine &gt; 2, acute myocardial infarction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with gliclazine, with or without Agaricus blazei Murill extract <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin resistance, adiponectin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hu 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> SETTING: Outpatient <br> Treatment N: 30 <br> Control N: 30 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus insulin COMPARISON: insulin plus rosiglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>N‐terminal pro‐brain natriuretic peptide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hundal 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 7 <br> Control N: 0 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doase unclear <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose production rate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hussain 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Iraq <br> SETTING: Outpatient <br> Treatment N: 31 <br> Control N: 32 <br> AGE: 49.1 <br> SEX: 54% men <br> INCLUSION: Type 2 DM, poorly controlled <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin plus melatonin, zinc acetate COMPARISOM: placebo plus metatonin, zinc acetate </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Imano 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: outpatient <br> Treatment N: 13 <br> Control N: 17 <br> Treatment AGE: 66+/‐8 <br> Control AGE: 62+/‐13 <br> Treatment SEX: 23% men <br> Control SEX: 29% men <br> INCLUSION: Type 2 DM with microalbuminuria <br> EXCLUSIONS: abnormal liver function </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID <br> COMPARISON: troglitazone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, blood pressure, BMI, fasting and postprandial glucose, albumin‐to‐creatinine ratio. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Inzucchi 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 29 <br> Control N: 24 <br> Treatment AGE: 51+/‐13 <br> Control AGE: 56+/‐12 <br> Control SEX: 43% men <br> Treatment SEX: 47% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: abnormal renal or hepatic function, recent atherosclerotic event </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1g BID <br> COMPARISON: troglitazone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HbA1, glucose tolerance, insulin, c‐peptide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jackson 1962 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: approximately 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: South Africa <br> SETTING: outpatient <br> Treatment N: 26 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: mild, not‐ketosis‐prone DM <br> EXCLUSIONS: ketosis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐3 g/day <br> COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, and dose of sulfonylurea.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jackson 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Single‐blind cross‐over trial <br> DURATION: 4.9 months average </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: general practice <br> Treatment N: 10 <br> Control N: 10 <br> AGE: 56.6+/‐1.9 <br> SEX: 100% men <br> INCLUSION: Type 2 DM, nonobese <br> EXCLUSIONS: excessive physical activity or a metabolic disorder </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dose adjusted clinically COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose, hepatic glucose output, forearm glucose uptake, and blood lactate levels. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jadzinsky 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial, pase 3 <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Mulitcenter, outpatient <br> Treatment N: 971 <br> Control N: 335 <br> AGE: 52 <br> SEX: 49% men <br> INCLUSION: Type 2 DM, 18‐77 years <br> EXCLUSIONS: Severe congestive heart failure, kidney or liver abnormalities, ketoacidosis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1 gm/day, with or without saxagliptin COMPARISON: Saxagliptin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jager 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised controlled trial <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> SETTING: multi‐center outpatient <br> Treatment N: 150 <br> Control N: 163 <br> Treatment AGE: 63 <br> Control AGE: 59 <br> Treatment SEX: 44% men <br> Control SEX: 52% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: history of acidosis, chronic renal insufficiency, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus insulin <br> COMPARISON: placebo plus insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Markers of endothelial function, inflammatory activity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Janka 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: multi‐national <br> SETTING: outpatient <br> Treatment N: 67 <br> Control N: 63 <br> Treatment AGE: 69.3 <br> Control AGE: 69.6 <br> Treatment SEX: 64% men <br> Control SEX: 48% men <br> INCLUSION: type elderly patients age &gt; 65 with 2 DM poorly controlled <br> EXCLUSIONS: history of acidosis, obesity </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus glimepiride plus insulin <br> COMPARISON: insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jeppesen 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over trial <br> DURATION: 12 weeks glipizide and 8 weeks metformin added </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: research center <br> Treatment N: 16 <br> Control N: 16 <br> AGE: 57+/‐3 <br> SEX: 63% men <br> INCLUSION: Type 2 DM, poorly controlled <br> EXCLUSIONS: patients not "in good health". </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically + glipizide <br> COMPARISON: glipizide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial and steady‐state glucose, lipids, free fatty acids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Johansen 1984 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Denmark <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 10 <br> AGE: 59 <br> SEX: 30% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg/day + placebo/day. COMPARISON: acarbose + placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HbA1, urinary glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Johnson 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 8 <br> Control N: 12 <br> AGE: 58+/‐8 <br> SEX: 62% men <br> INCLUSION: Newly diagnosed obese untreated Type 2 DM <br> EXCLUSIONS: renal or hepatic abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.85‐2.5 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, HbA1, insulin, c‐peptide, skeletal muscle biopsy, glucose synthetase activity. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Johnson 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: average 9 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Diabetes center chart review <br> Treatment N: 124 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: patients with type 2 DM treated with metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500‐2500 mg/day, with other medications as needed <br> COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin dose, BMI, and HbA1c.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jones 2000 b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESISN: Abstract: open‐label extension study of a randomised controlled trial. <br> DURATION: 30 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States. SETTING: outpatient. Treatment N: Control N: Age: not listed. Sex: not listed. Inclusion: Type 2 DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + rosiglitazone. COMPARISON: rosiglitazone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipds, HbA1c, beta‐cell function.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jones 2000a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Abstract of a prospective cohort trial. Some data reported in Fonseca 2000. Remaining data analysed <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 102 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: type 2 DM, poorly controlled on metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically + placebo, or metformin + rositglitazone 4 mg/day, or metformin + rosiglitazone 8 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jones 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 42 <br> Control N: 40 <br> Age: 14 +/‐ 1.8 <br> Sex: 30% men <br> Inclusion: pediatric patients age 10‐16 with type 2 DM <br> Exclusions: creatinine &gt; 76 mcmole/L, hepatic dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin up to 2 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1c</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Josephkutty 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 20 <br> Treatment AGE: 76.5 <br> Control AGE: 80.5 <br> Treatment SEX: 30% men <br> Control SEX: 30% men <br> INCLUSION: Type 2 DM patients, aged 65 or older <br> EXCLUSIONS: renal or liver function abnormalities, recent congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1g BID <br> COMPARISON: tolbutamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting insulin, glucose, lactate levels, lipids and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Josse 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial of acarbose versus placebo. Metformin in nonrandomised treatment strata <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> SETTING: outpatient <br> Treatment N: 83 <br> Control N: 271 <br> AGE: 57.4+/‐1.1 <br> SEX: 64% men <br> INCLUSION: Type 2 DM <br> EXCLUSION: debilitating disease, gastrointestinal disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Main: acarbose versus placebo. Treatment strata: Metformin (dosage adjusted clinically), diet, sulfonylureas, insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Jung 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: South Korea <br> SETTING: outpatient <br> Treatment N: 13 <br> Control N: 14 <br> Age: 57 +/‐ 10 <br> Sex: 45% men <br> Inclusion: type 2 DM on sulfonyluera <br> Exlcusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 g/day <br> COMPARISON: rosiglitazone 4 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Anthropometric parameters, fasting plasma glucose, HbA1, lipid profile, adiponectin, resistin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Juurinen 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: Outpatient <br> Treatment N: 88 <br> Control N: 0 <br> AGE: 55.9 <br> SEX: 57% men <br> INCLUSION: Type 2 DM, 20‐75 years <br> EXCLUSIONS: Ketoacidosis, alcohol or drugs, pregnancy, major systemic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin and insulin, with nateglinide 120 mg TID or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kabadi 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative study <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 24 <br> Control N: 14 <br> AGE: not stated <br> SEX; not stated <br> INCLUSION: type 2 DM poorly controlled <br> EXLCUSIONS: hepatic or renal dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with or without glimepiride <br> COMPARISON: glimepiride </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kadoglou 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Greece <br> SETTING: Outpatient <br> Treatment N: 70 <br> Control N: 0 <br> AGE: 65.3 <br> SEX: 40% men <br> INCLUSION: Type 2 DM, 50‐70 years, poor control <br> EXCLUSIONS: microvascular or macrovascular disease, congestive heart failure, over kidney or liver impairment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin and glicazide, with rosiglitazone or control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Novel cardiovascular risk factors</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kahn 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised trial <br> DURATION: 4 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: multi‐national <br> SETTING: outpatient <br> Treatment N: 1454 <br> Control N: 2897 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm BID <br> COMPARISON: rosliglitazone 4 mg BID or glyburide 7.5 mg BID </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Monotherapy failure</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kaku 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 40 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: Outpatient <br> Treatment N: 169 <br> Control N: 0 <br> AGE: 52.5 <br> SEX: 39% men <br> INCLUSION: Type 2 DM, 20‐65 tears <br> EXCLUSIONS: liver or kidney abnormalities, congestive heart failure, serious disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 500 ‐750 mg.day, with pioglitazone 15 mg/day or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin resistance, cardiovascular risk factors</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kann 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multi‐national <br> SETTING: outpatient <br> Treatment N: 128 <br> Control N: 127 <br> Treatment AGE: 61.5 <br> Control AGE: 61 <br> Treatment SEX: 54% men <br> Control SEX: 49% men <br> INCLUSION: type 2 DM, insulin‐naive <br> EXLCUSIONS: renal, hepatic, cardiovascular disiease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2 gm BID plus insulin <br> COMPARISON: glimepiride plus insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, hypoglycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Karlsson 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: outpatient <br> Treatment N: 9 <br> Control N: 21 <br> Age: 58 +/‐ 2.1 <br> Sex: 80% men <br> Inclusion: newly diagnosed type 2 DM <br> Exclusions: cardiovascular, renal or hepatic dysfunction, anemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: 2 g/day <br> COMPARISON: rosiglitazone 4 mg BID or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Euglycemic clamp measurements, skeletal muscle biopsies, insulin receptor substrate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kawai 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label, nonrandomised, comparative trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: Outpatient <br> Treatment N: 69 <br> Control N: 28 <br> AGE: 58.8 <br> SEX: 70% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 500 ‐ 750 mg/day COMPARISON: pioglitazone 15 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, metabolic parameters</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Khanolkar 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: Outpatient <br> Treatment N: 50 <br> Control N: 0 <br> AGE: 57.5 <br> SEX: not state <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses, with rosiglitazone 4 mg/day or glicazide 80 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Ciculating platelet activity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kiayias 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Comparative trial; not randomised <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Greece <br> SETTING: outpatient <br> Treatment N: 33 <br> Control N: 16 <br> AGE: 64.6+/‐9.5 <br> SEX: 51% men <br> INCLUSION: Poorly controlled type 2 DM <br> EXCLUSIONS: proteinuria, smokers, various medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, or metformin + sulfonylurea <br> COMPARISON: sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipoprotein (a) levels, lipids, HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kim 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 7 <br> Control N: 7 <br> Age: 56 +/‐ 1 <br> Sex: 79% men <br> Inclusion: type 2 DM <br> Exlcusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day <br> COMPARISON: troglitazone 600 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose disposal rate, HbA1, fasting glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kim 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Korea <br> SETTING: outpatient <br> Treatment N: 60 <br> Control N: 60 <br> Treatment AGE: 57.6 <br> Control AGE: 56.5 <br> Treatment SEX: 50% men <br> Control SEX: 53% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal disease, coronary artery disease, stroke, peripheral artery disease, malignancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1000 mg daily plus glimepiride <br> COMPARISON: rosiglitazone plus glimepiride </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, beta‐cell function, adiponectin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kirk 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 14 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 15 <br> Control N: 16 <br> Treatment AGE: 50.5 <br> Control AGE: 54.5 <br> Treatment SEX: 64% men <br> Control SEX: 31% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: women of childbearing potential, renal or hepatic disease, alcohol abuse, various medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.5‐1 g BID <br> COMPARISON: troglitazone 200‐400 mg/day. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting glucose and C‐peptide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Klein 1975 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 60 <br> Control N: 0 <br> AGE: not listed <br> SEX: 48% men <br> INCLUSION: maturity‐onset DM EXCLUSION: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage titrated clinically, some with chlorpropamide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, weight, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Klein 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 16 <br> Control N: 19 <br> Treatment AGE: 68+/‐10 <br> Control AGE: 66+/‐11 <br> Treatment SEX: 27% males <br> Control SEX: 20% males <br> INCLUSION: Type 2 DM with failure with sulfonylurea <br> EXCLUSIONS: renal insufficiency with creatinine &gt; 1.2, acute or severe disease, various medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + sulfonylurea <br> COMPARISON: insulin + sulfonylurea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, blood pressure, insulin, c‐peptide, HbA1, lipids, liver and renal function, and lactate levels. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kooy 2009a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4.3 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherland <br> SETTING: Multicenter outpatient <br> Treatment N: 196 <br> Control N: 195 <br> AGE: 61.5 <br> SEX: 46% men <br> INCLUSION: Type 2 DM, 30‐80 years <br> EXCLUSIONS: ketoacidosis, pregnancy, creatinine clearance &lt;50, class 3 or 4 congestive heart failure, serious medical illness </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg 1‐3 times/day, with insulin COMPARISON: placebo with insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, glycemic control, microvascular and macrovascular events</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kudolo 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of ginkgo biloba <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 0 <br> AGE: 39.2 <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: major cardiovascular, hepatic or endocrine disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin dosage unclear, with or without ginkgo biloba <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Pharmacokinetics of metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kusaka 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: Outpatient <br> Treatment N: 18 <br> Control N: 17 <br> AGE: 62 <br> SEX: 60% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: Cardiovascular disease, kidney or liver abnormalities, severe diabetic complications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 750 mg/day COMPARISON: pioglitazone 15‐30 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma ghrelin levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kvapil 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metfomin in a randomised trial of insulin <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multi‐national <br> SETTING: outpatient <br> Treatment N: 115 <br> Control N: 0 <br> AGE: 56.5 <br> SEX: 50% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: hepatic, renal or cardiac disase </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage titrated up, with or without glibenclmide and with or without biphasic insulin <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lalau 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2 months. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France <br> SETTING: outpatient <br> Treatment N: 24 <br> Control N: 0 <br> AGE: 74+/‐1.5 <br> SEX: 67% men <br> INCLUSION: patients over the age of 70 with type 2 DM <br> EXCLUSIONS: creatinine clearance &lt; 30 ml/min </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1770‐2550 mg/day COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Creatinine clearance, lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lalor 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: hospital clinic <br> Treatment N: 38 <br> Control N: 38 <br> AGE: 58 <br> SEX: 46% men <br> INCLUSION: Obese patients with type 2 DM <br> EXCLUSIONS: previous treatment with metformin or guar </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + placebo <br> COMPARISON: Guar + placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, weight, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lam 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort trial with 91% on metformin <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> SETTING: three‐center outpatient <br> Treatment N: 90 <br> Comparison N: 0 <br> AGE: 35‐70 <br> SEX: 45% men <br> INCLUSION: Type 2 DM with poor control on oral hypoglycemics <br> EXCLUSIONS: abnormal liver and renal function, significant diseases or conditions, ketonuria,abnormal gutmotility, lactose intolerance, pregnancy and lactation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: 91% on metformin, dosage adjusted clinically, + acarbose, 150‐300 mg/day, or metformin + placebo <br> COMPARISON: 9% on other oral agents + acarbose or placebo. These patients not analysed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, HbA1c, insulin levels, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Laurenti 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label comparative trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 30 <br> Control N: 30 <br> AGE: 38‐63 <br> SEX: not listed <br> INCLUSION: Type 2 DM with poor control on sulfonylurea <br> EXCLUSIONS: congestive heart failure, nephropathy, liver function abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glibenclamide <br> COMPARISON: sulfonylurea alone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, insulin, fructosamine, and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lawrence 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial DURATION: 3 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient Treatment N: 20 <br> Control N: 10 <br> Age: 60 +/‐ 9 <br> Sex: 60% men <br> Inclusion: overweight type 2 DM <br> Exclusions: Creatinine &gt; 150 mcmole/L, congestive heart failure, hepatic dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg BID <br> COMPARISON: pioglitazone 30 mg/day or glicazine 80 mg.day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, lipid profile, glucose, BMI</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lean 1983 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study or metformin in a randomised controlled trial of ciclazindol <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom SETTING: outpatient <br> Treatment N: 10 <br> Control N: 0 <br> AGE: 42‐68 <br> SEX: 30% men <br> INCLUSION: obese patients with type 2 DM, treated with metformin <br> EXCLUSIONS: hepatic or renal impairment, heart disease, psychiatric or alcohol problems </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg BID + placebo or metformin + ciclazindol 25‐75 mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma insulin, triglycerides, lactate pyruvate, and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lee 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 24 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: University center <br> Treatment N: 24 <br> Control N: 120 <br> Treatment AGE: 59+/‐3 <br> Control AGE: 61+/‐2 <br> SEX: 0 men <br> INCLUSION: Obese type 2 DM <br> EXCLUSIONS: major illnes, cardiac, renal or hepatic disorder, medicine known to affect body weight or cholesterol metabolism </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850 mg BID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Food consumption and weight loss</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lewin 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Stated <br> SETTING: outpatient multi‐center <br> Treatment N: 457 <br> Control N: 152 <br> Treatment AGE: 18‐79 years <br> Control AGE: 18‐79 <br> Treatment SEX: not stated <br> Control SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal insufficiency, untreated cardiovascular or hepatic disease <br> Treatment N: 4 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin extended‐release 1500‐2000 mg daily plus sulfonylurea <br> COMPARISON: sulfonylurea monotherapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Li 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: China <br> SETTING: Outpatient <br> Treatment N: 30 <br> Control N: 0 <br> AGE: 40‐70 years <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: major diabetic complications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fibroblast growth factor‐21 levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lingvay 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 19 <br> Control N: 0 <br> AGE: 43.7 <br> SEX: 83% men <br> INCLUSION: type 2 DM with hepatic steatosis <br> EXCLUSION: renal or hepatic disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Hepatic triglyceride content</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">List 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada, Mexico, Puerto Rico <br> SETTING: Muticenter outpatient <br> Treatment N: 56 <br> Control N: 333 <br> AGE: 53.5 <br> SEX: 40% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: kidney insufficiency </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin XR COMPARISON: Dapaglitfozin, varying doses, placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight, glucosuria, osmolarity and volume changes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lord 1983 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over trial with untreated controls <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 8 <br> Control N: 8 <br> AGE: 61+/‐5 <br> SEX: 38% men <br> INCLUSION: Obese, type 2 DM <br> EXCLUSIONS: abnormal renal or liver function </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID <br> COMPARISON: no metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose tolerance test, urinary glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Luna 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 6 <br> Control N: 0 <br> AGE: 50 <br> SEX: 66% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal, cardiovascular or neurologic problems </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1000 mg BID <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Atypical protein kinase C activation in muscle</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lund 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind cross‐over randomised trial <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Denmark <br> SETTING: outpatient <br> Treatment N: 48 <br> Control N: 48 <br> Treatment AGE: 59 <br> Control AGE: 63 <br> Treatment SEX: 75% men <br> Control SEX: 79% men <br> INCLUSION: non‐obese patients with type 2 DM <br> EXCLUSIONS: renal insufficiency, clinical heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: repaglinide, dosage unclear </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, c‐reactive protein, adiponectin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lund 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised cross‐over trial <br> DURATION: 4 months and 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Denmark <br> SETTING: Outpatient <br> Treatment N: 83 <br> Control N: 82 <br> AGE: 61.4 <br> SEX: 76% men <br> INCLUSION: Type 2 DM, nonobese, insulin‐naive <br> EXCLUSIONS: ketoacidosie, ketonuria </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm BID COMPARISON: repaglinide 2 mg TID</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Non‐glycemic cardiovascular risk markers, inflammatory and endothelial markers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lunetta 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient clinic <br> Treatment N: 12 <br> Control N: 0 <br> AGE: 55+/‐5 <br> SEX: 50% men <br> INCLUSION: Type 2 DM for at least one year, with good glycemic control <br> EXCLUSIONS: diabetic neuropathy, gastroparesis or diarrhea </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg BID, then a single dose of metformin 850 mg or placebo <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Makimattila 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: outpatient <br> Treatment N: 13 <br> Control N: 39 <br> Treatment AGE: 54+/‐2 <br> Control AGE: 58+/‐3 <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: congestive heart failure, cardiovascular disase, seizure, liver disease unrelated to DM </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 2 g/day + insulin NPH QHS COMPARISON: insulin BID</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight gain, urinary glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Manzella 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Blinded randomised controlled trial DURATION: 4 months</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 60 <br> Control N: 60 <br> Age: 57 +/‐ 11 <br> Sex: 55% men <br> Inclusion: obese type 2 DM <br> Exclusions: coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg BID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, insulin, triglyceride, free fatty acids, insulin resistance by HOMA method </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Marena 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 10 <br> AGE: 60.8+/‐10.7 <br> SEX: 60% men <br> INCLUSION: Type 2 DM with poor control <br> EXCLUSIONS: hepatic, renal, pulmonary or cardiac dysfunctions </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glibenclamide <br> COMPARISON: placebo + glibenclamide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, weight, insulin sensitivity.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Marfella 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 10 <br> Control N: 0 <br> AGE: 47+/‐0.8 <br> SEX: 50% men <br> INCLUSION: newly diagnosed patients with type 2 DM, with mild hyperglycemia <br> EXCLUSIONS: evidence of microvascular or macrovascular complications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1700 mg/day <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, glucose, HbA1, insulin, lipids, blood pressure, heart rate, platelet aggregation, blood viscosity, blood filterability, epinephrine, and norepinephrine. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mari 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospectiv cohort study <br> DURATION: 30 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 73 <br> Control N: 0 <br> AGE: 54 <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with or without exenatide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Beta‐cell function, insulin secretion rate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Marre 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France, Belgium, Netherlands, Denmark, Portugal <br> SETTING: outpatient <br> Treatment N: 308 <br> Control N: 103 <br> Age: 58 +/‐ 11 <br> Sex: 60% men <br> Inclusion: type 2 DM inadequately controlled on metformin <br> Exclusions: creatinine 127 mcmole/L, hypoxic states, hepatic dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day with and without glibenclamide <br> COMPARISON: glimenclamide 20 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting glucose, fructosamine, lipid profile</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mashavi 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort or metformin in a double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Israel <br> SETTING: Outpatient <br> Treatment N: 60 <br> Control N: 0 <br> AGE: 60.9 <br> SEX: 47% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: coronary artery disease, creatinine &gt;2, liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, high dose, plus folate, vitamin B12, vitamin B6 or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Homocysteine levels, small artery elasticity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mather 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised placebo‐controlled tral</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada, United States <br> SETTING: outpatient <br> Treatment N: 29 <br> Control N: 15 <br> Treatment AGE: 50.7 <br> Control AGE: 54.8 <br> Treatment SEX: 54% men <br> Control SEX: 73% men <br> INCLUSION: type 2 DM without metabolic syndrome <br> EXCLUSIONS: metabolic syndrome </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg BID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Endothelial function</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Matthews 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of pioglitazone <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 630 <br> Control N: 0 <br> AGE: 56.5 <br> SEX: 50% men <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: acidosis, myocardial infarction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear with pioglitazone or gliclazide <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, lipids, urinary albumin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">McAlpine 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label crossover trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 27 <br> Control N: 27 <br> AGE: 58 <br> SEX: 57% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: significant renal or hepatic impairment, various medications </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically <br> COMPARISON: glicazide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, fasting and postprandial glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">McBain 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Scotland. SETTING: outpatient. Treatment N: 14. Control N: 20. Treatment age: 56.5. Control age:56.3. Treatment sex: 36% men. Control sex: 35% men. Inclusion: Type 2 DM. Exclusions: low weight, Abnormal renal function, liver function. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500mgBID. COMPARISON: glipizide 5mg/day.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Calcium and magnesium levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">McIntyre 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Australia <br> SETTING: outpatient <br> Treatment N: 9 <br> Control N: 9 <br> AGE: 48‐75 <br> SEX: 44% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1.5‐3 g/day <br> COMPARISON: diet </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, total insulin, and c‐peptide levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mehta 1963 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: approximately 1 month. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: outpatient <br> Treatment N: 41 <br> Control N: 0 <br> AGE: not listed <br> SEX: not listed <br> INCLUSIONS: patients with DM on medications other than metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear <br> COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Menzies 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom <br> SETTING: outpatient <br> Treatment N: 64 <br> Control N: 0 <br> AGE: 64+/‐9 <br> SEX: 41% men <br> INCLUSION: obese patients with type 2 DM <br> EXCLUSIONS: ketosis, or abnormal electrolytes or renal function </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1.5‐2 g/day or 2.5‐3 g/day COMPARISON: none</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose, HbA1, and lactate.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mesirabi 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 8 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: outpatient <br> Treatment N: 101 <br> Control N: 0 <br> AGE: 56 <br> SEX: 66% men <br> INCLUSION: type 2 DM <br> EXLCUSIONS: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear, with pioglitazone plus glimepiride <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Moses 1999a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 22 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Australia <br> SETTING: outpatient <br> Treatment N: 54 <br> Control N: 28 <br> Treatment AGE: 57.8 <br> Control AGE: 60.3 <br> Treatment SEX: 63% men <br> Control SEX: 54% men <br> INCLUSION: Type 2 DM with poor control on metformin <br> EXCLUSIONS: clincally significant renal insufficiency, abnormal liver functions, cardiac diasease, history of lactic acidosis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + placebo; or metformin + repaglinide <br> COMPARISON: repaglinide + placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mourao‐Junior 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Brasil <br> SETTING: outpatient <br> Treatment N: 47 <br> Control N: 0 <br> AGE: 58.9 <br> SEX: 55% men <br> INCLUSION: type 2 DM with metabolic syndrome <br> EXCLUSIONS: none stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metfomrin, dosage unclear, plus insulin <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Mughal 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Karachi <br> SETTING: outpatient <br> Treatment N: 30 <br> Control N: 0 <br> AGE: 53.3 <br> SEX: 65% men <br> INCLUSION: type 2 DM with suboptimal control <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, up to 3 gm daily <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, lipids, glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Munk 1975 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label comparative trial <br> TRIAL DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 40 <br> Control N: 20 <br> AGE: unclear <br> SEX: 55% males <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear, or metformin + insulin COMPARISON: Sulfonylurea</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, liver function studies, and glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nagi 1993 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States. <br> SETTING: outpatient. Treatment N: 27. Control N: 27. Age: 56.8 +/‐8.9. Sex: not listed. Inclusion: Type 2 DM. Exclusions: cardiovascular disease, thromboembolic disease, renal or hepatic disease, retinopathy. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, lipids, BMI, insulin, c‐peptide, blood pressure, plasminogen activator inhibitor, and other factors </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nar 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: Outpatient <br> Treatment N: 19 <br> Control N: 15 <br> AGE: 46.9 <br> SEX: 74% men <br> INCLUSION: Type 2 DM, obese, not on meds, with nonalcoholic fatty liver disease <br> EXCLUSIONS: liver or kidney abnormalities, virall hepatitis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRRATMENT: metformin, varying doses COMPARISON: lifestyle changes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>plasma leptin levels, weight, degree of fatty liver disease</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Natali 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient: <br> Treatment N: 28 <br> Control N: 46 <br> Age: 58 +/‐ 9 <br> Sex: 70% men <br> Inclusion: type 2 DM <br> Exclusions: renal or hepatic dysfrunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mg TID <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity by euglycemic clamp, fat‐free mass, response to acetycholine</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nattrass 1977 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label, cross‐over comparative trial <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: United Kingdom. Setting: outpatient. Treatment N: 6. Control N: 6. Age: 50‐57. Sex: 67% men. Inclusion: Type 2 DM longer than 3 years. Exclusions: hepatic or renal disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENTt: Metformin 500mg TID. COMPARISON: intervention: phenformin 50mg BID (not analysed) or glibenclamide, 2.5‐5mg/day. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, lactate, pyruvate, 3‐hydroxybutyrate, acetoacetate,ketones, lactato pyruvate ratios, and cyclic AMP. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nauck 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter, outpatient <br> Treatment N: 1172 <br> Control N: 0 <br> AGE: 56.7 <br> SEX: 59% men <br> INCLUSION: Type 2 DM, 18‐78 years, not on meds <br> EXCLUSIONS: type 1 diabetes, recnet insulin use, kidney abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, with sitaglitpin 100 mg/day or glipizide 5‐20 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nauck 2009a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter, outpatient <br> Treatment N: 1091 <br> Control N: 0 <br> AGE: 55 <br> SEX: 51% men <br> INCLUSION: Type 2 DM, 18‐80 years, poor control <br> EXCLUSIONS: kidney impairment, cancer, congestive heart failure, coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1 gm BID, with liraglutide, glimerpiride or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nauck 2009b </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter outpatient <br> Treatment N: 527 <br> Control N: 0 <br> AGE: 55 <br> SEX: 47.9% men <br> INCLUSION: Type 2 DM, 18‐80 years, poor control <br> EXCLUSIONS: kidney impairment, congestive heart failure, cancer </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses, with alogliptin 12.5 mg/day or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nauck 2009c </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter outpatient <br> Treatment N: 306 <br> Control N: 0 <br> AGE: 52 <br> SEX: 49% men <br> INCLUSION: Type 2 DM, 18‐75 years <br> EXCLUSIONS: liver or kidney abnormalities, gastrointestinal disease, significant coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses, with taspoglutide, varying dosease or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Niazi 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Pakistan. SETTING: outpatient. Treatment N: 18. Control N: 36. Treatment age: 50 +/‐11. Control age: 48 +/‐11. Treatment sex: 61% men. Control sex: 56% men. Inclusion: Type 2 DM with sulfonylurea failure. Exclusions: cardiomegaly, lung disease, malnutrition, infection, various medications. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.5‐3g/day. COMPARISON: insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, blood pressure, weight, and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Nosadini 1987 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label trial with patients as own controls <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient. Treatment N: 7. Control N: 7. Age: 46 +/‐5. Sex: 57% men. Inclusion: Type 2 DM. Exclusions: age &gt; 65. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850mg TID. COMPARISON: diet</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose turnover and insulin binding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Noury 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France. SETTING: outpatient. Treatment N: 30. Control N: 27. Age: 55 +/‐9.1. Treatment sex: 53% men. Control sex: 44% men. Inclusion: Type 2 DM. Exclusions: renal or hepatic disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1700mg/day. COMPARISON: glicazide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Blood glucose, insulin levels, and weight loss</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ohira 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: Outpatient <br> Treatment N: 28 <br> Control N: 0 <br> AGE: 61.2 <br> SEX: 61% men <br> INCLUSION: Type 2 DM, taking sulfonylureas <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 500 mg BID with sulfonylurea</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipoprotein lipase mass levels, LDL cholesterol particle size</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ohnhaus 1983 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 1.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Switzerland. SETTING: outpatient. Treatment N: 12. Control N: 12. Age: not listed. Sex: not listed. Inclusion: Type 2 DM pts on phenprocoumon. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850mg TID. COMPARISON: diet</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Phenprocoumon pharmacokinetic</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ozata 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 0 <br> AGE: not stated <br> SEX: 100% men <br> INCLUSION: Obese men with type 2 DM <br> EXLCUSIONS: renal or cardiac disease <br> Treatment N </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg TID <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Waist circumference, body mass index, follicle‐stimulating hormine, leptin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pala 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label nonrandomised comparative, cross‐over trial <br> DURATION: 3 months, 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 30 <br> Control N: 0 <br> AGE: 65 <br> SEX: 23% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: recent insulin use, congestive heart failure, kidney or respiratory insufficiency, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, with insulin before or after meals</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Panikar 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort trial <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: Outpatient <br> Treatment N: 373 <br> Control N: 0 <br> AGE: 48.5 <br> SEX: 45% men <br> INCLUSION: Type 2 DM, new onset <br> EXCLUSIONS: cardiac, kidney or liver insufficiency </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 500 mg TID, with gliclazide 800 mg TID and pioglitazone 30 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Papathanassiou 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐lable randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Greece <br> SETTING: Outpatient <br> Treatment N: 28 <br> Control N: 0 <br> AGE: 63.2 <br> SEX: 22% men <br> INCLUSION: Type 2 DM, treated with metformin <br> EXCLUSIONS: kidney, liver or heart disease, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, plus glimepiride 4 mg/day or pioglitazone 30 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Flow‐mediated dilation of the brachial artery, vascular endothelial function</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pavo 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 8 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Russia <br> SETTING: outpatient <br> Treatment N: 100 <br> Control N: 105 <br> Age: 55 +/‐ 9 <br> Sex: 50% men <br> Inclusion: recently diagnosed type 2 DM naive to oral medications <br> Exclusions: hepatic and renal dysfunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day <br> COMPARISON: pioglitazone 45 mg/day or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose, insuliln resistance by HOMA method</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Peacock 1984 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: at least 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: United Kingdom. Setting: outpatient setting. Treatment N: 33. Control N: 0. Age: 58. Sex: 60% men. Inclusion: patients with type 2 DM, treated with high doses or oral hypoglycemics. Exclusions: history or ketosis or good control on oral agents. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, + glibenclamide, dosage adjusted clinically. After 3 months, some were treated additionally with insulin. COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, and fasting c‐peptide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Peacock 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Comparative trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: United Kingdom. Setting: outpatient. Treatment N: 27. Control N: 20. Treatment age: 59.9 +/‐2.1. Control age: 56.7 +/‐2.1. Treatment sex: 59% men. Control sex: 66% men. Inclusion: Type 2 DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear, + glibenclamide. COMPARISON: insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Platelet reactivity (ADP release, adrenaline release and NaAA threshold), and fasting glucose, HgA1. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pedersen 1965 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 18 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Denmark. Setting: inpatient and outpatient. Treatment N: 20. Control N: 0. Age: not listed. Sex: not listed. Inclusion: maturity‐onset DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose titrated up clinically, 1‐4g/day. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pedersen 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Denmark. Setting: outpatient. Treatment N: 10. Control N: 10. Age: 53 +/‐9. Sex: 20% men. Inclusion: Obese pts with Type 2 DM. Exclusions: renal or liver dysfunction. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500mg TID. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, fructosamine, insulin, c‐peptide, and adipocite insulin receptor binding. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Phillips 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 34 <br> Control N: 17 <br> AGE: 55 <br> SEX: 76% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: pregnancy, uncontrolled hypertension, treatment with more than one agent </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm BID, or 500 mg BID with rosiglitazone 2 mg BID COMPARIDON: rosiglitazone 4 mg BID </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Adiponectin levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pirart 1961 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 3 motnhs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Belgium. Setting: outpatient. Treatment N: 107. Control N: 0. Age: not listed. Sex: not listed. Inclusion: type 2 DM, poorly controlled on a single agent. Exclusions: obesity. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, unclear dose. COMPARISON: some patients treated with other agents, not analysed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, and glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pitocco 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: Outpatient <br> Treatment N: 24 <br> Control N: 0 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin with pioglitazone 45 mg/day or control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Monocyte activation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ponssen 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Netherlands. Setting: outpatient. Treatment N: 31. Control N: 62. Age: 62. +/‐10. Sex: 77% men. Inclusion: Type 2 DM. Exclusions: renal insufficency with Creatinine clearance &lt; 50 ml.min, hepatic disease, cardiovascular disease, alcohol abuse, various medications. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear, + insulin COMPARISON: placebo + insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, fructosamine, insulin requirements, lipds, BMI, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pradhan 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial with open‐label glargine insulin <br> DURATION: 14 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 250 <br> Control N: 250 <br> AGE: 53.5 <br> SEX: 25% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: type 1 diabetes, pregnancy, congestive heart failure, liver or kidney abnormalties </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin with or without glargine insulin COMPARISON: glargine insulin or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>CRP, inflammatory markers</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Prager 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label trial, cross‐over, with patients as their own controls <br> DURATION: 3 months control then 1 month metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Austria. Setting: outpatient. Treatment N: 12. Control N: 12. Age: 35‐62. Sex: 16% men. Inclusion: Type 2 DM. Exclusions: vascular disease, renal failure, liver function abnormalities. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850mg TID. COMPARISON: diet</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, fasting glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Puchegger 1964 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. Treatment N: 43. Control N: 0. Age:not listed. Sex: 28% men. Inclusion: patients with DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, alone or in combination with insulin, dosage adjusted clinically. COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rachmani 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 48 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Israel <br> SETTING: outpatient <br> Treatment N: 195 <br> Control N: 198 <br> Age: 64.5 +/‐ 4 <br> Sex: 60% neb <br> Inclusion: type 2 DM with at least one traditional contraindication <br> Exclusions: liver cirrhosis, actue myocardial infarction or pulmonary edema within previous 30 days, CO2 narcosis, malginancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose adjusted clinically <br> COMPARISON: no metformin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lactic acid levels, lactic acidosis, cardiovascular events, complications</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rains 1988 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Single‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom/ SETTING: hospital clinic. Treatment N: 35. Control N: 70. Age: not listed. Sex: not listed. Inclusion: Type 2 DM. Exclusions: age &gt; 70, BUN &gt; 6 mmol/L, abnormal liver functions. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐3g/day. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma glucose, lipoproteins, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rains 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over randomised controlled trial <br> DURATION: 1.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom. SETTING: diabetes clinic. Treatment N: 28. Control N: 14. Age: unclear. Sex: 64% men. Inclusion: Type 2 DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear. COMPARISON: glibenclamide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, lipds, glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raptis 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label crossover randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Greece. <br> SETTING: University center. Treatment N: 30. Control N: 30. Age: 60 +/‐7.5. Sex: 57% men. Inclusion: Type 2 DM. Exclusions: cardiac, renal, hepatic failure, autoimmune disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glibenclanide. COMPARISON: phenformin + glibenclanide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HgA1c, lipids, and blood lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label randomised controlled trial <br> DURATION: 34 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 200 <br> Control N: 0 <br> AGE: 53.7 <br> SEX: 42% men <br> INCLUSION: Type 2 DM, insulin naive <br> EXCLUSIONS: morbid obesity, HbAic &gt;12 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2500 mg/day plus pioglitazone 30‐45 mg/day, with or without insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2009a </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a open‐label randomised controlled trial <br> DURATION: 26 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: Outpatient <br> Treatment N: 561 <br> Control N: 0 <br> AGE: 54.8 <br> SEX: 5% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: significant disease history, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying doses with rosiglitazone 4 mg/day or replaglinide varying doses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ratner 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 82 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 150 <br> Control N: 0 <br> AGE: 54 <br> SEX: 69% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: none stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear plus exenative <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Percent of patient with HbA1 &lt; 7</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raz 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 30 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Outpatient <br> Treatment N: 190 <br> Control N: 0 <br> AGE: 55.2 <br> SEX: 47% men <br> INCLUSION: Type 2 DM, 18‐78 years <br> EXCLUSIONS: recent insulin, medications other than metformin, BMI &lt;20 or &gt;43 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2550 mg/day with sitagliptin 100 mg/day or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Reaven 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Nonrandomised open‐label trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: United States. Setting: research center. Treatment N: 13. Control N: 13. Age: 57 +/‐2. Sex: 77% men. Inclusion: Type 2 DM with poor control on sulfonylureas. Exclusions: Other drugs that effect lipids. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.5‐2.5g/day. COMPARISON: glipizide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Relimpio 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain. <br> SETTING: outpatient. Treatment N: 31. Control N: 29. Treatment age: 65 +/‐8. Control age: 66 +/‐6. Treatment sex: 21% men. Control sex: 40% men. Inclusion: Poorly controlled insulin‐treated Type 2 DM. Exclusions: life‐threatening condition, common contraindication to treatment, renal insufficiency. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clilnically, + insulin. COMPARISON: insulin increase. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, HbA1, and fasting glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Reyes 1969 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico. <br> SETTING: outpatient. Treatment N: 53. Control N: 0. Age: not listed. Sex: 28% men. Inclusion: DM, poorly controlled on sulonylureas. Exclusions: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1600‐2400mg/day + chlorpropamide 500‐750mg/day. COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, and glucosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Riccio 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, with control group for less than 1 month. Metformin data analysed <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: medical center. Treatment N: 6. Control N: 0. Treatment age: 48+/‐2. Sex: not listed. Inclusion: non‐insulin‐dependent type DM. Exclusion: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850mg BID. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Basal and insulin‐mediated glucose, free‐fatty acid metabolism, and lipds.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ristic 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter outpatient <br> Treatment N: 262 <br> Control N: 0 <br> AGE: 61.7 <br> SEX: 53% men <br> INCLUSION: Type 2 DM, poor control on metformin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, at least 1 gm/day, with hateglinide 180 mg TID or gliclazide 240 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roberts 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a ranomised trial of glimepiride <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: multi‐center <br> Treatment N: 170 <br> Control N: 0 <br> AGE: 56.5 <br> SEX: 61.6 % men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with pioglitazone or rosiglitazone, with or without glimepiride <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, glucose, HbA1, hypoglycemice</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Robinson 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind crossover randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom. SETTING: teaching hospital clinic. Treatment N: 35. Control N: 35. Treatment age: 61.3. Control age: 56.1. Treatment sex: 37% men. Control sex: 21% men. Inclusion: Insulin‐treated Type 2 DM. Exclusions: childbearing age, another anihyperglycemic medication, renal insufficiency with creatinine &gt; 125. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐2 g/day. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, lipids, weight, and blood pressure.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roden 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 917 <br> Control N: 916 <br> Age: 57 +/‐ 8.5 <br> Sex: 55% men <br> Inclusion: type 2 DM naive to metformin pioglitazone <br> Exlcusions: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day <br> COMPARISON: pioglitazone 45 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin sensitivity, fasting serum glucose and insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roden 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 2 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational in Europe, Australia, Canada <br> SETTING: Multicenter outpatient <br> Treatment N: 320 <br> Control N: 319 <br> AGE: 58 <br> SEX: 52% men <br> INCLUSION: Type 2 DM, 35‐75 years, poor control <br> EXCLUSIONS: symptomatic congestive heart failure, pancreatitis, cancer, heart attack, stroke </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin and gliclazide COMPARISON: Pioglitazone and gliclazide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Adipose tissue insulin sensitivity</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rodger 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial of acarbose vs placebo. Metformin in non‐randomised treatment strata <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada. SETTING: outpatient. Treatment N: 74. Control N: 242. Age: unclear. Sex: not listed. Inclusion: Type 2 DM. Exclusions: lactose intolerance, debilitating disease, gastrointestinal disease, various medications. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Main: acarbose vs placebo. Treatment strata: metformin (dosage adjusted clinically), diet, sulfonylurea, insulin. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, HbA1, insulin, and c‐peptide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rodriguez 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label prospective comparative trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain <br> SETTING: Outpatient <br> Treatment N: 723 <br> Control N: 851 <br> AGE: 61.1 <br> SEX: 50% men <br> INCLUSION: Type 2 DM, poor control on 2 meds <br> EXCLUSIONS: congestive heart failure, liver or kidney abnormaltities, ketoacidosis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin and pioglitazone or sulfonylurea COMPARISON: sulfonylurea and pioglitazone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, tolerability</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Roger 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: France. SETTING: community‐based multi‐center study. Treatment N: 127, with 63 on metformin + benflurex and 64 on metformin + placebo. Control N: 0. Age: not listed. Sex: not listed. Inclusion: obese patients with uncontrolled type 2 DM, treated with metformin. Exclusions: young patients, severe inervurrent illnes, kidney or liver failure, severehypertension, chronic pancreatitis,and alcoholism. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850mg BID + benflurex 150mg TID or metformin + placebo. COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Basal and stimulated insulin, HgA1, and body weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosak 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective study <br> DURATION: 24 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 11,014 <br> Control N: 0 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doage unclear plus roiglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, HbA1, blood pressure</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised controlled trial of acarbose <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States. SETTING: multicenter outpatient. Treatment N: 148. Control N: 0. Age: 56.7. Sex: 74% men. Inclusion: metformin‐treated patients with type 2 DM. Exclusions: acute or chronic acidosis, persistent ketonuria, or a history of ketoacidosis. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2‐2.5g/day + placebo or metformin +acarbosis 75‐300mg/day. COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, glucose, insulin, triglycerides, and plasma metformin levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of insulin glargine and rosiglitazone <br> DURATION: 24 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> SETTING: outpatient <br> Treatment N: 217 <br> Control N: 0 <br> AGE: 55.6 <br> SEX: 65% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: hepatic, renal and cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear plus sulfonylurea with and without glargine insulin <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, hypoglycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Russell‐Jones 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: OUtpatient <br> Treatment N: 581 <br> Control N: 0 <br> AGE: 57 <br> SEX: 56% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: recnet insulin use, liver or kidney abnormalities, cardiovascular disase, hypertension, cancer, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin and glimepiride, with liraglutide, glargine insulin or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, weight</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sahin 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>VOUNTRY: Turkey <br> SETTING: outpatient <br> Treatment N: 74 <br> Control N: 91 <br> Treatment AGE: 58.4 <br> Control AGE: 58.4 <br> Treatment SEX: 42% men <br> Control SEX: 38% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal insufficiency, congestive heart failure, stroke, cigarettes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg BID <br> COMPARISON: rosiglitazone 4 mg daily </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, homocysteine, folate, vitamin B12 levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sanchez‐Barba 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 30 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Spain. SETIING: outpatient. Treatment N: 30. Control N: 0. Age: not listed. Sex: not listed. Inclusion: type 2 DM. Exclusions: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically + insulin, dosage adjusted clinically. COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HgA1c, and plasma glucose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Santos 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 2.5 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Brazil. SETTING: metabolic laboratory. Treatment N: 14. Control N: 0. Age: 44+/‐2. Sex: 36% men. Inclusions: type 2 DM, on no medications. Exclusions: prior insulin treatment. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850mg BID. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, fasting insuling, lipids, and insuling receptor tyrosine kinase activity. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schernthaner 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: 12 European countries <br> SETTING: outpatient <br> Treatment N: 597 <br> Control N; 597 <br> Age: 57 +/‐ 9 <br> Sex: 60% men <br> Inclusion: poorly controlled type 2 DM <br> Exlcusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin850 mg TID <br> COMPARISON: pioglitazone 45 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose and insulin, lipid profiles</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schiel 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: Outpatient <br> Treatment N: 18 <br> Control N: 34 <br> AGE: 65.6 <br> SEX: 53% men <br> INCLUSION: Type 2 DM, poor control <br> EXCLUSIONS: liver or kidney abnormalities, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg BID with glimepiride and insulin COMPARISON: glargine insuline with or without glimepiride </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schneider 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. Treatment N: 18. Control N: 18. Treatment age: 60.4, Control age: 61.5. Treatment sex: 44% men. Control sex: 56% men. Inclusion: Patients with Type 2 DM and hyperlipoproteinemia. Exclusions: cardiovascular disease, pulmonary disease, hepatic or gastrointestinal diseaes, malignancy or psychiatric disorder. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMEN: Metformin, dosage adjusted clinically. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, and lipoproteins.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schulte 1973 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 36 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Mexico. SETTING: outpatient. Treatment N: 53. Control N: 0. Age: 57. Sex: 33% men. Inclusion: adult‐onset DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin + chlorpropamide, dose adjusted clinically. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, weight, and glycosuria.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schwartz 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of extended‐release metformin <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 706 <br> Control N: 0 <br> AGE: 54.5 <br> SEX: 50% men <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal, hepatic, cardiovascular or pulmonary disase </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, up to 2000 mg daily, in three extended‐release regimens <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schweizer 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational in Americas, Europe <br> SETTING: Multicenter outpatient <br> Treatment N: 253 <br> Control N: 526 <br> AGE: 53.2 <br> SEX: 54% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: type 1 diabetes, congestive heart failure, pregnancy, kidney dysfunction, cirrhosis, coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2 gm/day COMPARISON: vildagliptin 100 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schweizer 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational in Europe, Americas, Asia <br> SETTING: Multicenter outpatient <br> Treatment N: 166 <br> Control N: 169 <br> AGE: 71 <br> SEX: 50% men <br> INCLUSION: Type 2 DM, elderly, 65‐93 years <br> EXCLUSIONS: congestive heart failure, unstable coronary artery disease, cirrhosis, kidney dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1500 mg/day COMPARISON: vildagliptin 100 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic, safety, tolerability</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Scott 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 18 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multinational <br> SETTING: Multicenter outpatient <br> Treatment N: 273 <br> Control N: 0 <br> AGE: 55 <br> SEX: 58% men <br> INCLUSION: Type 2 DM, 18‐75 years <br> EXCLUSIONS: kidney or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, with sitagliptin, rosiglitazone or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sharma 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised controlled trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: outpatient <br> Treatment N: 15 <br> Control N: 15 <br> Treatment AGE: 47.7 <br> Control AGE: 50.8 <br> Treatment SEX: 67% men <br> Control SEX: 53% men <br> INCLUSION: type 2 DM, newly diagnosed <br> EXCLUSIONS: renal insufficiency, pulmonary dysfunction, hepatic dysfunction, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm BID <br> COMPARISON: pioglitazone 15 mg BID </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Adiponectin, leptin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Shimpi 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: India <br> SETTING: Outpatient <br> Treatment N: 31 <br> Control N: 0 <br> AGE: 49.1 <br> SEX: 48% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: kidney or liver abnormaltiies, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm/day with glimeperide or glibenclamice</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sieradzki 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Acarbose trial. Metformin in nonrandomised treatment strata <br> DURATION: 2 motnhs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Poland. SETTING: outpatient. Treatment N: 106. Control N: 374. Age: 31‐88. Sex: 44% men. Inclusion: Type 2 DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, +/‐ sulfonylurea + acarbose. COMPARISON: sulfonyurea + acarbose or acarbose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and posprandial glucose, urinary glucose, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stades 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Netherlands. Setting: outpatient clinic. Treatment N: 65. Control N: 0. Age: 64.5. Sex: not listed. Inclusion: patients with type 2 DM on metformin treatment for at least 6 months. Exclusions: insufficient follow‐up time, or no HgA1c on record. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Study duration: median 32 months. Treatment: metformin, dosage adjusted clinically. Comparison: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c and body weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stalhammar 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 35 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Sweden. SETTING: Swedish population study. Treatment N: 81. Control N: 0. Age: 50‐74 years. Sex: 51% men. Inclusion: Patients with type 2 DM receiving metformin. Exclusions: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Standl 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of miglitol <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: multi‐country <br> SETTING: multi‐center <br> Treatment N: 154 <br> Control N: 0 <br> AGE: 61.5 <br> SEX: 55% men <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: conditions that affect gastrointestinal motility </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, plus glibenclamide with or without miglitol <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, lipids, flatulence, diarrhea</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sterne 1963 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 60 motnhs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. <br> Age: not listed. Sex: not listed. Inclusions: maturity‐onset DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage titrated clinically, alone or in combination with insulin or sulfonyrureas. COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemia, side effects.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stewart 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN; Prospective cohort study of metformin in a randomised trial of rosiglitazone <br> DURATION: 14 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Multi‐national <br> SETTING: multi‐center <br> Treatment N: 526 <br> Control N: 0 <br> AGE: 59 <br> SEX: 55% men <br> INCLUSION: type 2 DM inadequately controlled <br> EXCLUSIONS: congestive heart failure, hypertension </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, up to 3 gm daily with or without rosiglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, C‐reative protein, beta‐cell function, blood pressure</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stocker 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 47 <br> Control N: 45 <br> Treatment AGE: 65 <br> Control N: 64 <br> Treatment SEX: 53% men <br> Control SEX: 50% men <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: renal insufficiency, congestive heart failure, myocardial infarction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 850 mg BID <br> COMPARISON: rosiglitazone 4 mg dailure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>c‐reactive protein, carotid artery intimal thickening</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stratmann 1965 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 8 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. Treatment N: 92. Control N: 0. Age: not listed. Sex: not listed. Inclusion: patients with DM, who have failed oral sulfonylureas. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage adjusted clinically. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Level of glycemic control.m</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Strowig 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 27 <br> Control N: 61 <br> Age: 52 +/‐ 9 <br> Sex: 50% men <br> Inclusion: type 2 DM inadequately treated on insulin <br> Exclusions: renal or hepatic dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2 g/day + insulin <br> COMPARISON: insulin with or without troglitazone 600 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, body weight, lipid profile</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Stumvoll 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, with control <br> DURATION: 4 monthsgroup studied for less than 1 month. Metformin data analysed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: United States. Setting: outpatient. Treatment N: 10. Control N: 0. Age: 58+/‐9. Sex: 60% men. Inclusion: healthy obese type 2 DM. Exclusions: none listed, but all were described as healthy. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Study duration: 4 months. Treatment intervention: metfomin 800‐2550mg/day. Comparison intervention: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fasting glucose, weight, plasma glucose turnover, and lactate conversion to glucose. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Sundaresan 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Australia. SETTING: outpatient. Treatment N: 14. Control N: 14. Age: 40‐73. Sex: 64% men. Inclusion: Type 2 DM. Exclusions: BMI &gt; 40 different from ideal body weight, vascular disease, microvscular disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐2g/day. COMPARISON: glibenclamicde</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Norepinephrine levels, blood pressure, and forearm vascular resistance.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Swislocki 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study <br> DURATION: 5 motnhs </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States. SETTING: Veteran's Administration Health Care system. Treatment N: 251. Comparison: 0. Age: mot listed. Sex: not listed. Inclusion: patients with type 2 DM receiving metformin. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, doses adjusted clinically. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, weight and blood pressure.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Szanto 1964 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label comparative trial <br> DURATION: 9 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Ireland. SETTING: diabetes clinic. Treatment N: 10. Control N: 9. Age: 51‐76. Sex: 45% men. Inclusion: Type 2 DM not controlled on sulfonylueas. Exclusions: hypoglycemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear. COMPARISON: phenformin (not analyses). Then acetohexamide‐biguanide combination was given. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, blood glucose, and insulin dose.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Taylor 1982 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Nonrandomised open‐label trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom. SETTING: outpatient. Treatment N: 23. Control N: 71. Age: 51‐52 years. Treatment sex: 43% men. Control sex: 77% male. Inclusion: Type 2 DM, obese and nonobese. Exclusions: renal or hepatic disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin (obese) 500mg TID. COMPARISON: glibenclamice (nonobese) 2.5‐15mg/day.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids and apolipoproteins</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Teranishi 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: Outpatient <br> Treatment N: 20 <br> Control N: 21 <br> AGE: 59.7 <br> SEX: 58% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: renal failure, severe liver dysfunction, severe congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 750 mg/day COMPARIDON: pioglitazone 30 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, intracellular lipid content in liver and skeletal muscle</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tessari 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient. Treatment N: 11. Control N: 6. Treatment age: 53 +/‐3. Control age: 60 +/‐3&gt; Treatment sex: 55% men. Control sex: 33% men. Inclusion: Diet‐treated Type 2 DM. ExclusionsL cardiovascular, gastrointestinal pulmonary or renal disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically. COMPARISON: placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial phenylalanine kinetics, weight, free fatty acids, BMI, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tessier 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada. SETTING: outpatient. Treatment N: 18 Control N: 18. Treatment age: 59.1 +/‐ 7.1. Control age: 59.3 +/‐7.3. Treatment sex: 16% men. Control sex: 44% men. Inclusion: Type 2 DM. Exclusions: acute cardiovascular or neurological events, malignancy, various medications. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 0.75‐2.5g/day. COMPARISON: gliclazide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1, fructosamine, glucose tolerance test.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Testa 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient clinic and metabolic laboratory. Treatment N: 80. Control N: 0. Age: 63+/‐9.7. Sex: 63% men. Inclusion: type 2 DM with good glycemic control on sulfonylureas for at least 2 years.. Exclusions: previous insulin treatment </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: 1.2‐1.7g/day. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasminogen activator inhibitor, lipoprotein(a), and BMI.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Teupe 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 24 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. Treatment N: 50. Control N: 50. Treatment age: 51.5 +/‐10. Control age: 56 +/‐8. Treatment sex: 40% males. . Control sex: 40% males. Inclusion: Type 2 DM, poor control. Exclusions: age &gt; 70, creatinine &gt; 1.2, iver cirhosis, ischemia or wasting disease, sever acute disease. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + diet. COMPARISON: diet</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, lipids, HbA1, c‐peptide, and lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tikkainen 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: outpatient <br> Treatment N: 11 <br> Control N: 9 <br> Age: 30.6 +/‐ 3.5 <br> Sex: 35% men <br> Inclusion: type 2 DM treated with diet <br> Exclusions: cardiovascular or renal disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 g BID + placebo <br> COMARISON: rosiglitazone 4 mg BID + placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, insulin, free fatty acid, body weight, adiponectin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Topiak 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of topiramate <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Austria <br> SETTING: outpatient <br> Treatment N: 640 <br> Control N: 0 <br> AGE: 53 <br> SEX: 58% men <br> INCLUSION: obese patients with type 2 DM <br> EXCLUSIONS: central nervous system of psychiatric illness </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with or without topiramate <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Percent change in weight and HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tosi 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled cross‐over trial <br> DURATION: 6 months for each treatment arm <br> DURATION: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy <br> SETTING: outpatient <br> Treatment N: 88 <br> Control N: 88 <br> Age: 57.3 +/‐ 7 <br> Sex: 70% men <br> Inclusion: type 2 DM <br> Exclusions: severe cardiovascular, renal or hepatic disease, insulin treatment, </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 3 g/day with or without glibenclamide <br> COMPARISON: glibenclamide 15 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>HbA1c, fasting glucose</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Triplitt 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of glargine insulin and rosiglitazone <br> DURATION: 16 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> Treatment N: 20 <br> Control N: 0 <br> AGE: 47.5 <br> SEX: 40% men <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: cardiac, hepatic or renal dysfunction </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with glargine insulin or rosiglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, insulin resistance</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Trischitta 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial cross‐over <br> DURATIPN: 2 months for each arm </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient. Treatment N: 20. Control N: 20. Age: 53.6 +/‐2.1. Sex: not listed. Inclusion: Type 2 DM with sulfonylurea. Exclusions: renal, liver, cardiovascular or systemic disese. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500mg TID. COMPARISON: insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, c‐peptide, HbA1, weight, and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Trischitta 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial cross‐over <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient. Treatment N: 50. Control N: 50. Age: 55.7 +/‐1.2. Sex: 24% men. Inclusion: Type 2 DM. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850mg TID + glibenclamide. COMPARISON: insulin + glibenclamide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, c‐peptide, and weight.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Turkmen 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: Outpatient <br> Treatment N: 16 <br> Control N: 30 <br> AGE: 55.9 <br> SEX: 24% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: kidney or liver abnormalities, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1700 mg/day COMPARISON: Rosiglitazone 8 mg/day or control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Plasma brain natriuretic peptide levels, myocardial performance index</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Uehara 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective randomised controlled trial <br> DURATION: 12 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Brazil <br> SETTING: outpatient <br> Treatment N: 13 <br> Control N: 13 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: overweight patient with type 2 DM and hypertension <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin sensisitivy</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">UKPDS‐34 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial. <br> DURATION: 6.6 ‐ 10.7 years. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTEY: United Kingdom SETTING: large multicenter. Treatment N: 683. Control N: 1631. Treatment age: 53 +/‐8. Control age: 53 +/‐8. Treatment sex: 46% men. Control sex: 46% men. Inclusion: Type 2 DM. Exclusions: severe vascular disease, accelerated hypertension, renalfailure with creatinine &gt; 175 mmol/L, life thretening disease, severe asthma, myocardial infarction in past year, current angina, congestive heart failure. <br> n = 1704 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 850mg QD‐TID. Comparison: diet, sulfonylurea, or insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DM‐related endpoint (sudden death, death for hyper‐ or hypoglycemia, myocardial infarction, stroke, renal failure, amputation, eye problems), diabetes‐related death, all‐cause mortality, HgA1, microalbuminuria. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Umpierrez 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of pioglitazone or glimepiride <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: outpatient <br> TREATMENT N: 203 <br> Control N: 0 <br> AGE: 53 <br> SEX: 55% men <br> INCLUSION: type 2 DM inadequately controlled <br> EXCLUSIONS: abnormal laboratory values including hematology, chemisty or urinalysis </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dosage unclear, with glimepiride or pioglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, hypoglycemia</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vahatalo 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: Outpatient <br> Treatment N: 26 <br> Control N: 26 <br> AGE: 62 <br> SEX: 67% men <br> INCLUSION: Type 2 DM, 40‐75 years <br> EXCLUSIONS: kidney or liver abnormalities, severe congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus insulin COMPARISON: Insulin with or without glipizide</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">van der Meer 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> SETTING: Outpatient <br> Treatment N: 39 <br> Control N: 39 <br> AGE: 56.4 <br> SEX: 100% men <br> INCLUSION: Type 2 DM, 45‐65 years <br> EXCLUSIONS: cardiovascular or liver disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, 1 gm BID COMPARISON: pioglitazone 30 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Echocardiographic function, myocardial substrate metabolism</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Van Gaal 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of miglitol <br> DURATION: 32 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Belgium <br> SETTING: outpatient <br> Treatment N: 152 <br> Control N: 0 <br> AGE: not stated <br> SEX: not stated <br> INCLUSION: type 2 DM inadequately controlled <br> EXCLUSIONS: not stated </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, up to 2250 mg daily, with or without miglitol <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Postprandial glucose, adverse effects</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vannasaeng 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label trial of acarbose. Metformin in nonrandomised treatment strata <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Thailand. SETTING: Outpatient. Treatment N: 24. Control N: 12. Age: 50.4 +/‐1.5, Sex: 19% men. Inclusion: Type 2 DM. Exclusions: pregnancy, liver disorder, renal insufficiency with Creatinine &gt; 2 mg/dl. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + sulfonylurea + acarbose. COMPARISON: sulfonylurea + acarbose </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1, lipids, insulin and c‐peptide.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Velojic‐Golubovic 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in an open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Serbia <br> SETTING: Outpatient <br> Treatment N: 50 <br> Control N: 0 <br> AGE: 58.7 <br> SEX: 60% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: cardiovascular disease, liver or kidney abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, varying dose, with biphasic or premixed insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Velussi 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label cross‐over nonrandomised comparative trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: general practive. Treatment N: 60. Control N: 60. Age: 68 +/‐ 3 Sex: 53% men. Inclusion: Type 2 DM with hypertension. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glibenclamide, doses on clinical grounds. COMPARISON: Phenformin + glibenclamide (not analysed). </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, HbA1c, basal C‐peptide, glucosuria, and lactate levels.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vigneri 1991 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Italy. SETTING: outpatient. Treatment N: 12. Control N: 12. Age: 52.3 +/‐2.1 Sex: not listed. Inclusion: Type 2 DM with failure to sulfonylureas. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + glyburide. COMPARISON: insulin + glyburide </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Viljanen 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective double‐blind randomised placebo‐controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: FInland <br> SETTING: outpatient <br> Treatment N: 12 <br> Control N: 25 <br> Treatment AGE: 57.8 <br> Control AGE: 58.7 <br> Treatment SEX: 58% men <br> Control SEX: 72% men <br> INCLUSION: type 2 DM <br> EXLCUSIONS: renal or hepatic disease, hypertension, cardiovascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1 gm BID <br> COMPARISON: rosiglitazone 4 mg BID or placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Subcutaneous adippose tissue glucose uptake</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vukovic 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 6 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Serbia <br> SETTING: Outpatient <br> Treatment N: 43 <br> Control N: 46 <br> AGE: 44.5 <br> SEX: not listed <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: non listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin plus diet COMPARISON: Placebo plus diet</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, insulin secretion</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Weissman 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trail of rosilglitazone <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany <br> SETTING: outpatient <br> Treatment N: 766 <br> Control N: 0 <br> AGE: 55.6 <br> SEX; not stated <br> INCLUSION: type 2 DM <br> EXCLUSIONS: renal or hepatic disase, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1000 ‐1500 mg daily with or without rosiglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Willey 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Country: Australia. Setting: outpatient. Treatment N: 38. Control N: 0. Age: 54+/‐1.7. Sex: 44% men. Inclusion: overweight patients with type 2 DM, and HbA1c &gt;normal. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Trial duration: 3 months. Treatment intervention: metformin, 1‐3g/day, + dexfenfluramine or metformin + placebo. Comparison: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Body weight, HbA1c, blood pressure, and fructosamine.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Willey 1994 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Australia. SETTING: diabetes center. Metformin treatment N: 20 (10 on dexfenfluramine, 10 on placebo). Age: 55+/‐1.9. Sex: 30% men. Inclusion: Type 2 DM, overweight with poor control, on maximum dose metformin. Exclusions: none listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, 1‐3g/day, + dexfluramine or metformin + placebo. COMPARISON: none. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, BMI, and HbA1c.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Willms 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial. Single‐blind for metformin versus other. <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Germany. SETTING: outpatient. Treatment N: 29. Control N: 60. Treatment ate: 53.4. Control age: 59.2. Treatment sex: 48% males. Control sex: 48% males. Inclusion: Type 2 DM. Exclusions: Severe hepatic or renal abnormalities, respiratory insufficiency, conditions that predispose to tissue anoxia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: MetfORmin 850mg BID. COMPARISON: acarbose or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Body weight, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wilson 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 2 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United Kingdom. SETTING: outpatient. Treatment N: 15. Control N: 45. Age: 65 +/‐2. Sex: 80% men. Inclusion: Type 2 DM on sulfonylureas. Exclusion: None listed. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500mg TID. COMPARISON: guar 5gmTID.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, and lipids</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wolever 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial of acarbose versus placebo. Metformin in 1 of 4 non‐randomized treatment strata. <br> DURATION: 11 years </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada. SETTING: outpatient. Treatment N: 83. Control N: 271. Treatment age: 55.8. Control age 57.6. Treatment sex: 44% men. Control sex: 57% males. Inclusion: Type 2 DM. Exclusions: renal or liver abnormalities. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: acarbos vs placebo. Treatment strata: Metformin (dosage adjusted clinically), diet, sulfonylurea, insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Lipids, HbA1, and serum acetate levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C ‐ Inadequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wolever 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 9 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada. SETTING: outpatient. Treatment N: 109. Control N: 90. Treatment age: 58.7 +/‐1.1. Control age: 59.5 +/‐1.1. Treatment sex: 80% men. Control sex: 69% men. Inclusion: Type 2 DM. Exclusions: insulin treatment, major debilitating disease, recent cardiovascular event or surgery, various medication, renal or liver idsease, emotional disorder. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 500 mgTID or metformin + miglitol. COMPARISON: miglitol or placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Serum folate and B12 levels, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wu 1990 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States. SETTING: inpatient and outpatient. Treatment N: 12. Control N: 0. Age: 56+/‐3. Sex: 58% men. Inclusion: type 2 DM. Exclusion: significant illness, or medication that could affect carbohydrate metabolism. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5g/day. COMPARISON: none.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting and postprandial glucose, HbA1c, insulin binding, lactate and lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wulffele 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Abstract of randomised controlled trial, placebo‐controlled <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Netherlands <br> SETTING: outpatient <br> Treatment N: 95 <br> Control N: 95 <br> AGE: not listed <br> SEX: not listed <br> INCLUSION: Type 2 DM treated with insulin <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage unclear, + insulin <br> COMPARISON: placebo + insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Daily dose insulin, and HbA1.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wulffele 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 48 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: The Netherlands <br> SETTING: outpatient <br> Treatment N: 171 <br> Control N: 182 <br> Age: 60 +/‐ 10 <br> Sex: 45% m4n <br> Inclusion: type 2 DM controlled with insulin <br> Exlcusions: renal insufficiency with GFR &lt; 50, congestive heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose adjusted clinically, + insulin <br> COMPARISON: placebo + insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Insulin requirements, lipid profile, glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wulffele 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: The Netherlands <br> SETTING: outpatient <br> Treatment N: 196 <br> Control N; 194 <br> Inclusion: type 2 DM <br> Exlcusions: renal insufficiency with GFR &lt; 50, congestive heart failure, pregnancy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin, dose adjusted clinically <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Homocystein, folate, vitamin B12, body weight, glycemic control</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wulffele 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Double‐blind randomised controlled trial <br> DURATION: 4 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: THe Netherlands <br> SETTING: outpatient <br> Treatment N: 89 <br> Control N: 93 <br> Age: 58 +/‐ 11 <br> Sex: 48% men <br> Inclusion: type 2 DM <br> Exclusions: congestive heart failure, serious illness, renal insufficiency with GFR &lt; 50 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 2.5 g/day <br> COMPARISON: placebo </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Systolic, diastolic, mean blood pressure, 24‐hour blood pressure</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yale 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of metformin in a randomised trial of troglitazone <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Canada <br> SETTING: mult‐center <br> Treatment N: 200 <br> Control N: 0 <br> AGE: 59 <br> SEX: not stated <br> INCLUSION: type 2 DM poorly controlled <br> EXCLUSIONS: creatinine &gt; 2, hepatic or cardiac disase, hypertension, anemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metofmrin, dosage unclear, plus sulfonylurea, with or without troglitazone <br> COMPARISON: none </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glucose, HbA1, lipids, insulin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yamanouchi 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 12 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Japan <br> SETTING: outpatient <br> Treatment N: 39 <br> Control N: 75 <br> Age: 55.4 +/‐ 9 <br> Sex: 55% men <br> Inclusion: newly diagnosed type 2 DM <br> Exclusions: standard </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin750 mg/day <br> COMPARISON: pioglitazone 30‐45 mg/day or glimepiride 1‐2 mg/day </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, free fatty acid, HbA1c, blood pressure, lipid profile</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>D ‐ Not used</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yener 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Open‐label randomised controlled trial <br> DURATION: 3 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Turkey <br> SETTING: Outpatient <br> Treatment N: 16 <br> Control N: 23 <br> AGE: 53.3 <br> SEX: 54% men <br> INCLUSION: Type 2 DM, 30‐70 years <br> EXCLUSIONS: hypertension, cardiovascular disase, pregnancy, morbid obesity, kidney or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin 1700 mg/day COMPARISON: rosiglitazone 4 mg/day</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Serum transforming growth factor‐beta 1 levels</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yki‐Jarvinen 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 1 year </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: Finland <br> SETTING: multicenter <br> Treatment N: 48 <br> Control N: 48 <br> AGE: 58+/‐1 <br> SEX: not listed <br> INCLUSION: Poorly controlled type 2 DM <br> EXCLUSIONS: congestive heart failure, liver diseae, creatinine &gt; 120 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin, dosage adjusted clinically, + placebo or metformin + glyburide <br> COMPARISON: insulin + glyburide + placebo or BID insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Weight, HbA1, plasma glucose, insulin, lipids.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yu 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: randomised controlled trial <br> DURATION: 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States <br> SETTING: research laboratory <br> Treatment N: 10 <br> Control N: 10 <br> Treatment AGE: 49+/‐9 <br> Control AGE: 51+/‐9 <br> Treatment SEX: 70% men <br> Control SEX: 80% men <br> INCLUSION: Type 2 DM with suboptimal contol <br> EXCLUSIONS: renal or liver abnormalities </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: Metformin 1‐2.5 g/day <br> COMPARISON: troglitazone </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Fasting glucose, insulin sensitivity.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zinman 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort of metformin in a double‐blind randomised controlled trial <br> DURATION: 6 months </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>COUNTRY: United States, Canada <br> SETTING: Outpatient <br> Treatment N: 533 <br> Control N: 0 <br> AGE: 55 <br> SEX: 57% men <br> INCLUSION: Type 2 DM <br> EXCLUSIONS: none listed </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>TREATMENT: metformin and rosiglitazone with liraglutide 100 microliter injection weekly or placebo injection weekly </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Glycemic control, safety</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>BID= two times a day; BMI=body mass index; DM=diabetes mellitus; TID=three times a day </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD002967-sec2-0018"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD002967-sec2-0017" class="jump-to">included studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0348">Aguilar 1992b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0349">Belsey 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Restrospective systematic review</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0350">Berhanu 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational study, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0351">Bernard 1965</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort, with varying durations of treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0352">Bodmer 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective case‐control analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0353">Bonfigli 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0354">Bruneder 1978</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0355">Cacciapuoti 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0356">Chan 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Restrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0357">Charlton 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort tiral, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0358">Chow 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort trial, that did not give length of treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0359">Clauson 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort trial, that did not give length of treatment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0360">Comaschi 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0361">Comaschi 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0362">Connolly 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0363">Cook 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retosepctive cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0364">Cunha 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, with duration &lt; one month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0365">Daniel 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0366">Debry 1964</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0367">Debry 1966a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study, with no durations given</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0368">Debry 1966b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective cohort study, with no durations given</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0369">Derosa 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort study, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0370">English 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0371">Eurich 2005a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective case‐control.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0372">Eurich 2005b</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0373">Evans 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retosepctive cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0374">Farah 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort study, with unclear number of patients</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0375">Faure 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0376">Fery 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0377">Forti 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0378">Galuska 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0379">Gibson 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, as part of another UKPDS trial, with patients studied less than 1 month </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0380">Gin 1982</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0381">Gin 1985</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0382">Gin 1989</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0383">Giugliano 1979</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0384">Gontier 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0385">Guthrie 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0386">Harris 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0387">He 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Randomized control trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0388">Herman 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0389">Hermansen 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0390">Hirsch 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0391">Home 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0392">Hong 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0393">Irsigler 1978</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0394">Ismail 1978</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0395">Isnard 1991</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0396">Isnard 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0397">Jansson 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0398">Javaid 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0399">Johansen 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0400">Kamber 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with unclear number of patients</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0401">Kim 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0402">Komajda 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0403">Lalau 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0404">Lalau 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0405">Lapina 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0406">Leslie 1987</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0407">Lim 1970</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0408">Lin 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0409">Magalhaes 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0410">Masoudi 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retosepctive cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0411">Mellbin 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0412">Messens 1965</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0413">Messens 1966</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0414">Monami 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0415">Monami 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0416">Monami 2008a</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective observational cohort study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0417">Muntoni 1965</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of varying durations</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0418">Nauck 1993</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0419">Nauck 1997</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective review of 4 trials</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0420">Nauck 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0421">O'Connor 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0422">Ong 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retosepctive comparative study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0423">Orlikowska 1966</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0424">Panahloo 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0425">Papa 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective observational cohort trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0426">Perriello 1994</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0427">Pilger 1978</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0428">Prager 1983</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0429">Rambert 1961</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study of varying durations.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0430">Rao 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0431">Rigas 1968</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0432">Rizkalla 1986</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0433">Runge 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0434">Sambol 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0435">Scarpello 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0436">Schaffalitzky 1979</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0437">Selby 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0438">Seufert 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospecctive observational cohort trial, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0439">Sharabashi 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0440">Signore 1996</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0441">Simpson 2006</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retosepctive comparative study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0442">Slama 1984</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0443">Stefanovic 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0444">Sugawara 1962</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of varying duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0445">Sum 1992</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0446">Teitelbaum 1963</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective cohort study, of unclear duration</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0447">Tomioka 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Restrospective analysis</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0448">Trischitta 1983</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0449">Turner 1995</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0450">Yegnanarayan 2008</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Observational cohort study, with not all patients on metformin</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0451">Zapecka‐Dubno 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Prospective comparative trial, lasting less than 1 month</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD002967-bbs2-0452">Zhang 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>TRIAL DESIGN: Retrospective meta‐analysis</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD002967-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD002967-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Fatal/nonfatal lactic acidosis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>148</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>62960</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.00, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD002967-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-001-01.png?filename=nCD002967-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Fatal%2Fnonfatal%20lactic%20acidosis%2C%20Outcome%201%20Lactic%20acidosis%20incidence%20per%20patient%E2%80%90years%20%28metformin%20minus%20non%E2%80%90metformin%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD002967-fig-00101" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-001-01.png" alt="Comparison 1 Fatal/nonfatal lactic acidosis, Outcome 1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Fatal/nonfatal lactic acidosis, Outcome 1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin). </p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD002967-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Blood lactate levels</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Net treatment effect, lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.12 [‐0.01, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD002967-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-01.png?filename=nCD002967-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%201%20Net%20treatment%20effect%2C%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD002967-fig-00201" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-01.png" alt="Comparison 2 Blood lactate levels, Outcome 1 Net treatment effect, lactate levels (mmol/L)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 1 Net treatment effect, lactate levels (mmol/L). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Net treatment effect, lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.12 [‐0.01, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean treatment lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1547</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.13, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD002967-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-02.png?filename=nCD002967-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%202%20Mean%20treatment%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD002967-fig-00202" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-02.png" alt="Comparison 2 Blood lactate levels, Outcome 2 Mean treatment lactate levels (mmol/L)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 2 Mean treatment lactate levels (mmol/L).</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Mean treatment lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1387</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.00, 0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Mean treatment lactate levels (metformin minus phenformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.86, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Peak stimulated lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>92</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.05, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD002967-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-03.png?filename=nCD002967-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%203%20Peak%20stimulated%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD002967-fig-00203" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-03.png" alt="Comparison 2 Blood lactate levels, Outcome 3 Peak stimulated lactate levels (mmol/L)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 3 Peak stimulated lactate levels (mmol/L).</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Peak stimulated lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>72</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.09 [‐0.03, 0.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Peak stimulated lactate levels (metformin minus phenformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.37 [‐1.06, 0.32]</p> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD002967-fig-00101"> <img data-id="CD002967-fig-00101" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-001-01.png" alt="Comparison 1 Fatal/nonfatal lactic acidosis, Outcome 1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Fatal/nonfatal lactic acidosis, Outcome 1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-001-01.png?filename=nCD002967-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Fatal%2Fnonfatal%20lactic%20acidosis%2C%20Outcome%201%20Lactic%20acidosis%20incidence%20per%20patient%E2%80%90years%20%28metformin%20minus%20non%E2%80%90metformin%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD002967-fig-00201"><img data-id="CD002967-fig-00201" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-01.png" alt="Comparison 2 Blood lactate levels, Outcome 1 Net treatment effect, lactate levels (mmol/L)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 1 Net treatment effect, lactate levels (mmol/L). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-01.png?filename=nCD002967-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%201%20Net%20treatment%20effect%2C%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD002967-fig-00202"><img data-id="CD002967-fig-00202" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-02.png" alt="Comparison 2 Blood lactate levels, Outcome 2 Mean treatment lactate levels (mmol/L)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 2 Mean treatment lactate levels (mmol/L).</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-02.png?filename=nCD002967-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%202%20Mean%20treatment%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD002967-fig-00203"><img data-id="CD002967-fig-00203" src="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-03.png" alt="Comparison 2 Blood lactate levels, Outcome 3 Peak stimulated lactate levels (mmol/L)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Blood lactate levels, Outcome 3 Peak stimulated lactate levels (mmol/L).</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/ppt/CDSR/CD002967/image_n/nCD002967-CMP-002-03.png?filename=nCD002967-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20Blood%20lactate%20levels%2C%20Outcome%203%20Peak%20stimulated%20lactate%20levels%20%28mmol%2FL%29.&amp;citation=Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010, 4. Art. No.: CD002967. DOI: http://dx.doi.org/10.1002/14651858.CD002967.pub4"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD002967.pub4/media/CDSR/CD002967/image_n/nCD002967-CMP-002-03.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD002967-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Fatal/nonfatal lactic acidosis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Lactic acidosis incidence per patient‐years (metformin minus non‐metformin) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>148</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>62960</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.00, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Fatal/nonfatal lactic acidosis</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD002967-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Blood lactate levels</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Net treatment effect, lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.12 [‐0.01, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Net treatment effect, lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.12 [‐0.01, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Mean treatment lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1547</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.13, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Mean treatment lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1387</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.00, 0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Mean treatment lactate levels (metformin minus phenformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.86, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Peak stimulated lactate levels (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>92</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.05, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Peak stimulated lactate levels (metformin minus non‐metformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>72</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.09 [‐0.03, 0.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Peak stimulated lactate levels (metformin minus phenformin, mmol/L)</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.37 [‐1.06, 0.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Blood lactate levels</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD002967.pub4/references#CD002967-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="fr#CD002967-note-1204">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD002967-note-1203">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ta#CD002967-note-1205">தமிழ்</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581422282000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581422282000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002967\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002967\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002967\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002967\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002967\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581422282000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002967.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002967.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD002967.pub4/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD002967.pub4/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002967.pub4%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583243623575" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583243623579" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD002967&#x2e;pub4&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD002967.pub4";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 